PG Textbook of Pediatrics (3 Volumes) Piyush Gupta, PSN Menon, Siddarth Ramji, Rakesh Lodha
INDEX
Page numbers followed by b refer to box, f refer to figure, fc refer to flowchart, and t refer to table.
A
α-1 antitrypsin deficiency. See Alpha-1 antitrypsin deficiency
α-fetoprotein. See Alpha-fetoprotein
Aarskog syndrome 53
Abacavir 1559, 3583
Abdala vaccine 1193
Abdomen 475, 598, 2558
computed tomography scan of 1641f, 1737
contrast-enhanced computed tomography of 1743f, 1842
magnetic resonance imaging of 1736
plain X-ray of 604, 749, 754, 1809
transverse span of 768f
tuberculosis of 1842f
ultrasound of 1837, 1842
Abdominal crisis
in sickle cell disease 2015
Abdominal distension 1066f, 1760, 1833
massive 147f
Abdominal mass 775, 1761, 2488
Abdominal migraine 1759, 1778, 1791, 2660
Abdominal pain, recurrent 1419, 1789
Abdominal tuberculosis 1433, 1840, 1841f, 1843
classification of 1841t
Abdominal ultrasound 90, 749, 2317
Abdominal viscera, herniation of 753
Abdominal viscus, protrusion of 1851
Abdominal wall
defects 620, 759f
malformations 769
Abetalipoproteinemia 86, 1745, 1813, 2728, 2765
Ab-externo surgeries 3250
Ab-interno surgeries 3250
ABG. See Arterial blood gas
Ablepharon 3212
Abnormal uterine bleeding 1268
differential diagnosis of 1268b
management of 1269t
ABO incompatibility 552
Abortions 532
Abrasions 545
Abscess formation, stages of 2687
Absence seizures 2634, 2643
Absolute lymphocyte count 1987
Absolute neutrophil count 215, 635, 1985
Absorption 1990
defects of 1740
Abusive head trauma 3481
Academic challenge 1286fc
Acalculous cholecystitis 1542
Acanthocyte 1977t
Acanthosis nigricans 861f
Accessory tongue 843f
Accidental contamination 1092
Accidental poisoning 412
Accommodative esotropia 3263
Accredited social health activist 29, 448, 460, 480, 3514f
ACE. See Angiotensin-converting enzyme
Acellular pertussis vaccine 1209, 1360
Acetabular index 3428
Acetaminophen 3583
Acetazolamide 2550, 3583
Acetylcholine 1052
Acetylcholinesterase 2609, 2917
Acetylsalicylic acid 3583
Achalasia addisonianism-alacrimia syndrome 2926
Achalasia cardia 1755, 1777f, 1778f, 1780, 1781, 1781f
barium esophagogram of 1780f
Achlorhydria syndrome 1803
Achondroplasia 43, 44, 71, 73, 799f, 872f, 2775, 3446, 3447, 3447f
Acid burns 431f
Acid fast bacilli 1437f, 1443, 1447, 1456, 1457, 1669, 1840, 1847, 2142, 2670, 2677
Acid glucosidase 179
Acid maltase deficiency 2835
Acid peptic disease 1793, 1796
Acid poisoning 390
Acid sphingomyelinase
action, chemical basis of 157f
deficiency 156, 158
Acid suppression therapy 1785
Acid-base
abnormalities 263
balance, abnormalities of 263
disorder 261, 261t, 262fc, 2111t
disturbance 110, 1712, 1939
equilibrium 258
homeostasis 720
nomogram 2112f
regulation 2482
status 2111
Acidemia 258, 2539
Acidified glycerol lysis test 2033
Acidosis 92, 109, 113, 258, 261, 1589, 2465, 2541, 2577, 2970
Acinetobacter baumannii 1318, 1321, 1901
Acinic cell carcinoma 1774
ACLS. See Advanced cardiac life support
Acne 1224
syndrome 3201
Acneiform erution 3356f
ACoRN scoring system 474t
Acoustic nerve 2589
Acquired growth hormone
deficiency 2873
resistance 2874
Acquired immunodeficiency syndrome 5, 6, 16, 28, 1052, 1096, 1223, 1275, 1402, 1415, 1456, 1544, 1547b, 1605, 1622, 1646, 1662, 1676, 1729, 1744, 1814, 1829, 1898, 2707, 3285. Also See HIV
Acquired myasthenic syndromes 2846, 2849
Acrocallosal syndrome 53
Acrocentric chromosomes 58
Acrocyanosis 3301
Acrodermatitis enteropathica 1071f, 3363, 3363f
Acromegaly 2463
Acroparesthesia 136
Acropustulosis 3377
ACTH. See Adrenocorticotropic hormone
ACTH stimulation test 2924
Actinomyces israelii 1417, 1423
Actinomycosis 1417, 1418
Activated charcoal 372
Activated coagulation time 2095
Activated partial thromboplastin time 166, 586, 855, 2047, 2052, 2053, 2056, 2099, 2125, 2713
Activated protein C resistance 2711
Active immunization 1357, 1404, 1481, 1483, 1499
Active listening 1282, 1284, 1285t
Active surveillance 1101t, 1128
Acute abdominal pain 1759
causes of 1759t
Acute allergic bronchopulmonary aspergillosis 1658
Acute asthma exacerbations, home management of 2198b
Acute bacterial rhinosinusitis 2149f, 2150, 2152
clinical presentations of 2150t
Acute central nervous system event 2015
Acute cerebellar ataxia 2807
Acute chemical injury 3229f
Acute chest syndrome 2016, 2019
Acute childhood ataxia 2727f
Acute demyelination
diagnostic evaluation of 2742
differential diagnosis of 2742
Acute diarrhea. See Diarrhea
Acute disseminated encephalomyelitis 2736
Acute encephalitic syndrome 1565, 1565b
Acute encephalopathy 114, 2757, 2758
Acute flaccid myelitis 1532, 2803
Acute flaccid paralysis 1135, 1468, 1529, 1532, 1536, 2800, 2802t, 2803, 2804, 2804fc
surveillance 1538, 1539t
Acute fluoride intoxication 1079
Acute generalized exanthematous pustulosis 3346, 3348f, 3348t, 3349t
Acute hematogenous osteomyelitis 3405
Acute hemorrhagic conjunctivitis 1532
Acute hepatitis 1906, 1909
A, atypical features of 1542
etiology of 1906b
Acute hypersensitivity pneumonitis 2225
Acute inflammatory demyelinating polyneuropathy 2805, 2862
Acute inflammatory demyelinating polyradiculopathy 2781, 2786
Acute intercurrent illnesses 110
Acute intermittent porphyria 194, 197, 2807
Acute interstitial nephritis 399, 2530
Acute intraepithelial inflammatory cells 1814
Acute kidney injury 399, 678, 1523, 1689, 1694, 2513, 2527, 2528, 2530b, 2530t, 2531, 2532
causes of 2532b
clinical features of 2529b
community acquired 2528
complications of 2531t
diagnosis of 2530
etiology of 2528t
infection-associated 2529
pathophysiology of 3114
staging of 2527t
Acute liver failure 1906, 1930, 1938, 1939, 1940t
causes of 1938t
Acute lower respiratory infection 1182
Acute lymphoblastic leukemia 209, 1681f, 2092f, 3018, 3019t, 3020, 3021t, 3022f, 3022t, 3023f
maintenance of 3023f
morphology of 3020f
World Health Organization classification of 3021b
Acute meningitis 1391. Also See Meningitis
Acute meningococcemia 1391
Acute metabolic crises 113
Acute motor axonal neuropathy (AMAN) 2805, 2862
Acute myasthenic crisis 2807
Acute myeloid leukemia 1682f, 3024, 3025b, 3025f, 3027, 3027f, 3028f, 3029, 3029t, 3030
bone marrow in 3027f
World Health Organization classification of 3027b
Acute myeloblastic leukemia 3019
Acute myelogenous leukemia 1978, 2070
Acute nephritic syndrome. Also See Nephritic syndrome, nephritis 2507, 2508
causes of 2508b
evaluation of 2508b
Acute onset focal neurological deficits 2758
Acute otitis media 1184, 2135, 2137, 2137f, 2180
Acute pancreatitis 94, 408, 1542, 1797, 1799, 1800b, 1801
clinical features of 1798t
complications of 1799t
idiopathic 1798
Acute pandysautonomia pure sensory variant 2807
Acute pericarditis 2438, 2439, 2439f
Acute pharyngitis 2143, 2147
Acute pharyngotonsillitis 1380
Acute phase reactants 3151, 3163, 3170
Acute postinfectious measles encephalitis 1476
Acute promyelocytic leukemia 2099, 3029
Acute pyelonephritis 2566
Acute recurrent headache 2659
Acute recurrent pancreatitis 1797
Acute renal failure 1696, 2527
Acute respiratory acidosis 340
Acute respiratory alkalosis 264, 340
Acute respiratory distress syndrome 255, 337, 343, 343t, 345f, 345t, 346348, 348t, 354, 368, 380, 417, 990, 1401, 1410, 1519, 1523, 1623, 1689, 1691
Berlin definition of 344t
management of 347fc
Acute respiratory failure 337, 340, 340t, 341
Acute respiratory infections 336, 2143, 2202
control program 2208
Acute retroviral syndrome 1545
Acute rheumatic fever 1379, 1382, 2402, 2403fc, 2404t, 2406
differential diagnosis of 2405t
treatment of 2407t
Acute rhinosinusitis 2149, 2149b, 2149f
differential diagnosis of 2151t
Acute schistosomiasis 1623
Acute seizures 2672
Acute severe asthma 2197, 2197t
Acute splenic sequestration crisis 2016, 2017f, 2019
Acute suppurative otitis media 2133
Acute suppurative thyroiditis 2889
Acute symptomatic seizures 2632
Acute thyroiditis 2889
Acute tonsillitis 2154, 2154f
Acute tubular necrosis 396, 2487, 2528
evaluation of 2487
Acute upper respiratory infection 2150
Acute urticaria 3334
Acute vasoreactivity testing 2400
Acute viral hepatitis 1539, 1540, 1543, 1844
differential diagnosis of 1542t
Acute vomiting 1775
Acute watery diarrhea 1707, 1710, 1712. Also See Diarrhea
Acute wheezing 2176
Acute-on-chronic liver failure 1909, 1910b, 1921
Acyanotic defects 865
Acyclovir 1471, 3583
Acylcarnitines 120, 121
Acylglycine 120
Adalimumab 3145
Adamantiades-Behçet disease 3292
Adams forward bending test 3400
Adaptive behavior 918t
Adaptive immunity 204, 205, 3111
Addison disease 188, 1746, 2546, 2924, 2925f
Adductor angle 629t
ADEM. See Acute disseminated encephalomyelitis
ADH. See Antidiuretic hormone
ADHD. See Attention-deficit hyperactivity disorder
Adenine 35f, 36
Adenine phosphoribosyltransferase 2550
Adeno-associated viruses 1467
Adenocarcinoma 1419
Adenohypophysis 2868
Adenoid cystic carcinoma 1774
Adenoid facies 2156f
Adenoid hypertrophy, endoscopic grading of 2157f
severe 2157f
Adenoids 2154, 2157f
diseases of 2154
Adenoiditis 2154, 2156
acute 2156
recurrent 2156
Adenoma sebaceum 2750f, 3371f
Adenomatous polyposis coli 1943
Adenopathy 2155
Adenosine 317, 697, 2452, 3584
Adenosine deaminase 229, 1736, 1842
Adenosine deaminase deficiency 218
Adenosine diphosphate 167, 250f, 1954
Adenosine triphosphate 122, 123, 127, 167, 250f, 278, 567, 671, 677, 678, 681, 993, 1613, 1702, 1935, 1954
Adenosylcobalamin deficiency 1998
Adenotonsillar hypertrophy 2158
Adenotonsillectomy 2161
Adenovirus 1490, 2506, 2675
Adenylate cyclase toxin 1358
Adenylosuccinate lyase deficiency 2762
Adhesinolysis 2496
Adhesive injury 3310
Adie pupil 3260
Adipocyte rebound 857
Adipokines
in obesity 859t
Adiponectin 859t
Adipsic hypernatremia 2880
Adjunctive antibiotics 1396
Adjunctive therapy 179, 637, 1442
Adjustment disorders 1252
Admixture lesions 2386
physiology of 2386
Adnexal injuries 3278
Adolescence. See Adolescent
Adolescent 15, 2656
counseling 1225, 1281
depression 1252
antidepressants and psychotherapy trial 1252
drinking index 1253
friendly health services 1294, 1295, 1296f
growth 797
gynecomastia 2914
health 3513
homosexuality 1228
idiopathic scoliosis 3420
immunization 1224
kyphosis 3423
medicine 4
mental health issues 1223
nutrition 1242, 1248
reproductive and sexual health 1094, 1222
reproductive tract infections 1224
rights 1221
vaccination 1144
with calpainopathy 2784f
Adolescent health. Also See RMNCH+A
Adolescent immunization 1224, 1290
Adoption 3487b
medical and legal issues 3486
present status of 3486
screening checklist for 3489b
ADR. See Adverse drug reactions
Adrenal androgens 2910
Adrenal carcinoma 2935
Adrenal cortex, physiology of 2915
Adrenal crisis 2924, 2927
Adrenal disorders 2907
Adrenal gland 2867, 2915
cortex of 2915
medulla of 2915, 2917
physiology of 2915
Adrenal hemorrhage
massive 2924
Adrenal hyperplasia 80, 2929
Adrenal insufficiency 188, 256, 2924, 2926fc, 2935, 2999
causes of 2924b
diagnosis of 2924
Adrenal tumors 2935
Adrenaline 2086, 3583
Adrenarche 2897t
Adrenocortical hormone 2621
Adrenocortical steroid biosynthesis 2916
Adrenocorticotropic hormone 188, 868, 1032, 2558, 2745, 2898f, 2915, 2918, 2924, 2930, 2944, 2947, 2972, 2989, 3001, 3583
Adrenocorticotropin 1780
resistance syndromes 2929
Adrenoleukodystrophy 88, 128, 27652767
Adult respiratory distress syndrome 1665
Adult serine deficiency phenotype 101
Advanced cardiac life support 439
Advanced trauma life support 414, 438, 439
Adventitious sounds 2118
Adverse drug reactions 284, 285b
Adverse events following immunization 1123, 1124, 1124t, 1147
Advisory Committee on Immunization Practices 1142, 1154, 1185, 1212
AED. See Antiepileptic drugs
Aedes aegypti 1206, 1568, 1573, 1578
AEFI. See Adverse events following immunization
Aerobic bacteria 644
Aerosol therapy 2199
Afibrinogenemia 2065
congenital 2055
AFP. See Acute flaccid paralysis
AFP surveillance 1539
Agammaglobulinemia 39
Age-dependent anthropometric measurements 1034
Age-independent anthropometric measurements 1035
Agenesis 843, 844f, 3227
Ages and Stages Screening Questionnaire 893
Agglutination tests 1310
Agonal breathing 309
Aicardi syndrome 53
Aicardi-Goutiere syndrome 2586, 2611
AIDS. See Acquired immunodeficiency syndrome
AIDS. See HIV
Air bronchograms 711f
Air displacement plethysmography 857t
Air leak syndromes 337, 355, 359, 620, 2215
Air pollution 3504
Air transport 621f
Air ventilation 1327
Airborne virus 1497
Airway 300, 315, 320, 322, 367, 412414, 438, 439, 467, 617, 618, 636, 1575, 1576, 2197
abnormality 694
clearance 2815
clearance techniques 2234, 2241
deposition 2199
disorders 337
foreign body 2246
hyper-responsiveness 2191
obstruction 596, 2120t, 2156
pressure release ventilation 357
resistance 2114
AKI. See Acute kidney injury
Alacrimia 2926
Alagille syndrome 1875, 1876f, 2342, 3292
diagnosis of 1875b
Alanine 93, 108
Alanine aminotransferase 331, 855, 1523, 1539, 15411543, 1801, 1865, 1866, 1869, 1878, 1907, 1911
Alanine transaminase 109, 234, 1568, 1917, 1920, 1921
Alarm therapy 2502
Albendazole 1630, 2685, 3584
Albert stain 1308
Albinism 82f, 1867, 1908, 3287, 3322, 3399f
Albright hereditary osteodystrophy 2988, 2990, 2991f
Albumin 3584
excretion rate 2572, 2972
levels of 2523
Albuminocytologic dissociation 2586
Albuminuria 162
Albuterol 3613
ALCAPA 2337
Alcohol 387, 1272
abuse 15
Alcoholic stem thermometers 1122
Aldosterone 2540, 2917
antagonists 2304
deficiency 2546
receptor antagonist 2560
related hypertension 2940t
unresponsiveness 2540
Alendronate 288
Alexander disease 2770
Algid malaria 1589
Alimentary tract 1468
Aliphatic hydrocarbons 379
Alkalemia 258
Alkali 390
Alkali poisoning
DROOL score for 392t
Alkali therapy 731
Alkalosis 258, 261, 274, 2630
Alkalotic syndrome 280
Alkaline peptone water 1721
Alkaline phosphatase 1866, 1878, 1893, 1906, 1911
abnormal 1866t
Alkaptonuria 82f, 98, 2550, 3287
ALL. See Acute lymphoblastic leukemia
Alleles 38
specific oligonucleotide 2011
Allen's picture chart 3222
Allen's test 260
Allergy 3, 208, 213, 236, 237, 1794, 2150
basis of 236
testing, modes of 214t
Allergen 237, 246, 2191
immunotherapy 2130
specific immunoglobulin E levels, interpretation of 245t
specific immunotherapy 246
testing 2130
Allergic disorders 241, 242, 242t, 243, 246
burden of 241
classification of 241
diagnosis of 241
management of 241
Allergic asthma 242
Allergic bronchopulmonary aspergillosis 1657, 1658b, 1658f, 1659t, 1659t
Allergic bronchopulmonary mycosis 1657
Allergic conjunctivitis 242
Allergic contact dermatitis 3334
Allergic fungal airway disease 1657
Allergic reactions 1350
Allergic rhinitis 241, 242t, 21282130, 2130t, 2132f, 2144
classification of 242t, 2129t
intermittent 2128
Allgrove syndrome 2926, 2929
Allogeneic hematopoietic stem cell transplants 3123
Allografts 2577
Allopurinol 288, 2550, 3584
Almotriptan 2662
Alopecia areata 62, 3395, 3396f
treatment of 3397t
Alpers syndrome 124
Alpha-1 antitrypsin deficiency 1867, 2183
Alpha-aminoadipic semialdehyde 2760
Alpha-blockers 2560
Alpha-cells 1758
Alpha-dystroglycanopathy 2831, 2832f
Alpha-fetoprotein 541, 1867, 1878, 1917, 1923, 1943, 2606
Alpha-glycoprotein 1993
Alpha-hemolytic streptococci 1379
Alpha-linolenic acid 999
Alpha-thalassemia 79, 2018
classification of 2021t
intellectual disability syndrome 2951
Alport syndrome 2509, 2516, 2517, 2519, 3292
diagnosis of 2517
Alprostadil 3584
ALPS. See Autoimmune lymphoproliferative syndrome
Alström syndrome 2960, 2988, 2991
ALTE. See Apparent life-threatening episodes
Altered sensorium 2665
Alternate exotropia 3267f
Alternating hemiplegia 2656, 2710
Alveolar bleeds 2225
Alveolar capillary dysplasia 2219, 2220f
Alveolar hemorrhage 2226
management of 2226
Alveolar hypoventilation 595, 2248fc
Alveolar macrophages 145
Alveolar ventilation 349, 2111f
Alzheimer disease 62
Amanita phalloides 386
Amantadine hydrochloride 3584
Ambiguous genitalia 57, 2524
Ambiguous vaccine-derived poliovirus 1537
Amblyopia 615, 3219
therapy 3295f
treatment 3226
Ambulatory blood pressure monitoring 2557
Ambulatory electroencephalography 2589
Amebiasis 1601, 1603, 1623, 1716, 1741
medical treatment of 1604t
Amebic colitis 1602
Amebic liver abscess 1602, 1901, 1902
Amebic meningoencephalitis 1604
differential diagnosis of 1604t
Amebic serology 1903
Amegakaryocytic thrombocytopenia 2070, 2084
Amelogenesis imperfecta 844, 844f
Amenorrhea 1263, 1263b, 1266, 1266fc
causes of 1263
etiology of 1264b
Ametropia 3219, 3220
Amiel-Tison neurological examination 628
Amikacin 1446, 2563, 2672, 3584
Amiloride 2560
Amino acid 36, 74, 89, 91, 93, 188
analysis 92
catabolism, disorders of 91
concentrations, normal range of 93t
derivatives 2865
essential 989
formula 1744
interconversion 2605
interpretation of 94fc
metabolism disorders 91
normal pattern of 92f
plasma levels of 103
requirement 1087t
synthesis, disorders of 91, 100
transport, disorders of 101
Aminoacidopathy 83, 89, 91, 92b, 114
evaluation of 91
identification of 92
Aminoaciduria 122, 2541, 2543, 2554
Aminoglycosides 2530
Aminolevulinate synthase 195f
Aminolevulinic acid 197, 198
Aminomethyltransferase 99
Aminophylline 3584
Aminopyrine breath test 1868
Aminosalicylic acid 1830
Aminosidine 1598
Aminotransferases 1865
Amiodarone 288, 317, 2453, 2454, 2456fc, 3584
Amitriptyline 2662
AML. See Acute myeloid leukemia
Amlodipine 2526, 2560, 3585
Ammonia 89, 91, 104, 107, 109, 191, 1868, 1930f
concentration of 1868
detoxification 109
hypothesis 1930
production, inhibition of 110
Ammonium
chloride, oral load of 2541
excretion 260
Amniocentesis 83
Amnionicity 530, 530b
Amniotic fluid 3581
acetylcholinesterase 785
Amniotocele 3277, 3277f
Amodiaquine 3585
Amoxicillin 1371, 2565, 3344f, 3585
clavulanic acid 288
Amphotericin B 1598, 1647, 1674, 3585
colloidal dispersion 1647, 1649
lipid complex 1647, 1649
toxicity 2540
Ampicillin 288, 1371, 3585
rash 1489
sodium trihydrate 3585
Amplatzer septal occluder 2296f
Amplitude-integrated electroencephalography 679, 682
Amrinone 3585
Amylase-rich food 1009
preparation of 1009b
Amyloidosis 150
Amyopathic dermatomyositis 3169
ANA. See Antinuclear antibodies
Anabaena variabilis 97
Anaerobe transport media 1423
Anaerobic bacteria 644, 1422
Anaerobic glycolysis 2035
Anaerobic infections 1422, 1423
Anaerobic liver abscess 1424
Anagen 3395
Anakinra 3146
Anal canal 777f
Anal fissure
acute 1855
Anal intraepithelial neoplasia 1197
Anal reflex 2583
Anal sphincter tone 178
Analgesia 360, 730, 2699
Anaphylaxis 242, 243, 1125
Anaplastic large cell lymphoma 3049, 3049f, 3051, 3054
Anastomotic leak
minor 751
ANCA. See Antineutrophil cytoplasmic antibody
ANCA-associated vasculitides 2514, 3186
Ancillary tests 2205
Ancylostoma duodenale 1616f
Anderson disease 1813
Anderson Fabry disease 160
Androgen 1979, 2915, 2917, 2919
biosynthesis, disorders of 2949, 2949t
insensitivity syndrome 1264
Androstenedione 2913
acute 1958, 1974
age-specific causes of 1958
causes of 1958
classification of 1974
clinical manifestations of 574t
congenital sideroblastic 1973
correction of 2366
diagnosis of 1957, 1957t
etiology of 1974
evaluation of 574, 1958, 2573
pathophysiology of 1991
prevalence of 1028f, 1989t, 1990t
prevention of 580
severity 1958t
grades of 1958
severe 152, 1589, 1593
signs of 1958f
types of 1958
Anemia Mukt Bharat 1095, 1247, 3516, 3517f
Anencephaly 786, 2610, 2872
Aneuploidy 38, 59, 2071
Aneurysm clips 2597
Aneurysmal rupture 2596
Anganwadi 1247
center 29
services 3515
Angelman syndrome 49, 51, 52, 55, 66, 916, 2636
Angiocardiography 2314
Angioedema 3334t, 3336f, 3345
diagnosis of 3338fc
therapy of 3339
Angiogenesis 2252
Angiography 1899, 2119
Angiokeratoma 86f, 136, 161f, 2518
Angioneurotic edema 2171
Angio-osteohypertrophy
ocular manifestations of 3289
Angiotensin-converting enzyme 153, 276, 395, 1515, 1517f, 2432, 2468, 2497, 2546, 2574, 2822
inhibitors 2304, 2519, 2530, 2546, 2559, 2972
receptors 409, 455
Angiotensin-receptor blocker 276, 2304, 2546, 2560
Angle kappa 3261
Angle's classification 839
Angular cheilitis 1653, 1654f
Angular cheilosis 1053f, 1992
Angular stomatitis 1961
Anhidrosis 2861
Anidulafungin 1648, 1650, 3586
Animal bites 422
management of 1507t
Animal-related injuries, management of 423
Anion gap 89, 264, 368
metabolic acidosis 265
Aniridia 3215, 3250, 3251f
Anisocytosis 2026f
Anisometropia 3219, 3221, 3263
correction of 3224t
Anisosphygmia 2262
Anitschkow cells 2403
Ankle foot orthosis 2853f
Ankle jerk 2583
Ankyloblepharon 3212, 3273
Ankyloglossia 1769
Ann Arbor classification of Hodgkin lymphoma, modified 3044t
Anna Freud theory 1228
Anocutaneous fistula 767
Anodontia 843, 2499
Anogenital warts 3318
Anopheles
culicifacies 1587
stephensi 1587
Anophthalmos 3214
Anorectal disorders 1855
Anorectal malformation 767769, 769f, 773f
spectrum of 767f
Anorectal manometry 1806, 1809
Anorectal varices 1884f, 1899
Anorexia 1760, 1802, 2508, 2541
Anorexia bulimia 978
Anorexia nervosa 978981
management of 980t
Anovestibular fistula 769, 769f, 770f
Antenatal counseling
for breastfeeding 495
Antenatal diagnosis
of neural tube defect 2609
of skeletal dysplasia 3453
Antenatal hydronephrosis 779, 2491
classification of 2491t
Antenatal steroids 710, 715, 746
Antenatal ultrasound examination 2498
Anterior bleeds 2124
Anterior capsular plaque 3240, 3240f
Anterior cataract 3240
Anterior chamber injuries 3280
Anterior cingulate cortex 958
Anterior cord syndrome 2774t
Anterior cortical cataract 3240, 3240f
Anterior epistaxis, site for 2125f
Anterior horn cell 2780
Anterior lenticonus 2517, 3218
Anterior mitral leaflet 2412
Anterior sagittal anorectoplasty 768
Anterior uveitis 3233, 3237
Anthracycline-induced cardiomyopathy 2437
Anthropometry 471
Anthropometric parameters, interpretation of 828
Anthropozoonoses 1303
Antiandrogenic therapy 1271
Antiannexin antibodies 3196
Antibiotic 332, 650, 740, 1318, 1355, 1712, 1716, 1903, 2137, 2152, 2231
administration 430
adverse effects of 1351b
choice of 1370, 2691
classification of 1347t
duration of 2137, 2691
for anaerobic infections 1424t
future of 1324
indications of 1370
prophylaxis 2565, 2566, 2567
resistance 650, 1371, 1377, 1385
mechanisms of 1318, 1319f
timeline of 1317f
selection pressure 633
susceptibilities 1345
therapy 424, 636, 636b, 654, 1359, 1423, 2207, 2211, 2234, 2407
deciding duration of 1347
duration of 637t
indications for 1388b
principles of 1344
reassessment of 1347
Antibiotics, role of
oral 2691
Antibiotic-associated diarrhea 1749, 1750, 1752
prevalence of 1750t
Antibiotic-associated diarrhea treatment 649, 1892
Antibiotic regimen, selection of
optimal 1344
Antibody 1491, 3135
competition test 1464
deficiency 220, 229
disorders 215
dependent cellular
cytotoxicity 207
phagocytosis 2075
detection 1677
screening 216
titers 662
Anticancer drugs 3013f
Anticardiolipin antibody 2707, 2710, 3196
Anticell antibody 209
Anticholinergics 2197, 2504, 2721
Anticholinesterase drugs 403
Anticipation 47
Anticipatory guidance 2019, 2179
Anticoagulant 2099, 2101
drugs 2094, 2305
oral 2399
therapy 2094, 2713
Anticonvulsants 71
Anticyclic citrullinated protein antibodies 3133
Anti-D
for ITP 2078
Antidiabetics 378
Antidiuretic hormone 251, 1709, 2668, 2693, 3001
secretion of 255, 2501
Antidotes 371, 372, 374
Anti-dsDNA antibodies 3134
Antiendomysial antibodies 211
Antiepileptic drugs 2605, 26422644
maintenance dose of 674
mechanism of action of 2643
side effects of 2645t
therapy 100, 673
Antifibrinolytic agents 2101
Antifilarial drugs 1630
Antifungal 1649
resistance pattern 1656t
spectrum 1648f
therapy 1647, 1684
Antigen
antibody
based tests 1438
reactions 2507
detection 1513, 1629, 1677
methods 1644
presenting cell 237, 1429
recognition 205
specific clone, proliferation of 206
Antigenic drift 1493
Antigenic shift 1493
Antiglomerular basement membrane 2508, 2509, 2516
Antigravity adaptations 2474
Antigravity movements 2584
Antihelminthic therapy 2685
Antihistamine 246, 374
Antihypertensive agents 2559t
Anti-immunoglobulin E antibody 246
Anti-inflammatory drugs 2241
Antileishmanial drugs 1598
Anti-liver cytosol antibody 1923
Anti-liver kidney microsomal antibody 211, 1923
Antimalarial chemotherapy 1593
Antimalarial combination therapy 1592
Antimannobioside carbohydrate antibody 1842
Antimicrobial 2241
agents 1344, 1350
choice of 1371
prophylaxis 1350
resistance 633, 1316, 1351
detection of 1351
mechanisms of 1351
surveillance of 1321
stewardship 1323, 1352
therapy 423, 636, 653, 659, 1309, 1346, 1724, 2423, 2691, 3112
treatment 1722
Antimicrobial resistance 13161324, 1351
Antimitochondrial antibodies 211
Anti-Müllerian hormone 1270, 2945
Antineutrophil cytoplasmic antibody 210212, 240, 1829, 2183, 2226, 2513, 3134, 3140, 3186, 3187, 3187f
atypical 235
Antinuclear antibodies 208, 209, 213, 1907, 1916, 1923, 1924, 1939, 2557, 2711, 3133, 3164, 3192
types of 210
Antioxidant 994, 2476f
pathways 2035
system 2474
Antiparietal cell antibodies 211
Antiphospholipid antibody 455, 2075, 3135, 3164
nonthrombotic manifestations of 3195
syndrome 2972, 3162, 3195, 3196
Antiphospholipid syndrome, diagnostic criteria for 3196b
Antiplatelet antibodies 2075
Antiprothrombin antibodies 3196
Antipyretics 365, 2631
choice of 1334
Antipyresis. Also See Fever management 1333
Antirabies
antibody titers, assessment of 1167
vaccine 1507
Antiretroviral drugs 1556, 1556t, 1557
use of 1560
Antiretroviral therapy 1510, 1544, 1549, 1554, 1559, 1561, 1646, 1663, 1680
fundamental principles of 1554t
Antiribonucleoprotein antibodies 2515
Anti-saccharomyces cerevisiae antibody 1829
Antiseizure drugs 2651
Antisense oligonucleotide therapy 73
Anti-Smith antibodies 2515
Antismooth muscle antibodies 211, 1923
Antisnake venom 394, 402, 3586
administration criteria 402, 403, 403b
Antisocial personality disorder 964
Anti-soluble liver antigen antibody 1923
Antistreptococcal vaccine 2407
Antistreptolysin O 1381, 2508, 2557
Antithrombin 2054
deficiency 2089
Antithrombotic therapy 1528
Antithymocyte globulin 3586
Antitubercular drugs 1440, 1441t, 1446
therapy, principles of 1440
Antitubercular therapy 1447, 1550, 1559, 1843, 1910, 1931
evolution of 1440
Antivascular endothelial growth factor drugs 614
Antiviral agent 1472
Antiviral drugs 1470
Antiviral therapy 1534
Anti-voltage-gated potassium channel encephalitis 2694
Anus 475, 769f
Anxiety 1251
disorders 983, 984
disorders, subtypes of 983b
Anxiety-related emotional disorders 1223
Aorta 2350f, 3181f
severe coarctation of 2348f
Aortic aneurysmal disease 2270
Aortic arch 2255, 2256, 2372f
anomalies of 2123
arteries 2256
hypoplasia 2392f
sidedness 2273
Aortic coarctation 64
Aortic regurgitation 2266, 2338, 2352, 2352f, 2358, 2360, 2410, 2416, 2418f
Aortic root angiogram 2295f, 2354f, 2366f
Aortic stenosis 2266, 2268, 2293, 23492352, 2352f, 2410, 2465
clinical features of 2349
features of 2350t
moderate-to-severe 2349
pathophysiology of 2349fc
severe 2352f
subtypes of 2351t
Aortic valve 2350f
balloon
angioplasty of 2352
dilatation of 2352
ejection click 2264
endocarditis 2422
involvement 2416
pathology 2406b
stenosis 2473
Aortoarteritis
nonspecific 2514
Aortopulmonary collateral arteries 2358, 2366f
Apert syndrome 53, 1769, 3286
Apgar score 626
Aphakic glaucoma 3252
Aphallia 777, 777f
Aphthous ulcer 1829f, 2155
Aplasia 2490, 2873
Aplasia cutis 53
congenita 3307
Aplastic anemia 1542, 1972f, 1985, 1985f, 1986, 1988t
acquired 1985b, 1987fc
severe 1987
severity of 1986t
very severe 1987
Aplastic crisis 2017, 2032
Apnea 151, 697, 698, 706
causes of 698t
hypopnea index 2159
pathophysiology of 697fc
testing 2702
Apophysomyces variabilis 1681
Apoptosis 133
Apparent life-threatening episodes 945
Appendiceal tissue 1620f
Appendicectomy 1839f
Appendicitis 1498, 1838, 1839
acute 1838, 1838t, 1839f
spectrum of 1838
Appendicular tone 2583
Appendix testis, torsion of 1854f
Appetite test 1040b
Apple peel atresia 763f
Applied nutrition program 1094
Apt test 578
Aquaporins 2482
Arachidonic acid 2086
metabolism pathway 1334fc
Arcanobacterium haemolyticum 2146, 2155
Arch atresia 2344
Archimedes spiral drawing 2719f
ARDS. See Adult respiratory distress syndrome
Arenaviruses 1581
Argentaffin cells 1757
Arginase 107
Arginase deficiency 84, 86, 106, 108
Arginine 93, 108, 110
succinate synthase enzyme 105
vasopressin 2302, 2916
Argininemia 108
Argininosuccinate 105, 108
lyase 105f, 107
deficiency 104, 108
synthetase 105, 107
deficiency 108
Argininosuccinic aciduria 84, 108
Argyll-Robertson pupil 3260
Arm recoil 472
Arm span 799f
Arnold-Chiari malformation 789, 3291
Aromatic hydrocarbons 379
Array comparative genomic hybridization 68
Arrector pili muscle 2791f
Arrest rhythms 316f
Arrhythmias 694, 2270, 2285, 2441, 2469, 2543, 2651
basic mechanisms of 2443b
diagnosis of 2444
Arrhythmogenic right ventricular
cardiomyopathy 2429, 2435, 2436t
dysplasia 2457
ART. See Antiretroviral therapy
Artemether 1594, 3586
Artemisinin-based combination therapy 1592
Arterial anomalies 2710
Arterial blood gas 191, 347, 682, 695, 754, 2358
analysis 260, 711, 2170
measurement of 260b
parameters 340
values 340t
Arterial ischemic stroke 2096t, 2705, 2712
Arterial occlusion 1391f
signs of 2091b
Arterial pulse 2262
Arterial switch operation 2377, 2379
Arterial system, development of 2255
Arterial thrombosis 2090
treatment of 2095
Artesunate 1594, 3587
Arthralgia 2405, 2513, 2514, 3185
Arthritis 1498, 1511, 2505, 2513, 3129, 3149f, 3185
acute 3129
enthesitis-related 3130, 3147, 3153
Arthrocentesis 3409
Arthrogryposis 84, 151, 3458, 3459
multiplex congenita 3438f, 3458
Articular inflammation 3129
Articulation disorders 949
Artificial detoxification systems 1941
Ascariasis 1611, 1613, 1623
prevention of 1614
treatment of 1613b
Ascaris lumbricoides 1584, 1797
life cycle of 1612f
worms, mass of 1613f
Ascended testis 782
Ascending aorta 2324f
Ascending reticular activating system 2693
Aschoff-Geipel bodies 2403
Ascites 1844, 1846, 1848, 1892, 1892fc
causes of 1844t
management of 1892
Ascitic fluid 1848t
absolute neutrophil count 1892
analysis 1842
color of 1847f
culture 1892
Ascorbate 3596
Ascorbic acid 98, 1056, 1245
ASD. See Atrial septal defect
Asepsis 1301
Aseptic meningitis 1480, 1484, 1529, 1531, 1542, 2667
Ash leaf macule 3371f
ASHA. See Accredited social health activist
Ashwell-Morell receptor 1953, 2075
Asparagine 93
Asparagine synthetase deficiency 101
Aspartate aminotransferase 855, 1539, 15411543, 1865, 1866, 1878, 1907, 1911, 1921
Aspartate glutamate
carrier deficiency 108
transporter defect 105, 106
Aspartate transaminase 109, 234, 1523, 1568, 1866, 1869, 1917, 1920, 1921
Aspartic acid 93
Aspartylglucosaminuria 135
Asperger's disorder 969
Aspergillosis 1657
Aspergillus flavus 1647, 1657
Aspergillus fumigatus 1657
Aspergillus lentulus 1647
Aspergillus niger 1657
Aspergillus pneumoniae 229
Aspergillus terreus 1647
Asphyxia 535, 677, 693
Asphyxial lung injury 719
Aspiration 1641, 1770, 2184
causes of 694
investigations for 2186
syndrome 694, 2142, 2184, 2186
treatment of 2187b
Aspirin 288, 3583
ingestion, effects of 2087
Asplenia 2317
Asplenia syndrome 1212, 2312f, 2314f, 2316, 2317
Assent 25
Assessment
of sick child 299302
Assist-control ventilation 352, 704, 705, 705f, 2113
Assisted reproductive technologies 529
Astatic seizures 2634, 2635
Astemizole 288, 3587
Asthma 3, 208, 213, 354, 2128, 2129, 2142, 2151, 2192, 2197b, 2198
biologic therapies for 2196
control of 2196, 2196b
diagnosis of 2192
predictive index 2190t
Astigmatism 3220, 3224
Astrocytomas 3062, 3062t
Asymmetric septal hypertrophy 564, 2436
Asymmetric tonic neck reflex 629, 2584
Asymptomatic bacteriuria 2565
Asymptomatic lead poisoning, medical management of 3511
Ataxia 48, 86, 92, 122, 123, 136, 274, 279, 280, 2580, 2654, 2725, 2765
acute 2726
causes of 2726b
classification of 2726b
intermittent 2726
telangiectasia 219, 2729, 3289, 3372
with oculomotor apraxia 2729
with polymyoclonus 2726
with selective vitamin E deficiency 2728
Atazanavir 3587
Atenolol 2560, 3587
Athetosis 2724
Atlantoaxial dislocation 2775f
Atlantoaxial rotatory displacement 3412
Atlantoaxial subluxation 2775
ATLS. See Advanced trauma life support
Atonic seizures 2634
Atopic dermatitis 239, 3288, 3331, 3331f
Atopic wheeze 2188b
Atopy 2116
Atovaquone 288
Atransferrinemia 1973
Atraumatic limp 3403
Atretic gallbladder 1873f
Atrial fibrillation 2446
Atrial flutter 2446
Atrial natriuretic peptide 2301, 2530
Atrioventricular valves, development of 2255f
Atrial septal defect 62, 748, 2251, 2262, 2266, 2268, 2270, 2274, 2276f, 2293, 2324, 2327, 2328, 2329f, 2330, 2330f, 2339, 2344, 2377, 2388, 2472, 2614
closure 2294
Atrioventricular septal defect 2268, 2270, 2330, 2330f, 2331, 2331t, 2356, 2358, 2360, 2361, 2465
morphological classification of 2330f
Atrioventricular block 2459
Atrioventricular canal 2253, 2368f
Atrioventricular re-entrant tachycardia 2442, 2447, 2452, 2454, 2456
Atropine 317, 409
eye drops 3226
sulfate 3587
Attention-deficit hyperactivity disorder 106, 454, 519, 529, 916, 957, 958t, 961, 962t, 964, 967, 968, 1070, 1071, 1251, 2501, 2654, 2749, 2824, 3479
differential diagnosis of 961t
Atypical absence 2634
Atypical Burkitt lymphoma 3047
Atypical genitalia 2951t
recognition of 2950
Atypical pneumonia 2204
Audiology 90
Auditory brainstem implants 928
Auditory processing disorders 950
Auditory steady state response 926
Auerbach's plexus 1756
Aural medications, administration of 290b
Auscultation 2117
intermittent 542
Austin flint murmur 2266
Autism 62, 949, 973, 1484, 2579
spectrum disorder 454, 529, 949, 969, 974t
complimentary assessments for 973b
diagnosis of 970b
etiological evaluation for 973b
red flag signs for 972b
risk factors of 969b
Autoantibodies 3133, 3138, 3170
generation of 2512
Autoimmunity 3335
indicators of 3336
Autohemolysis test 2034
Autoimmune disorders 74, 208, 455, 2072, 2972
Addison disease 2925
adrenal failure 2927
adrenalitis 2927
Autoimmune encephalitis 2587, 2885
Autoimmune endocrinopathies 2927
Autoimmune hemolytic anemia 219, 1542, 1968, 2006, 2032, 2039, 2042, 2042fc
classification of 2039b
Autoimmune hepatitis 209, 213, 1539, 1542, 1744, 1916, 1920, 1928, 1928fc
diagnosis of 1928fc
Autoimmune liver disease 1886f, 1907, 1927
Autoimmune lymphoproliferative syndrome 215, 220, 221
Autoimmune neurological syndromes 2745t
Autoimmune neuropsychiatric disorders 983, 1379, 1382
Autoimmune pancreatitis 1798
Autoimmune phenomenon, perpetuation of 2075
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome 1654, 2927, 2977
Autoimmune polyglandular syndrome 2927, 2927t, 2928
Autoimmune sclerosing cholangitis 1918, 1928
Autoimmune thyroid disease 2887b
Autoinflammatory disorders 225, 225t
Autologous hematopoietic stem cell transplants 3119
Automated auditory brainstem response 925
Automated external defibrillator 308311
Automatic atrial tachycardia 2450
Automation 1309
Autonomic disorders 2859
Autonomic dysfunction
secondary causes of 2862
symptoms of 2855
Autonomic dysregulation 2248, 2249, 2862
Autonomic nervous system 1532, 1756, 2868
anatomy of 2854
physiology of 2854
Autonomic nervous system dysregulation 2855t, 2860t
Autonomic function tests 2855, 2856t
Autonomic neuropathy 2854, 2859, 2973
Autonomous functional ovarian follicular cysts 2907
Autonomy 24
Autopositive end-expiratory pressure 352, 357f, 359
Autosomal deafness 2070
Autosomal dominant 47, 123, 215, 219, 221, 222, 224226, 526, 2522, 2545, 2548, 2558, 2655
disorders, inheritance of 43b
hyperparathyroidism 2544f
hypocalcemia 280
hypomagnesemia 280
hypophosphatemic rickets 2982
inheritance 42, 43, 83
limb-girdle muscular dystrophies 2824
polycystic kidney disease 71, 2497
tubulointerstitial kidney disease 280
Autosomal recessive 42, 44, 44f, 45, 47, 108, 123, 215, 218222, 224226, 2545, 2558
congenital ichthyosis 3387, 3388t
disorder 83, 102
hypophosphatemic rickets 2982
microcephaly 2613
polycystic kidney disease 2498, 2498f
trait 2498
Auxiliary nurse midwife 29, 589f, 3514f
Avascular necrosis 148
Avian influenza 1493
Axenfeld-Rieger syndrome 2621, 3214, 3216f, 3251f
Axial hypotonia 2836
Axillary excoriated rash 2765f
Axillary freckling 3369f
Ayushman Bharat 464, 464t
Azathioprine 1830, 1928, 3144, 3165
Azithromycin 1371, 3587
Azoles 1648
Azoospermia 47
Azotemia 2506, 2514
Aztreonam 3587
B
β-globin chain disorders 2023t
β-thalassemia. See Beta-thalassemia
Bacillus anthracis 1304
Bacillus Calmette-Guérin 228, 234, 479, 1100, 1116, 1118, 1120, 1212
infection 227
Baclofen 288, 3588
Bacteremia 1371t, 1377, 1385, 1423, 1715
Bacteria 661, 1302, 2486, 2562
Bacterial cell 1349f
Bacterial colitis 1623
Bacterial conjunctivitis 642, 643
Bacterial deoxyribonucleic acid 1346
Bacterial destruction 1397
Bacterial endocarditis 2419b, 2420t
Bacterial index 1464
Bacterial infections 642, 1336, 1341, 1497, 3283, 3305, 3311, 3311b
natural history of 1341
Bacterial meningitis 2666f
diagnosis of 2586
Bacterial rhinosinusitis 2151, 2151t
Bacterial toxins 1091
Bacterial tracheitis 2171
Bacterial vaginosis 1274, 1275, 1276f
Bactericidal therapy 1346
Bacteriological tests 1435
Bacteriostatic therapy 1346
Bacteriuria
asymptomatic 2565
detection of 2562
Bacteroides fragilis 644, 1309, 1313, 1424, 1901
Baculovirus inhibitory repeat domain 204
Balamuthia mandrillaris 1605
Balanitis 1654
Balanoposthitis 1654
Balantidium coli 1304
Ball valve phenomenon 2245
Ballard score 472t
Baller-Gerold syndrome 57
Ballismus 2724
Ballistic movements 2655
Balloon angioplasty 2294, 2343, 2347, 2352, Balloon aortic valvuloplasty 2294f, 2352, 2353f
Balloon atrial septostomy 2293, 2294f, 2379, 2399
Balloon enteroscopy 1736
Balloon expandable stent 2347
Balloon mitral valvotomy 2415
Balloon occluded retrograde transvenous obliteration 1889
Balloon pulmonary valvuloplasty 2294f, 2341
Balloon tamponade 1896
Baloxavir 1495
Balwadi Nutrition Program 1094
Bambuterol 3588
Band ligation 1896
Bannayan-Riley-Ruvalcaba syndrome 2895
Bangle test 1035
Barbiturate 363, 1930f, 2485
coma 2701
Barbour-Stoner-Kelly medium 1411
Barcelona liver clinic staging 1946
Bardet-Biedl syndrome 49, 861f, 2727, 2988, 2990, 2991f
Barium
enema 1809, 1809f, 1843
gastrointestinal series 2317
meal 1842
swallow 1777f
Bark scorpion, venom of 408
Barker hypothesis 1248
Barkley model 958
Barlow test 474, 3427, 3427f
Baroda development screening test 630
Barrage laser 3281
Barrett's esophagus 1783, 1784
Bartholin glands 1276
Bartonella henselae 422
Bartter syndrome 256, 279, 2544, 2545
antenatal 2544f
Basal cell carcinoma 3396
Basal energy expenditure 989
Basal ganglia 680f, 1564f, 2601, 2616, 2742f
anatomy 2715f
disorders 2580
lesion 126f
Basal infusion rate 2965
Basal metabolic rate 990, 1086
Basal plasmacytosis 1828f
Base excess 260b
Basic life support 308310
Basilar artery aneurysm 178
Basilar impression 3412, 3414
causes of 3414t
Basilar invagination 2775b
Basophil
mediators of 238t
Basophilic stippling 1977t
Bassen-Kornzweig syndrome 1813
Batten disease 83, 90, 3291
Bayley scales of infant development test 517, 894
BCG. See Bacillus Calmette-Guérin
BCG vaccine 29, 1125, 1129, 1130
B-cell 218, 1954
activation 206
depletion 3146
development 1955f
non-Hodgkin lymphoma 3053t
receptor 205
Beck depression inventory 1252
Becker's asthma severity score 2197t
Becker's muscular dystrophy 2780, 2785, 2788f, 2816, 2817f, 2818
Beckwith-Wiedemann syndrome 49, 53, 188, 526, 874, 875, 1849, 2499, 2930
Beclomethasone dipropionate 3588
Bedaquiline 1446
Behavior 519, 862, 929
problems 62
rating scales 961
therapy 921
Behavioral disability 2619
Behavioral management technique 967
Behçet disease 1332, 2463, 2513, 3237
Behçet syndrome 3292
Bell Clapper deformity 1853f
Bell's stage 604b
Belly-tendon montage 2591
Benazepril 2559
Benedict's test 2761
Beneficence 24
Benign childhood epilepsy with centrotemporal spikes 2645
Benign childhood occipital epilepsy (Gastaut type) 2640
Benign neonatal sleep myoclonus 673
Benign paroxysmal torticollis 2656
Benign paroxysmal vertigo 2655, 2660
Benign rolandic epilepsy 2646
Benign tumors 1774
Benzathine penicillin 3588
Benzimidazoles 1608
Benzodiazepine 363, 377, 1930f, 2651
poisoning 377
Benzonsky's identity style model 1235
Benzyl penicillin 1425, 3588
Beraprost 2399
Beriberi 1052, 2400
Berlin's edema 3281f
Berlin-Frankfurt-Münster protocol 3023f
Berlins edema 3281
Bernard-Soulier syndrome 2070, 2084, 2085, 2087
Besicoureteric reflux 2561
Beta-blockers 378, 1887, 2304, 2366, 2560
overdose of 378
Beta-cell 1758
function 2959
Beta-globin 39, 40
Beta-glucocerebrosidase deficiency 148
Beta-hemolytic streptococci 1379
Beta-human chorionic gonadotropin 541
Beta-hydroxybutyrate 119
Beta-lactamase inhibitor 1350, 1423
Betamethasone 2522
Beta-oxidation cycle 119fc
Beta-thalassemia 39, 40, 45, 79
classification of 2024t
clinical phenotypes of 2024
pathophysiology 2022fc
Bethanechol 288
Bethlem myopathy 2830
Bevacizumab 3588
Beverages 1003, 1090
Bhatia's battery of performance test 920
Bhutani hour-specific postnatal risk stratification 557f
Biallelic mutations 46
Bicarbonate 261
fractional excretion of 2541
loading test 2541
proximal tubular reabsorption of 2482
Bicarbonaturia 2539, 2554
Bicuspid aortic valve 64, 2262, 2268, 2352
Bielschowsky phenomenon 3267
Bifid tongue 843f
Bifidobacterium bifidum 1816
Bifunctional enzyme deficiency 129
Bifunctional protein 129
Bilateral aortic arches 2256f
Bilateral basal ganglia 126f, 2596f
Bile acid 1758
analog, measurement of 1812
synthetic defect 129, 1876, 1912, 1920
test 1868
transporter defects 1874
Bile metabolism 1863
Bile salt 1758
Bile salt diarrhea 1745
Bile salt export pump 1917, 1924
Bilevel positive air pressure 347, 353
Bilharziasis 1643
Biliary ascariasis 1901
Biliary ascites 1845
Biliary atresia 1871, 1872f, 1873f, 1886f, 1917, 1921f, 1985
anatomical types of 1872f
splenic malformation 1917
Biliary cirrhosis 1914f
Biliary diversion procedures 1875
Biliary ectasia 2498
Biliary tract
anatomy of 1861
anomalies 1901
physiology of 1861
Bilious vomiting 764f, 1834
Bilirubin
excessive production of 552
induced neurologic dysfunction score 554, 554t, 555
metabolism 551, 552t, 1865fc
neurotoxicity 553, 554b
classification of 554t
prevention of 554
Bilirubin-induced neurologic dysfunction 554, 554t, 555
BIND. See Bilirubin-induced neurologic dysfunction
Biological agents
for rheumatic disorders 3145
Biosynthetic capacity 1864
tests of 1867
Biot's respiration 2117
Biotin 70, 90, 1055, 3362
Biotin deficiency
nutritional 115
Biotinidase deficiency 70, 80, 83, 88, 90, 115, 199, 2765f, 3362f
Biparietal diameter 539
Bird-headed dwarfism 53
Birmingham Eye Trauma Terminology System 3278
Birth asphyxia 14, 447, 466, 670
Birth defects 80
Birth injury 528, 544
types of 545
Birth trauma 3278
Birth weight 462, 483, 500, 513, 525, 607, 2955
Birt-Hogg-Dubé syndrome 2213
Bisacodyl 288, 3588
Bisphosphonates 71, 153
Bitot's spots 1048, 1048f
Bivalent whole cell vaccines 1722
Biventricular hypertrophy 2357, 2358
Black dot fungus 3314f
Bladder 785, 2608
bowel
dysfunction 25652567
involvement 2801
control 2500
maturation of 2569
distention, sensation of 2569
dysfunction 2502
exstrophy 2494
function postoperatively 2495
problems 2569
wall abnormalities 2491
Blalock-Taussig shunt 2472
modified 2374f, 2470
Blast cells 1965f
Blast crisis 3032, 3034
Blastocystis hominis 3335
Blastomyces dermatitidis 16481650, 1672
Blastomycosis 1672, 1674
multiple verrucous plaques of 1673f
Blau syndrome 225
Bleach 386
Bleeding 97, 1036, 2050
acute 2126
management of 2126f
episodes, prevention of 2061
etiology of 583
in neonate 583, 585, 585fc
management of 586
manifestations 152, 1960, 2057f
severity of 2075
site of 2075
telangiectasia 2127f
time 2069, 2085
Bleeding diathesis 636
Bleeding disorders 583, 1268, 2052b, 2125b
Bleeding episodes, treatment of
minor 2061
Bleomycin 3356f, 3588
Blepharitis 3274
Blepharophimosis 3272
syndrome 3210, 3272, 3273f
single staged correction of 3211f
Blepharoptosis 3273
congenital 3211
Blepharospasm 3248
Blinatumomab 3013
Blindness 1965f, 3205
Blistering dactylitis 3313
Bloch-Sulzberger syndrome 3288, 3373
Blood 1469, 2004, 2485
flukes 1631
gas 89, 339, 368, 722, 2259
classification 339, 340fc
interpretation 339
interpretation of 261
measurements 707t
glucose 89, 2958
monitoring of 568
investigations 1487, 1735, 2362, 2513
loss 573, 1586
plasmalogens 89
produces, hemoglobin in 2600
products 292, 332
sample collection 201, 2069
volume 635
Blood gas
normal values 260, 261t
Blood acylcarnitine analysis 115
Blood borne virus infection 1124
Blood brain barrier 1930f
Blood component therapy 2100, 2102, 3116
Blood culture 635, 653, 1903, 2210
Blood pressure 64, 301t, 320, 322, 331, 366, 474, 592, 1224, 1569, 1576, 2262, 2263, 2302, 2919
measurement of 2556
recording 2263
Blood transfusion 153, 580f, 700, 1488, 2019
judicious use of 615
Blood urea 2486
Blood urea nitrogen 1339, 2486
Blood vessels 1080
formation of 2252f
Bloodstream infection 1394
Bloom syndrome 3394
Blount's disease, bilateral 3401f
Blowout fracture 3279, 3280f
BLS. See Basic life support
Blueberry muffin rash 662f
Blunt injuries 421
BMI. See Body mass index
Bochdalek hernia 753
Body dissatisfaction 1250
Body fluid 1676
compartments 248f
distribution 252fc, 248f
Body image disturbance 980
Body mass index 454, 540, 541, 798, 807, 820t, 822t, 825f, 826f, 829, 829t, 857, 979, 1184, 1243, 2898, 2932
chart 833f, 834f
role of 798
Bohan and Peter criteria 3170b
Bone 155, 1386, 2597
density 90
development of 847, 2983
disorders of 2573, 2999, 3400
health 906, 976
infarcts 148
involvement, recognition of 148
lesions 668
pain 148, 152, 3409
resorption, inhibition of 2979
scan and skeletal survey 2910
strength, assessment of 2984
tumors 3098, 3099t, 3100
Bone age 55, 847, 855, 2905, 2910
assessment, methods of 850
estimation, clinical application of 849
Bone conduction hearing aid 928
Bone marrow 145f, 152, 154, 203, 1676, 1948, 1964f, 1972f, 1979, 1981, 1985, 2004, 2074, 3104, 3341
aspiration 157f, 1994, 2040, 3044
examination 151, 1970, 1994, 1999
failure 225, 226t, 1978, 2073
hyperplasia 2004
infiltration 148
transplantation 71, 90, 138f, 208, 216, 233, 1488, 2020, 2029t, 2528, 2556, 2999, 3119
Bone mineral density 148, 1062, 2898, 2984
Bony cage 2274
Bony fusion surgery 3439
Borderline leprosy 1463
Bordetella pertussis 1305, 1357, 1358
Börjeson-Forssman-Lehmann Syndrome 2988, 2991
Bornholm disease 1533
Borrelia afzelii 1413
Borrelia burgdorferi 1332, 1413, 1414
Borrelia garinii 1413
Borrelia recurrentis 1410
Borrelia turicatae 1410
Bosentan 733
Botulinum toxin 1781
Botulism 1426, 2807
Boutonneuse fever 1691b
Bowed legs 3401
Bowel
bladder dysfunction 2569
disease 280
function 2608
incontinence 2608
obstruction of 763
sphincter dysfunction 2608
Bowel duplication cyst 769
Bowel in-bowel sign 1837
BPAP. See Bilevel positive air pressure
BPD. See bronchopulmonary dysplasia
Brachial palsy, Narakas classification system 549t
Brachial plexus injury 526f, 548, 548f
Brachycephaly 2580, 2991f
Bradyarrhythmias 318, 2458
causes 318, 320
signs 318
symptoms 318
Bradycardia 318, 319f
management of 320fc
Brain 48, 2611, 2613
computed tomography scan of 53, 1432f, 2910
death 2693, 2701, 2701t
declaration of 2702
derived neurotrophic factor 858
development 2619
abnormalities of 2623
dysfunction 880
edema 2595f
evaluation of 2593
imaging 2761
infiltration of 2873
inflammation of 2873
injury 566, 690t
irradiation of 2873
lesions 2696t
magnetic resonance imaging of 126f, 129, 193, 662, 671, 1553f, 2423, 2602f, 2603f, 2689, 2789
parenchyma 2595
seven windows of 2870
spectroscopy of 1933
stem hypoplasia 2623
stroke 2016f
Brain abscess 2585, 2633, 2687, 2688, 26902692
clinical features of 2689t
empirical antibiotic therapy for 2691b
histological stages of 2687t
management of 2692
poor prognostic markers of 2692b
radiological appearance of 2690t
surgical drainage of 2691b
Brain malformations 2579, 2619, 2620
classification of 2619, 2619b
Brain natriuretic peptide 1525, 1527, 2400, 2428
Brain tumors 979, 2585, 3055, 3056t, 3060
general classification of 3056t
genetics of 3058t
incidence of 3056f
molecular genetics of 3057
Brainstem 2579, 2601, 2669
development, disorders of 2619
disorders of 337, 2621
encephalitis 1502
gliomas 3064
hyperintensities 126f
reflexes 2695
Brainstem auditory evoked potential 2589, 2591t
normal 2591f
Branched-chain alpha-ketoacid
dehydrogenase 93, 112
Branched-chain amino acid 95, 112fc, 1930, 1935
aminotransferase deficiency 93
catabolism 93
disorders of 93
Breakthrough disease 1176
Breast
abscess 494
cancer 80
development 2900
engorgement 493
enlargement 479
nodule 472
tissue 2908
Breastfeeding 246, 488, 494, 521, 1008, 1020
jaundice 553, 553t
positions 491f
practices 493
technique of 490
Breastmilk 488, 551, 1469
manual expression of 496f
Breath
types of 352
Breath hydrogen test 1812
Breath sounds 2117
Breath-holding spells 938, 939, 2653, 2653t
characteristic features of 939b
Breathing 300, 320, 322, 367, 413, 414, 426, 438, 439, 467, 617, 618, 636, 1575, 1576, 2197
initiation of 457
mechanics of 2113
work of 2114
Breathlessness, acute onset of 2223
Breteau index 1574
Brief resolved unexplained events (BRUE) 945
Brilliant cresyl blue dye test 2036
Bristol stool 2569
Broad-spectrum therapy 1346
Bronchial anatomy 2313f
Bronchial arteries 2107
Bronchial asthma. Also See Asthma, acute asthma, chronic asthma 2188, 2191, 2193
control of 2194t
treatment of 2195t
Bronchial breath sounds 2117
Bronchial provocation tests 2192
Bronchiectasis 2238, 2239, 2239t, 2240f, 2241
etiology of 2240fc
pathogenesis of 2238f
Bronchiolitis 21772179, 2181b, 2182
differential diagnosis of 2178t
drug treatment for 2180t
management of 2180f
severe, risk factors for 2178b
Bronchoalveolar lavage 1439, 1549, 1623, 1660, 1676, 1679, 2186
Bronchodilators plus glucocorticoids 2181
Bronchogenic cyst 2163, 2167
Bronchomalacia 2168f
Bronchophony 2117
Bronchopulmonary dysplasia 489f, 506, 507, 515, 518, 626, 696, 698, 742, 744, 746t, 2180
etiopathogenesis of 744fc
Bronchoscopy 2119, 2122, 2186
Brown superior oblique tendon sheath syndrome 3268
Brown syndrome 3269f
clinical features 3269b
Brucella abortus 1406
Brucella melitensis 1407
Brucella suis 1304
Brucellosis 1405, 1407b, 1408
acute 1407
asymptomatic 1407
treatment of 1408b
Bruckner reflex 3263f
Bruckner test 3221, 3263, 3263f
Brudzinski's sign 2584
Brugada syndrome 2444
Brugia malayi 1627
Brugia timori 1627
Bruises 3480
Bruton tyrosine kinase gene 205, 215
Bryant's sign 1799
B-type natriuretic peptide 2301
Bubble continuous positive airway pressure 713
Bubonic plague 1403
Budd-Chiari syndrome 1882, 1890, 1895, 1905
management of 1890t
Budesonide 3588
Buffer systems 259
Bulbar polio 1537
Bulbar weakness 178
detection and management 2800
Bulbospinal polio 1537
Bulimia nervosa 978, 980, 982
diagnostic criteria for 981t
management of 982t
Bull's eye 1413f
Bullet fragments 2597
Bullous fixed drug eruption 3345
Bullous impetigo 3311, 3376f
Bullous pemphigoid 3374
Bullying 1250
Bumetanide 674, 3589
Bundle branch block 2283, 2449f
Bungarus caeruleus 395, 395f
Bunyaviruses 1581
Buphthalmos 2518
Burette of infusion set 292
Burkholderia cepacia 222, 652
Burkitt lymphoma 3047, 3048f, 3050, 3050f, 3053
Burn 188, 412, 426, 1385
depth of 427, 429f
infectious complications of 430
injuries 425
minor 426
wound 430t, 432
colonization 430
infection 430
Burning micturition 1277
Burnt sugar odor 113
Burst-forming unit
erythroid 1949
megakaryocyte 1954
Buruli ulcer 1131
Busan pledge 3509b
Busulfan 3589
Butterfly vertebra 1876f
Byler disease 1874
Bypassing oxidative phosphorylation defects 127
C
Cabot's ring bodies 1977t
Cachexia 150f
Café-au-lait
macule 2752, 2752f
spots 43, 910, 3368
Caffeine 518, 699
citrate 3589
therapy 747
Caffey disease 3452
Calcimimetic agent 2979
Calcineurin inhibitors 2524, 2526, 2577
Calcinosis 3169, 3169f, 3364
Calcipenic rickets 2553, 2980, 2981
Calcipenic rickets, causes of
non-nutritional 2980
Calcitonin 2558
gene-related peptide 1794, 2954
Calcitriol 3363
Calcium 512, 567, 992, 1244, 1876, 2048f, 2549, 2550, 2551, 2553, 2974
carbonate 2573, 3589
channel blockers 367, 378, 2399, 2454, 2456, 2526, 2560
chloride 317
deficiency 1064b, 2555, 3363
disorders 2976
excretion 2487
free binders 2573
gluconate 3589
homeostasis 146
intake 1245
ions 2866
oxalate crystals 2486, 2551
phosphate homeostasis, disorders of 2573
release-activated calcium 220
sensing receptor 2545, 2974
supplementation 2305
indications for 2305
Calculi
location of 2552
type of 2552
Calf hypertrophy 2785f
Calf pain
bilateral 3404
Caloric supplements
oral 2236
Calorie 1244
requirement 855
Calymmatobacterium granulomatis 1275
Campomelic dysplasia 2951
Campylobacter coli 1716
Campylobacter jejuni 1304, 1305, 1370, 1707, 1716, 2805, 2806f
Canakinumab 3146
Canavan disease 2600, 2771
Cancer 3006
associated myositis 3170
cachexia 979
chemotherapy 3000
epidemiology of 3006
therapy 3354
Candesartan 2304
Candida albicans 639, 651, 652, 1274, 1651, 1652, 1655f, 1737, 1895, 3284, 3304
Candida auris 1648, 1649, 1651, 1652
Candida famata 1650, 1652
Candida glabrata 1652, 1655f
Candida guillerimondii 1647, 1650, 1652
Candida krusei 1649, 1651, 1652
Candida lipolytica 1647
Candida lusitaniae 1647
Candida parapsilosis 1650, 1652
Candida pelliculosa 1652
Candida rugosa 1652
Candida tropicalis 1652
Candida infection 3315
diaper dermatitis 641
risk factors 651b
meningitis 651
vulvovaginitis 1275
Candidiasis 113, 1275, 1550, 1652, 1655
extensive cutaneous 641f
superficial 1653, 1655
Capillary bilirubinometers 556
Capillary malformation 3320, 3320f
Capillary refill time 471, 475, 585
Capillary zone electrophoresis 2011
Capnocytophaga canimorsus 422, 2034
Capreomycin 1446, 2672
Capsule endoscopy 1736, 1899
Captopril 288, 2304, 2559, 3589
Caput quadratum 1963f
Caput succedaneum 546, 546t
Carbamate poisoning 382
Carbamazepine 288, 2605, 2608, 2638, 2640, 2645, 3589
Carbamoyl phosphate 105
synthetase 84, 85, 105, 107, 108
deficiency of 104
Carbapenem 1371, 1424
resistant
Acinetobacter baumannii 1319
Pseudomonas aeruginosa 1320
Carbenicillin 3589
Carbohydrate 512, 989, 990, 1729, 1738
malabsorption, investigations for 1811
metabolism 258, 165t, 1863
defects of 165
inborn errors of 165
recognition 232
requirement 1086
Carbon dioxide 338t
arterial partial pressure of 340, 346, 2700
bound 258
inhalation 699
partial pressure of 260263, 331, 338f, 340, 368, 696, 707, 708, 942, 2111, 2112f, 2113f
removal of 703, 709
transport 258, 259
Carbon monoxide 367, 1430, 2119
Carbonic acid 258
Carbonic anhydrase 108
Carboxyfluorescein succinimidyl ester 215
Carboxyhemoglobin concentrations 367
Carboxylase 89
Carcinoid syndrome 1742
Carcinoma breast, familial 70
Cardiac anomalies 2710
Cardiac arrest 302, 303f, 312, 314
causes of 314t
management of 314b, 315fc
pathophysiology of 303, 304fc
phases of 314
treatment of 304
Cardiac arrhythmias 178
Cardiac catheterization 2293, 2327, 2341, 2346, 2372, 2379, 2398, 2433
hemodynamics 2336
Cardiac disease 161, 2528
Cardiac dysrhythmias 2441
Cardiac emergencies 2465
Cardiac failure 563, 2260
Cardiac loop, formation of 2253
Cardiac magnetic resonance imaging 2297, 2433, 2428
Cardiac resynchronization therapy 2307
Cardiac tamponade 2467
Cardiobacterium hominis 2420
Cardiomyopathy 71, 86, 136, 694, 2270, 2427, 2429, 2437, 2543
classification of 2429fc
Cardiopulmonary resuscitation 302, 303f, 307f, 308, 309, 311, 315, 317, 320, 417, 439
Cardiorespiratory monitoring 2651
Cardiorespiratory polygraphy 2248
Cardiotocography 542
Cardiovascular adaptation 457, 458
Cardiovascular diseases 74, 1269, 2250, 2268
Cardiovascular-mediated syncope 2858
Carditis 2403
Career guidance 1287
Caries 17621766
Carnitine 70, 120, 1935, 3590
acylcarnitine translocase deficiency 119, 120
cycle 119fc
metabolism 190
palmitoyltransferase deficiency 86, 119, 120, 188
therapy 121
Caroli disease 1901, 2499
Carotenoids 994
Carotid pulse 2262
Carpal bones 848f
Carpal tunnel syndrome 136
Carpenter syndrome 57, 2928, 2988, 2991
Carpopedal spasms 2653
Cartridge-based nucleic acid amplification test 1332, 1436, 1438, 1442, 1447, 2587
Carvedilol 288, 2304, 2305, 2560, 3590
Casal necklace 1053
Casoni's test 1640
Caspase recruitment domain 204, 205
Caspofungin 1648, 1651
acetate 3590
Casts 2486
Cat eye syndrome 65
Cat scratch disease 3284
Cat urine odor 113
Catagen 3395
Catamenial pneumothorax 2214
Cataract 55, 2518, 3239, 3245
bilateral 663f
Catch-up vaccination 1142, 1144, 1148, 1150, 1171, 1176
Catecholamine resistant hypotension 2306fc
Catecholaminergic polymorphic ventricular tachycardia 2458
Catheter 2533
ablation 2455, 2455b
indications for 2455b
associated urinary tract infection 632
drainage 779f
Cation-exchange high-performance liquid chromatography 2011
Cationic amino acid transport 102
Cattle-related injuries 421, 424
Caudal duplication 773f
Causality assessment classification 1128f
Cavitary pulmonary parenchymal disease 1431f
CblB disease 1998
CblF disease 1998
CCF. See Congestive heart (cardiac) failure
Cefaclor 2563
Cefadroxil 2563
Cefazolin sodium 3590
Cefepime 3590
Cefixime 2563, 3590
Cefoperazone-sulbactam 3590
Cefotaxime 2563
Cefoxitin 3590
Cefpodoxime 288
proxetil 3590
Ceftazidime 3590
Ceftriaxone 2563
sodium 3590
Cefuroxime axetil 3590
Celiac disease 61, 1743, 1745, 1745f, 1819, 1820f, 1821t, 1822, 1822f, 1822fc, 1822t, 1823f, 2510
clinical features of 1820t
diagnosis of 1821
nonresponsive 1820
pathogenesis of 1819f
Cell 203
count 1847
culture 1494, 2230
median infectious dose 1134
vaccines 1164, 1507
free fetal deoxyribonucleic acid 63, 540
membrane 250
proliferation, abnormalities of 2617f
Cell-mediated immunity 207, 634, 1429
effector mechanisms of 206
Cellular function 232
Cellular immunity 218
Cellular iron functions 1989
Cellulitis 2523, 2526, 2943f, 3312
Cellulose acetate 2011
Cement burns 431f
Central alpha-antagonist 2560
Central alveolar ventilation 2247
Central apnea 697
episode of 2160f
Central auditory processing disorders 950
Central bronchiectasis 1658f
Central cyanosis 597, 2358
Central facial nerve injury 548
Central hypoventilation 2247
Central nervous system 52, 106, 133, 145, 174, 193, 226, 263, 330f, 366368, 383, 563, 598, 645647, 662, 664, 676, 693, 784f, 880, 905, 954, 1032, 1330, 1386, 1423, 1429, 1473, 1491, 1502, 1530, 1546, 1563, 1604, 1644, 1691, 1760, 1790, 1840, 1930f, 2586, 2625, 2668, 2736, 2780, 2862, 2879, 2898, 3006, 3018, 3368, 3393
congenital 783
cryptococcosis 1661
depression 367
directed therapy 3028
disease 1662
histopathology of 1675
infection 651, 1423, 2691
injury 339
invasion of 647fc, 1468
malformations 783, 785, 2872
pathology of 2583, 2593
toxicity, mechanisms of 105
tuberculosis 1432, 2669, 2670b, 2671, 2672
prevention of 2674
treatment of 2671b
types of 2604
vasculitis 2697
Central nervous system tumors 2873, 3055b, 3057t, 3058t
Central precocious puberty 2906, 2907f
causes of 2907b
management of 2910
Central sleep apnea 943
Central venous pressure 1801
Centromere 58
Centronuclear myopathy 2840, 2843
Centruroides exilicauda 408
Cephalexin 2563, 3590
Cephalic fold defect 769
Cephalohematoma 546, 546t
Cephalosporins 1393
Cereals 995
nutritive value of 1005t
Cerebellum 2601, 2616, 2669
disorders of 2619
Cerebellar astrocytoma 3062, 3063f
Cerebellar ataxia 136, 2676
Cerebellar cortical dysplasia 2623
Cerebellar development 2621
Cerebellar disease 2584
Cerebellar function 2725
Cerebellar hemorrhage 688f
Cerebellar hypotonia 2584
Cerebellar lesions 2584
Cerebellar signs 152, 2583, 2630
Cerebellar vermis hypoplasia 2619
Cerebral cortex, loss of 193f
Cerebral edema 1938, 2971
diagnosis of 2971t
Cerebral gigantism 526, 875
Cerebral hemispheres 2620
fusion of 2620
Cerebral hydatid cysts 1640
Cerebral hypoplasia 2611
Cerebral hypotonia 2812
Cerebral malaria 1589, 1593
Cerebral nocardiosis 1416f
Cerebral palsy 507, 518, 624t, 630, 690, 896, 896f, 897, 898, 898fc, 900903, 903t, 904f, 907t, 2584
classification of 898fc
modified Swedish classification systems of 897t
prevention of 907
surveillance of 896, 898fc
topographical classification of 897f
Cerebral perfusion pressure 2694, 2697, 2700
Cerebral venous sinus thrombosis 2088, 2089, 2091t, 2705, 2706, 2713
Cerebral visual impairment 3271
analysis 2665, 2690
biochemistry 2586
cytology 2586
drainage 2699
examination 2585, 2586
flow of 2585
glucose 89, 2586
gross examination 2585
leakage 1377
macrophages 145
pathway 2626f
pleocytosis 1476
pulsatile flow of 2626f
rhinorrhea 2129
Cerebrovascular disease 2579
Certolizumab 3145
Ceruloplasmin 1927
Cervical anomalies 3412
Cervical cancer 1195, 1229
Cervical cytological abnormalities 1199
Cervical ectopy 1274
Cervical instability 3412
causes of 3414b
Cervical intraepithelial neoplasia 1195, 1197
Cervical lymph node enlargement 1432f
Cervical spinal cord injury 2776b
Cervical spine 3416, 3417
infections 3416
precautions 425
tuberculosis 3416
Cervical stenosis 1267
Cervical vertebral synostosis 3415
Cervicofacial actinomycosis 1418f
Cetirizine 3591
CFTR modulators 2237
CGD. See Chronic granulomatous disease
Chagas disease 12, 1780
Chain amino acids 111, 2600
Chalazion 3274
right upper eyelid 3274f
Chalcosis 3282
Chancroid 1278f
Chandipura virus 2677
Chaotic atrial rhythm 2447
Chaperone therapy 90, 139, 179
Charcot-Leyden crystals 1633
Charcot-Marie-Tooth disease 39, 28502853
classification of 2853t
Charcot-Marie-Tooth neuropathy score 66, 2853
CHARGE syndrome 748, 2951t
Chediak-Higashi syndrome 134, 221, 223
Chelation therapy 2027
Chemical burn 430, 431f, 3253
classification of 431
pathophysiology of 431
Chemical conjunctivitis 643
Chemical injuries 3278, 3282, 3282f
Chemical meningitis 2586
Chemical pollution 3509
Chemiluminescent immunoassay 1521
Chemobiokinetics 1078
Chemokines 204
Chemoprophylaxis 1301, 1374, 1404, 1434, 1594
Chemotherapeutic agents 2530
Chemotherapy 108, 1211, 1641, 1944, 1945f, 1946, 2777, 3002, 3012, 3045, 3060, 3074, 3080, 3095, 3101
agents, emetogenic potential of 3118b
principles of 3012
Cherry red spot 88f, 137, 158f, 159, 911f
Chest 2117
circumference 1035
compression 309f, 469
computed tomography 346f, 2118
scan of 2186, 2186f, 2440f
contrast-enhanced computed tomography of 2218
high-resolution computed tomography of 1548f, 2226, 2748
pain 2116
physiotherapy 2181, 2234
plain radiograph of 749, 754
radiograph 711, 722, 2205, 2343, 2393
retraction 1336
roentgenogram 2417
skiagram 717, 1062f, 2273
tube in situ 724f
tube placement 724
ultrasound 717
CHF. See Congestive heart failure
Chickenpox 4, 1496, 1497. See Varicella
congenital 1500
Chiclero ulcer 1599f
Chikungunya 15771579, 2680
diagnosis of 1578
fever 1577, 1579t
virus 1577, 1578
Chilblain 435, 435f
Child abuse 4, 365, 431, 3286, 3478, 3480b, 3482
and neglect 3476, 3479b
etiology of 3479
history of 3477
Child adoption resource information and guidance system 3487
Child behavior checklist 933
Child labor 17, 3469, 3472fc, 3473, 3478
physical health hazards of 3474t
Child morbidity 14
age-wise distribution of 14
Child mortality 9, 10
Child nutrition programs and strategies 3515
Child protection services 3515
Child psychiatric disorders 985
Child rights 3490, 3491
Child-rearing practices 930
Child sexual abuse 3477, 3483
presentations of 3483
prevention of 3484
Child Survival and Safe Motherhood Program 460, 3513
Childhood absence epilepsy 2635, 2638, 2642
Childhood anemia 1962
Childhood asthma, pathogenesis of 2191t
Childhood autism rating scale 973
Childhood blindness, causes of 3293b
Childhood cancer 3008t, 3013, 3014t
etiology of 3007
incidence of 3006
Childhood cholestatic liver disease, evaluation of 1924t
Childhood epilepsy 2639
Childhood interstitial lung disease (CHILD) 2219, 2222b, 2223t. See Interstitial lung disease
treatment for 2224
Childhood linear scleroderma 3192f
Childhood myelodysplastic syndrome 3036t
prognostic classification of 3039t
Childhood stroke 2705
Chimera 38
Chimeric antigen receptor T-cell therapy 3015
Chimeric vaccine 1163, 1566
Chlamydia 1358
infections 1702, 1703
psittaci 1304
trachomatis 642, 643, 1268, 1275, 1306, 1702, 2134, 2204
Chlamydial cervicitis 1278
Chlamydiasis 1275
Chlamydophila pneumoniae 1702, 1703, 2205
Chlamydophila psittaci 1702
Chloral hydrate 362, 3591
Chloramphenicol 3591
Chlorhexidine 645
Chloride 255
channel 2823
Chlorofluorocarbons 1117
Chloroquine 288, 372
phosphate 3591
Chlorothiazide 2547, 3591
Chlorpheniramine maleate 3591
Chlorpromazine 409, 3591
Choanal atresia 2121
Choking 310
Cholangiogram 1874f
Choledochal cyst 1871, 1901
Choledocholithiasis 1901
Cholelithiasis 150, 2007
Cholera 13, 1718, 1719, 1719f, 1721
bacteria 1719
dolores 1720
gravis 1721
Cholera vaccine 1174, 1175, 1722
oral 1174, 1722
Cholestasis 122
Cholestatic disorders 1928
Cholestatic pruritus, step-wise management of 1926t
Cholesterol 89, 2523
synthesis 129
Cholesteryl ester storage disease 1911
Cholinergic stimulation 406
Cholinergic toxidrome 383t
Chondrodysplasia punctate 53
Chondroitin sulfate 182
Chorea 2718, 2724
etiology of 2718t
Choreoathetoid movements 113
Choreoathetosis 2581, 2655
Chorionic villus sampling 83, 129, 540, 785
Chorionicity 530, 530b, 531f
determination of 531
Chorioretinal lacunae 53
Choroid and retina, gyrate atrophy of 100
Choroid plexus 687, 687f
ependymal cells of 2585
papilloma 3069f
tumors 3067
Choroidal detachment 3281
Choroidal fissure 3205
Christmas tree appearance 763, 763f
Christ-Siemens-Touraine syndrome 3391
Chromatids 58
Chromium 1074, 1088
Chromosome 58, 1924
analysis, methods of 69f
mutations 39
nomenclature of 58
structure of 59f
Chromosomal abnormalities 880, 2613, 2620
balanced 65
numerical 58
types of 59t
Chromosomal analysis 53, 55, 67, 2271
Chromosomal disorder 58, 69, 3285
diagnosis of 69
Chromosomal microarray 55, 58, 89, 919, 919f
Chromosomal syndrome 53, 2268
Chronic abdominal pain 1759, 1759b, 1789, 1790. See Functional abdominal pain
management of 1792b
Chronic acidosis 2574
Chronic adenoiditis 2156
Chronic anemia 1512, 1958, 1974
Chronic arthritis 3130
Chronic aspiration syndrome 2187
Chronic ataxia 2727, 2730fc
Chronic biliary disease 1918
Chronic blood loss 1992
Chronic brucellosis 1407
Chronic bullous disease 3375, 3375f
Chronic chloride diarrhea 1731
Chronic cold stress 484
Chronic daily headache 2660
Chronic dialysis modality 2575b
Chronic dialysis, outcomes of 2576
Chronic diarrhea 1729, 1732, 1734fc, 1735t, 1737, 1739, 1746
causes of 1733b
classification of 1730b
pathophysiology of 1731
prognosis of 1748
Chronic encephalopathy 2757, 2758
Chronic granulomatous disease 222, 1828, 1901
Chronic hemolytic anemia 865, 2035
Chronic hepatitis 1542, 2542
C virus infection 1912
Chronic infection, treatment of 1413
Chronic inflammatory diarrhea 1738, 1739fc
Chronic intraepithelial inflammatory cells 1814
Chronic kidney disease 161, 1445, 1992, 2501, 2528, 2532, 2555, 2572, 2572t, 2575
diagnosis of 2488
management of 2486
stages of 2572t
Chronic liver disease 152, 855f, 1865, 1866, 1869, 1898, 1909, 1911f, 1915b, 1925, 1930
childhood 1911f, 1921t
classification of 1910
complications of 1923
etiology of 1912t
evidence for 1910t
stigmata of 1885t, 1914
Chronic lung disease 507, 512, 693
Chronic lymphocytic
leukemia 209
thyroiditis 2887, 2895f
Chronic mucocutaneous candidiasis 1654
Chronic myeloid/myelogenous leukemia 1961, 3030, 3032t, 3033
chronic phase of 3032t
cytogenetics in 3031
treatment of 3035b
Chronic neurodegenerative disorders 83
Chronic nonprogressive headache 2659
Chronic nonspecific diarrhea 1732, 1746
Chronic obstructive pulmonary disease 2183
Chronic organ damage 2017
Chronic osmotic diarrhea 1732t, 1738
Chronic pain abdomen 1792b
Chronic pancreatitis 1801, 1802
causes of 1802b
Chronic peritoneal dialysis 2575, 2576b
Chronic plaque psoriasis, erythematous scaly plaques of 3378f
Chronic pneumonia 1673
Chronic progressive headache 2659
Chronic pulmonary disease 803, 1456
Chronic refractory heart failure 2307
Chronic renal disease 803
Chronic renal failure 803, 865, 1214, 1975
Chronic respiratory
acidosis 340
alkalosis 340
disorders 342
failure 340, 340t
Chronic suppurative otitis media 2133, 2136
Chronic systemic disease 868, 1181
Chronic thromboembolic pulmonary hypertension 2400
Chronic tonsillitis 2155
Chronic urticaria 3335, 3339fc
diagnosis of 3338fc
treatment of 3339fc
Chronic ventilatory support 2248
Churg-Strauss syndrome 212, 2509
Chvostek sign 2653
Chylomicron retention disease 1813
Chylous ascites 1845, 1845f
Cicatricial alopecia 3367f
Cidofovir 1471
Cilia
studies 2230
ultrastructure of 2229f
Ciliary neurotropic factor 1330
Ciliopathies 2727
Cimetidine 288
Ciprofloxacin 1318, 1371, 2563, 3591
Circadian rhythm 459
Circle of Willis 2595f, 2596, 2601f
Circulating vaccine derived poliovirus 1100, 1536, 1537
Circulation 300, 320, 322, 367, 413, 414, 426, 438, 439, 467, 617, 618, 636, 1575, 1576, 2197
maintenance of 739
Circumventricular organs 2870
Cirrhosis 97, 102, 1880, 1883, 1885, 1886t, 1930, 2510
causes of 1885t
classification of 1918
complications of 1918
development of 1912
molecular pathogenesis of 1913f
Cirrhotic ascites 1845, 1848
clinical presentations of 1846
complications of 1847
management of 1848fc
Cisterns 2596
Citalopram 1252
Citrate 2551
phosphate-dextrose-adenine 2103
Citrin deficiency 106, 108
Citrobacter freundii 1160
Citrulline 93, 108, 110
Citrullinemia 105, 108
CKD. See Chronic kidney disease
Clarithromycin 1446, 3591
Classic hereditary periodic fever syndromes 3199
Classic transient neonatal hypoglycemia 568
Classical Hodgkin lymphoma, histopathologic classification of 3043t
Clavicle fracture 550
Clavulanic acid 3585
Claw hand deformity 2852f
CLD. See Chronic liver disease, Chronic lung disease
Cleansing agents
for newborns 3309
Cleft lip 52, 495, 1767, 1768f, 1770, 1771f
Cleft palate 41, 52, 71, 495, 1767, 1770
Cleidocranial dysostosis 3450f
Cleidocranial dysplasia 53, 3449
Clicker frequency test 1933
Clindamycin 1423, 3591
Clinically isolated syndrome 2737, 2743
CLL. See Chronic lymphocytic leukemia
Cloacal exstrophy 775, 776, 776f
Cloacal malformations 778
Clobazam 2645, 3592
Clofazimine 288, 1446, 2672
Clonazepam 2645, 3592
Clonic seizures 672
Clonidine 2560
hydrochloride 3592
Clonorchis sinensis 1631
Closed loop syndrome 1833
Closed neural tube defects 786
Clostridium botulinum 1343, 1425
Clostridium butyricum 1752
Clostridium difficile 1313, 1717, 1749, 1898
associated diarrhea 1750t, 1751
infection 1425, 1749
relevance of 1749
Clostridium perfringens 1305, 1306, 1343, 1717, 1749, 1752
Clostridium septicum 652
Clostridium tetani 658, 1142, 1304, 1306, 1343, 1360, 1425
Clotting factor deficiencies 20642067
Clouston syndrome 3392
Cloxacillin 3592
CMD. Also See Congenital muscular dystrophy
CML. See Chronic myeloid leukemia
Coagglutination 1310
Coagulase negative staphylococci 633, 1384, 1386
Coagulation 2047
disorders 2050
inherited disorders of 584
Coagulopathy, management of 1940
Coanda effect 2354
Coarctation of aorta 85, 2266, 2295f, 2344, 2344f, 2347t, 2365, 2372f, 2473, 25572559, 2710, 3177
balloon dilation of 2348f
Coarctation, balloon angioplasty of 2295f
Cobalamin 1054, 1999
absorption of 1999b
deficiency 2000
Cobalt 1076
Cobblestone malformation 2622
Coccidioidal disease 1670t
Coccidioidal meningitis 1666, 1667f
diagnosis of 1668
Coccidioidal pneumonia 1665f
diagnosis of 1668
Coccidioides immitis 1332, 1647, 16481650, 1663
Coccidioides posadasii 1663
Coccidioidomycosis 1663, 1669
severe 1664
Cochlear implants 927
Cock Robin position 3412
Cockayne syndrome 3394, 3395, 3395t
Codeine phosphate 3592
Coenzyme A 112, 118, 119, 129
Coffin lids 2551
Coffin-Siris syndrome 55
Cogan syndrome 2498
Cognitive behavior therapy 1252
Cognitive development 882, 884886, 888, 1233
Piaget's stages of 1233, 1233t
Cohen syndrome 2988, 2992
Coiled spring sign 1837, 1837f
Cold agglutinin syndrome 2039, 2042
Cold boxes 1121
Cold chain 1116
equipment 1119
monitoring of 1121
network 1117f
system 1117
Cold exposure 434
Cold feet syndrome 1221
Cold injuries 434
peripheral 434
Cold panniculitis 3304
Cold reactive autoimmune hemolytic anemia 2039
Cold shock 331
Cole's vicious cycle model 2238f
Colectomy 70
Colicky pain 1836
Colistimethate sodium 3592
Colistin sulfate 3592
Collagen 2086
dressing 432
vascular diseases 2586, 2885
cutaneous manifestations of 3364
Collagenous colitis 1736
Collapsed lung 721f
Collapsing glomerulopathy 2520
Collapsing pulse 2262
Collodion baby 3273f, 3389
causes of 3389b
Colloid 333
cyst 2659
Colon cancer 80
Colonic transit study 1806
Colonoscopy 1843, 1899
Colony-forming unit 1949f, 1953f
megakaryocyte 1953f, 1954
Colony-stimulating factors 1949f
Color vision 2581
Colostrum 488
Column agglutination technique 2943
Coma 2693, 2694, 2697
causes of 2693, 2693b
Combination therapy 2399
Combination vaccines 1147, 1151, 1208, 1209
Combined adenosylcobalamin 1998
Combined valve lesions 2411
Common bile duct 1884f
Common cold 2143, 2144, 2149f
differential diagnosis of 2144b
Communication 618
and family support 619
disorders 948, 951t, 953
classification of 949
types of 951, 952
for behavioral impact 1574
skills 1284
Community 1237
adolescent care counseling programs 1222
health center 462
protection, vaccination schedule for 1113
screening 2018
violence 1259
Comparative genome hybridization 2616
Compensatory head posture 3261
Compensatory scoliosis 3418
Complement-dependent cytotoxicity 212, 2074
Complement fixation test 1629, 1677
Complement regulatory defects 226
Complementary feeding 246, 488, 1006, 1010b, 1021
indicators 1007f
Complementary foods, types of 1009
Complete blood count 89, 740f, 1523, 1527, 1633, 1700, 1830, 1993, 2011, 2019, 2053, 2075, 2521, 3150, 3163
Complete enzyme deficiency 115f
Complete gonadal dysgenesis 2948
Complete heart block 2282f, 2455, 2459, 2459f
Complex allergic disorders 242
Complex febrile seizures 2630
Complex focal seizures 2637
Complex vascular lesion 2396f
Complicated malaria 1589
Computed tomography scan 55, 152, 418, 648, 664f, 673, 679, 769, 770f, 775f, 789f, 1418, 1457, 1458, 1640, 1683f, 1736, 1738, 1739, 1813, 1826, 1903f, 2092, 2211, 2221f, 2223, 2298f, 2346, 2396, 2593, 2670, 2682, 2711, 2913, 3060
Computer vision syndrome 3226
Computer-assisted skeletal age scores 849
Concomitant strabismus 3261
Conduct disorder 964968, 968t
Conductive hearing loss 924
Condyloma acuminata 3318
Conflict of interest 26
Congenital adrenal hyperplasia 70, 80, 88, 199, 200, 276, 543, 849, 850f, 874, 875, 1776, 2558, 2907, 2918, 2919t, 2922, 2929
clinical features of 2950f
Congenital amegakaryocytic thrombocytopenia 1982, 2068, 2070, 2084
Congenital aniridia 3216f
Congenital bilateral perisylvian syndrome 2623
Congenital bone marrow failure 1978
Congenital cataract 2543, 3215
etiological classification of 3244b
types of 3217f
Congenital central hypoventilation syndrome 337, 945, 2247, 2248, 2855, 2862
Congenital chloride diarrhea 1816
Congenital clubfoot
clinical features of 3437
diagnosis of 3437
Congenital cricopharyngeal achalasia 1780
Congenital cutaneous candidiasis 641, 1653
Congenital cystic adenomatoid malformation 598, 694, 2164
Congenital diaphragmatic hernia 598, 753755
anatomical sites of 753f
Congenital duodenal obstruction 762
Congenital dyserythropoietic anemia 1968, 1972, 1973, 1983, 1983t
Congenital erythropoietic porphyria 198
Congenital esophageal stenosis 749, 1777f
Congenital fructose intolerance 70
Congenital heart disease 528, 599, 620, 717, 732, 803, 1769, 2142, 2267, 2271t, 2272, 2288, 2300, 2319, 2351, 2352, 2355, 2389, 2395, 2396, 2403, 2419, 2425, 2465, 2468, 2470, 2470t, 2471, 2556, 2626
genetic causes of 2267
incidence of 2470
management of 2289
Congenital hepatic fibrosis 1890, 1891t, 1911f, 1918, 2498
Congenital hydrocephalus 788
treatment of 788
Congenital hyperinsulinemic hypoglycemia 189f
Congenital hyperinsulinism 188, 191
Congenital hypertrophic pyloric stenosis 1754
Congenital hyperventilation syndrome 945
Congenital hypothyroidism 62, 70, 80, 88, 90, 199, 200, 2884, 2886, 2886b, 2886t, 2889
causes of 2885b
incidence of 914
Congenital intestinal malformations 758b
Congenital lactase deficiency 170, 1741, 1816
Congenital large hyperlucent lobe 2166
Congenital lens abnormalities 3240t
Congenital leptin deficiency 2989
Congenital lobar emphysema 2163, 2166, 2216
Congenital megacolon 1755
Congenital microcephaly 2612, 2613
Congenital miosis 3259
Congenital muscular dystrophy 2812, 2822, 2823t, 2827, 2831, 2834, 2835, 2838
classification of 2828t
subtypes, diagnosis of 2836
Congenital muscular torticollis 3411
Congenital myasthenic syndrome 2812, 2836, 2842, 2846, 2849
Congenital mydriasis 3259
Congenital myopathy 2812, 2835, 2840, 2842t, 2844
classification of 2840t
subtypes 2844t
clinical features of 2841t
Congenital myotonic dystrophy 2812, 2823, 2842
Congenital nasolacrimal obstruction 3248, 3277
Congenital nephrotic syndrome. See Nephrotic syndrome
Congenital nevi 3306
Congenital orbital lesions 3275
Congenital ovarian cyst 777
Congenital pericardial disease 2440
Congenital pneumonia 719
Congenital portosystemic shunts 1930, 1937
Congenital ptosis, correction of 3213f
Congenital pulmonary adenomatoid malformation 754
Congenital pulmonary airway malformation 2163, 2164, 2165f, 2166, 2243
classification of 2165t
Congenital renal disease 2556
Congenital smooth muscle hamartoma 3306
Congenital syphilis 641, 666, 3284
early 666b
Congenital talipes equinovarus 2608, 3436, 3438, 3458
Congenital telangiectatic erythema 3394
Congenital thrombocytopenia 219
Congenital tuberculosis 667, 1434
signs of 667
Congenital varicella syndrome 665, 1499, 1500
Congestive cardiac failure. See Congestive heart failure
Congestive heart failure 322, 1844, 1962, 1992, 2174, 2317, 2319, 2320, 2325, 2337, 2345, 2350, 2351, 2356, 2370, 2449f, 2454, 2456, 2461, 2465, 2468
treatment of 2468t
Conjoined twins 533
Conjugate vaccine 1101
Conjunctiva 642, 3227
xerosis of 1048
Conjunctival injuries 3279
Conjunctival intraepithelial neoplasia 3230
Conjunctival xerosis 1048f
Conjunctivitis 1376, 2614
Connective tissue disorders 1332, 2462, 3286
Conotruncal relationship 2316
Consciousness 2693
level of 2695
Consensus 25
Consent 25
Constant eye turning 3208
Constipation 900, 1365, 1760, 1803, 1804, 1805t, 1806, 1833, 2500, 2501, 2654
acute 1804, 1806
causes of 1805t
chronic 1804, 1806
etiology of 1804b
evaluation of 1805fc
idiopathic 1809t
organic causes of 1760t
treatment of 1806t
Constitutional tall stature 874
Constraint-induced movement therapy 903
Constrictive pericarditis 2440, 2441
chronic 2440f
Contact dermatitis 3333
Contact immunity 1135
Contact lenses 3225
Contact thermal methods 1896
Contaminated wounds 1328
Contiguous gene deletion syndrome 2613
Continuous glucose monitoring 2966
Continuous murmur 2266, 2266t
Continuous positive airway pressure 332, 347, 353, 462, 468, 604, 612, 620, 704, 710f, 713f, 716, 745, 2167, 2181, 2588
system, components of 713f
Continuous renal replacement therapy 2534
Continuous venovenous hemofiltration 2534
Contraceptives 1224
Contraction stress test 541
Contrast-enhanced computed tomography 785, 790f, 1801, 1802f, 2683, 2684
Conus cordis 2255
Conus medullaris syndrome 2774t
Convalescent carriers 1303
Convention on the rights of the child 3490
Convergent squint 150f
Conversion disorder 986t
Convex facial profile 840f
Convidecia vaccine 1192
Coombs negative hemolytic anemia 1907
Coombs test 1916, 2040, 2041f
direct 552, 2041f, 2077, 2943
indirect 2041f
Copeptin measurement 2880
Coping 1291
by street children 3467b
Copper 1074, 1088
deficiency 3363
Coprolalia 2655
Cord
blood
banking 74
transplants 3126
care 466, 478
cell transplant 90
clamping, timing of 458
compression 2674f, 2775
Corectopia 3259
Core-rod myopathy 2842
Corn meal agar 1655f
Cornea 3227, 3249
absence of 3227
congenital anomalies of 3212
conjunctivalization of 3231f
plana 3214
verticillata 161
Corneal dermoids 3230
Corneal diameter measurement 3249
Corneal endothelical dystrophies 3228
Corneal erosions 2517
Corneal injuries 3279
Corneal keloid 2543, 3230
Corneal scarring 1049f
Corneal ulcer 1048f, 3228f
Corneal xerosis cornea 1048
Cornelia de Lange syndrome 55, 56f, 2614
Coronary arterial fistula 2337
Coronary artery
abnormalities 3181f
aneurysms 234
anomalies 2361
disease 44, 1569, 2556
fistula 2338
Coronary sinus 2324f
rhythm 2312f
Coronary vein 1880
Coronavac 1192
Coronavirus disease 2019 (COVID-19) 6, 17, 28, 307f, 311, 1217, 1332, 1514, 1522, 1665, 1681, 1699, 1701, 1892, 1937, 2198, 2462, 2469
associated thrombosis 2096
clinical features 1519
crisis 3493
disease 1193
management of 1528
epidemic 3463, 3465
indirect effects 1519
infection 13, 353, 758, 764, 1192, 1339, 1514, 2529
pandemic 6, 13, 16, 23, 306, 311, 455, 1106, 1242, 1261, 1292, 1323, 1495, 1682, 3493
effect of 3472
progress of 1189
pathognomonic 1519
reporting and data system 1520
vaccination 1105
vaccine 1106, 1119, 1187, 1217, 1290
development of 12
Corpus callosum 689, 2616, 2621f
agenesis of 894f, 2619, 2621
genu of 2620
splenium of 2601
Corrigan's pulse 2417
Corrosive ingestion 390, 393fc
Corrosive poisoning 390, 391, 400
Cortical bone 2598
Cortical cataract 3240
Cortical collecting duct 273
Cortical development
malformations of 2619, 2622
normal stages of 2612
Cortical dysplasia 2613, 2620
diffuse 2640
Cortical sensation tests 2580
Cortical spreading depression 2658
Cortical visual impairment 3259
Corticosteroids 332, 348, 1211, 1679, 2078, 2172, 2208, 2514, 2522, 2524, 2574, 2672, 2685, 2699
oral 3319
therapy 2820
withdrawal of 2943
Corticotropes 2868
Corticotropin-releasing hormone 1760, 2866, 2898f, 2915
Cortisol 191, 1032, 2916
production, disorders of 2940
Cortisone reductase deficiency
apparent 2923
Corynebacterium diphtheriae 1305, 1343, 1353, 1356, 2155
Corynebacterium pseudotuberculosis 1353
Corynebacterium ulcerans 1353
Coryza 1331, 1332
Costello syndrome 526
Cotrimoxazole 288, 2563
acute 2140
chronic 21402142, 2142t
medication toxicity 374
nature of 2116, 2141t
recurrence of 2140
specific pointers of 2141t
syrups, overdose of 375
three clinical patterns of 2140f
timing of 2141t
Counseling
principles of 1282
process of 1283
scope of 1281f
Counterimmunoelectrophoresis 1603
Covaxin 1192
Cover-uncover test 3262
COVID-19. See Coronavirus disease 2019
Cow's milk protein allergy 1014f, 1729, 1744, 1796f, 1828, 1829f
Cowden syndrome 2895
Coxiella burnetii 1685
Coxsackievirus 668, 1529, 2147
CPAP. See Continuous positive airway pressure
Cracked nipples 493
Cradle cap 3398f
CRAFFT questionnaire 1253b
Crampy lower abdominal pain 1267
Cranberry muffin lesions 3305
Cranial dysraphism 2606
Cranial nerve examination 2581
Cranial radiation 3001
Cranial ultrasound 648, 679, 687, 687f
Craniocervical abnormalities 2775, 2775b
Craniofacial abnormalities 3286
Craniofacial anomalies 3275
Craniofacial reconstructive procedures 2162
Craniopharyngioma 3065, 3068f, 3068t
classification of 3068t
Craniosynostosis 53, 55, 790, 790b, 790f, 2580, 2593, 2611
syndromes 3449
Crash cart 325
C-reactive protein 234, 605, 635, 644, 653, 1400, 1520, 1523, 1527, 1532, 1686, 1800, 1826, 1827, 1839, 2174, 2205, 2403, 2406, 2428, 2666, 2786, 3136
Creatine deficiency 2762
Creatine kinase 89, 99, 179, 2842
Creatine metabolism, disorders of 89, 2761
Creatine phosphokinase 120, 127, 1399, 2786, 2799, 2804
elevated 2717
Creatinine 2486
Crescentic glomerulonephritis, treatment of 2510b
Creutzfeldt-Jakob disease 231
Cricoid pressure 309
Cri-du-chat syndrome 39, 64, 3285
Crigler-Najjar syndrome 70
Crimean-Congo hemorrhagic fever 1580
Crisis, prevention of 2019
Critical congenital cardiac diseases 2466
Critical congenital heart disease 80, 480, 601fc
screening for 200
Critical pulmonary stenosis 2340
Crohns colitis 1747f
Crohns disease 1743, 1794, 1798, 18241827, 1827f, 1829, 1829f, 1829t, 18301832, 1841, 1899, 2986, 3292
Croup 2168, 2170, 2171
differential diagnosis of 2171t
severity of 2170t
Crouzon syndrome 44, 55, 1769, 3286
Crowe's sign 3369f
Crown-rump length 539
Crude birth rate 9
Crusted scabies 3317
Cruveilhier-Baumgarten murmur 1881
Cryoglobulinemia 2525
Cryopyrin-associated periodic syndromes 3200
Cryptococcosis 1661
treatment of 1662
Cryptococcal disease, treatment of 1662t
Cryptococcal meningitis 1662, 2586
Cryptococcal pneumonia 1662
Cryptococcus neoformans 1308, 1332, 16471651, 1661, 1662, 1797, 3285
Cryptophthalmos 3212
Cryptorchidism 2954, 2955t, 2956
Cryptosporidiosis 1609, 1610, 1741
burden of 1609
Cryptosporidium 1609
detection of 1610
hominis 1609
parvum 1609, 1609f, 1797
Crypts of Lieberkühn 1757
Crystalloids 333
C-type lectin receptors 204
CTEV. See Congenital talipes equinovarus
Cubitus valgus 64
Cuddalore model 1223
Cuff leak test 356
Culex tritaeniorhynchus 1563
Cullen sign 1798
Culture-negative endocarditis 2420, 2422
Currarino triad 786
Cushing disease 2934
Cushing syndrome 861f, 870, 1264, 2557, 2874, 2930, 2931f, 2932f, 2933, 2933t, 2934, 2934fc
striae of 2931f
Cushingoid facies 3238f
Cutaneous adverse drug reactions, classification of 3343t
Cutaneous angiofibromas 3371f
Cutaneous blastomycosis 1673
Cutaneous desquamation
superficial 3303
Cutaneous leishmaniasis 1598, 1599, 1599f
Cutaneous lupus disease 3365
Cutaneous mastocytosis 3340
Cutaneous mucormycosis, black appearance of 1681f
Cutaneous neurofibromas 2752f, 3369, 3370
Cutaneous nocardiosis 1416, 1416f
Cutaneous porphyria 197, 198t
Cutaneous tuberculosis 1433
Cutis laxa syndrome 2342
Cutis marmorata 3301, 3301f
alba 3301
telangiectatica congenita 3320
Cyanide 368
Cyanocobalamin 3362
Cyanosis 535, 593, 597, 2118, 2355, 2465, 2634
appearance of 594f
causes of 596t
diagnosis of 597t
etiopathogenesis of 595
factors determining detection of 594
neurological causes of 599t
time of onset of 597
Cyanotic heart disease 696, 2073, 2355, 2357
congenital 2266, 23552358, 2386, 2687, 2688f, 2689
Cyanotic spell 2467. Also See Hypercyanotic spells
treatment of 2366
Cyclic adenosine monophosphate 731, 1708, 1715, 1720, 2045, 2045f, 2916
Cyclic neutropenia 222
Cyclic vomiting syndrome 1775, 1778, 2660
Cyclooxygenase 125f, 728f
Cyclophosphamide 2514, 2523, 2524, 3144, 3165
Cyclopia 2620
Cycloserine 2672
Cyclospora 1549
Cyclosporine 1928, 1987, 2523, 2524, 2577, 3144, 3592
Cypermethrin 365
Cyproheptadine 2662
hydrochloride 3592
formation 2497
hemorrhage 2497
Cystic dysplasia 2499
Cystic fibrosis 39, 40, 72, 79, 80, 199, 267, 766, 1395, 1601f, 1606f, 1732, 1746, 2201, 2233, 2234, 2237, 2238, 2550
clinical features of 2234t
management of 2235fc
transmembrane conductance regulator 39, 40, 72, 1731, 1738, 1802
Cystic kidney 2490
diseases 2491, 2497
acquired 2499
classification of 2497b
disorders 2499
Cystic lung lesions 2214
Cystic periventricular leukomalacia 518
Cystic renal disease 2506
Cystic white matter injury
bilateral 685f
Cysticercal meningitis 2684
Cysticercosis 3236, 3276. Also See Neurocysticercosis
Cysticercus cellulosae 3236
Cystine 92, 93, 2552
stones 2550
Cystinosis 135, 136, 2543, 3289
Cystinuria 91, 102, 2550
Cystography 2563
Cytarabine 3023f
Cytidine monophosphate 3013f
Cytochrome C 1989
oxidase deficiency 178
Cytogenetics 3025, 3031, 3038
Cytokine 204, 605, 637, 859
mediating antiviral action 204
production 206
targeted therapy 3202
Cytokine storm 634
Cytomegalic neurons 2624
Cytomegaloviral retinitis 3285
infection 1490
Cytomegalovirus infection
congenital 662, 662f
clinical features of 662b
Cytopathic hypoxia 2529
Cytopenia 136
Cytosine 36, 47, 58
adenine-guanine 47
thymine-guanine 2798
Cytotoxic T-lymphocyte 221, 2075
D
Daboia russelii 395, 395f
Dacryocystocele, congenital 3277
Dactylitis 2015f
Daily living, activities of 908, 913
Dalfopristin 3612
Dallas criteria 2428
Damage-associated molecular patterns 1798, 1846
Dancing peripheral arteries 2417
Dandy-Walker malformation 790, 2621, 2727
Dandy-Walker syndrome 2626
Danger signals 203
Danon disease 133, 135, 136
Daptomycin 1346
Darling's disease 1675
Darunavir 3592
Datura poisoning 386
Daytime incontinence 2501
1000-day window of opportunity 1096
de Lange syndrome 52, 53
de Morsier syndrome 2872
de Musset's sign 2417
Deadly fever 1596
Deafness 80, 136, 1998
Deamidated gliadin peptide 1737, 1738, 1822
DEBONEL 1688
Deciduous dentition 836, 837, 838f
development of 837t
Decompressive craniectomy 2701
Decontamination 367, 380, 391, 1301
Deep anterior lamellar keratoplasty 3232f
Deep brain stimulation 2724
Deep invasive candidiasis 1654
Deep mentolabial sulcus 840f
Deep morphea 3367
Deep partial-thickness burns 433f
Deep tendon reflexes 1538, 2583, 2780, 2801, 2804
Deep upper lid wound 421f
Deep vein thrombosis 332, 2455
extremity 2089
prophylaxis 332
Deferasirox 2028, 3593
Deferiprone 2027, 3593
Defibrillation 310, 317
Deficiency of the debrancher enzyme 173
Deficit fluid therapy 256
for diarrhea 1710
Deflazacort 2820
Deformations 52
Deformity
assessment of 3401
Degenerative brain disorders, classification of
childhood 2766t
Dehydration 256, 257, 257t, 1041
assessment of 1710, 1710t
classification of 1710
clinical features of 256t
fluid therapy for 1716
management of 1042fc, 1721
prevention of 1724
severe 256, 257
treatment of 1724
Dehydroepiandrosterone 2899, 2908, 2952
sulfate 1265, 1266, 2908, 2913
Dehydrogenase 1989, 2536
Dejerine-Sottas
disease 2852
syndrome 2812
Delayed cord clamping 458
Delayed hemolytic transfusion reactions 2106
Delayed puberty 53, 2902, 2904, 2905fc, 2998
causes of 2902, 2903t
22q11.2 deletion syndrome
cervical spine in 3417
Delinquency 1254
Delivery
expected date 522
room 456, 526
management 563, 712
resuscitation 505
timing of 533
Delta cells 1758
Delta coronavirus 1516
Delta F 508 mutation 2233
Dementia 159
childhood 86
Demyelinating disorders 2585, 2586
acquired 2736t
Dendritic cell 203, 232, 1429
Dengue 1204, 1208, 1567, 2680
classification of 1569fc
encephalitis 2678f
fever 339, 1201, 1484, 1567, 1569, 1572
diagnostic tests for 1572t
hemorrhagic fever 1201, 1567, 1569
grading of 1567b
hemorrhagic shock syndrome 2055
illness, course of 1571f
infection 1567
severe 1571
shock syndrome 1201, 15671569
treatment of 1573t
viral encephalitis 2677
virus 1201, 1568, 1570
infection 1567
serotypes 1201
Dengue, moderate 1574fc
Dense granule deficiency 2054t
Dent disease 2543
Dental anomalies 2324, 3392f
Dental caries 1224, 1762, 1762t, 1764f, 1765, 1766f
complications of 1763
microbiology of 1763f
prevention of 1765
types of 1763
Dental development 836
Dental fluorosis 1079, 1079f
Dental procedures 153, 2425t
Dentinogenesis imperfecta 844, 845f
Dentition, development of 836
Dentofacial region, anomalies of 841
Denver developmental screening test 894
Denys-Drash syndrome 2523, 2524, 2951
Deoxycytidine monophosphate 3013f
Deoxyhemoglobin 2597, 2598, 2600
Deoxyribonucleic acid 5, 35, 36, 42, 67, 73, 101, 122, 127, 211, 212, 218, 219, 232, 531, 634, 678, 1100, 1136, 1145, 1195, 1363, 1380, 1397, 1400, 1471, 1501, 1540, 1610, 1629, 1651, 1715, 1754, 1935, 1953, 1977, 2201, 2711, 3013f. See DNA
based tests 143
damage 677
double helix 35f
repair 219
replication 35
synthesis 783
vaccines 1190
Deoxythymidine monophosphate 3013f
Deoxyuridine monophosphate 3013f
Depigmentation 3322
Depression 1251, 1252
Depression rating scale
childhood 1252
Depressive disorders 1252, 2661
Deranged aminotransferases, causes of 1866t
Dermal hypoplasia 46
Dermal melanocytoses 3306
Dermal sinus 788f, 2607
Dermatan sulfate 182
Dermatitis
ancylostoma 1616
perioral 3332
Dermatitis herpetiformis 2510, 3375
Dermatomyositis 209, 211, 2779
familial 3168
sine myositis 3169
Dermatophyte infections 3314
Dermatophytosis 3315
Dermoid 3228, 3229
cysts 3275
Dermolipomas 3229
Dermonecrotic toxin 1358
Descending aorta 2288f
Desferrioxamine 3593
toxicity 2997
Desloratadine 3593
Desmopressin 70, 2547
Detrusor muscle
contraction 2500
relaxation 2500
Developmental disorder 891, 2654, 3227
Developmental hematopoiesis 572f
Developmental language disorders 950
Developmental verbal dyspraxia 950
Dexamethasone 2522, 3593
Dexamethasone suppression test
overnight 2933
Dexmedetomidine 364, 2453
Dextrocardia 2275f, 2309, 2309f, 2311f, 2312f, 2316f
Dextromethorphan 99, 3593
Dextrose 255, 3593
Dhaka solution 1721
Diabetes insipidus 1998, 2501, 2502, 2546, 2547, 2620, 28782880
causes of 2547t
central 2546, 2547
classification of 2879t
differential diagnosis of 2880fc
etiology of 2879t
Diabetes mellitus 41, 188, 191, 564t, 1531, 1533, 1664, 1682, 1746, 1867, 1998, 2499, 2501, 2502, 2957, 2958, 2858t, 29612963, 2967t, 2998, 3290
acute complications of 2969, 2969b
adult-onset 561
chronic complications of 2969, 2969b, 2971
classification of 2957
diagnosis of 2962b
etiologic classification of 2958t
staging of 2960
type 1 2957, 2961, 2962b
type 2 2958
Diabetic autonomic neuropathy 2862
Diabetic ketoacidosis 265, 2174, 2540, 2693, 2961, 2970, 2970t, 2971, 2969
severity of 2969t
Diabetic macular edema 2972
Diacylglycerol 2866
Dialectical behavior therapy 1254
Dialysis 2575, 2979
complications of 2576b
Dialyzers 2534
Diamniotic dichorionic pregnancy 530
Diamond-Blackfan anemia 1961, 1964f, 1972, 1982, 1983
Diaper dermatitis 1653
Diaphragm 2274
eventration of 753
malformations of 753
Diaphragmatic hernia 753
Diarrhea 3, 92, 102, 188, 254, 265, 1707, 1710, 1712, 1713, 1717, 1729, 1759, 2485, 2535, 2541, 2561, 2676. Also See Acute watery diarrhea, chronic diarrhea, persistent diarrhea
acute 1707, 1708, 1709f
pathogens for 1707t
rehydration therapy for 1711t
acute watery 1707, 1710, 1712
characteristic of 1811t
global annual burden of 1707
prolonged 1723
treatment of 1713b
Diarrheal dehydration, pathophysiology of 1709
Diarrheal disease 14
program on control of 3512
Diastematomyelia 788
Diastolic blood pressure 2263
Diastolic murmurs 2265, 2266f
Diastrophic dysplasia 53
Diazepam 2631, 3593
Diazoxide 3593
DIC. See Disseminated intravascular coagulation
Dichlorodiphenyltrichloroethane 1404
Diclofenac 288
Diclofenac sodium 3593
Dicloxacillin 288
Dicyclomine hydrochloride 3593
Didanosine 288, 3594
2,4-dienoyl-CoA reductase deficiency 120t
Dietary management 110, 1716, 1724
Dietary salt substitutes 276
Diethyl-3-methylbenzamide 1414
Diethylcarbamazine 3594
Diethylenetriaminepentaacetic acid 785, 787
Dieulafoy's lesion 1895
Differential cyanosis 2355t
Diffuse hypertrichosis, causes of 3399t
Diffuse intrinsic brainstem glioma 3065f
Diffuse large B-cell lymphoma 3048, 3051, 3053
Diffuse mesangial sclerosis 25222524
Diffuse neuronal heterotopia 2622
Diffuse proliferative lupus nephritis 3160
Diffusion 249
impairment 595
tensor imaging 689, 2599, 3059
weighted imaging 2598, 2689, 2727f, 2761
DiGeorge syndrome 40, 219, 220, 1746, 1769, 2362, 2380, 2977
Digestible indispensable amino acid score 991
Digestion
defects of 1740
physiology of 1729
Digestive enzymes 1754t
Digestive tract 242
Digital rectal examination 1805
Digital subtraction angiography 2702, 2709f, 2711
Digitalis 2303
Digoxin 2399, 3594
Dihydrobiopterin reductase 97
deficiency 97
Dihydrofolate 1349f, 3013f
reductase 1996
Dihydrotestosterone 1270, 2945
Dilated cardiomyopathy 2270, 2285, 2429, 2431, 2431f, 2467
clinical presentations of 2431t
management of 2432t
Dilated posterior urethra 779f
Dilated urinary tract 2488
Diltiazem 2453
Dilutional hyponatremia 506
Dimeglio classification 3438
Dimenhydrinate 3594
Dimercaptosuccinic acid 775, 785, 787, 2494, 2564, 2565
Dinitrophenylhydrazine test 2761
Diphenhydramine hydrochloride 3594
Diphtheria 1353, 1355, 3284
antitoxin 1355, 3594
diagnosis of 1354
specific therapy of 1355
tetanus 1120
pertussis 29, 1120, 1125, 1139, 1178, 1212, 1362, 1373
tetanus acellular pertussis 1116
vaccine 1141
whole cell pertussis 1116, 1147
types of 1355
Diphyllobothriasis, summary of 1637
Diphyllobothrium latum 1304, 1637
life cycle of 1638f
Direct agglutination test 1597, 2040
Direct antiglobulin test 577, 2006, 2008, 2041f
Direct fluorescent antibody tests 1494
Direct microscopic examination 1307
Direct pulmonary injury 345
Dirty neck disease 3386
Disability-adjusted life years 14, 1244, 1256
Disaccharidase deficiency 166, 170, 1739, 1740
Discitis
anaerobic 1425
Discoid lupus erythematosus 3365, 3396
lesion 3159f
Discordant twins 532
Disease modifying antirheumatic drugs 3141, 3152
Disk pallor, causes of 3259t
Disruption 52
Disseminated coccidioidomycosis 1668f
Disseminated disease 1456, 1460, 1682
Disseminated intravascular coagulation 539, 573, 583, 592, 635, 736, 1355, 1391, 1411, 1498, 1691, 1799, 1867, 1903, 1919, 1959, 1977, 2006, 2007, 2050, 2068, 2097, 2097b, 2098, 2100, 2125, 2301, 2694, 3025
acute 2098
chronic 2098
pathogenesis of 2098
pathophysiology of 2098fc
types of 2098
Dissociative disorder 986t
Distal convoluted tubule 2545, 2548
Distal esophageal spasm 1782
Distal femoral metaphysis, Erlenmeyer flask deformity of 148f
Distal femur, osteosarcoma of 3099
Distal foot muscle atrophy 2785f
Distal hypoplastic urethra 777f
Distal ischemia, relief of 3178
Distal muscular dystrophies 2826, 2826t
Distal renal tubular acidosis 2499, 2539, 2542
Distal spinal muscular atrophy 2811
Distal tubular sodium delivery 2482
Distal tubule acidification 259
Distichiasis 3273
Diuresis 2548
Diuretics 332, 747
Divalent metal transporter 1990f
Diversity 205
Diverticula 2495
Dizygotic gestation 530
Dizygotic twins, diagnosis of 531fc
D-lactic acidosis 266
DMARD. See Disease modifying antirheumatic drugs
DMARDs 3141
DMSA scan 2562
DNA 35
based diagnostic 74
extragenic 38
mitochondrial 38
nuclear and mitochondrial 122t
Dobutamine 317, 3594
Dock's sign 2274
Docosahexaenoic acid 512, 518, 991, 1087
supplementation of 129
Dog bites 424
Dog tapeworm 1638
Dolichocephaly 2581
Dolutegravir 1559, 3594
Domperidone 3595
Donath-Landsteiner test 2042
Donor human milk 488, 497
role of 496
Donor nephrectomy 2577
Donor specific antibody testing 216
Donovanosis 1275
Dopamine 70, 83, 317, 3595
Dopamine-beta-hydroxylase deficiency 2861
Dopa-responsive dystonia 70, 2721
Doppler interrogation 2371
Doppler ultrasonography 1885, 2393
Doppler velocimetry 540
Dorsal aortae, formation of 2253
Dorsiflexion angle 629f
Dorsolateral prefrontal cortex 958
Double aortic arch 2123, 2124f, 2298f
Double balloon enteroscopy 1899
Double-chambered right ventricle 2342
Double elevator palsy 3269
Double hit hypothesis 2630
Double inlet left ventricle 2358
Double outlet right ventricle 2268, 2270, 2295, 2357, 2361, 2386
Double volume exchange transfusion 637
Double-stranded deoxyribonucleic acid 36f, 209, 211
Down syndrome 38, 52, 53, 55, 56, 58, 60, 60f, 61f, 61f, 62, 62b, 63t, 76, 78, 79, 762, 843, 871, 911f, 917, 917f, 1965f, 2324, 2330, 2362, 2775, 2796, 3030, 3214f, 3272, 3285, 3415, 3417. Also See Trisomy-21
diagnosis of 62
gestalt diagnosis for 56
management 62
myeloid leukemia of 3037
translocation 60
Downes’ respiratory distress scoring system 694t
Downey cells 1490
Downey test 578
Doxapram 699
Doxorubicin 3023f
Doxycycline 288, 3595
DPT vaccines 11391143
AEFI 1125t
Dravet syndrome 2630, 2635, 2637, 2646
Dried blood spot 120, 121, 137, 201
DROOL score
for caustic ingestion 392t
Drop attack 2635
Droplet infection 1305
Drowning 412, 417, 1257
prevention of 1258
Drug 252, 1272, 1794, 1797
absorption 282
administration 288
concentration 291
delivery 317
devices, choice of 2195
distribution 282
excretion 284
interactions 1351
metabolism 283, 1864
rash eosinophilia systemic symptoms 240
reactions 1484
resistance, development of 1446
therapy 739, 1224, 2415, 2859
for scrub typhus 1694t
principles of 282
toxicity 1351
treatment 2650
withdrawal 671
Drug dosages 284
Drug formulary 3583
Drug resistance. Also See Antimicrobial resistance
Drug-induced autoimmune hemolytic anemia 2040
pathogenesis of 2040b
Drug-induced epidermal necrolysis 3353
Drug-induced erythroderma 3348, 3349
differential diagnosis of 3350t
Drug-induced hepatitis 1444
Drug-induced liver
disease 1907
injury 1866, 1907, 1917
Drug-induced sleep endoscopy 2162
Drug-induced thrombocytopenia 2072
Drug-induced urticaria 3345, 3346
Drug-resistant tuberculosis 1439, 1446, 1447, 1449, 1450
diagnosis of 1447, 1447fc
management of 1453fc
treatment 1450
Drug-resistant tuberculous meningitis, treatment of 2672t
Drug-susceptibility test 1436, 1457
Dry beriberi 1052, 3361
Dry eye 3230f
Dry powder inhalers 289, 2199, 2201
DT vaccine 1141
DTaP vaccine 1139
DTwP vaccine 1139, 1209
DTPA scan 2488
Dual-energy X-ray absorptiometry 148, 153
Duane retraction syndrome 3267, 3269f
Dubin Hohnson syndrome 1868
Dubowitz scoring 472
Duchenne muscular dystrophy 39, 40, 45, 73, 79, 178, 2437, 2779, 2783f, 2785, 2786fc, 2816, 2817f, 2820, 2821b, 2821f, 2821t, 2985
Duchenne-Erb palsy 548
Ductal plate malformation 1890
Ductal tissue
extension of 2344f
theory 2344
Ductus arteriosus 457, 457f, 458f, 506, 2333, 2335
Ductus venosus 457
Duke criteria 2421
DUMBBELLS 383
Duodenal atresia 61, 759, 759f, 761, 762
Duodenal cytochrome B reductase 1990f
Duodenal obstruction 762
Duodenal stenosis 61
Duodenal ulcer 1419, 1795f, 1895
Duodenojejunal flexure 762f
Duodenojejunal junction 760, 761
Duodenum, endoscopic appearance of 1822f
Dupilumab 2196
Duplex kidneys 774
22q11.2 duplication syndrome 66t
Duroziez's sign 2417
Dust-borne infection 1305
Dwarf tapeworm 1638
D-xylose absorption test 1736, 1812
Dysarthria 178, 2583
Dysautonomia, familial 1780
Dysautonomic crisis 2859
Dysbetalipoproteinemia, familial 2995
Dyscalculia 954
Dysdiadochokinesia 2584
Dyselectrolytemia 368, 2533, 2800
Dysembryoplastic neuroepithelial tumor 3065, 3067f
Dysentery 1708, 1714, 1717, 1717fc, 1759
antimicrobial treatment of 1717t
Dyserythropoiesis 2070
Dysfibrinogenemia 2066
Dysfunctional elimination syndrome 2569
Dysgenetic testis 2495
Dysgraphia 954
Dyskeratosis congenita 226, 1961, 1965f, 1980, 1981, 1981f, 2070
Dyslexia 954
Dyslipidemia 2526, 2577
secondary causes of 2995
Dysmaturity syndrome 523
Dysmenorrhea 1263, 1267
prevalence of 1267
Dysmetria 2584
Dysmorphism 87, 2354, 2622
Dysmorphology 51
pearls of 52, 53t
Dysmotility 1732
Dysnatremia 270, 272
acute 271
causes of 271t
clinical features of 271
Dysostosis multiplex 183, 184f, 3448, 3449t, 3450f
Dysphagia 178, 751, 1760, 2517
causes of 1760
Dysplasia 50, 2490, 2494, 3426
Dysplastic kidney 2490
Dysplastic neural tube 2607
Dysrhythmias 2415
Dystemic lupus erythematosus 795
Dystonia 86, 159, 2582, 2655, 2716
causes of 2717t
Dystonic syndrome 2772
Dystrophic epidermolysis bullosa 3376
severe 3377f
Dystrophic nails 1981f
Dystrophin
deficiency 2820f
glycoprotein complex 2817f
normal immunostaining for 2820f
Dystrophinopathy 2785f, 2818
Dysuria 2506
E
Eagle-Barnett syndrome 2955
Ear 473, 662
cartilage 472
infections 1395
nose, and throat 901
Early intervention 892, 912
Early morning neuroparalytic syndrome 396
Early myoclonic encephalopathy 2636
Early neonatal mortality rate 443, 3499t
Early onset benign childhood occipital epilepsy (panayiotopoulos type) 2639
Early onset sepsis. Also See Neonatal sepsis
Early transitional adaptive hypoglycemia 567
Eating disorder 978, 1249
examination-questionnaire 978
Ebola 13, 1580, 1582
virus disease 1582
Ebstein's anomaly 2278f, 2285, 2286f, 2341f, 2383, 2384f, 2385, 2450f, 2467
EBV-specific antibodies 1490
ECG. See Electrocardiography
Echinocandins 1650
Echinococcosis 1641
Echinococcus granulosus 1304, 16381640, 3276
tapeworm 1639
Echinococcus multilocularis 1639, 1640
Echinocyte 1977t
Echinostoma ilocanum 1631
Echis carinatus 395, 395f
ECHO. See Echocardiography
Echocandins 1650
Echocardiogram 2326, 2335, 2340, 2346, 2370, 2382, 2396
Echocardiographic criteria 2412
Echocardiography 53, 55, 125, 127, 178, 347, 749, 2020, 2092, 2288, 2289, 2291, 2303, 2314, 2331, 2338, 2343, 2350, 2362, 2378, 2388, 2393, 2397, 2406, 2411, 2422, 2427, 2433, 2435
Echovirus 668
ECMO. See Extracorporeal membrane oxygenation
Ecthyma 3312
gangrenosum 1395f, 3305
Ectodermal dysplasia 3391, 3392, 3392f
Ectopia lentis 3218, 3243, 3252
et pupillae 3245
Ectopic adrenocorticotropic hormone syndrome 2935
Ectopic atrial tachycardia 2452, 2454, 2456
Ectopic kidney 775, 1964f, 2493, 2494
Ectopic thyroid 2885f, 2886
Ectopic ureter 2494, 2501
Ectothrix 3397
Ectrodactyly-ectodermal dysplasia-cleft lip/palate (EEC) syndrome 3322
Ectropion 3273
Eculizumab 2538
Eczema 3288
herpeticum 3317, 3317f
Edema 2505, 2507, 2525, 2535
generalized 2972
Edinburgh postpartum depression scale 481
Edrophonium bromide test 2848
Edward syndrome 60f, 62, 3285
EEG. See Electroencephalography
EEG, in epilepsy. Also See Electroencephalography
Efavirenz 1559, 3595
Effectiveness 22
of vaccine 1103
of program 1103
Efficacy 22
of vaccine 1103
Efflux pump inhibitors 1396
Ego 1231
Ehlers-Danlos syndrome 53, 1897, 2126, 2213, 2342, 2499, 3287, 3423, 3453
Eicosapentaenoic acid 991, 1087
Eikenella corrodens 2420
Eisenmenger reaction 2357
Eisenmenger syndrome 2277f, 2321, 2334
Ejection systolic murmur 2350
Ektacytometry 2034
Electric burns 431, 432f
Electrocardiography 153, 163, 362, 417, 600, 942, 2302, 2388, 2406, 2427, 2433, 2436
Electroencephalogram 944f, 1502, 1933, 2588, 2697, 2700
Electroencephalographic seizure 672
Electroencephalography 312, 679, 901, 959, 2588, 2589b, 2631, 2677, 2799
Electrolytes 110, 248, 636, 1031, 1087, 1712
abnormalities 2532, 2574
balance 714
concentrations 269t
disorders 2574
free water 253
estimation of 253
imbalance 506, 1721
management 779
Electromyogram 942, 944f, 2248, 2804
Electromyography 1426, 1538, 2588, 2592, 2842, 2848, 3170
Electron microscopy 1814, 2085
Electron transfer flavoprotein
alpha 120
beta 120
dehydrogenase deficiency 120
Electron transfer pathway 120
Electrooculogram 2591
Electrophysiological tests 2766
Electrophysiology 2721, 2803
Electroretinography 2588, 2591
Ellis-van Creveld syndrome 2324
Eltrombopag 2079
Embden-Meyerhof pathway 1863
Embryonic fissure 3205
Emergency severity index 299
Emergency splenectomy 2082
Emerging viral infections 1469
Emery-Dreifuss muscular dystrophy 2784, 2785, 2821, 2822, 2829
Emmetropia 3220
Emollients 3309
Emotional development 883886, 888
Emotional intelligence 1235
Empirical antibiotic
therapy 2667, 2691b
treatment 2423
Empty sella syndrome 2873
Empyema 2209
evolution of 2209
thoracis 2211
Emtricitabine 1559, 3595
En coup de sabre 3366, 3366f
Enalapril 2304, 2526, 2559
maleate 3595
Enamel hypoplasia 845, 1079f
yellowish spots of 845f
Encephalitis 1487, 1531, 1532, 1542, 1696, 2585, 2680t, 2684
diagnostic criteria for 2676b
early-onset 1480
late-onset 1480
Encephalocele 786
Encephalofacial angiomatosis 2755
Encephalomyeloradiculitis 1502
Encephalopathic crises 113
Encephalopathies 92, 94, 27442748, 2758
Encephalotrigeminal angiomatosis 3289, 3371
Encopresis 940, 941, 2501
etiology of 940
management of 941fc
Endemic cretinism 2883
Endemic typhus 1696, 1697
Endocardial cushion defect 2614
Endocardial fibroelastosis 2266
Endocarditis 1498, 1696
anaerobic 1424
Endocardium 2252
Endocrine 332, 2557, 2558
disorders 279, 870, 1268, 2463, 3001
dysfunction 88
function 450
glands 1757, 2866
disorders of 2864
hypertension 2936
diagnosis of 2936fc
metabolic disorders 3289
organs 48
secretions, neural control of 2868
system 1032, 3105
Endocrinopathy 119, 1746, 2874
Endometriosis 1267
Endomyocardial biopsy 2428
Endomysial antibody 1737, 1738, 1822
Endopeptidase 2554
Endophthalmitis 3235
endogenous 3236
Endoplasmic reticulum-associated degradation 145
Endorphins 697
Endoscopic injection 2567
Endoscopic retrograde cholangiopancreatography 1634, 1738, 1797, 2017
Endoscopic therapy 1781, 1887, 1900
Endoscopic third ventriculostomy 2629
Endoscopy 370, 1736, 1895
Endosymbiotic theory 122
Endothelial cell 2018f, 2396f, 2481
synthesize 2046
Endothelial injury 2090f
Endothelin receptor antagonists 2399
Endothelium
derived mediators 728f
fenestrated 2481
Endothrix 3397
Endotoxins 1342
Endotracheal intubation 346, 367, 2181
Endotracheal tube 349
Endovascular therapy 2712
End-stage liver disease score, model for 1919
End-tidal carbon dioxide 311
Energy 989, 1244, 1245
deprivation 83
drinks 1091
expenditure 990
requirements 511
rich food 995
Enhanced liver fibrosis test 1868
Enoxaparin 3595
Entamoeba coli 1601
Entamoeba hartmanni 1601
Entamoeba histolytica 1305, 1586, 1601, 1601f, 1716, 1737
infection 1602
Entamoeba moshkovskii 1601
Entamoeba polecki 1601
Enteral feeding
complications of 1085, 1086b
tube 288
Enteral nutrition 1083
indications for 1083, 1084b
modes of 1085f
Enteric fever 1365, 1366, 1961. See Typhoid fever
clinical features of 1365t
Enterobacter cloacae 654
Enterobacter sakazakii 2688
Enterobiasis 1619, 1620
Enterobius vermicularis 1619, 1620f, 1838
Enteropathy 2928
Enterotoxins 1343
Enteroviral encephalitis 2677
Enteroviral infection 1484, 1531
differential diagnosis of 1534t
Enteroviruses 1529
Entropion 3273
Enuresis 2018, 2500, 2502t, 2503fc
alarm therapy 2502
Envenomation 365
Environmental enteric dysfunction 1742
Environmental pollution 1585
Enzyme 3577
activity, estimation of 162
analysis 2788
assay 121, 2037
deficiency 91, 174, 2948t
severity of 106
enhancement therapy 153, 154
immunoassay 1698
inducers 2645
inhibitor 2526
Enzyme replacement therapy 71, 138f, 139, 149f, 151f, 162, 177, 179, 186
indications for 154b
Enzyme-linked immunosorbent assay 209, 588, 1014, 1176, 1206, 1288, 1310, 1365, 1408, 1414, 1420, 1464, 1521, 1597, 1603, 1623, 1625, 1626, 1629, 1636, 1640, 1644, 1674, 1677, 1686, 1692, 1694, 1735, 1751, 2205, 2509, 2513, 2684
Eosinophilic ascites 1845
Eosinophilic esophagitis 1777, 1780
Eosinophilic granuloma 3103, 3104
Eosinophilic myositis 3170
Eosinophilic pustular folliculitis 3303
Ependymoma 3062, 3063f
Epiblepharon 3210, 3272
bilateral 3272f
Epibulbar dermoid 3229
Epicanthus 3210, 3272
Epidemic typhus 1695, 1696
Epidermal growth factor 488, 801
receptor inhibitor 3356f
Epidermal nevus syndrome 2756f, 3373
Epidermodysplasia verruciformis 225
Epidermolysis bullosa 3374, 3376, 3376t
simplex 3376
Epidermolytic ichthyosis 3388
Epidermolytic toxin 3305
Epidermophyton 3314
Epididymo-orchitis 1480
acute 1277
Epidural hemorrhage 547
Epigastric pain 2517
Epilepsia partialis continua 123, 2635
Epilepsy 274, 279, 280, 900, 947, 2619, 2623, 2631, 2632, 2643, 2653, 2656, 2759
classification of 2633
diagnosis of 2633f, 2634, 2642
genetics of 2636
idiopathic 2638
management of 2642
surgery 2645
syndrome 2633, 2633b, 2635
identification of 2633f, 2635
treatment of 2644f, 2642
Epileptic cry 2634
Epileptic encephalopathy 2638
Epileptic seizures 670, 2653t, 2656t
Epileptic spasms 2634, 2637
Epinephrine 317, 469, 2086, 3583
deficiency 188
Epiphora 3248
causes of 3248t
Epiphyseal centers, development of 849b
Epiphyseal dysplasia 71
Episodic acidosis 165
Episodic ataxia 280, 2656, 2726
Episodic lactic acidosis 165
Episodic syndromes 2659
diagnostic criteria for 2660b
Episodic vomiting 165
Epispadias 775, 775f, 2494
exstrophy complex 775, 776
Epistaxis 2082, 2125, 2126
Epithelial cells 2486, 2509
integrity 1047
Epithelial conjunctival tumors 3230
Epithelial giant cells 1475
Epithelial sodium channel 457, 2482, 2558
Epithelium 2608
Epivaccorona vaccine 1193
Eplerenone 2560
Epoprostenol 2399
Epstein pearls 473
Epstein-Barr nuclear antigen 14891491
Epstein-Barr virus 218, 221, 228, 240, 1468, 1488, 1489, 1534, 1549, 1910, 1931, 2039, 2073, 2146, 2676, 2677, 2680, 2805, 3042
infection 1907
meningitis 2587
Equine rabies immunoglobulin 1507
Eradication 1098t, 1301
Ergotamine tartrate 3595
Erikson theory 1228, 1232
Erikson's psychosocial stages 1232t
Erlenmeyer flask deformity 148, 148f
Eruptive hypomelanosis 3328
Erysipelas 3312
Erythema 545, 3362f
Erythema infectiosum 1484, 1510f, 1511, 1511f
Erythema marginatum 2404
Erythema migrans 1413, 1413f
Erythema multiforme 1700f, 3288
Erythema neonatorum 3301
Erythema nodosum 1391, 1826
Erythema toxicum 476, 476f, 639f
neonatorum 3302, 3302f
Erythematous papulovesicular lesion 3380f
Erythematous scaly papules 3378f, 3382f
Erythroblastosis fetalis 2071
Erythrocyte sedimentation rate 1332, 1411, 1490, 1633, 1686, 1735, 1827, 1903, 2174, 2205, 2403, 2406, 2428, 2786, 2876, 3136, 3406
Erythrocytosis 2038
Erythroid hyperplasia, evidence for 2004, 2004b
Erythroid progenitor cells 1951
Erythromycin 3595
Erythropoiesis 1949
regulation of 1951
site of 1950f
stages of 1951f
transcriptional regulators of 1951
Erythropoietic protoporphyria 197, 198
Erythropoietin 1951, 1951f, 1956, 1992, 3595
Erythrovirus 1509
Escharotomy 429f
Escherichia coli 167, 189, 223, 270, 633, 644, 646, 652, 1175, 1312, 1319, 1336, 1341, 1344, 1370, 1475, 1550, 1707, 1715, 1720, 1898, 1901, 1917, 2071, 2485, 2535, 3335, 3405
infections 14
meningitis 1370
pyocephalus 647f
Escitalopram 1252
ESKAPE bugs 1319
Esmolol 2559, 3595
Esodeviation 3224
Esophagus 475, 2124f
congenital short 749
Esophageal atresia 620, 748, 749f, 750f, 751t, 2164, 2164f
Esophageal disorders, diagnosis of 1782
Esophageal diverticulum 749
Esophageal dysmotility 751
Esophageal injuries, severity of 392t
Esophageal motility, disorders of 1779
Esophageal motor disorders 1779b
Esophageal smooth muscle, disorders of 1780
Esophageal varices 1881f, 1888fc
band ligation of 1897f
Esophageal webs 747
Esophagitis 1895
severe 1777f
Esophagogastric junction 1780
Esophagogastroduodenoscopy 1826, 1895
Esotropia 3221f, 3263, 3266fc
classification of 3264b
Essential fatty acids 991
Essential oil poisoning 388
Essential pentosuria 166t
Estimated average requirement 989b
Estradiol 801, 2913
Estrone 2913
Etanercept 3145, 3596
ETDRS charts 3222
Ethambutol 1440, 1446, 3596
Ethics
issues in pediatrics 2426
obligations in 25
principles of 24
Ethionamide 1446, 2672, 3596
Ethnicity 800
Ethosuximide 2645, 3596
Ethylenediaminetetraacetic acid 76, 92, 1318, 1990, 1990f, 2069, 2076
Etidronate 288
EULAR classification
for Henoch-Schonlein purpura 3185t
for JDM 31723173f
for polyarteritis nodosa 3182b
for small vessel vasculitis 3184t
for Takayasu arteritis 3177b
Euryblepharon 3212, 3273
Euryblepharon, bilateral 3273f
Euthermia 483
Evidence
quality of 20
Evidence-based health care 19
Evidence-based medicine 19t
Evidence-based practice 20
E-waste 3507
exposure, adverse health effects of 3508f
exposure, modes of 3507f
Ewing sarcoma 3100f, 3101b
Exanthema subitum 14841486
Exanthematous fever 3229
Exchange transfusion 558, 2071
Excisional biopsy 3016
Excitotoxic-oxidative cascade 677
Exclusive breastfeeding 12, 488
promotion of 2208
Exencephaly 786
Exercise-induced proteinuria 2519
Exercise testing 2445
Exercise tolerance test 2193
Exercise-related hypoglycemia, prevention of 2965b
Exfoliative dermatitis 3348
Exocrine pancreas
diseases of 2959
disorders of 2958
deficiency disorders of 1817t
dysfunction 1812
insufficiency 1817
Exomphalos 770, 771, 771f, 771t
Exon-skipping therapy 74
Exothermic mattress 487
Exotoxins 1342
Exotropia 3264
intermittent 3264, 3266f
Expanded dengue syndrome 1567
Expanded disability status scale 2739
Expressed breastmilk 514
Extended-spectrum beta-lactamase 1318, 1351f
Extensive alveolar injury 345f
Extensively drug-resistant tuberculosis 144654
Extensor digitorum brevis muscle, atrophy of 2582f
External genitalia examination 2951f
External urinary sphincter 2494
Extracellular fluid 248, 248f, 249, 255, 283
volume 1709
Extracellular matrix 1913f, 2045
Extracellular methemoglobin 2597
Extracorporeal membrane oxygenation 332, 342, 346, 347, 439, 620, 732, 733, 1975, 2306, 2379, 2432, 2468
Extracorporeal shock wave lithotripsy 2552
Extracorpuscular defects 2002, 2003b
Extractable nuclear antigens 3164
Extraembryonic yolk sac 1950f
Extragenic deoxyribonucleic acid 38
Extrahepatic biliary atresia 1866, 1867
Extrahepatic portal hypertension 1882
Extrahepatic portal venous obstruction 1880, 1882, 1895, 1911, 1918, 1932
Extraintestinal invasive nontyphoidal
salmonellosis infection 1371t
Extraocular retinoblastoma, management of 3087
Extrapulmonary tuberculosis 1439
Extrathoracic tuberculosis 1432
Extrauterine growth retardation 511
Extravaginal torsion 1853
Extremely low-birthweight 499, 632
Extrinsic incubation period 1568
Extrinsic motivation 1287
Exudate 2209
Eye 48, 473, 662, 1961, 2018, 3393. Also See Ocular
abnormalities 3205
anomalies 2710
anterior segment of 3212
care 466, 479
congenital anomalies of 3209
development of 3205
examination 53, 3149
infections 1395
involvement 88
layers of 3205
light pigmentation of 82f
manifestations 161
movements, smooth pursuit of 1931
of tiger sign 2765
problems 3207
Eyeball 2581
genetic anomalies of 3272
Eyebrows 2634
Eyelids 2634, 3272
anomalies 3272
congenital anomalies of 3272
disorders of 3272
inflammations of 3274
injuries 3279
pediculosis 3274f
F
F-75 diet 1043t
F-100 diet 1043t
Fabry cataract 161, 161f
Fabry disease 71, 83, 86, 86f, 87, 133, 136, 160, 161t, 162, 162t, 2518
diagnosis of 163fc
management of 163fc
Face mask 341
Facial angiofibroma 43, 2750f
Facial asymmetry 3192f
Facial dysmorphism 151, 2580
Facial edema 2508, 3360f
Facial hair 2904f
Facial nerve injury 547
Facial plethora 861f
Facial telangiectasias 1914f
Facial telangiectatic rash 3169f
Facility-based integrated management of newborn and childhood illnesses (F-IMNCI) 3514, 3524
Facility-based newborn care 29, 460
Facioscapulohumeral dystrophy 2784f, 2785, 2824, 2826f
congenital onset of 2835
Factitious diarrhea 987, 1748
Factitious disorder, diagnosis of 987
Factor replacement therapy 2059
Factor VIII bypassing agent 2062
Factor XIII deficiency 2055
Fever of unknown origin 13381340
Failure to thrive 92, 165, 516, 851, 855, 855f, 946, 1729, 1739
clinical evaluation of 854t
etiology of 852t, 853t
laboratory evaluation of 855t
severity of 853t
Faine's criteria, modified 1399, 1400t
Falciparum malaria 188, 190, 1966f
Falciparum ring 1590f
Fallot tetralogy, anatomic variants of 2361
Famciclovir 1471
Familial chylomicronemia syndrome 2993, 2995f
Familial cold autoinflammatory syndrome 3200
Familial hemophagocytic lymphohistiocytosis syndromes 220, 221
Familial mediterranean fever 225, 226, 3198, 3199
Fanconi anemia 226, 872f, 1961, 1978, 1979, 1979t, 1980fc, 2070
Fanconi syndrome 97, 2540, 2541, 2543, 2553, 2554
Fanconi-Bickel syndrome 166, 167f
Farber disease 3291
Fasciculation 2592
Fasciola gigantica 1631
Fasciola hepatica 1631, 1633
life cycle of 1634f
Fascioliasis 1634
Fasciolopsiasis 1632
Fasciolopsis buski 1631, 1632f
life cycle of 1632f
Fast breathing 2173, 2174, 2174b, 2174t
causes of 2173b
management of 2174fc
Fast foods 1090
Fasting plasma glucose 2960
Fat 991, 1244, 1730
digestion of 1730
distribution, abnormal 171f
globules 1812
malabsorption, investigations for 1812
metabolism 1863
soluble vitamins, quantitative measurement of 1812
Fatal infantile multisystemic disease 122
Fatty acid 118, 190, 2549
beta-oxidation diseases 178
composition 991t, 1000t
essential 989, 991
oxidation
defect 70, 118, 119, 120t, 121, 193, 1877, 1936, 2765
disorder 89, 108, 119, 188
pathway 118
Fatty diarrhea 1738, 1738fc
Fatty liver 64
Favism 2036
Favus 3314
Fazio-Londe disease 2812t
Febrile illness
nonspecific 1531
Febrile neutropenia 3110, 3111, 3111b, 3112
risk stratification in 3112b
treatment of 3112
Febrile seizures 1486, 26292631, 2648, 2667
management of 2631
plus 2630
treatment of 2631b
Febrile status epilepticus 2630, 2647, 2648
Fecal fat 1736
excretion 1812
Fecal incontinence 1804, 2501
Fecal microbiota transplantation 1315
Fecal porphyrins 198
Feces 1469
Feeding 488, 514, 563, 718, 1011, 1940
adaptation 459
assessment of 627
baby 478
cues 513
methods of 512
mixtures, types of 1083
pattern 855
problems 1770
related apnea 698
schedule 513
Feingold syndrome 2614
Felbamate 288, 2645
Felodipine 2560
Female genital
malformations 777
mutilation 1259, 3483
Femoral head deformation, pathogenesis of 3431
Femur
fracture 550
length 539
osteosarcoma distal end of 3100f
X-ray of 655f
Fenestration, Amplatzer device closure of 2376f
Fenofibrate 288
Fentanyl 3596
Fenton intrauterine growth chart 504f, 505f
Fenton reaction 677
Ferroportin disease 1973
Ferrous sulfate 3596
Fertility 1080
Fertilizers 1091
Fetus 83
Fetal acetylcholine receptor inactivation syndrome 2847
Fetal alcohol syndrome 123, 917, 2614, 2621, 3286
Fetal anomalies, targeted imaging for 539
Fetal ascites 2495
Fetal autopsy 76
Fetal biophysical profile 541
Fetal breathing 696
Fetal circulation 451, 457, 457f, 2257, 2392
course of 2257f
Fetal damage, mechanisms of 663
Fetal dysplasia 3454f
Fetal echocardiogram 754
Fetal echocardiography 539, 2288, 2331
indications for 2288t
technique of 2288
Fetal electrocardiogram 542
Fetal growth 449, 562, 795
phases of 795
physiology of 795
restriction 499, 540
Fetal heart
four-chamber view of 2288f
normal four-chamber view of 2288f
rate 451, 538, 540, 542f
pattern classification system 452, 452t
Fetal hemoglobin 1960, 2028
Fetal immune system 459
Fetal lung 457
Fetal lymphatic obstruction 2344
Fetal lymphopoiesis 1954
Fetal magnetic resonance imaging 539, 754, 773
Fetal medicine 12
Fetal monitoring
electronic 675
Fetal movements 84, 540
Fetal myelopoiesis 1954
Fetal nutrition 450
Fetal phenytoin 52
Fetal physiology 449, 500
Fetal pulmonary vascular resistance 2324
Fetal scalp, digital stimulation of 543
Fetal surgery 12, 755
Fetal therapy 72
Fetal thyroid ultrasonography 455
Fetal tissue 451
Fetal varicella syndrome 3306
Fetal well-being
assessment of 451
monitoring of 540
Fetoscopic laser surgery 533
blisters 1501
differential diagnosis of 1477
etiology of 1331, 1331t, 1332b
management of 1337fc, 3113f
measurement of 1330
of unknown origin 1336, 1338, 1340
causes of 1339b
pathophysiology of 1331fc
prolonged 1332
Fexofenadine hydrochloride 3596
Fibrillations 2592
Fibrin
degradation products 2006
formation of 2097
Fibrinogen 1868, 2099
deficiency 2065
Fibrinolysis 2097
Fibrinolytic system 2049
Fibroblast growth factor 801, 1861, 2555
Fibrocystin 2498
Fibrodysplasia ossificans progressiva 3448, 3449f
Fibromatosis gingivae 843
Fibrosis 2509, 2512
detection of 1864
development of 1912
molecular pathogenesis of 1913f
pointers toward advancement of 1919
Fibrous crescents 2509
Fibrous dysplasia 846f, 2982
Fibrous plaque on face 2750f
Ficolins 204
Figure-of-eight appearance 2277f
Filamentous hemagglutinin 1139, 1209
antigen 1358
Filarial parasites, characteristic of 1627t
Filariasis 1627, 1630
Filoviruses 1581
Fimbrial hemagglutinins 1209
Fine-needle aspiration cytology 1436, 1457, 1736
Fingerprint-like inclusions 125f
Finkel type SMA 2811
FiO2 352. See Fraction of inspired oxygen
Fire cracker injuries 3278
First arch syndrome 1769, 1770f
First heart sound 2264
First-generation vaccines 1158
Fish tapeworm 1637
FISH. See Fluorescence in situ hybridization
Fissure-in-ano 1855, 1855f
Fistula-in-ano, Park's classification of 1858f
Fistulogram 1858
Fite-Faraco staining 1464
Fixed drug eruption 3344, 3345, 3345f
Flank pain 2491, 2494, 2506
Flank veins 1882
Flat nipples 494, 494f
Flavin adenine dinucleotide 119, 123
Flaviviruses 1581
Flavonoids 2476f
Flea-borne typhus 1697
Fleischer ring 3231
Flexible bronchoscopy 2218, 2240
Floppy infant 2793, 2799
clinical features of 2794t
Flow cytometric assay 215t
Flu vaccine 1183
Fluconazole 1648, 1649, 3596
Fludrocortisone 288
furosemide test 2542
Fluency disorder 949
childhood-onset 949
Fluid 110, 239, 248, 348, 636, 718, 2179, 2197
attenuated inversion recovery 1933, 2598, 2727f, 2746f
balance 459, 714
maintenance of 2531
calculations 2970
distribution 248
exchange, regulation of 249
homeostasis of 248
imbalance 506
management 408, 779, 2699
overload, treatment of 1573
restriction of 1848
resuscitation 331, 332, 427
supplementation 559
therapy 252, 256, 1716
phases of 252, 253f
Fluid thrill 1846
Flukes 16311635
intestinal 16311632
liver 16331634
lung 16321633
Flunarizine 2662
Fluorescence in situ hybridization 53, 67, 79, 1309, 1981, 2268, 2271, 2272, 2797, 2952, 3033f
methods of 69f
Fluorescent leprosy antibody absorption test 1464
Fluorescent spot test 2036
Fluorescent treponemal antibody 666, 1310
Fluoride
adequate intake for 1077t
ingestion 1078
metabolism of 1078fc
source of 1077
Fluoride ingestion
chronic 1079
Fluorodeoxyglucose 2119
positron emission tomography 2604
Fluoroquinolones 1346, 1446
Fluoroscopy 2118
Fluorosis 1077, 1081, 2554
diagnosis of 1081f
pathophysiology of 1078fc
Fluoxetine 1252
Fluticasone propionate 3596
FNAC. See Fine-needle aspiration cytology
Focal brainstem tumors 3064t
Focal cerebral arteriopathy 2708
Focal cortical dysplasia 2624
Focal epilepsies 2640
Focal fibrous dysplasia 49f
Focal nodular hyperplasia 1946
Focal proliferative lupus nephritis 3160
Focal segmental glomerulosclerosis 2522
Focal seizures 2633, 2635
Fogo selvagem 3374
Folate 1243, 1246
administration 2034
deficiency 1996, 1998, 2000
causes of 1997t
rich diet 2610
Folic acid 78, 1054, 3362, 3596
deficiency 1054
role of 2605
Folinic acid 100, 2760
Follicle-stimulating hormone 1227, 12641266, 2865, 2871, 2898f, 2899, 2904, 2905, 2913, 2933, 2948
receptor 2908
Folliculitis 3311, 3312
Fonsecaea pedrosoi 1649
Fontan operation 2706
Fontan procedure 2470
Food
allergen, characteristic of 1013
allergy 243, 1011, 1012, 1015, 1015fc, 1744, 3335
categories 1090
cobalamin malabsorption 1997
contamination 1091
glycemic index of 990
grouping systems 995, 995t, 1012
habits 1584
hypersensitivity reactions, types of 243t
maintaining safety of 1009
nutritive value of 995
poisoning 1306, 1369, 1386
protein-induced enterocolitis syndrome 1744
pyramid 1003, 1003f
quality 1021
quantity 1021
security 1028
thermic effect of 989
Foodborne
botulism 1425
infections 1306
Foot
ectrodactyly of 3451f
gross edema of 3169f
pad culture 1464
progression angle 3403f
Football sign 759, 759f
Foramen of Luschka 2628f
Foramen of Monro 2595, 2627f
Foramen ovale 457
Forced expiratory flow 2115f
Forced vital capacity 2115f
Forebrain development, disorders of 2619
Foreign body
aspiration 2178t
cough in 2141
in airway 2245
intraocular 3282
laryngeal 2245
tracheobronchial 22452246
Foremilk 488
Forkhead box protein 3 207f
Formiminoglutamic acid 2000
Formoterol fumarate inhalation 3596
Fortified human milk 514
Foscarnet 1471, 3596
Fosinopril 2559
Fosphenytoin 3597
Fossa ovalis 2328f
Fourth aortic arch arteries 2256
Fourth heart sound 2264
Fourth nerve palsy 3266, 3268f
Fox's sign 1799
Fraction of inspired oxygen 331, 332, 343, 347, 348, 354, 355, 707, 745, 2113, 2700
Fractional exhaled nitric oxide 2193
Fractures 550, 2984, 3480
Fragile X syndrome 39, 46, 67, 73, 79, 916, 917f, 2636
facial gestalt of 68f
Fragmentary erratic myoclonia 2636
Franceschetti-Zwahlen-Klein syndromes 3286
François dyscephalic syndrome 3286
Frasier syndrome 2951
Free erythrocyte protoporphyrin 1967, 1970
Free fatty acid 85, 121, 191, 1863
Free hepatic vein pressure 1880
Free radical injury, theories of 1031
Freeze-dried vaccine 1129
Fresh frozen plasma 586, 2050
Freud's psychosexual theory 1228, 1231
Friedreich ataxia 47, 2464, 2727, 2728, 2960
Frontal lobe epilepsy 2635
Frontoparietal polymicrogyria
bilateral 2623
Frostbite 435, 436, 436f
Frostnip 434
Fructose
bisphosphatase deficiency 70, 169
diphosphatase deficiency 188, 190
metabolism 169fc
disorders of 168
Fruits 996, 998t
Fruit drinks 1090
Fruit juice 1090
Frusemide 2550
FTT. See Failure to thrive
Fucosidosis 136
Fukutin-related protein 2623, 2834
Fukuyama congenital muscular dystrophy 2623, 2780, 2832, 2833f
Fukuyama muscular dystrophy 2822
Full-blown small bowel obstruction 765
Fulminant neonatal hepatitis 1533
Fumarate 3596
Functional abdominal pain 17891793
childhood 1791
Functional abdominal pain disorder 1759, 1789, 1790, 1792
Functional diarrhea 1748
Functional dyspepsia 1759, 1791
Functional echocardiography 2290
Functional gastrointestinal disorders 1789, 1790
Functional iron deficiency 1989
Functional nonimmune hyperthyroidism 2892
Functional voiding disorder 2568
Fungi 205, 244, 661, 1302, 1646
Fungal
culture 1655
endocarditis 2424
meningitis 2587
sensitization 1657
yeast forms 1674f
Fungal infections 1646, 3284, 3306
burden of 1646b
superficial 3314
Funnel chest 2117
FUO. See Fever of unknown origin
Furosemide 2304, 2560, 3597
stress test 2531
Furuncle 3311, 3312, 3312f
Fusion inhibitor 1558
Fusobacterium necrophorum 1901, 2090, 2155
Fusobacterium nucleatum 1423
G
Gabapentin 2645, 3597
Gait 902, 2608, 3400
abnormalities of 96, 3401t
Galactitol 82, 83
Galactokinase deficiency 168
Galactose
1-phosphate uridyl transferase 166, 1878, 1923, 1939
metabolism 167fc
disorders of 166
mutarotase deficiency 168
Galactosemia 55, 70, 80, 82, 83, 166168, 188, 189, 199, 202, 480, 1874, 1877, 2541, 3242f, 3290
Galactosylceramide 133
Galeazzi sign 3428
Gallbladder 1758, 1878
development of 1755
Galloway-Mowat syndrome 2524
Gallstones 1798
Gamma-aminobutyric acid 94, 377, 658, 671, 672f, 697, 1052, 1930, 2630, 2643, 2749
Gamma-glutamyl transferase 1939, 2530
Gamma-glutamyl transpeptidase 1826, 1867, 1878, 1911, 1920
Gamma-hemolytic streptococci 1379
GAMT deficiency 2760t
Ganciclovir 1471, 3597
Ganglioneuroblastoma 1746
Ganglioneuroma 1746
Gangliosidosis 133, 141, 142f, 143, 144, 2580, 3290
Gangrenous rash 1687f
Gap junction theory 608
Gardener syndrome 843
Gardner and Venkatraman's classification 1720
Gardnerella vaginalis 1275
Gardos channelopathy 1973
Gas chromatography mass spectrometry 89, 126, 191, 192, 1924, 2696, 2711, 2731
Gas exchange 451, 2110
assessment of 339, 711
physiology of 349
Gas flow, principles of 701
Gas gangrene 1423
Gastrointestinal system 1314, 1759, 3104
Gastrointestinal tract 102, 103f, 145, 251, 282, 563, 585, 588, 687, 761, 901, 905, 1083, 1340, 1700, 1708, 1738, 1754, 1824, 1894, 1914, 2514, 2537
anomalies 748
congenital defects of 61
Gastric
aspirate 1442, 1447, 2186f
shake test 712
decontamination 372
intrinsic factor deficiency 88
lavage 372, 1436
ulcers 1895
varices 1881f, 1888fc
Gastric volvulus 1788, 1789
Gastrinoma 1746
Gastritis 1419, 1777, 1795f, 1895
causes of 1794b
severe 1796f
Gastroduodenoscopy 1632f
Gastroesophageal reflux 2185
complications of 1783t
Gastroesophageal reflux disease 694, 698, 751, 900, 1358, 1744, 1759, 1776, 1777, 1782, 1783, 1784f, 1784t, 1785, 1785fc, 1791, 1793, 2116, 2121, 2141, 2142, 2174, 2178, 2184, 2186, 2192, 2216, 2222, 2654
severe 1895
symptoms of 1783t
therapeutic strategies for 1785t
Gastrointestinal bacterial overgrowth 108
Gastrointestinal bleeding 1676, 1882, 1894
Gastrointestinal calcium absorption, reduction of 2979
Gastrointestinal candidiasis 1654
Gastrointestinal diseases 803, 1425, 1775, 3162
symptoms of 1759
Gastrointestinal disorders 1729, 1754, 3292
Gastrointestinal endoscopy 1813, 1909
Gastrointestinal malformation, spectrum of
congenital 758
Gastrointestinal mucormycosis 1682
Gastrointestinal stromal tumor 2937
Gastrointestinal transmission 1305
Gastroschisis 770, 771, 771f, 771t
Gastrostomy 1084
Gasul's effect 2321
Gatifloxacin 3597
Gaucher cells 145f, 152
Gaucher disease 71, 72, 86, 88, 90, 132134, 136, 145, 146, 146t, 147, 147f151f, 151153, 153t, 154b, 154f, 155, 1915, 1917, 2769, 3291
atypical features of 150t
differential diagnosis of 152t
spectrum of 146f
supportive therapy of 153b
Gaucheromas 150
bilateral infrarenal paraspinal 151f
Gavage feeding 513f
G-cells 1757
GDD. See Global developmental delay
Gene 36
defects 2619
expression, regulation of 36
mutation 39, 2219, 2983
replacement therapy 2813
therapy 73, 76, 90, 97, 139, 180, 230, 2020, 2029, 2062, 2237, 2272, 2308, 2820
approval of 74
procedure 2029f
General anesthesia 2455
Generalized anxiety disorder 983
Generalized clonic seizures 2634
Generalized hypopigmentary disorders 3322
Generalized morphea 3366
Generalized seizures 2633, 2634
Generalized tonic-clonic seizure 901, 2634, 2647
Genetic 114, 116, 156, 1825, 2497, 2658, 3447, 3448
anomalies 3272
code 36
constitution 35
counseling 62, 75, 140, 164, 922, 2618, 2815
management of 70
cutaneous disorders 3391
defects 72
disorders 42, 45, 70, 2497, 3423
management of 70
prevention of 77, 77fc, 78t
generalized epilepsy 2638
hemophagocytic lymphohistiocytosis 3108t
heterogeneity 2636
information, transmission of 35
obesity 2987, 2992
assessment of 2992
treatment of 2992
types of 2987t
resistance 1318
screening 80
negative consequences of 80
short-stature syndromes, characteristic features of 870t
skeletal disorders, classification of 3441t
syndromes 87, 871, 2613, 2956
role of 89
Genioglossus 2582
Genital ambiguity 2952
Genital development 2901
Genital diphtheria 1354
Genital discharge 643
Genital herpes 1275, 1502
Genital infections 1503
Genital malformations 2499
Genital skin lesions 1279
Genital surgery 2921
Genital ulcers 1277, 1278, 3484
Genital vesicles 643
Genital warts 1199
Genitalia 53, 472, 475, 2558
abnormal 53, 2622
Genitourinary anomalies 2929
Genitourinary infections 1224
Genitourinary tract 145
Genodermatoses, classification of 3391b
Genome
expression 1471
hybridization 2617
mutations 38
Gentamicin 1383, 2563
sulfate 3597
Genu valgum deformity
bilateral 3402f
Genu varum 3401, 3401f
GER. See Gastroesophageal reflux
GERD. See Gastroesophageal reflux disease
Germ cell 782
tumors 3067
German measles 1152
Germinal matrix 684
Germline mosaicism 44, 48
Gestation, disorders of 499
Gestational age 43, 462, 517f, 607, 637, 735f, 742, 796, 880
appropriate for 500, 519f, 526
assessment 535
correlation 500
large for 500, 503, 525, 525b, 526f, 527, 562, 570f, 695, 796
small for 191, 500, 503, 514, 517, 524, 535, 570f, 607, 695, 796, 866, 867, 870, 892f
Gestational diabetes mellitus 2957, 2960
Ghrelin 802
Giant hemangioma 2072
Giant molluscum contagiosum 3318
Giant platelet disorders 2070
Giant pulmonary arteriovenous malformation 2384f
Giardia intestinalis 1308
Giardia lamblia 1305, 1586, 1606, 1606f, 1741, 1811, 1814
Giardiasis 865, 1606, 1607, 1741
extraintestinal complications of 1607t
treatment of 1608t
Gibson's continuous murmur 2334
Gilbert disease 1868
Gingiva, developmental disorders of 843
Gingivitis 2972
Gitelman hypomagnesemias 279
Gitelman syndrome 279, 2545, 2548
Givosiran 197
Glands of Zeis 3274
Glandular fever 1488
Glandular tissue 2912
Glanzmann thrombasthenia 2084, 2085
Glasgow coma scale 301, 302, 418, 2695t, 2700
Glaucoma 137, 615, 2324, 3246, 3247
acquired 3253
congenital 3248
iatrogenic 3253
surgery 3249f
Glenn shunt, bidirectional 2470, 2472
Glial fibrillary acidic protein 684
Gliomas 3057
Global developmental delay 908, 912, 913
causes of 909t
Global enteric multicenter study 1606, 1609, 1707
Global malaria programme 15
Global multidimensional poverty index 28
Global polio eradication initiative 1136
Globoid cell leukodystrophy 135
Globotriaosylceramide 162
Globus pallidus pars interna
bilateral 2724
Glomerular basement membrane 2506, 2517f
Glomerular capillary hydrostatic pressure 2484
Glomerular disease 2505
pathognomonic of 2486
Glomerular filtration
barrier 2520
Glomerular hyperfiltration 2497
Glomerular inflammation 2507
Glomerular injury 2525
Glomerular microscopic hematuria 2517
Glomerular proteinuria 2518
Glomerulonephritis 1498, 2506, 2507, 2509, 2519, 2557
infectious 2506
rapidly progressive 2509
Glomerulopathy 2506
Glossitis 1961, 1992
Glossopharyngeal nerves 2582
Glucagon hydrochloride 3597
Glucocerebrosidase 134
Glucocorticoid 796, 802, 2915, 2921, 3143
antenatal 746
deficiency, familial 2929
exogenous 2943
induced osteoporosis 2986
pharmaceutical preparations of 2942
remediable hypertension 2558
replacement 2926
therapy, adverse effects of 2926, 2942
withdrawal syndrome 2943
Gluconate 3596
Gluconeogenesis 169fc
disorders 188
Gluconeogenic disorders 165, 169
Glucose 109, 191, 317, 636, 648, 2485, 2586
abnormalities 368
control 528
galactose intolerance 1816
metabolism 566
abnormalities of 2998
oxidase 2485
phosphate isomerase deficiency 2037
transporter 165, 166, 187, 187f
deficiency 165, 190, 2656, 2760
Glucose homeostasis 187, 187f
Glucose malabsorption
severe 1727
Glucose tolerance test 2960, 2962
intravenous 2962
Glucose-6-phosphate dehydrogenase 72, 480, 539, 555, 556, 573, 587, 1959, 19751977, 1992, 20052008, 2035
deficiency 70, 71, 80, 199, 200, 543, 551, 553, 576, 577, 1960, 1976, 2003, 2035
Glucosuria 2541, 2543
Glucosylceramide 145
Glucosylsphingosine 145
Glue injection 1887
Glut 2 defect 166
Glutamate
dehydrogenase 1751
transporter 108
Glutamic acid 40, 93
decarboxylase 94, 2587
Glutamine 93, 108
synthase 105
Glutamyl transpeptidase 1866
Glutaric acidemia 86, 116, 117
Glutaric aciduria 116, 117f, 120, 188
Glutathione 994
peroxidase 994
Gluten free diet 1822
Glycemic index 990, 990t
Glycemic load 990
Glycine 93
catabolism, disorders of 99
cleavage system 99
encephalopathy 99
N-methyltransferase 99, 99f
deficiency 98
Glycogen
branching enzyme 174
debranching enzyme 174
storage disease 1, 3, 6, 9, 70, 84, 85, 89, 172, 173, 173f, 174f, 175177, 188, 189, 191, 1920, 2540, 2835
types of 174t
storage disorder 86, 166, 171, 175, 1912, 1917, 1931
Glycogen metabolism 172, 172fc
Glycogenolysis 188
Glycohydrolases 141
Glycomacropeptide 96
Glycoprotein 2076, 2084, 2481
Glycosaminoglycans 137, 182
elevation of 1078
Glycosphingolipid 133, 160
metabolism 2518
Glycosuria 2963
Glycosylation
congenital disorders of 53, 54f, 83, 86, 87f, 89, 171f, 2766
defects of 2828b
disorders of 2619
Glycosyltransferase deficiency 2831
GM1 gangliosidosis 141, 142f
Goblet cells 1757
Goiter 1067f, 2886f, 2894, 2895
classification of 1067b
Goldenhar syndrome 53, 2324, 3229f, 3286
Golgi complex enzyme phosphatidylinositol 2543
Golgi intermediate compartment complex 1517f
Golimumab 3145
Goltz syndrome 46
Gomez classification 1034t
Gomori trichrome, modified 124f, 2842
Gonad 2867, 3002
Gonadal biopsies 2952
Gonadal development, disorders of 2948
Gonadal dysgenesis 1264, 2949t
Gonadal failure 2913
Gonadal mosaicism 44, 48
Gonadarche 2897t
Gonadotropes 2868
Gonadotropic hormone 2621
Gonadotropin 802, 1033, 2495, 3001
in PEM 1033
stimulation 2909
Gonadotropin-releasing hormone 1227, 1271, 2866, 2898, 2898f, 2902
analog 2910, 2910t
Goniometer 629f
Gonorrhea 1275, 1277f, 1278, 1341
prevention of 1393
treatment of 1393b
Gonosomal mosaicism 48
Goodpasture syndrome 2509
Goodsall's rule 1858, 1858f
Gooseneck deformity 1843
Gordon syndrome 2546, 2558
Gottron papules 3131f, 3168f, 3169, 3364, 3364f
Gower sign 45, 2784f, 2817f
G-protein-coupled receptor signaling 2865
Graafian follicles 1227
GRACILE syndrome 122t
Gradenigo syndrome 3284
Gradient-recalled echo sequences 2598
Graft function 2577
Graft versus host disease 1213, 1794, 2104f
Graham Steell murmur 2326
Gram stain 1277, 1308, 1418, 1847, 1901, 2205, 2562
Granisetron 3597
Granular casts 2486
Granular cells 2482
Granules 1954, 1955
secretion, disorders of 2085
types of 1955t
Granulocyte
hyperplasia 3033f
macrophage colony-stimulating factor 238f, 239, 1956, 2223
monocyte infusion 637
transfusion 2104
Granuloma inguinale 1275, 1278f
Granulomatosis 211, 2509, 2513, 2514, 3187
Granulomatous amebic meningoencephalitis 1604, 1605
Granulomatous angiitis 212
Granulomatous arthritis 3200
Granulomatous gastritis 1794
Granulomatous polyangiitis 2506
Grasp reflex 2584
Graves’ disease 62, 209, 2891, 2892
pathogenesis of 2891f
Graves’ ophthalmopathy 2892f
Gray matter disorders 2771
Great arteries 2378f
corrected transposition of 2285, 2383, 2385
dextro-transposition of 2266, 2315
D-transposition of 2357, 2358, 2465, 2467
L-transposition of 2358
transposition of 694, 2251, 2274, 2278f, 2339, 2368, 2372f, 2377, 2378, 2379fc, 2471, 2471t
Great toe 53
Great vessels, transposition of 2386
Greulich and Pyle atlas 848
Grey Turner's sign 1798
Griscelli syndrome 134, 3323, 3324f
Grisel syndrome 3412
Griseofulvin 288, 3597
Groove sign 1278f
Gross-motor function classification scale (GMFCS) 899t, 901
Ground-glass appearance 711f, 1834f, 2277f
Group A streptococcal infections 1379
Group A streptococcal pharyngitis 2146b, 2148t
Group A β-streptococcal infection 2406
Group B streptococcal infections 1383
Growth 155, 506, 517, 795, 800, 804, 865, 1047, 2018, 3000, 3153
abnormalities of 53
and puberty, constitutional delay in 2902, 2903
assessment of 851
chart 806, 835f, 865f, 868f
detection 1458
disorders 2221
factor 2046
failure 1034
goal of 511
hormone 191, 801, 858, 866, 870, 875, 1032, 2574, 2621, 2865, 2876, 2989, 2997, 3001
deficiency 849f, 865, 870, 871t, 2620, 2871, 2872, 2872t, 2875, 2876fc, 2997
excess 875
inhibiting hormone 801
insensitivity 870
production 2871
receptor gene mutation 2873
releasing hormone 797, 801, 802, 2866, 2874f
resistance 2871, 2873, 2874f, 2876, 2877
secretion and action 2872f
suppression of 2943
therapy 64, 71
impairment 2574
infancy-childhood-puberty model of 796
longitudinal assessment of 832
measurement, techniques of 804
monitoring 12, 515, 627, 832, 3001
parameters 53
interpretation of 829
promoting strategies 2921
references 806
regulation, pathophysiology of 2871
restriction 53
retardation 53, 97, 122, 1035, 1419, 1883
standards 806
velocity 798
Growth hormone deficiency
isolated 188
Gruber-Frantz tumor 1803
Guanidinoacetate methyltransferase 2760, 2761
Guanine 36, 47, 58
Guanosine triphosphate 97
Gubernaculum 2955
Guillain-Barré syndrome 235, 350, 397, 1142, 1184, 1207, 1354, 1392, 1484, 1538, 1542, 1578, 1700, 2204, 2779, 2781, 2805, 2807b, 2808, 2862
diagnosis of 2807b
immunopathogenesis of 2806f
Gut
associated lymphoid tissue 1754
blood supply of 1756
brain interaction, disorders of 1759
development of 1754
fixation of 1755
microbiota 858
peritoneal relations of 1755f
Guttate psoriasis 3379
Gynecomastia 1226, 2912, 2912f, 2914
evaluation of 2912b
management of 2913fc
pathological causes of 2912b, 2913
therapeutic options for 2914b
Gyral pattern abnormality 2615
H
H1N1 1186
influenza 1183
H3N2 1186
H5N1 viruses 13
Haemophilus ducreyi 1275
disease 1373, 1375
infection 1372, 1373, 1373b
clinical manifestations of 1373b
vaccine 29, 1125, 1147, 1214, 1290
Haemophilus influenzae type B (HIB) vaccines 11471149
Hair 53, 88
abnormalities 2580
changes 1035, 2733, 3303
disorders 3395
pigmentation, diffuse loss of 3399f
tuft of 474f, 788f
Hair-on-end appearance 1058, 2025f
Hairy ears 47
Hairy pinna 562f
Hallermann-Streiff syndrome 3286
Halo nevi 3325
Halogenated hydrocarbons 379
Haloperidol 3598
Hamartomas 3306
Hamilton depression rating scale 1252
Hammersmith infant neurologic examination 630, 900
Hand
dorsum of 2734f
edema of 63
Hand-arm bimanual intensive therapy 903
Hand, foot, and mouth
disease 1531, 1531f, 1534, 2147f
syndrome 1964f
Handigodu syndrome 3451
Hand-Schüller-Christian disease 3103
Hansen's disease 1462, 1578
Haptocorrin deficiency 1997
Harada scoring system 234t
Harlequin ichthyosis 3387
differential diagnosis of 3388b
Harpenden calipers 1035
Harris-Benedict equation 990
Hartnup disease 91, 102
Hashimoto's encephalitis 2694
Hashimoto's encephalopathy 2697, 2746, 2747
Hashimoto's thyroiditis 62, 209
Hashimoto-Pritzker disease 3104
HBV infection
prevention of perinatal 1145
hCG-secreting tumors 2907
Head circumference 471, 519, 539, 805, 1035
Head computed tomography of 2689
contrast-enhanced computed tomography of 2683f
growth 628
Headache 947, 2508, 2658, 26602662
acute 2659
disorders, classification of 2659, 2659b
management of 2662
severe 2508
Headache, treatment of 2663
HEADSS screening tool 1236
Head-tilt chin-lift maneuver 310f
Head-up tilt test 2855
Health 7
check-up 29
education 1404
expenditure 13
facility attributes 1294
inequality 9
influencing factors 1237
promotion 921
technology assessment 22
Healthcare
associated infection 632, 1324
workers, immunization of 1218
Healthy human microbiome, biodiversity of 1313
Hearing 88, 889, 923
aids 927, 2517
assessment 480, 627
defects of 880
deficits 507
development of 923
disorders 61
impairment 923, 927
congenital 924
effects of 925
types of 924
involvement 86
loss 64, 88, 668, 923, 925, 2136
acquired 925
degrees of 924f
detection of 926fc
risk indications for 925b
screening for 200
screening 80, 623
Heart 48, 150, 1386, 1644
block 2543
conduction defects of 71
defects 52, 2261
congenital 61, 64, 2251, 2309, 2368
development of 2252, 2267
dextroposition of 2310f
disease 2706
acquired 2267, 2468
coronary 520f
causes of 2300b, 2468t
effects of 2301
features of 2362
signs of 2302b
symptoms of 2302b
murmurs 2265
rate 320, 328, 366, 468, 471, 474, 1569, 2180f, 2855
calculation 2279
shadow, radiological appearance of 2273
shape of 598
sounds 2264, 2325
transplantation 71, 2307
Heart failure. Also See Congestive heart failure
Heat hyperpyrexia 1335
Heat loss 434, 482
mechanisms of 483f
Heat production 482
Heated humidified high-flow nasal cannula 714
Heavy menstrual bleeding 1268, 1269
Height velocity chart 798f
Heimlich maneuver 311
Heiner syndrome 1014t
Heinz bodies 2004, 2317
Helicobacter pylori 1055, 1419, 1759, 1777, 1791, 1793, 1794, 2076, 3335
diagnostic tests for 1420t
infection 1421b, 1895, 1992
treatment of 1421t
Heliotrope rash 3131f, 3169f, 3364
periorbital 2783f
Heller myotomy 1782
Helminth infections 2462
Hemagglutination inhibition assay 1579
Hemagglutinin 1479, 1493
Hemangioendothelioblast 1948
Hemangioendotheliomas 1942
Hemangioma 1774, 2710
congenital 3320, 3321
Hematemesis 1894
Hematochezia 1894
Hematocrit 1568, 1569, 1575, 1966
Hematology 605, 803, 1542, 1839
Hematopoietic system 1948
disorders of 1948
Hematoma 97
Hematopoiesis 571, 572f, 1956t
site of 1948
Hematopoietic cell 1948
transplantation 1982
Hematopoietic colony-stimulating factors 3117
Hematopoietic stem cell 1948
therapy 185
transplantation 74, 139, 154, 227, 230, 1154, 1213, 1980, 1981, 3016, 3018, 3034, 3119, 3124t
Hematuria 2486, 2488, 25052508, 2510, 2516, 2529, 2556
detection of 2505
etiology of 2506t
Heme
biosynthesis of 195f
synthesis
pathway 194
regulation of 194
Hemiagenesis 2895f
Hemifacial macrosomia 3286
Hemifacial microsomia 1769
Hemifacial sensorimotor seizures 2639
Hemiplegia 2584
Hemiplegic migraine, familial 2656, 2710
Hemispheric epilepsy 2640
Hemodialysis 70, 90, 2534, 2575, 2576
chronic 2576
Hemodynamic 2324, 2325, 2334, 2337, 2340, 2360, 2369
auscultation 2266t
instability 2651
monitoring 332
status 2533
theory 2344
Hemofiltration 70
Hemoglobin 328, 556, 572f, 594f, 1269, 1569, 1920, 1952, 1957, 1977, 1989, 2485, 2505
abnormal 595
analysis 2011
C disease 2009
concentration 594, 594f, 1966
content of 1993
D disease 2010
E disease 2010
electrophoresis 595, 2011, 2025
gene locus 1952f
inherited disorders of 2023
structure of 1952f
synthesis, disorders of 1972
types of 1952t
Hemoglobin high-performance liquid chromatography 44, 2010f
Hemoglobinopathies 80, 152, 199, 2009, 2011
Hemoglobinuria 1589, 2003, 2505
Hemogram 3136
Hemolysis 102, 573, 2098
acute 2036
elevated liver enzymes, low platelet count 120, 584, 2008
Hemolytic anemia 573, 1700, 2002, 2005fc, 2006fc, 2007, 2008b, 2009, 2031, 2035b
acquired 2003b, 2004t
clinical presentations of 2008
congenital 2002b, 2004
diagnosis of 2002
Hemolytic crisis 2032
Hemolytic disease 551, 2102
Hemolytic facies 1961, 1963f
Hemolytic uremic syndrome 1715, 1975, 1976, 2006, 2007, 2068, 2069, 2072, 2076, 2100, 2487, 2506, 2535, 2536f, 2537, 2537b
atypical 2506, 2535, 2538, 2576
causes of 2536t
classification of 2535b
Hemophagocytic lymphocytosis 1910
Hemophagocytic lymphohistiocytosis 102, 215, 218, 1698, 1872, 1877, 1878, 1931, 2050, 3103, 3108
diagnostic criteria for 3108b
Hemophilia 79, 584, 2056, 2059, 2063t
A 39, 40, 2059
acquired 2055
diagnosis of 2057f
prevention of 2062
Hemophilic joints 2058f
Hemophilic knee 2062t
Hemophilic pseudotumor 2058f
Hemoptysis 2225, 2226
causes of 2225b
Hemorrhage 548f, 1894, 2597
gastrointestinal 1761
management of 1940
Hemorrhagic conjunctivitis
acute 1532
Hemorrhagic disease 584, 585, 587, 2066
Hemorrhagic fevers 1582
Hemorrhagic measles 1475
Hemorrhagic pulmonary edema 2303f
Hemorrhagic stroke 2705, 2714, 2714f, 2715
Hemorrhoids 1899
Hemosiderin 2598
Hemosiderinuria 2003
Hemostasis 2044
acquired disorders of 2054
physiology of 583, 2044
Hemostatic system, four important components of 2045f
Hemothorax 339
Henderson-Hasselbalch equation 259
Henoch-Schönlein purpura 1623, 1798, 1894, 1895, 2506, 2513, 3184, 3185t, 3186
Heparan sulfate 182
Heparin 2093
induced thrombocytopenia 2072
sodium 3598
Hepatic acinus 1758
Hepatic angiography 2514
Hepatic cell 1880
Hepatic development 1861t
Hepatic encephalopathy 1911, 19301933, 1933f, 1937, 1938, 2693
causes of 1931t
classification of 1916t, 1932t, 1938b
management of 1939
pathophysiology of 1930f
pattern of 1933f
staging of 1931t
types of 1932t
Hepatic failure
neonatal 584
Hepatic hydatid disease 1640b
Hepatic injury 375t
Hepatic lobule 1757
classic 1862f
Hepatic phosphorylase kinase 174
Hepatic porphyria 197
Hepatic stellate cells 1913, 1913f
Hepatic venous outflow tract obstruction 1910, 1912
Hepatitis 1498, 1539, 1907, 2039, 2676. Also See Acute hepatitis
Hepatitis A 1229
vaccine 1125, 1178
Hepatitis B 29, 479, 643, 1099, 1120, 1124, 1208, 1216, 1226, 1229, 1373, 1469, 2514, 2577
immune globulin 1145
infection 1145
prevention of 1144
surface antigen 1276, 1543
vaccine 479, 1125, 1144
Hepatitis C 1124, 1229, 1469, 2577
cholestatic 1542
Hepatitis D 1469
virus 1539, 1540, 1543, 1544
Hepatitis E 1539, 1540, 1543, 1544, 1906, 1910, 1939
virus 666, 1544t
Hepatobiliary apparatus, development of 1756f
Hepatobiliary diseases 1861
Hepatobiliary iminodiacetic acid 1878
Hepatobiliary system 2017
Hepatoblastoma 19421944, 1945f
pretext staging of 1943t
staging 1943
Hepatocellular carcinoma 1867, 1876, 1916, 1945, 1946, 1946f
Hepatocellular necrosis 1865
Hepatocyte growth factor 801
Hepatocyte injury, tests for 1865
Hepatoerythropoietic porphyria 198
Hepatomegaly 97, 147, 152, 155, 1035
Hepatoportal sclerosis 1891
Hepatopulmonary syndrome 147f, 1914, 1918, 1923
Hepatorenal syndrome 1847, 1919, 1924
Hepatosplenomegaly 86, 136, 151, 152, 1846, 1961
Hepatotropic virus 1540, 1906
infection 1541
Hepcidin, role of 1990, 1991b
Herd immunity 1104, 1135, 1175, 1374
Hereditary benign intraepithelial dyskeratosis 3230
Hereditary coproporphyria 197, 198
Hereditary elliptocytosis 577f, 2032
peripheral smear of 2033f
Hereditary fructose intolerance 168, 169, 188, 189, 1912, 1917
Hereditary gingival fibromatosis 843, 843f
Hereditary hemochromatosis 80, 2464
Hereditary hemorrhagic telangiectasia 2384
Hereditary ichthyosis 40
Hereditary motor sensory neuropathy 2779
subtypes of 2851t
Hereditary neurodegenerative disorders 2765t
Hereditary neuropathy 2853
Hereditary orotic aciduria 88
Hereditary platelet function defects 2084
Hereditary pyropoikilocytosis 2032
peripheral smear of 2033f
Hereditary sensory autonomic neuropathy 2786
Hereditary spastic paraparesis 109
Hereditary spherocytosis 43, 70, 553, 577f, 1973, 2005, 2031, 2032
peripheral smear of 2033f
Hereditary stomatocytosis 1973, 2032, 2033
dehydrated 1973
peripheral smear of 2033f
Hermansky-Pudlak syndrome 134
Hernia 770, 780, 1850f, 2324
Herniation, type of 2698
Herpangina 1531, 2147f
Herpes gladiatorum 1502
Herpes labialis 2147f
Herpes simplex 53
encephalitis 1503f, 2675, 2678f
infection 665f, 665b, 1274, 1736, 1877, 1878, 1907, 3317
Herpes simplex virus encephalitis 1502
Herpes zoster 1499, 1499f
meningoencephalitis 2586
Herpetic genital ulcers 1278
Herpetic gingivostomatitis 1502f
Heterochromia iridis 53, 54f
Heterogeneity, reasons for 1130
Heterophile antibody test 1490
Heterophoria 3261
Heterophyes heterophyes 1631, 1632
Heteroplasmy 48
Heterosexual peripheral precocious puberty 2908
Heterotaxy syndromes 2316, 2318
Heterotopias 2620
Heterotropia 3261
Heterozygotes 2516
Heterozygous mutations 2516
Hexosaminidase 141
Hexose-6-phosphate dehydrogenase deficiency 2923
Hiatal hernia 1782, 2524
Hib. See Haemophilus influenzae type B
Hib vaccines 1147, 1374
Hidrotic ectodermal dysplasia 3392, 3393f
HIE. Also See Hypoxic ischemic encephalopathy
Higgins’ self-discrepancy theory 1234
High blood pressure, correlation of 2556
High erythrocyte sedimentation rate 1603
High performance liquid chromatography 2761
High-arched palate 64, 87f
High-dose calcitriol 70
High-dose dexamethasone 2080
suppression tests 2934
High-dose flu vaccine 1183
High-dose intravenous immunoglobulin therapy, side effects of 235
High-efficiency particulate air 306f
filters 1327
High-flow nasal cannula 353, 2162, 2201
High-frequency ventilation 358, 709, 722, 745
Highly active antiretroviral therapy 1548, 1663, 1676, 1744
High-molecular-weight
kininogens 2048f
multimer 2065
High-order multiple gestations 529
High-performance liquid chromatography 44, 92, 588, 1457, 2018, 2024
High-pressure liquid chromatography 1047
High-quality cardiopulmonary resuscitation 312
components of 309b
High-resolution computed tomography 1458, 1549, 2142, 2226
High-resolution esophageal manometry 1780
High-resolution magnetic resonance imaging 911
High-risk intraocular retinoblastoma 3087
High-serum aspartate aminotransferase 1800
Hilgenreiner line 3428
Hill's sign 2417
Hindmilk 488
Hip
click 3401, 3427
dislocation 2836
dysplasia, prevention of 3429
developmental dysplasia of 474, 528, 3426
Hippocampal malrotation 2648
Hirschberg corneal reflex 3263f
Hirschberg test 3262f
Hirschsprung disease 758, 761, 764, 764f766f, 1746, 1755, 1808, 1808f, 1809, 1809f, 1809t, 1855
barium enema of 1809f
Hirsutism 3398
His-Purkinje system 2442
Histamine 2 receptor antagonists 1785
Histidine 93
rich protein 1590, 1591
Histiocytic disorders 3103
historical classification of 3103
Histocompatibility complex 237
Histoplasma
capsulatum 16471650, 1675, 1677f, 1797
life cycle of 1675, 1675f
Histoplasmin skin testing 1677
Histoplasmosis 1675, 1676f, 1677, 1678
acute pulmonary 1675
HIV. See Human immunodeficiency virus. Also See Acquired immunodeficiency syndrome
HLA 3123
Hoagland's diagnostic criteria 1490
Hodgkin disease 3000, 3011
Hodgkin lymphoma 2520, 3041, 3042t, 3043f, 3044, 3044f, 3045, 3045t, 3046t
HOIL1 deficiency 224t
Holandric inheritance 46
Holliday and Segar calculation 253t
Holoprosencephaly 790, 2620, 2872
Holter monitoring 2445
Holt-Oram syndrome 55, 71, 2324
Homan's sign 2089
Homeopathic medicinal products 2145
Homocitrulline 108
Homocitrullinemia 107
Homocitrullinuria 83, 102, 108, 109
Homocysteine 89, 99, 99f
Homocysteinemia 2464
Homocystinuria 70, 80, 86, 8890, 98, 99, 115f, 875, 3245, 3287
classic 98
physical signs of 87f
Homogentisic acid 98
Homonymous hemianopia 2581
Homoplasmy 48
Homozygosity, regions of 89
Honeycomb appearance 1641f
Hookworm
anemia 1616
infection 1623
infestation 1615, 1617
prevention of 1617
life cycle of 1616f
Hordeolum externum 3221f
Horizontal gaze palsy 152
Hormonal imbalance 119
Hormone 801, 859
biochemical actions of 2864
categories of 2864
influencing growth 801fc
mechanisms of action of 2865
production, feedback control of 2865
receptors 2865
replacement therapy 64
Horner syndrome 549, 2695, 3260, 3260f
Horseshoe kidney 64, 774, 774f, 2493
Hospital-acquired pneumonia 2202
Host 8, 1403
factors 1672
genetics 1585
Host-parasite relationship 1585
Hottentotta tamulus 404
Hounsfield units 2594
24-hour urinary iodine 1067
24-hour esophageal pH monitoring 2185
Household poisoning 382
Howell-Jolly bodies 2017, 2317
Hoyeraal-Hreidarsson syndrome 1980
HPV. See Human papillomavirus
HSV. See Herpes simplex virus encephalitis
Hughes classification 3282
Human androgen synthesis 2947fc
Human antithymocyte globulin 1987
Human body louse 1695f
Human brucellosis 1406
Human chorionic gonadotropin 63, 2912, 2913
secreting tumors 2907
Human cortical development 2612
Human cosavirus 1468
Human diploid cell vaccine 1164, 1507
Human enterovirus serotypes 1530t
Human genome 37, 38
analysis of 41
organization of 37, 37fc
project 12, 40
completion of 40
Human growth
curve 796
hormone 873t
Human herpesvirus 1485, 1486, 1488, 2676, 2677
Human immunodeficiency virus 5, 13, 74, 153, 205, 231, 455, 627, 664, 855, 916, 1052, 1096, 1184, 1206, 1217, 1224, 1275, 1290, 1306, 1325, 1376, 1393, 14271429, 1498, 1534, 1547b, 1550, 1598, 1604, 1661, 1676, 1735, 2071, 2213, 2510, 2577, 2665, 2742, 2807, 3285, 3518. Also See Acquired immunodeficiency syndrome
infection 25, 213, 233, 336, 1144, 1211, 1350, 1364, 1369, 1490, 1544, 1547t, 1553, 1664, 2440, 2862
infection, diagnosis of 1553
vaccination of 1207
Human intestinal tract, metagenomics of 1313
Human metapneumovirus 1314
Human milk 488
Human papillomavirus 225, 1100, 1116, 1120, 1195, 1212, 1229, 1274, 1275, 1290
infection 1275
vaccinations 1226
Human papillomavirus vaccines 1125, 1195, 1196t, 1208
new 1199
population impact of 1199
Human placental lactogen 450
Human rabies immunoglobulin 1507, 3598
Human tetanus immunoglobulin 3599
Human T-lymphotropic virus 1306, 1621
Humerus
avascular necrosis of 2016f
fracture 550
Humidity 2172
Humoral immunity 205, 218, 1136
effector mechanisms of 207
Hunter syndrome 83, 182, 183, 183f
Huntington disease 44, 47
Hurler syndrome 83, 88, 182, 183, 3228
Hurler-Scheie syndrome 182, 183f
HUS. See Hemolytic uremic syndrome
Hutchinson-Gilford progeria syndrome 39
Hyaline membrane disease 350, 598, 710, 711f, 712, 739f, 2358
Hyaluronic acid 1206
Hybrid surgery 2323
Hydatid cyst 1641f
treatment of 1641t
Hydatid disease 1639, 1640f
diagnosis of 1640
Hydralazine 2304, 2559, 2560
hydrochloride 3599
Hydration 1223, 1333, 2979
Hydrocarbon
aspiration 380t
compounds 379, 379t
poisoning 379, 380
Hydrocele 780, 1628
Hydrocephalus 136, 789f, 2580, 2596f, 2608, 26232625, 2626f, 2628, 2671f
chronic 2626
clinical features of 2626t
congenital causes of 789b
etiology of 2625t
external 2625
treatment of 2672
Hydrochloric acid burns 431
Hydrochlorothiazide 2560, 3599
Hydrocortisone 288, 2522
Hydrofluorocarbons 1117
Hydrogen
breath test 1736, 1737
cyanide 430
ion 258
nuclei 2597
Hydrogenation 991
bomb 2475
Hydronephrosis 780, 2491
Hydrophobic tail 711f
Hydrops fetalis 137, 152, 2260b
Hydrotherapy 1333
Hydroureteronephrosis 2489f, 2495
Hydroxocobalamin 115
Hydroxychloroquine 288, 3143
21-hydroxylase deficiency 2919
11β-hydroxylase deficiency 2922
17β-hydroxylase deficiency 2922
3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) lyase deficiency 120t
3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthetase deficiency 120t
3β-hydroxysteroid dehydrogenase deficiency 2922
Hydroxylase deficiency 2919, 2921, 2922
Hydroxylysine 92, 111
Hydroxyproline 92
Hydroxysteroid dehydrogenase deficiency 2922
Hydroxyurea 2019, 2020
Hydroxyzine hydrochloride 3599
Hymenolepis nana 1638
egg of 1638f
Hyoscine butylbromide 3599
Hyperammonemia 83, 84, 84fc, 85, 102, 105107, 112, 188, 1937
causes of 108t
syndrome 108
Hyperammonemia-hyperornithinemia-homocitrullinemia syndrome 2759
Hyperammonemic crisis
neonatal 1936fc
Hyperammonemic episodes, duration of 106
Hyperargininemia 108
Hyperbaric oxygen 1424
Hyperbilirubinemia 507, 508, 554t, 563, 1959f, 2003
types of 1865fc
Hypercalcemia 1797, 2501, 2978, 2979
causes of 2978b
familial hypocalciuric 2979
Hypercalciuria 2506, 2539, 25482550, 2983
Hypercalciuric hypomagnesemia 279
Hypercholesterolemia 280, 2994, 2995
familial 43, 80, 2994
Hyperconvex nails 63
Hypercyanotic spells 939
Hyperendemic 1301
Hyperekplexia 2717, 2724
Hyperextensible joints 53
Hyperferritinemia 151
Hyperglycemia 2586, 2605
Hyperglycemic hyperosmolar state 2969
management of 2971
Hyperglycinemia 99
Hypergonadotropic hypogonadism 1265t, 2903, 2956
congenital syndromes of 1265t
Hyperhomocysteinemia 2707
Hyper-IgE syndrome 215, 220
Hyperimmune plasma 1534
Hyperimmunoglobulinemia D syndrome 225, 226
Hyperinfection syndrome 1623
Hyperinsulinemia 188, 192, 2605, 3004
Hyperinsulinemic hypoglycemia 188
Hyperinsulinism 108, 188
Hyperkalemia 275, 277, 2482, 2508, 2531, 2545, 2546, 2574
causes of 276b
treatment of 277t
Hyperkalemic acidosis 2539
Hyperkinetic disorders 960b
Hyperkinetic reaction 959
Hyperlactacidemia 108
Hyperleukocytosis 3031, 3115
management 3116b
Hyperlipidemia 2519, 2973, 2993, 2996
classification of 2994t
familial combined 2995
Hypermagnesemia 280, 281
Hypermetropia 3220
Hypernasal speech 178
Hypernatremia 256, 269, 270, 271, 272, 1712
Hypernatremic dehydration 1712
treatment of 257b
Hyperopia 3224
Hyperornithinemia 102, 107109
Hyperoxaluria 2549, 2550, 2551f
Hyperoxia 600
test 599, 2358
Hyperparasitemia 1589
Hyperparathyroidism 2549, 2941, 2978
Hyperphenylalaninemia 97, 280
Hyperphosphatemia 2531
Hyperphosphaturia 2539, 2543
Hyperpigmentation 3301
Hyperpipecolic acidemia 129
Hyperpyrexia 1594
Hyperreflexia 96
Hypersegmented neutrophil 2000f
Hypersensitivity 214, 237, 1657
classification of 242t
pneumonitis 1657, 2222f
reactions 1207, 1350
vasculitis 3187f
Hypersplenism 57, 152, 2028
chronic 2017
Hypertelorism 3209
Hypertension 64, 274, 280, 540, 1920, 1924, 2263t, 2270, 2497, 2521, 2526, 2531, 2535, 2556, 2557, 2559, 2571, 2574, 2936, 3292
causes of 2559
etiology of 2574
monogenic causes of 2558t
pregnancy-induced 2071
therapy of 2559
severe 2508, 2521
Hypertension, staging of 2557t
Hypertensive emergency 2557, 2559, 2559t
Hypertensive urgency 2557
Hyperthermia 487, 644
related hyperventilation 2630
Hyperthyroidism 455, 979, 1746, 2463, 2557, 2891
causes of 2891b, 2892
signs of 2892t
Hypertonic cryohemolysis test 2033
Hypertonic dehydration 256, 257
Hypertrichosis hair 3398
Hypertriglyceridemia 1797, 2993, 2995
syndrome, familial 2994
Hypertrophic cardiomyopathy 177, 2266, 2429, 2432, 2434, 2434t, 2467
echocardiography of 2433f
Hypertrophic obstructive cardiomyopathy 2351
Hypertrophic pyloric stenosis 1787
Hypertrophic scars 2836
Hypertrophied tonsils 2156
Hypertrophy 2818
Hyperuricemia 280, 2499
Hyperuricosuria 2550
Hyperventilation 731, 2589, 2634, 2699
Hyperviscosity 508
syndrome 3291
Hypervitaminosis
Hypnale hypnale 395
Hypoalbuminemia 261, 2519, 2520
Hypoaldosteronism 276, 2540, 2546
Hypobetalipoproteinemia 2728
Hypocalcemia 280, 563, 565, 659, 2171, 2305, 2531, 2548, 29762978
childhood 2977
correction of 673
familial hypercalciuric 2977
hood, causes of 2977b
management of 509
prevention of 509
Hypocalciuria 280
Hypocellular marrow 1972f
Hypochlorite 2505
Hypochlorous acid 1812
Hypocitraturia 2539, 2549, 2550
Hypocortisolism 2620
Hypodontia 843, 3252f
Hypofibrinogenemia 2066
Hypogammaglobulinemia 225, 1340
Hypogenitalism 2498
Hypoglycemia 84, 85fc, 97, 113, 187, 187t, 188, 190, 192, 378, 506, 508, 563, 671, 1041, 1589, 1594, 2971
clinical features of 190b
correction of 673
management of 509
operational threshold for 187
prevention of 509
signs of 2971b
symptoms of 2971b
Hypoglycemic brain injury 193f
Hypoglycorrhachia 2586
Hypogonadism 2986, 2998
Hypogonadotropic hypogonadism 2902, 2903, 2956, 2998
Hypohidrotic ectodermal dysplasia 3391, 3392f
Hypokalemia 274, 275, 276fc, 1712, 1803, 2539, 2544, 2545t, 2548
causes of 274b, 2544b
renal causes of 2544
Hypokinesia 2734
Hypomagnesemia 279, 280, 563, 565, 2548, 2549, 2976
acquired 2548b
causes of 279b, 2547
familial 280, 2548
genetic causes of 279t
isolated dominant 280
severe, sign of 2548
Hypomelanosis 3322, 3398
of Ito 53, 2580, 2756f, 3327, 3327f
Hypomelanotic macule 43, 2750f
Hyponatremia 255, 269, 270, 271t, 272, 1712, 1715, 1946, 2498, 2531, 2672
asymptomatic 2881
severe 2881
Hyponatremic dehydration, treatment of 257b
Hypoparathyroidism 119, 2596f, 2927, 2977, 2998
congenital 1746
Hypophosphatasia 72, 88, 89f
Hypophosphatemia 2970, 2982fc
Hypophosphatemic rickets 70, 2554, 2555, 2983
Hypopigmentary diseases 3322
Hypopigmentary disorders 3329fc
acquired 3328b
Hypopigmentation 220, 3322
diagnosis of 3322
early-onset 3322
Hypopigmented disorders 3330
Hypopituitarism 191
Hypoplasia 2117, 2380, 2621, 2873
Hypoplastic anemia 573
Hypoplastic left heart syndrome 85, 598, 600, 2270, 2344, 2392, 2392f, 2393, 2394t, 2465, 2466, 2472
diagnosis of 2393t
Hypoplastic lung 2164
Hypoplastic myelodysplastic syndrome 1986
Hypoplastic right heart syndrome 2358, 2385
Hypopnea, episode of 2161f
Hyporegenerative anemias 1972
Hyporeninemia 2546
Hyporeninemic hypoaldosteronism 2546
Hypospadias 776, 777f, 2324, 2496
anterior 776
severe 777f
Hyposplenia 1212
Hypotelorism 3209
Hypotension 644, 1391, 2526, 2534, 2576, 2651
Hypotensive decompensated shock 1576fc
Hypothalamic dysfunction 2248, 2249, 2862
Hypothalamic hamartoma 2906
Hypothalamic hormones 2868t
Hypothalamic obesity, causes of 858b
Hypothalamic-pituitary-adrenal axis 2130, 2931f
assessment of 2943
suppression of 2527
Hypothalamic-pituitary-gonadal axis 1226, 2897, 2898
Hypothalamic-pituitary-ovarian axis 1227, 1265, 1266
Hypothalamic-pituitary-thyroid axis, regulation of 2882
Hypothalamus 2866, 2873, 3001
role of 2871
Hypothermia 417, 436, 438, 439, 439f, 483, 506, 508, 644, 1041, 2701
clinical signs of 483
differential diagnosis of 437b
grades of 483
management principles for 486fc
prevention of 484
risk factors for 434t
prolonged 484
severity of 483t
stages of 437fc, 437t
Hypotheses 1930
Hypothyroid 64
Hypothyroidism 55, 80, 480, 543, 870, 1066f, 1264, 2463, 2874, 2884, 2908, 2998
beyond neonatal period 2887, 2888
causes of 2887b
clinical features of 2887b
Hypotonia 86, 87f, 136, 165, 167f, 257, 495, 2524, 2580, 2583, 2795t, 2837fc
central 2792f
differential diagnosis of 2797t
generalized 177
localization of 2793, 2794f
Hypotonic dehydration 256
Hypotonic fluids 256
Hypoventilation 596, 2112f, 2248, 2249, 2862
Hypovolemia 715, 2521, 25242526
Hypovolemic shock 329, 2676
Hypoxemia 2160, 2179, 2223
assessment of 261
causes of 338, 338t, 2112f
Hypoxia 368, 2071
ischemia 418, 686
Hypoxic depression 697
Hypoxic ischemic encephalopathy 447f, 539, 598, 626, 676, 677, 677t, 678f, 678fc, 680f, 681, 682, 682t, 694, 909, 2693, 2796
etiology of 677t
Levene's classification of 679t
management of 681b
pathophysiology of 677f
Sarnat and Sarnat classification of 679t
Hypoxic ischemic injury 417
Hypoxic respiratory failure 620
Hypsarrhythmia 2635
Hysterical vision loss 3259
I
IAP. See Indian Academy of Pediatrics
IBD. See Inflammatory bowel disease
Ibuprofen 1334, 2662, 3599
I-cell disease 185
ICDS. See Integrated child development service scheme
Ice lined refrigerators 1120
Icepack test 2848
Ichthyosis 855f, 3288, 3384, 3385b, 3390
classification of 3384fc
congenital 3214f
diagnosis of 3390f
management of 3389
vulgaris 3384, 3386, 3386t
differential diagnosis of 3386b
ICP. See Intracranial pressure
Idiopathic hypercalciuria 2549
Idiopathic infantile hypercalcemia 2978
Idiopathic inflammatory myopathies 3170
Idiopathic intracranial hypertension 2585
Idiopathic juvenile osteoporosis 2985
Idiopathic ketotic hypoglycemia 187
Idiopathic left ventricular tachycardia 2458
Idiopathic portal hypertension 1891
Idiopathic pulmonary arterial hypertension 209, 2399
management of 2399fc
Idiopathic pulmonary hemosiderosis 2222f, 2225
Idiopathic scoliosis 3419, 3419f
Idiopathic thrombocytopenic purpura 456, 585, 2074, 2087, 3162
Idiopathic urticaria 3336
IgA nephropathy 25102512
Ileal atresia 759, 761
Ileocecal junction 762f
Ileum 1756
Iloprost 2399
Illness anxiety disorder 986t
Imatinib mesylate 3033
Imerslund-Grasbeck syndrome 1973, 1997, 1999
Imipenem-cilastatin 3599
Immature reticulocyte fraction 1968
Immersion foot 435
Immune cytopenia 3165
Immune deficiency disorders 1332
Immune dysregulation 215, 222, 2072
diseases of 220, 221t
Immune hemolytic anemia 2039, 2043
Immune reconstitution inflammatory syndrome 1663
Immune system
cell of 203
organs of 203
Immune thrombocytopenia 221, 2050, 2072, 2074, 20772082, 2078t
chronic 1420, 2079
treatment of 2077b, 2079t
Immune thrombocytopenic purpura 232, 233, 1960, 1962, 2043, 2051, 2068, 2074, 2077
Immune-mediated disorders 3230
Immune-mediated platelet destruction 2072
Immunity 203, 223t, 1031, 1474, 1531
Immunization 29, 479, 510, 627, 922, 1098, 1280, 1560, 1831, 1926, 2208, 3118
anxiety-related reaction 1124
error-related reaction 1124
program
assessment of 1104
evaluation of 1104
Immunobullous disorders 3374
Immunochromatographic test 1597
Immunocompetent hosts 1662
Immunocompromised host 1676
disorders of 2221
Immunodeficient-associated VDPV 1537
Immunodeficiency disorders 71
Immunoelectrophoresis 588
Immunofixation electrophoresis 216
Immunofluorescence 1308
assay 1691, 1692
microscopy 2231
Immunogenicity 8, 1147, 1162, 1168, 1169, 1196
Immunoglobulin 215, 219, 220, 240, 1490, 1572, 3598
Immunoglobulin A 240, 488, 647, 1342, 1822, 2510
nephropathy 2510
vasculitis 3139, 3184
Immunoglobulin D 225
Immunoglobulin E 214, 237, 238f, 239, 1629
functions of 239
mediated allergic reactions, mechanisms of 239
Immunoglobulin G 209, 1290, 1763, 1923, 1928, 2043, 2586, 2707
antibody binding portion of 231
molecule 233f
Immunoglobulin M 150, 209, 1498, 1763, 1939, 2707
therapy, side effects of 234t
Immunoglobulin E-mediated allergic reactions 239
Immunology 88, 2154
basics of 203
Immunomodulatory therapy 1526
Immunopathogenesis 1524, 1596, 1599, 2191
Immunoperoxidase 1686
Immunoproliferative small intestinal disease 1742
Immunoprophylaxis 1434
Immunosorbent agglutination assay 664
Immunosuppression 2524
Immunosuppressive therapy 1211, 1985, 1987t, 2305
IMNCI. See Integrated management of neonatal and childhood illness
Imperforate anus 1755
Imperforate hymen 778f
Impetigo 1379, 1382, 3311, 3312f
Implantable defibrillator 2307
Imprinting disorders 42, 48
IMR. See Infant mortality rate
In utero
exposure 1080
herpes simplex infection 665f
infection 665
renal dysplasia 2495
transmission 1570
In vitro
diagnostic tests 244, 245
fertilization 47, 79
Inactivated influenza vaccine 1183, 1185t, 1217
Inactivated poliovirus 1120
INAP. See India Newborn Action Plan
Incisional biopsy 3016
Incontinence, classification of 2569fc
Incontinentia pigmenti 53, 610, 2756f, 3288, 3373, 3373f, 3373t
stages of 3372t
verrucous stage of 3373f
Incubator 485
Indeterminate leprosy 1463
India Newborn Action Plan 29, 443, 460
Indian Academy of Pediatrics 807, 832, 1063, 1090, 1142, 1150, 1212, 1224, 1290, 1360, 2148
Advisory Committee of Vaccination and Immunization Practices 1495, 1538
growth chart 830f, 831f, 1248
guidelines 1064b
recommendations 1181, 1204
schedule for office practice 1137
Indian Council of Medical Research 23, 995, 1129
Indian Growth Reference Data 807
Indian Penal Code 25, 3493
Indian tick typhus 1688, 1691b
Indinavir 288, 3599
Indirect antiglobulin test 2041f
Indirect fluorescent antibody tests 1310, 1597
Indirect hemagglutination test 1603
Indirect immunofluorescence 209, 212
technique of 3133f
Indirect inguinal hernia 1851
Indomethacin 288, 3599
Indoor pollutants 246
Inducible nitric oxide synthase 1720
Induction therapy 3028, 3189
Industrialization pollution 3509
Indwelling catheters 2526
Infant and young child feeding 10061010
Infant milk formula 246
Infant mortality rate 9
Infant of diabetic mother 527t, 561565
Infantile acropustulosis 3303, 3377
Infantile alternating esotropia 3264f
Infantile atopic dermatitis 3331f
Infantile beriberi 1052
Infantile choledochal cyst 1877
Infantile colic 934, 935
Infantile cortical hyperostosis 3452
Infantile epileptic encephalopathy 2635
Infantile esotropia 3261, 3263
clinical features of 3264b
Infantile hemangioma 33193321
Infantile hypertrophic pyloric stenosis 1777, 1786, 1787, 1787f
etiology of 1786
Infantile idiopathic scoliosis 3419
Infantile lupus erythematosus 3330f
Infantile tremor syndrome 2719, 2732, 2734f, 2735
Infantometer 471f, 804
airborne 1302
atypical 1302
control program 1325
cross 1301
endogenous 1302
exogenous 1302
iatrogenic 1301
inapparent 1302
intensity 1644
intrauterine transmission of 666
laboratory diagnosis of 1307
latent 1302
nosocomial 1302
prevention of 292, 466, 479, 509, 1131
primary 1301
reservoir of 1303
source of 1303, 1585
spread of 1302
subclinical 1302
transmission of 1341
treatment of 229
types of 1504
Infectious disease 13, 16, 1299
epidemiology of 1301
Infectious mononucleosis 1484, 1488, 1889, 1491, 1965f
diagnosis of 1490t
like syndrome, differential diagnosis of 1490t
potential complications of 1491t
serological diagnosis of 1491t
Infective colitis 1828
Infective endocarditis 1350, 2413, 2415, 2419, 2420, 2421, 2421t, 2423, 2423t
complications of 2425b
diagnosis of 2422b
Infective keratitis 3228
Inferior mesenteric
artery 1756
vein 1880
Inferior petrosal sinus sampling 2934
Inferior vena cava 457, 457f, 458f, 753f, 1844, 1880, 1891f, 1893, 1917, 1930f, 1942, 2258, 2258f, 2294, 2314f, 2324f, 2387, 2401f
Infertility 782, 2495
Infestations 3311
Inflammasome 205
Inflammation 1586, 1732
Inflammatory aneurysms 2512
Inflammatory bowel disease 1623, 1729, 1734, 1746, 1791, 1804, 1824, 1826, 1827, 1829, 1897, 1992
diagnosis of 1827fc
early-onset 3201
extraintestinal manifestations of 1826t
treatment of 1830t
Inflammatory cells 345f
Inflammatory demyelinating disorders 2736
Inflammatory disorders 337, 1332, 2986, 3201
Inflammatory joint disorders 2462
Inflammatory myopathies 3137
Inflammatory myositis 3135
Inflammatory pathway, activation of 2098
Inflammatory syndrome 88
Infliximab 3145
Influenza 1490, 1492, 1494, 2680
bacterial 1372
complications 1184b
diagnosis of 1494b
dose 1186fc
epidemics 1182
epidemiology of 1182
immunization 1186
pandemics of 1183
vaccination recommendations 1185
vaccines 1125, 1183
choice of 1184
types of 1183
virus 668, 1314, 1468, 1492, 1493f, 2675
Infra-auricular abscess 1385f
Infratentorial tuberculomas 2673
Infratentorial tumors 3061
Infusion bag 292
Infusion equipment 619
Ingestion 1586
Inguinal bubo 1277
Inguinal hernia 781, 1851, 1852
bilateral 1851f
Inhalation injury 429
Inhalational drugs, administration of 289b
Inhaled bronchodilators 2180
Inhaled corticosteroids 2194
Inhaled mucolytics 2241
Inhaled nitric oxide 332, 342, 347, 348, 732, 733, 2400
Inhaled nitric oxide for PPHN 733
Inheritance
genetic basis of 41
non-Mendelian types of 42
Inherited bone marrow failure syndromes 1978, 2051, 2071
Inherited ichthyoses, classification of 3385b
Inherited immune disorders 221
Inherited platelet disorders, classification of 2084, 2084t
Inherited thrombophilias 2088
Injury 15, 411, 544, 546, 1256
causes of 845b
childhood 411
classification of 1256b
common modes of 411b
description of 392
mechanisms of 421
modes of 411
prevention of 1257
risk factors for 411t
Innate immune system 203, 204
cellular components of 203
components of 203
soluble components of 204
Innate immunity 204, 223
Innocent murmur 2266
Inositol trisphosphate 2866
Inotuzumab ozogamicin 3015
Insomnia 947, 947t
Inspiratory time 708
Inspired gas temperature 721
Inspired oxygen concentration 468
Insular epilepsy 2635
Insulin 191, 802, 1032
autoantibodies 2958
dependent diabetes mellitus 2605, 2957
dose 2965
like growth factor 450, 520f, 801, 866, 870, 1883, 2876
oral 2968
pump therapy 2965
regimens 2964, 2964t
resistance
clinical relevance of 3005
syndrome 2960, 3004
secretion, regulation of 189f
sensitivity 3004
therapy 2964, 2970
tolerance test 2944
Integrase strand transfer inhibitor 1558, 1559
Integrated Child Development Service Scheme (ICDS) 29, 1093, 1094
Integrated Child Protection Scheme (ICPS) 3492
Integrated digital thermometers 1122
Integrated Disease Surveillance Program (IDSP) 1101, 1496
Integrated management of neonatal and childhood illness 35203524
Integrated neonatal cholestasis card 1871, 1871f
Integrin-alpha7 deficiency 2834
Intellectual disability 913, 918f, 920, 2611, 2621
causes of 916t
classification of 914
differential diagnosis of 917b
severity of 914fc
Intelligence quotient 518, 892f
Intensified National Iron Plus Initiative Program 514
Intensive care unit 324, 418, 1324, 1395, 1646, 1652, 2580
Intensive neonatal care package 464
Intensive plasmapheresis 2524
Intention tremor 2584
Interatrial septation 2254
Interatrial septum, development of 2255f
Intercostal chest tube drainage 2211
Intercostal drainage tube in situ 380f
Interferon gamma 1455, 1607
release assay 1435
INTERGROWTH standards 527
Interleukin 207f, 229, 239
receptor antagonist, deficiency of 3201
Interlobular bile ducts, paucity of 1875
Intermediate uveitis 3234, 3237
Intermediate-density lipoproteins 2993
Intermittent mandatory ventilation 352, 704
Intermittent photic stimulation 2589
Internal anal sphincter 1757
Internal capsule
anterior limb of 2601, 2603
posterior limb of 2603
Internal genitalia 2900
development of 2945
Interosseous membrane, calcification of 1082f
Interpersonal therapy 1252
Interpersonal violence 1256, 1259
Interrupted aortic arch 600, 2270
Interstitial lung disease 136, 159, 745f, 2141, 2142, 2219, 2223t, 2224
Interstitial nephritis 2486
Interstitial pneumonia 102
Intertriginous freckling 3368
Intertrigo 1654
Interventricular septum 2266
formation of 2254
intact 2356
Intestinal amebiasis 1603t
Intestinal biopsy 1623
Intestinal calcium absorption 2978
Intestinal colonization 1720
Intestinal disease 1602
Intestinal epithelium 1709f
Intestinal flukes 1631
Intestinal giardiasis 1607
Intestinal immune response, modulation of 1740
Intestinal infections 1623
Intestinal lymphangiectasia 1745, 1817
Intestinal malabsorption 1818
Intestinal malignancies 1820
Intestinal mucosal diseases, tests for 1813
Intestinal obstruction 1777f, 1832, 1834, 1834f, 1835b
causes of 1833b
stages of 1834
Intestinal stroke 764
Intestinal tuberculosis 1829
Intestinal worm infestations 865
Intestine, neuroendocrine tumors of 1742
Intoeing gait 3402
Intra-abdominal infections 1423
Intra-abdominal pressure 2955
Intra-aortic balloon pump 2468
Intra-atrial re-entrant tachycardia 2446
Intracardiac obstruction 2374
Intracellular cytotoxic edema 2598
Intracellular fluid 248, 248f, 249
Intracerebral hemorrhage 2632
Intracorpuscular defects 2002, 2002b
Intracranial abscess 2688
Intracranial aneurysms 2497
Intracranial bleed 2585
Intracranial calcification 664f
Intracranial hemorrhage 544, 547, 588f, 670, 2067, 2075, 2078, 2082
Intracranial hypertension 2585
diagnostic of 2585
management of 1939
Intracranial infection 671
Intracranial pressure 320, 1392, 2670, 2694, 2697, 2699f, 2703, 2727f
monitoring 2698
noninvasive monitoring of 2698
waveforms 2698
Intracranial tension 2174
Intracranial tuberculoma 2673
Intracranial tumors 2580
Intractable constipation 1804
Intractable diarrhea 1739
Intractable epilepsy 2620
Intractable watery diarrhea 1803
Intracytoplasmic sperm injection 47
Intracytoplasmic vesicles 2482
Intradermal injections 1109
Intradermal skin test 213
Intradermal technique 1129
Intraepithelial lymphocytes 1747f
Intrahepatic cholestasis, benign recurrent 1867
Intrahepatic portal hypertension 1882
Intralobar sequestration 2165
Intraluminal obstruction 2491
Intramedullary tumors 2777
Intramuscular injections 1108, 1109
Intranasal antihistaminics 2130
Intranasal corticosteroids 2129, 2162
Intranasal steroids 290, 293, 2130
Intraocular lens
implantation 3245
optic capture of 3245f
Intraocular pressure measurement 3249
Intraocular retinoblastoma, management of 3086
Intrapartum 524
antibiotic prophylaxis 651
infection 665
monitoring 452
Intrathecal infection 2587
Intrauterine contraceptive device 1267
Intrauterine fetal death 1512
Intrauterine growth 796
Intrauterine growth charts 503
Intrauterine growth restriction 52, 450, 499, 503, 503f, 503t, 508, 518b, 532, 538, 539, 572, 592, 598, 626, 736, 744, 1045, 1878, 2070, 2893, 2906
complications of 508, 508b
Intrauterine growth retardation 869, 870, 2071
Intrauterine infections 455, 661, 668t, 2929
Intravaginal torsion 1853
Intravascular hemolysis 2002, 2486
evidence for 2003
Intravascular pressures 2258
Intravascular stents 2343
Intravenous fluid 254, 255, 509, 634f
calculation of 427
indications for 252b, 427
therapy 252, 438
Intravenous immunoglobulin (IVIG) 227, 231, 234, 332, 559, 579, 637, 1513, 1524, 1533, 1548, 1560, 2071, 2077, 2078, 2102, 2305, 2745, 3145
effects of 232
human 3598
indications of 233
side effects of 233
Intravenous infusion technique 291
Intravenous pyelography 2551f
Intravenous urogram 774, 774f, 780
Intraventricular hemorrhage 506, 518, 547, 547f, 567, 585, 626, 670, 684, 686t, 687, 688f, 689, 690, 697
clinical features of 687t
Intraventricular neurocysticercosis 2683
Intrinsic acute kidney injury 2530t
Intrinsic immunity 223
Intrinsic motivation 1286
Intrinsic positive end-expiratory pressure 352
Intussusception 1835, 1837
parts of 1836f
Invaginated membrane systems 1954
Invariant natural killer T cells 203
Invasion 1302, 1586
Invasive aspergillosis 1660
Invasive bacterial infections surveillance 1372
Invasive candidiasis 1655
treatment of 1656t
Invasive diarrhea 1708
Invasive group A beta-hemolytic streptococci infections 1381
Invasive meningococcal disease 1390
Invasive pneumococcal disease 1169, 1378
Invasive sepsis 430
Inverted nipples 53, 54f, 87f, 171f, 494, 494f
Iodine deficiency 9
assessment of 1066
disorders 1025, 1065
spectrum of 1066b
health consequences of 1066
Iodine nutrition 1029f
Ion exchange chromatography 92
Ionizing radiation 3507
Ipex syndrome 2928
Ipratropium bromide 3599
Irbesartan 2560
Iridocorneal dysgenesis 3214
Iridocyclitis 1578
Iris lisch nodules 2752
absorption, mucosal cell control of 1990f
and folic acid 1096
cycle 1990
deficiency 563, 1989, 1992, 2024t, 2573, 3363
nonhematologic consequences of 1992
intoxication 373t
metabolism 1989, 1991b
overload 2026, 2027
pathogenesis of 2027f
preparations 288
studies 2025
therapy 579, 1994
toxicity 373, 374
Iron chelators
oral 2998
Iron therapy
intravenous 1995b
Irradiation 2873, 3117
Irritable bowel syndrome 1607, 1732, 1734, 1747, 1759, 1791
Irritant contact dermatitis 3333
Isavuconazole 1650
Ischemic hepatitis 1908
Ischemic stroke 2705, 2711t, 2713t
etiology of 2707b
management of 2712fc
Islet cell
adenomas 188
antibodies 2958
transplants 2968
Islets of Langerhans 1758
Isolated hypogonadotropic hypogonadism 2902
Isolated hypomagnesemia 280
Isolated immune thrombocytopenia 2071
Isolated nuclear cataract 3241
Isolated sulfite oxidase 86
deficiency 88
Isolation 1302
Isoleucine 93, 94
Isometropia, correction of 3224t
Isoniazid 1318, 1440, 1446, 3599
hepatotoxicity 1908
poisoning 377
preventive therapy 1550
Isoprinosine 1476, 3600
Isosexual peripheral precocious puberty 2907
Isospora 1549
Isotonic dehydration 257
Isotonic fluids 256
Isovaleric acidemia 85, 114
ITP. See Immune thrombocytopenic purpura
Itraconazole 1648, 1649, 1660, 3600
capsules 288
IUGR. See Intrauterine growth restriction
Ivermectin 1630, 3600
IVH. See Intraventricular hemorrhage
IVIG. See Intravenous immunoglobulin
IYCF. See Infant and young child feeding
J
Jaccoud's arthritis 2403
Jacobsen syndrome 2052b, 23922395
Jacquet's dermatitis 3304
Janani Shishu Suraksha Karyakram 29, 448, 3515
Janani Suraksha Yojana 29, 448, 3514, 3515
Jansen metaphyseal chondrodysplasia 2978
Janssen COVID-19 vaccine 1191
Janus kinase inhibitors 3146
Japanese encephalitis 1120, 1164, 1206, 1208, 1563, 1565, 1565t, 2675
vaccination 1163
vaccine 1162
virus 1563, 1564, 2677
Jaundice 535, 551, 1589, 2003, 2005, 2017
acholuric 2034
cholestatic 86
Jaws, developmental disturbances of 845
Jejunal atresia 759, 761, 762f
Jejunoileal atresia 762
Jejunostomy tube 1084, 1085f
Jejunum 1756
Jendrassik maneuver 2583
Jet injections 1129
Jet nebulizers 2199
Jeune syndrome 3451
JIA. See Juvenile idiopathic arthritis
Jitteriness 673
Job syndrome 1385
Johanson-Blizzard syndrome 1810, 3272
Joint 1386, 2558
contracture 136
assessment of 2838
damage
pathogenesis of 2056
stages of 2057t
deformities 2836
disorders of 3400
management 3410
pain 2509, 2541, 3128
replacement 71
surgery 153
Joubert syndrome 55, 2622, 2727
Judicious oxygen therapy 615
Jugular venous pressure 2340, 2356, 2358
JUNCS guidelines 1248b
Junctional ectopic tachycardia 2455
Junctional epidermolysis bullosa 3376
familial 2834
Junk food 1090
Juvenile absence epilepsy 2639
Juvenile arthritis disease activity scores 3151
Juvenile dermatomyositis 2783f, 3131, 3131f, 3168, 3171, 3171t, 3172fc, 3364, 3364f
diagnosis of 3170b
severe, treatment of 3173fc
Juvenile idiopathic arthritis 3130, 3137, 3147, 3150t, 3151, 3154, 3233, 3234f, 3292
Juvenile idiopathic scoliosis 3420
Juvenile Justice (Care and Protection of Children) Act 3479, 3492
Juvenile mitral stenosis 2411f
Juvenile myelomonocytic leukemia 3036, 3038, 3039f, 3040, 3040f, 3040t
Juvenile myoclonic epilepsy 2635, 2639
Juvenile nephronophthisis 2498, 2499
Juvenile neuronal ceroid lipofuscinosis 3291
Juvenile Parkinson disease 2721
Juvenile plantar dermatosis 3332
Juvenile polymyositis 3170
Juvenile pyomyositis 3171t
Juvenile rheumatoid arthritis 3147
Juvenile scleroderma 3191, 3365
Juvenile serine deficiency phenotype 101
Juvenile Sjögren syndrome 1774
Juvenile spondyloarthropathies 3233
Juvenile systemic lupus erythematosus 3365
Juvenile systemic scleroderma 3194
clinical criteria for 3194b
diagnostic criteria for 3194b
Juvenile systemic sclerosis 3367, 3367f
Juxtaglomerular apparatus 251, 2482
Juxtaglomerular cells 2482
K
Kabuki syndrome 2324
Kagami-Ogata syndrome 49
Kala-azar 1596, 1966f. See Leishmaniasis
Kaliuresis 2543
Kallmann syndrome 2902, 2956
Kanamycin 1446, 2672
sulfate 3600
Kangaroo mother care 461, 477f, 485, 486f, 509, 516, 521, 617, 623, 699
Kaplan-Meier analysis 3021f
Kaposi's varicelliform eruption 3317
Karydakis flap 1859
Karyotype 2950
Kasabach-Merritt syndrome 1962, 3320
Kasai portoenterostomy 1874f, 1917
Kashin-Beck disease 1075
Katayama syndrome 1644
Kawanet study 234
Kawasaki disease 233, 234t, 1332, 1339, 1484, 1520, 2271, 2284, 2469, 2512, 3139f, 3138, 3181b, 3182, 3292
diagnosis of 3180b
treatment of 3182b
Kayser-Fleischer ring 1907, 1915, 1915f
KDIGO criteria 2527t
Kearns-Sayre syndrome 48, 122, 124, 127, 280, 2784, 2785, 3272, 3291
Keloid formation 2836
Kenny-Caffey syndrome 280
Keratan sulfate 182
Keratectasia 3214
Keratoconjunctivitis 1498, 1654, 3229
Keratoconus 3231, 3232, 3232f
Keratoglobus 3227
Keratomalacia 1048, 3248
Kerion 3314f
Kernicterus 554t
Kernig's sign 2584
Keshan disease 1075
Ketamine 100, 364, 3600
Ketoacidosis 2963
Ketoconazole 288, 3600
Ketone 2485
synthesis 119fc
Ketonuria 92
Ketosis 109, 112, 113
Ketotic hypoglycemia 189, 193
Kidney 785, 1386, 2490, 2493, 2497, 2514
and urinary bladder, ultrasonography of 2571
biopsy 2508, 2512, 2514, 2515
congenital anomalies of 2490
damage 2556
disease 2485, 2527
end-stage 2516, 2517, 2575
severity of 2499
failure 137, 196, 2523
function 2523
test 1939, 2513
histology 2520
infections 1696
involvement 150
longitudinal section of 2481f
replacement therapy 2527, 2532
indications for 2532b
tissue, examination of 2487
transplantation 71, 2509, 2968
Kidney mass
bilateral 778f, 861f
Killed whole cell oral cholera vaccine 1174
Kimura's extrathoracic esophageal elongation 752
Kindler syndrome 3376
King-Denborough syndrome 2841
Kingella kingae 3405
Kinyoun stain 1308, 1415
Kishori Shakti Yojana 1094
Kissing disease 1488
Klebsiella granulomatis 1275
Klebsiella oxytoca 1749
Klebsiella pneumonia 633, 644, 656, 1319, 1351f, 2203, 2243
Kleihauer-Betke test 578f, 1959f
Klein-Waardenburg syndrome 3286
Klinefelter syndrome 38, 60f, 875, 2324, 2903, 2913, 2949, 2956, 3286
Klippel-Feil malformation 2775
Klippel-Feil syndrome 3415, 3415f
Klippel-Trenaunay syndrome 3130f, 3289, 3320
Klisic sign 3428
Klisic test 3428f
Klumpke palsy 549
Knee joint
intra-articular corticosteroids in 3143f
swelling of 653f
Knee pain
anterior 3404
Knight's move transmission pattern 45
Knudson's two-hit hypothesis 3084
Kobayashi risk score 234
Koch's postulates 1341, 1341b
Koch's triangle 2324f
Kohlberg's theory 929, 1233, 1233t
Koilonychia 1992, 1993f
Kostmann syndrome 1983
Krabbe disease 90, 133, 135, 136, 2770
Krait 395f
Krait venom 398f
Kramer's rule 555t
Krause-Kivlin syndrome 3251
Krebs cycle 105f, 106, 1935, 1952
Krichenko classification 2333
Kugelberg-Welander disease 2811
Kupffer cells 145, 1863, 1880, 1913, 2510
Kussmaul respiration 266
Kwashiorkor 1033, 1033f, 3360, 3360f
Kyasanur Forest disease 1580
Kyasanur Forest virus 1580
Kyphoscoliosis 3425f
Kyphosis 2581, 3418, 3423
congenital 3424
etiology of 3423b
severe 151f
L
Labetalol 2559, 2560, 3600
Laboratory safety 1307
Laceration 546
Lacrimal sac 3272
Lacrimal system
congenital lesions of 3277
disorders of 3277
genetics of 3272
Lacrimo-auriculo-dento-digital syndrome 3272
Lactase deficiency 166, 170
Lactate 89, 109, 113, 191
dehydrogenase 103, 1527, 1679, 1800, 1999, 2003, 2006, 2209, 3052
Lactation
management 488, 495, 497f
physiology of 489
Lactic acidosis 48, 83, 85, 122, 123, 127, 265, 1594, 2707, 2710
Lactobacillus rhamnosus 1752
Lactoferrin 637
Lactose intolerance test 1736, 1816
Lactotropes 2868
Lactulose 3600
Ladd's band 760
Lambert-Eaton myasthenic syndrome 2846
Lamellar cataract 3241, 3241f
Lamellar ichthyosis 3387
differential diagnosis of 3388b
with plate-like scales 3387f
Lamina propria 1827f
Laminin alpha-2 deficiency 2828t
Lamivudine 3601
Lamotrigine 2636, 2645, 3601
Lancefield grouping 1379
Landau reflex 2584
Landau-Kleffner syndrome 2633, 2638
Landolt's chart 3222
Langerhans cell 3103
histiocytosis 1918, 3103, 3106, 3106t, 3107b, 3107t, 3291
morphology of 3103f
Language 519, 948
delay 916
development 883, 884, 886
disorders 948950
problems 900
skills 2579
Lansoprazole 288, 3601
Laparoscopic inguinal hernia, port placement for 1852f
Laplace's law 710f
Large B-cell lymphoma 3049f
Large for gestational age 525529
Large neutral amino acid 96
Large vessel vasculitis 3174
Laron dwarfism 2873
Larva currens 1616
Larva migrans 1616
Laryngeal cleft 2122, 2122f
Laryngeal cyst 2122, 2122f
Laryngeal web 2122, 2122f
Laryngomalacia 2121, 2121f
Laryngopharyngeal reflux disease 2121
Laryngotracheal diphtheria 1354
Laryngotracheobronchitis 2170
Laryngotracheoesophageal cleft 749, 2122
Laser photocoagulation therapy 614
Lassa fever 1580
Late neonatal hypocalcemia 2977
Late onset sepsis. Also See Neonatal sepsis
Late systolic murmur 2265
Latent tuberculosis infection 1550
Latex agglutination assay 1490
Laurence-Moon-Bardet-Biedl syndrome 2960
Lawson's sign 1846
LBW. See Low-birthweight
Lead poisoning 3510, 3511
Learning disability 106, 950, 954, 2654
assessment of 955
genetics of 955
neurobiological basis of 954
signs of 955
Learning disorders 954, 956
Leber's hereditary amaurosis 2591
Leber's hereditary optic neuropathy 48, 122, 124, 3258
Lecithin-cholesterol acyltransferase 1868, 2993
Ledipasvir 3601
Leeway space 838f
Leflunomide 3143
Left superior vena cava 2268, 2270
Left ventricular hypertrophy 161, 2283, 2284f, 2347f, 2350, 2357, 2358, 2368, 2370f
Left ventricular outflow tract 2289f, 2331, 2332f, 2349
obstruction 2268, 2270
Leg
asymmetric swelling of 1846f
cramps 2526, 2534
ulcers 2017
Legg-Calve-Perthes disease 152, 3430
treatment of 3433t
Legius syndrome 3370
Leigh's disease 48, 86, 126f, 2600f, 2761, 2762
Leigh's syndrome 122, 123, 2772
Leishmania donovani 1585, 1596, 1676, 1966f
Leishmaniasis 1595
Leiurus quinquestriatus 408
Lemierre's syndrome 2090, 2155, 2156
Lennox-Gastaut syndrome 2619, 2636, 2638, 2646
Lens 3205, 3239
dislocation 87f, 88
epithelium-derived growth factor 211
injuries 3280
Lenticular opacities, classification of 3239
Lenticulostriate arteries, mineralization of 2708
Lentiglobus 3218
Lepra reactions 1464
Lepromatous leprosy 1463
Lepromin test 1464
Leprosy 1131, 1341, 1462, 1465, 3284
standard treatment of 1465t
types of 1464, 1464t
Leptin 802
deficiency 803, 2989
melanocortin system 2987, 2989f
Leptomeningeal carcinomatosis 2585
Leptospira icterohaemorrhagiae 1399
Leptospira interrogans 1399
Leptospirosis 1399, 1400f, 1401, 1696, 3235
Lesch-Nyhan syndrome 1998
Lethal serine deficiency phenotype 101
Lethargy 764f, 2693
Letterer-Siwe disease 3103
Leucine 93, 94
aminopeptidase 1867
Leuconostoc cremoris 1752
Leukemia 152, 1965f, 1999, 3291
biological subtypes of 3021f
inhibitory factor 1330
Leukocoria 3087t
Leukocyte 2485
adhesion deficiency 215, 222, 223, 223
cysteine, levels of 2543
esterase 2485, 2562
Leukocyte antibodies 61
Leukocyte antigen 74, 205, 215, 237, 1530, 1657, 1819, 1819f, 1821, 1822, 1924, 1955, 1987, 2511, 2739, 2958, 2961, 3136, 3364, 3350t, 3352t
role of 1819f
Leukocytoclasia 2512
Leukocytoclastic vasculitis 3186f
Leukocytosis 188, 1603, 3040f
Leukocyturia 2562
Leukodystrophy 136, 2579, 2721, 2758
Leukopenia 88, 102, 1597
Leukoreduction 3117
Leukotriene modifier therapy 2162
Leukotriene receptor antagonists 246, 2130, 2195
Levamisole 2522, 2523
hydrochloride 3601
Leveen and Denver shunts 1849
Levetiracetam 674, 2639, 2645, 3601
Levocardia 2309, 2311f
Levofloxacin 1371, 2672
Levosalbutamol 3602
Levothyroxine 288, 3602
Levy-Hollister syndrome 3272
Leydig cell 2913
tumors 2907
LGA. See Large for gestational age
LHON. See Leber's hereditary optic neuropathy
Licensed typhoid conjugate vaccines 1159
Lichen nitidus 3381, 3382, 3382f
Lichen planopilaris 3396
Lichen planus 3381
Lichen striatus 3332, 3382, 3382f
hypopigmented papules 3327f
Lid
coloboma 3212
distortion 3254f
lacerations 3279
tear 3279f
Liddle syndrome 2558
Lidocaine 317, 674
Life expectancy index 10
Life-threatening hyperkalemia 2546
Li-Fraumeni syndrome 2930
Ligament of Treitz 1894
Ligase chain reaction 1311
Lignocaine hydrochloride 3602
Limb 3401
incoordination of 2584
ischemia 3175
joint contractures 2836
Limbal dermoids 3229
Limberg's flap 1859
Limb-girdle muscular dystrophies 178, 2780, 2785, 2824, 2825t, 2831, 2835
Limbic encephalitis 2748f
Limosilactobacillus reuteri 1752
Lincosamide 1318
Line probe assay 1438, 1448, 1457, 1458
Linear growth 2900, 2901
Linear hypopigmented papules 3382f
Linear nevus
sebaceous syndrome 2983
sebaceum 3288
Lines of Blaschko's 53
Linezolid 1424, 1446, 2672, 3602
Lingual thyroid 2886f
nodule 842
Linoleic acid 991
Linton tube 1896f
Lip pit syndrome 1768
Lip, embryology of 1767f
Lipemia retinalis 2995f
Lipemic serum 2995f
Lipid 511, 991, 1868
infusion, recommended dose of 1087t
storage disorders 3290
Lipoamide dehydrogenase 99
Lipoarabinomannan 1438
Lipoatrophy syndromes 2958
Lipodystrophy 2525, 2972, 3169
Lipoid pneumonia 2222f
exogenous 2222f
Lipopeptidophosphoglycan 1602
Lipopolysaccharide 207, 1406, 1715
Lipoprotein 1868, 2993t
metabolism 2993
disorders of 2993
Liposomal amphotericin B 1647, 1649
Liquid chromatography-mass spectrometry/ mass spectrometry 92
Liquid crystal thermometry 483
Lisch nodules 2580
Lisinopril 2559
Lissencephaly 2622
Listeria monocytogenes 639, 668, 1304, 1336, 1344, 2071
infection 640
Listeriosis
intrauterine infection 668t
Lithium 288
Little's area 2125
Live Japanese encephalitis vaccine 1107
Live varicella vaccine 1176
Live-attenuated hepatitis A vaccine 1178
Live-attenuated influenza vaccine 1110, 1184, 1185, 1185t
Live-attenuated oral cholera vaccine 1175
Live-attenuated tetravalent dengue vaccine 1576
Liver 124, 1861, 1948
abscess 1901, 1902t, 1902, 1903, 1903f
management of 1904fc
anatomy of 1861
aspirate 1603
cirrhosis 1541
development of 1755, 1861, 1863b
disorder 64, 1445, 1445t
dysfunction 97
failure 108, 2054, 2528
fibrosis 1541, 1921f
flukes 1631, 1633
function tests 89, 126, 367, 556, 1489, 1523, 1527, 1830, 1864, 1869fc, 1893, 1933, 1939, 2400, 2513, 2913, 3136, 3350f
abnormal 64
advantages of 1864b
limitations of 1864b
glycogen phosphorylase 174
hemangiomas 1942
hydatid
cyst 1642f
disease 1640, 1640f
iron 2027
content 2027
kidney microsomal antibodies 1939
lobes of 1862f
physiology of 1861, 1863
radioisotopic scanning of 2317
transplantation 71, 96, 110, 116, 1849, 1875, 1917, 1921, 1935, 1940, 1944
role of 1927
tumors 1942
classification of 1942t
ultrasonography of 1942
Liver cell failure. Also See Acute liver failure
Liver disease 86, 106, 1868, 1916f, 2486, 2498, 2510, 3162
cholestatic 1818, 1917
severe 2486
spectrum of 1909
Liver failure. Also See Acute liver failure
LMNA-deficient CMD 2834
LMNA-related CMD 2828t
Loa loa 1627
Lobar pneumonia, pathogenesis of 2203fc
Local anesthetic intoxication 671
Localized hypopigmentary disorders 3323, 3328
Locked-in syndrome 396, 397, 397b
Lockhart-Mummery procedure 1859
Locomotor system 3400t
assessment of 3400
Locus heterogeneity 45
Loeys-Dietz syndrome 3453
Loffler's pneumonia 1623
Long-chain fatty acid 118
oxidation disorder 1935
transporter protein 120
Long-chain polyunsaturated fatty acids 512, 991
Loop of Henle 2544f, 2545, 2548
Loop-mediated isothermal amplification 1392, 1457, 1520
Lopinavir 3602
Loratadine 288, 3602
Lorazepam 674, 2631, 3602
Lorber's criteria 2609
Lordosis 2581
L-ornithine L-aspartate 1935
Losartan 2304, 2560
Louis-bar syndrome 3289
Louse-borne relapsing fever 1410, 1411
Low alkaline phosphatase 1866
Low cerebrospinal fluid 166
Low density lipoproteins 156, 2993
cholesterol 44
Low dose adrenocorticotropic hormone
stimulation test 2925
Low dose dexamethasone suppression tests 2934
Low mixed venous saturation, causes of 329b
Low molecular weight
heparin 2089, 2093t, 2096, 2713
proteinuria 2541
Low renin hypertension 2939
Low risk intraocular retinoblastoma 3086
Low risk Langerhans cell histiocytosis 3106
Low vision 3205, 3295
Low vision devices
electronic 3297
Low-birthweight 14, 201, 446, 447f, 466, 499, 503, 532, 607, 892f, 1145, 2005
classification of 499
etiology of 500b
feeding of 511
infant, long-term outcome of 517, 517b
Lowe syndrome 2540, 2543, 3290
Löwenstein-Jensen medium 1437f, 1459f
Lower abdominal pain 1279
Lower esophageal sphincter 1757, 1779, 1781f, 1783
transient relaxation of 1783
Lower gastrointestinal bleeding 1894, 1897
causes of 1897b, 1898
etiological diagnosis of 1898t
Lower lid entropion, congenital 3210f
Lower limbs 2608
Lower moiety ureter 774f
Lower motor neuron 2588
Lower respiratory tract 2120
congenital malformations of 2163
infections 1492, 2178, 2202, 2204, 2320
Lower segment cesarean section 538
Lower urinary tract obstruction
signs of 2491
symptoms 2500, 2568t
Lown-Ganong-Levine syndrome 2448
Luciferase immunoprecipitation system 1623
Lumbar nerve root 2587
Lumbar plexus injuries 2592
Lumbar puncture 635, 637, 647, 1426, 2667, 2677, 2684
complications of 2587
indications of 635
role of 2631
Luminal sessile polyp 1836f
Lund and Browder chart 427, 428f
Lung 1644, 2107, 2108, 3104
acute infection of 1703
agenesis of 2164
anatomy of 2107
anomalies 2226
blood supply of 2107
collapse 2117
development
disorders of 337
stages of 2163
diffusing capacity of 2119
disease 88, 2219
efferent nervous system of 2108f
embryology of 2107
eosinophilic infiltration of 1623
extrinsic compression of 596
fluid, clearance of 457
flukes 1631, 1632
lymphatic of 2107
mechanics 349
assessment of 2114
metastases, management of 3081
microscopic appearance of 345f
nodule response, completeness of 3082
parenchyma 2274
protective ventilation strategy 347t
sliding, absence of 723
ultrasound 696, 723
vasculature 2273
Lung agenesis
ipsilateral 2117
Lung abscess 2243, 2244, 2244f
Lung injury 343, 347, 353, 354
Lupus erythematosus 209
Lupus nephritis 2506, 2512, 2515, 2515t, 3165
active 2515
childhood-onset 2516
management of 3166fc
manifestations of 2516
Luteinizing hormone 1227, 12641266, 2899, 2904, 2905, 2913, 2933
receptors 2912
Lyme disease 1413, 1414, 1414b
clinical stages of 1413t
diagnosis of 1414
stages of 1413
Lyme neuroborreliosis 1414
Lymph node 145, 1436
aspiration 1447
necrotic bunch of 1743f
Lymphadenitis 1456, 1460
Lymphadenopathy 1332b, 1961, 2676
massive 3108
severe 150
Lymphatic filariasis 1627, 1628. See Filariasis
elimination of 1630
Lymphatic malformations 1774
Lymphatic spread 1468
Lymphedema 1628, 1630
Lymphoblastic lymphoma 3048
Lymphocyte 3043f
activation 205
nucleus 577f
Lymphocytic choriomeningitis virus 667, 668, 2675, 2676
Lymphocytic colitis 1736, 1747f
Lymphocytic interstitial pneumonia 1679
Lymphogranuloma venereum 1275, 1278f
Lymphoid interstitial pneumonitis 1548, 1549
Lymphoid organs 1956fc
Lymphoma 152, 1419, 1961
classification of 3042
Lyophilized Baker's yeast 1816
Lysergic acid diethylamide 366
Lysine 93
metabolism 111
Lysinuric protein intolerance 88, 92, 102, 103, 103f, 107, 108
Lysol burns 431f
Lysosomal acid lipase 137
deficiency 1911
Lysosomal enzyme
deficiencies 135
movement of 133f
trafficking defect of 135
Lysosomal hydrolase activity 138
Lysosomal membrane proteins 135
Lysosomal storage disorder 83, 132, 133f, 134, 136t, 137fc, 138, 138f
differential diagnosis of 136t
therapies for 71
Lysosome 132, 133
Lytic cocktail 409
M
3-M syndrome 870t
MacConkey's agar 1309
Macrocephaly 53, 2580
Macrocytic anemia 1967fc, 1976t
Macrocytosis 577f
Macrodontia 843, 844f
Macroglossia 841, 842f
causes of 842t
Macrognathia 846
Macrolide 1446
resistant Mycoplasma pneumoniae pneumonia 1701
Macrominerals 992
Macronodular cirrhosis 1918
Macronutrient deficiencies 900
Macronutrient malnutrition 1016
Macroorchidism 67
Macrophages 203
activation syndrome 3162
proliferation of 2509
Macrosaccades 3271
Macroscopic hematuria 2505, 2515
Macroscopic villi 1822f
Macrosomia 525, 527, 562, 562f
Macrostomia 1769f
Macrothrombocytopenia 2070
Macula densa 2482
Macular cherry red spots 88
Macular hypomelanosis 3329f
Maculopapular viral exanthem 3344t
Maculopathy 2972
Madelung deformity 64
Magnesium 278, 317, 993, 1244, 2551, 2630, 2976
ammonium phosphate 2550
balance 278
physiology, basics of 278
sulfate 733, 3602
therapeutic uses of 279
Magnesium sulfate 2198
Magnetic resonance imaging 24, 53, 126, 131, 148, 152, 163, 363, 422, 520, 680f, 682, 690f, 785, 901, 911f, 919f, 1058, 1080, 1532, 1564, 1640, 1668, 1832, 1933, 1942, 2092, 2119, 2164, 2248, 2298f, 2346, 2396, 2436, 2588, 2616, 2711, 2770, 2804, 2876, 2928, 3058, 3170, 3409
angiography 63, 2601, 2711, 2727f, 3059
cholangiopancreatography 1801
enterography 1826, 1829f, 1842
fistulography 1858
scan 361, 649, 1458
spectroscopy 101, 126, 127, 2599, 2691, 2710, 2762, 3060
studies 688
urography 2489
venography 3059
Magnetoencephalography 2589
Main pulmonary artery 2339
Maintenance intravenous fluids 255
composition of 254
Maintenance therapy 3028, 3189
Majeed syndrome 3201
Major aortopulmonary collateral arteries 2361
Major depressive disorders 1252, 1252b
Major endocrine glands, summary of 2864f
Major hemoglobin disorders 2023, 2023t
Major histocompatibility complex (MHC) 218, 1382, 1602, 3015, 3123
Major salivary glands 1772
Malabsorption 188, 1735t, 1761, 1810, 2553, 2875
disorders 1810
classification of 1810
signs of 1810t
symptoms of 1810t
syndrome 1735
etiology of 1814, 1814t
Malabsorptive disorders, etiological classification of 1811t
Malaise 2508
Malar rash 3131f, 3159f, 3365f
Malaria 15, 339, 1587, 1589, 1696, 1961, 2529
complications of 1593
diagnosis of 1307, 1590, 1591
parasite 1590f
life cycle of 1588f
pigment 1591f
recrudescence of 1589
relapse of 1589
severe 1589, 1593, 1594t
vaccine 1595
Malassezia furfur 1649
Malassezia infection 3315
Malate alpha-ketoglutarate transporter 105
Maldigestion 1735t, 1810
Malformations 563, 693, 694, 748, 2621
Malformation, Smith's patterns of 55
Malignancy 150, 1332
risk of 782, 2954
Malignant ascites 1845
Malignant hyperthermia 2818
Malignant peripheral nerve sheath tumor 2752
Malignant salivary neoplasms 1774
Mallory-Weiss tears 1895
Malnutrition 15, 188, 1716, 2875, 3111. Also See Undernutrition, PEM
assessment of 1034, 1036t
causes of 1915b
clinical signs of 1036t
management of 29
projection of 1020f
severe 1713b, 2461
Malnutrition, prevalence of 1018t
Malocclusion
Angle's classification of 839, 840
treatment of 840
Malonic aciduria 111
Malta fever 1405
Malposition
of the heart 2308
Malrotation 760
MALT lymphomas 3049
Mandibular arches 838f
Mandibular deciduous dentition 837f
Mandibulofacial dysostosis 3286
Manganese 1075, 1088
Manic episodes 1252
Mannitol 3602
Mannose-6-phosphate 132
Mannose-binding protein
bacterial 1193
Mantoux test 240, 1435
Manual ability classification system 899t
Maple syrup urine disease 70, 71, 80, 8385, 91, 93, 94, 94f, 95, 111, 112, 114, 188, 202
treatment of 95b
Marasmic kwashiorkor 1034t
Marasmus 1033, 3360, 3361f
Marburg viruses 1580, 1582
Marcia's identity status theory 1234, 1234t
Marcus Gunn jaw winking ptosis 3212f
Marcus Gunn pupil 3260
Marfan syndrome 43, 44, 72, 98, 799f, 875, 875f, 2462, 3218, 3244, 3253f, 3286, 3416, 3423, 3452, 3452t, 3453f
clinical features of 875t
losartan for 72
Marfanoid habitus 87f, 98
Margin of pupil, congenital cysts of 3215
Marginal artery of Drummond 1756
Marinesco-Sjögren syndrome 2836
Maroteaux-Lamy syndrome 72, 182
Marsh classification 1745
Marsh criterion, modified 1813
Marshall syndrome 2155
Marsh-Oberhuber grading 1822t
MAS. See Meconium aspiration syndrome
Masked hypertension 2557t
Masquerade syndromes 3237
Mass casualty incident 414
Mass media 1240
Mass reactive vaccination 1392
Mass spectrometry 1309
Mast cell 237
degranulation 238f, 3335f
Mastectomy 70
Mastitis 494
Mastocytoma 3340
Mastocytosis 3334, 3340, 3341, 3341b
clinical classification of 3340t
treatment of 3341t
Mastodynia 2912
Masturbation 1229
Matched unrelated donor transplant 3126
Maternal antibody, effects of 1153
Maternal antinuclear antibodies 455
Maternal antiphospholipid antibodies 455
Maternal autoantibodies 2605
Maternal body mass index 525
Maternal drug exposure 456
Maternal endocrine disorders 454
Maternal health
optimal 453
Maternal idiopathic thrombocytopenic purpura 456
Maternal infections 455
Maternal iron deficiency, effects of 1995
Maternal malnutrition 1020
Maternal mortality ratio 9, 10
Maternal nutrition 453, 501, 533
Maternal phenylketonuria 2614, 2618
Maternal serum alpha fetoprotein 79, 785
Maternal severe vitamin D deficiency 2977
Maternal stress 454
Maternal thyroid disorders 454
Matrix metalloproteinase 1 1913f
Matrix-assisted laser desorption ionization-time of flight 1309, 1345
Mature milk 488
Mature red blood cells 2035
Mauriac syndrome 2971
Maxilla, macrognathia of 846f
Maxillary central incisors 845f
Maxillary deciduous dentition 836f
May-Hegglin anomaly 2054t
Mayer-Rokitansky-Küster-Hauser syndrome 778, 1264, 1265t
MC4R deficiency 2990
McArdle disease 86
McBurney's point 1839
McCallum's patch 2403
McCune-Albright syndrome 2907, 2908f, 2911, 2930, 2982
M-cells 1342
MDR-TB 14461454. See Multidrug-resistant tuberculosis
MDG. See Millennium development goals
Mead theory 1228
Mean airway pressure 349, 352, 355, 703, 707
Mean arterial pressure 332, 510
Mean corpuscular hemoglobin 574, 576, 1953, 1966, 1967, 2005, 2021, 2024
concentration 574, 1953, 1966, 1967, 1976, 2010
Mean corpuscular volume 574, 576, 579, 1952, 1959, 19661968, 1970, 1970t, 1976, 1979, 2005, 2021, 2024, 2031, 2040
Mean intelligence quotient 519f
Mean platelet volume 2069
Measles 29, 41, 1120, 1471, 1474, 1477, 1484, 3284
acute postinfectious encephalitis 1476
and rubella 1208
control 1099
strategy 1477
convalescent stage of 1475f
elimination 1099
inclusion body encephalitis 1476
initiative partnership 1151
maculopapular rash of 1475f
mumps, and rubella 1107, 1120, 1116, 1206, 1208, 1212, 1290, 1477, 2076
plus varicella 1177
vaccine 1125
systemic complications of 1476t
vaccine 1125, 1149, 1477
virus 668, 1149, 2675, 2677
Mebendazole 288, 3603
Mechanical circulatory support 2306, 2306fc
Mechanical ventilation 346, 349, 354, 355, 714, 732, 2198
complications of 359
indications of 350b
Mechanobullous disorders 3374
Meckel's band 771
Meckel's diverticulum 771, 1755, 1898, 1960
Meckel's scan 769, 1899f
Meckel's syndrome 2727
Meconium aspiration syndrome 508, 528, 598,693, 695, 706, 719, 720, 720f
consequences of 719
Meconium ileus 761, 766, 767
Meconium passage in utero 719
Meconium stained amniotic fluid 467
Meconuria 768f
Mediastinal neuroblastoma 3073f
Mediastinum 2108
Medical nutritional therapy 2965
Medical therapy 1896, 1900, 3446
Medicinal iron therapy 1994
Mediterranean fever 1405
Mediterranean spotted fever 1688, 1691, 1691b
Medium vessel vasculitis 3179
Medium-chain acyl-CoA dehydrogenase 85, 119
deficiency 120
Medium-chain triglycerides 514, 1731, 1878
Medullary cystic kidney disease complex 2498
Medullary sponge kidney 2499
Medulloblastoma 3061, 3061f
clinical features of 3061b
multidisciplinary management of 3062t
Medullocerebellar angles 2669
Mefenamic acid 1334, 3603
Mefloquine hydrochloride 3603
Megacystis 2495
Megakaryocytes 1948, 1954
development 1953f
maturation of 1954
precursors, proliferation of 1954
Megalencephaly 2580
Megalencephalic leukodystrophy 2765, 2766
Megalencephalic leukoencephalopathy 2771
Megaloblastic anemia 1960f, 1996, 1998, 2000
acquired 2001t
causes of 1996t
Megaloblastic crisis 2032
Megaloblastosis 1972f
Megalocornea 3213, 3227
Megaureter 2494
secondary causes of 2494
Meier-Gorlin syndrome 869
Meiosis 35
Meiotic nondisjunction 60
Meissner's plexus 1756
Melanocortin-4 receptor deficiency 2990
Melanocyte stimulating hormone 2989
Melanocytic nevi, congenital 3306, 3321
MELAS. See Mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes
Membranoproliferative glomerulonephritis 2506, 2520, 2526, 2576
Membranous cataract 3241, 3241f
Membranous lupus nephritis 2515
Membranous nephritis 3160
Membranous nephropathy 2506, 2525
Memory 205
cells, development of 206
Menarche 1227, 1267
Mendelian inheritance 42, 43
Ménétrier's disease 1794
Meningeal carcinomatosis 2586
Meningeal inflammation, absence of 2584
Meningeal leukemia 3031
Meningeal signs 2584, 2665
Meninges 548f
Meningismus 2584
Meningitis 659, 1376, 1391, 1532, 1696, 2602f, 2671f
acute bacterial 2587, 2664, 2665b, 2667
complications of 2668b
pathogenesis of 2664f
anaerobic 1424
community acquired 1386
diagnosis of 1668
progression of 647fc
Meningocele 786, 787f, 2607
Meningococcal conjugate vaccines 1181, 1392
Meningococcal disease 1180
Meningococcal infection 1392
Meningococcal polysaccharide 1107
vaccine 1181
Meningococcal sepsis 1392b
Meningococcal vaccine 1180, 1181, 1392
Meningococcemia 1391, 1391f
Meningoencephalitis 1487, 1498, 2585, 2587
Meningomyelocele 474f, 620, 786, 787f, 2607, 2608f, 2609f
Menkes disease 83, 2580, 2636, 2761, 2771, 3290
Menorrhagia 1227, 1263, 2082
Menstruation 1227
Menstrual disorders 1263
Menstrual hygiene 1223
Menstrual suppression 1269
Mental disorders 933t, 967
diagnostic manual of 949, 959, 969, 972, 986, 1249, 1253
statistical manual of 949, 959, 965b, 969, 972, 983b, 986, 1249, 1253
Mental health 15, 1226, 1250, 1255, 1519
determinant of 1250
disorders, screening for 1225
issues 1224, 1230, 1251
problems 1251
Mental retardation 52, 98, 165, 280, 2614
Mental well-being, evaluation of 932
Mepolizumab 2196
Mercaptopurine 1830
Mercedes-Benz sign 2350f
Meropenem 3603
Merosinopathy 2822, 2822f
MERRF. See Myoclonic epilepsy with ragged red fibers
Mesangial cells 2507
Mesangial proliferative lupus nephritis 3160
Mesencephalon 2619
Mesenchymal cells 1914
Mesial temporal lobe epilepsy 2641
Mesial temporal sclerosis 2630
Mesiodens 844f
Mesobuthus tamulus 404, 404f
Mesocardia 2309, 2309f
Mesoportal rex bypass 1889
Messenger ribonucleic acid 35, 36t, 139, 239, 1100, 1349f
Metabolic acidosis 85, 85fc, 97, 112, 261, 264, 265t, 266, 693, 1712, 2495, 2531, 2540, 2541t, 2545, 2546, 2574
Metabolic alkalosis 261, 266, 267, 267t, 2544, 2544b, 2545t
causes of 266
Metabolic autopsy 90b
Metabolic bone disease 507
management of 2573
Metabolic corneal opacities 3228
Metabolic disorders 82, 89t, 915, 2463, 3031
Metabolic idiosyncrasies 1908
Metabolic ketoacidosis 85
Metabolic liver disease 1915, 1917, 1928
Metabolic myocardial dysfunction syndromes 2467
Metabolic rickets 2980
Metabolic syndrome 520, 859, 1249
Metabolic test 55, 919
Metabolism 82, 1078
disorders of 1998
inborn errors of 82, 83, 83b, 83fc, 85, 86b, 90, 111, 113, 189, 199, 212, 2463, 2694, 2696, 2759b
Metabolites, serum levels of 138
Metacentric chromosomes 58
Metachromatic leukodystrophy 86, 133, 133f, 135, 136, 137, 27652767, 2771
Metagonimus yokogawai 1631
Metaiodobenzylguanidine 2726, 2727f, 3074f
scintigraphy 2558
Metallic coils 2597
Metallic stents 2597
Metaphyseal dysplasia 2929
Metaphysis 850f
Metastatic tumors 3068
Metered-dose inhalers 287, 289
Metformin 3603
Methadone 3603
Methemoglobin reduction test 2036
Methemoglobinemia 594, 2038
congenital 2011
Methicillin-resistant Staphylococcus aureus 654, 13181320, 1325, 1386f, 2209, 3312
prevention of 1320t
Methionine 93
adenosyltransferase 98, 99, 99f
metabolism, disorders of 99t
Methotrexate 288, 1830, 2485, 3141, 3153
Methylcobalamin 3603
deficiency 1998
Methylene blue 3603
5, 10 methylene tetrahydrofolate reductase (MTHFR) 2605
Methylenedioxymethamphetamine 366
Methylenetetrahydrofolate reductase 2707, 2711
mutations 2089
Methylmalonic acidemia 85, 109, 114, 115, 188, 202
Methylmalonic acids 114
Methylmalonic aciduria 115f
Methylmalonyl-CoA mutase 112, 115f
deficiency of 1998
Methylphenidate 3603
Methylprednisolone 288, 2522, 3604
Methylxanthines 698, 699
Metoclopramide hydrochloride 3604
Metoprolol 2304, 2560, 3604
Metronidazole 288, 1423, 3604
Meuromuscular disorders, muscle biopsy in 2788t
Mevalonate kinase deficiency 225, 226
Mevalonic aciduria 87, 129
Micafungin 1648, 1651, 3604
Micrencephaly 2611
Microalbuminuria 161, 2486
Microangiopathic disorders 2072
Microbiome 1013, 1312, 1313
Microbiota 1825
Microblepharon 3212
Microcephaly 2580, 2611, 2613
causes of 791b
development of 2613t
etiology of 2612, 2613t, 2615t
genetic evaluation of 2616
pathogenesis of 2612
prevalence of 2612
vera 53, 791
Microcoria 2518, 2523, 2524, 3259
Microcornea 3212, 3227
Microcytic hypochromic anemia 1967fc
Microdeletion syndromes 55, 66
Microdontia 843, 844f, 3252f
Microduplication syndromes 66
Micro-erythrocyte sedimentation rate 644
Microfilaremia 1628
Microglia 145
Micrognathia 54f, 845, 1979f
Microimmuno diffusion 1677
Microminerals 992
Micronodular cirrhosis 1918
Micronutrient 1245, 2144
deficiency 16, 900, 1016f, 12421244
malnutrition 1016, 1034
supplementation 2399
Micropenis 2954, 2956, 2957
clinical workup of 2956t
Microphakia 3218
Microphallus 777
Microphthalmia, management of 3215fc
Microphthalmos 3213
bilateral 3214f
Microscopic colitis 1746
Microscopic hematuria 2505, 2507, 2515, 2518
Microscopic polyangiitis 212, 2514, 3188
Microspherophakia 3218, 3218f
Microsporum 3314
gypseum 1303
Microvillous inclusion disease 1816
Micturating cystourethrogram 657f, 774, 785
Micturating cystourethrography 25632565, 2571
Micturition reflex 2501
Midazolam 674, 2631, 3604
Midborderline leprosy 1463
Mid-day Meal Scheme 1095, 1247
Middle cerebral artery 552
Middle ear implants
active 928
Middle ear infection 1770
Middle east respiratory syndrome 13, 1514
Midfacial hypoplasia 57
Mid-upper arm circumference 805, 832, 1035, 1036t
measurement of 805
Migraine 2655, 2658, 2659, 2660f, 2662
diagnostic criteria for 2660b
disability assessment 2662
headaches 2655, 2659
management of 2662t
subtypes of 2659b
with aura 2660
without aura 2660
Mild aortic stenosis 2349
Mild dehydration 256, 257
Mild hematuria 2530
Mild hemophilia A 70
Mild hyperphenylalaninemia 96
Mild proteinuria 2510
Milia 3303, 3303f
Miliaria 3303
crystalline 639f
profunda 3304
rubra 3303, 3303f
Miliary tuberculosis 1432, 1433f
Milk
and milk products 997
production 489
regurgitation of 476
Milky bronchoalveolar lavage fluid 2223
Millennium development goals 1561
Miller-Dieker syndrome 55, 66, 2614, 2619
Miller-Fisher syndrome 2805
Milrinone 317, 733, 3604
Miltefosine 1598
Mineral 989, 992, 992fc, 1727
Mineralocorticoid 2915, 2921
deficiency 2546
causes of 2546b
excess 2544
receptor 2931
related hypertension 2939
replacement 2926
Miniature puberty 3302
Minimal brain dysfunction 959
Minimal hepatic encephalopathy 1932
Minimal mesangial lupus nephritis 2515, 3159
Minimal residual disease 3013
Minimum enteral nutrition 512, 512b
Minimum inhibitory concentration 1309, 1345, 1385, 1389, 1459f
Minipuberty 2899
Minoxidil 2560, 3604
Minute ventilation 703
20-minute whole blood clotting test (20-WBCT) 402
Mirage syndrome 2951
MISC. See Multisystem inflammatory syndrome
Misoprostol 288
Mission Indradhanush 29, 3516
Mite-born spotted fever 1689, 1692b
Mitochondria 105f, 125f, 2521
function of 123
Mitochondrial cytopathy 1877, 1878, 2543
Mitochondrial deoxyribonucleic acid 38, 122t
Mitochondrial diseases 38, 48, 122, 2780
Mitochondrial disorder 83, 89, 122, 122t, 123b, 123t, 127, 127t, 2524, 2721f
biochemical classification of 122
Mitochondrial encephalomyopathy 48, 83, 122, 123, 127, 2710
Mitochondrial encephalomyopathy lactic acidosis syndrome 2766
Mitochondrial encephalopathy 2707
Mitochondrial genetic bottleneck 48
Mitochondrial hepatopathy 1872, 1930, 1935, 1936fc
treatment of 1936t
Mitochondrial hypomagnesemias 280
Mitochondrial inheritance 42, 47, 48f
Mitochondrial liver disease 1935
Mitochondrial membrane 1936
Mitochondrial myopathy 2791f, 2835
encephalopathy, lactic acidosis, and stroke-like episodes 86
Mitochondrial neurogastrointestinal encephalomyopathy 122, 125
Mitochondrial nicotinamide adenine dinucleotide phosphate 1998
Mitochondrial ornithine transporter 83
Mitochondrial respiratory chain defects 108, 178
Mitochondrial trifunctional protein deficiency 120
Mitochondriopathies 2618
Mitosis 35
Mitosis-Karyorrhexis index 3071
Mitotic spindle 2612
Mitral valve 2268, 2409, 2410, 2412
abnormalities of 2412t
lesions of 2409
prolapse 2266, 2268, 2412
stenosis 2473
Mitral regurgitation 2266, 2303f, 24102412, 2416
severe 2413f
Mitral stenosis 2266, 2410, 2411, 2413f, 2415
catheter-based management of 2415
Mitten glove deformity 3377f
Mitten hands 53
Mittendorf's dot 3239
Mixed cataract 3243
Mixed connective tissue disorders 209, 211
Mixed dentition period 837, 841
Mixed gonadal dysgenesis 1265, 2949
Mixed hearing loss 924
Mixed sleep apnea 943
Mixoploidy 38, 59
Mobile cardiac telemetry 2445
Möbius syndrome 3269
Moderna COVID-19 vaccine 1190
Modified vaccinia virus ankara 1208
Molar-tooth sign 2622f
Molds 244
Molecular adsorbent recirculating system 1935
Molecular amplification methods 1310
applications of 1311
Molecular-based polymerase chain reaction 1603
Molecular diagnostic testing 2210, 2786
Molecular genetic testing 130, 2819, 2838
Molecular methods 1437, 1677
Mollaret's meningitis 1502
Molluscum conjunctivitis 3318, 3318f
Molluscum contagiosum 1308, 3285, 3318, 3318f
Molluscum dermatitis 3318
Molybdenum 1075
cofactor deficiency 86, 88
Mongolian races 3272
Mongolian spots 142f, 476, 476f, 3306, 3321
Monkey bite 421f, 424
Monoamine oxidase inhibitors 366
Monoamniotic twin pregnancy 530
Monochorionic twin 532
pregnancy 530
Monoclonal antibody 1508
Monocular elevation deficiency 3269, 3270f
Monoethylglycinexylidide test 1868
Monogenic defects 2959
Monogenic inflammatory bowel disease, therapeutic strategies for 1831
Monogenic obesity 2987
types of 2989
Monogenic syndromes 2960
Monomeric formulations 1084
Monomorphic adenoma 1774
Mononeuritis 1542
multiplex 1542
Monosaccharide metabolism, disorders of 165
Monosodium glutamate 2661
Monosomy 38, 46, 58, 63
Monospot test 1490
Monosymptomatic enuresis 2500, 2501, 2503t, 2504
Monosymptomatic nocturnal enuresis 2503
Monosynaptic stretch reflex 2583
Monounsaturated fatty acids 999
Monovalent meningococcal conjugate vaccine 1181
Monozygotic gestation 530
Monozygotic twins, diagnosis of 531fc
Montelukast sodium 3604
Mood disorders 964
Moon facies 861f
Moral development 887, 888, 929, 1233
Kohlberg's theory of 1233, 1233t
stages of 930t
theories of 929
Moraxella catarrhalis 2134, 2156
Morbilliform rash 3344f
Morgagni hernia 753
Morning glory
anomaly 3219, 3256
syndrome 3257f
Morning serum cortisol 2924
Moro's reflex 475, 476f, 2584
Morphea 3366, 3366f
Morphine 409
sulfate 3605
Morphological classification 1976, 2330f
Morquio syndrome 72, 87, 182, 184f, 2775, 3415
Mosaicism 40, 42, 48, 53, 60
Moses’ sign 2089
Mosquito repellent ingestion 381
Mother and child tracking system 29
Motile cilia 2229
Motility disorders 3261
Motivation enhancement therapy 1253
Motor deficits 2618
Motor development 882, 883, 886
milestones 628
Motor examination 2582
Motor nerve 2592
conduction velocity 2851
Motor screening examination 2584
Motor seizures 672t
Mounier-Kuhn syndrome 2239
Mouse brain killed vaccine 1566
Mouthwash 387
Movement disorder 86, 114, 117, 2715, 2716, 2721, 2722t, 2758
Moxifloxacin 2672
Moyamoya disease 2708f
Moyamoya syndrome 2707
MPS. See Mucopolysaccharidoses
MRI. See Magnetic resonance imaging
MUAC. See Mid-upper arm circumference
Muckle-Wells syndrome 3200
Mucocele 3277
Mucocutaneous candidiasis 1746, 2927
Mucocutaneous fungal infections 640
Mucocutaneous histoplasmosis 1676
Mucocutaneous leishmaniasis 1599
Mucoepidermoid carcinoma 1774
Mucolipidosis 135, 137
Mucolytic agents 2234
Mucopolysaccharidoses 71, 86, 135137, 182, 183, 184f, 185, 185f, 842f, 2412, 2464, 2765, 2766, 2769f, 3151f, 3290
types of 182t
Mucor irregularis 1681
Mucormycosis 1681, 1684
differential diagnosis of 1683t
Mucosal associated lymphoid type lymphoma 1419
Mucosal biopsy 1813
Mucosal cell control theory 1990
Mucosal ischemia 1836f
Mucosal neuroma syndrome 3288
Mucous membranes 242
Mucous neck cells 1757
Mueller-Hinton broth 1459f
Müllerian anomalies 1267
Multicenter growth reference study 800
Multichannel intraluminal impedance study 1784, 2186
Multicolor flow cytometry 1981
Multicystic dysplastic kidney 774, 2491, 2499, 2499f
laparoscopic excision of 774f
Multicystic kidneys
bilateral 2490
Multidetector computed tomography 2120, 2164, 2245
Multidrug therapy 1465, 1598
Multidrug-resistant Plasmodium falciparum 1311
Multidrug-resistant tuberculosis 1318, 1434, 1438, 1443, 1446, 1453
Multifocal coccidioidal osteomyelitis 1667f
Multi-inflammatory syndrome 1514
Multilobar persistent pneumonia 2216
causes of 2217t
Multiminicore disease 2790f
Multinucleated giant cells 1674f
Multiorgan failure 2532
Multiple acyl-CoA dehydrogenase deficiency 120, 121
Multiple café-au-lait macules 3369f
Multiple drug-resistant protein 2 1863
Multiple endocrine neoplasia 70, 876, 1737, 1746, 2549, 2930, 3288
Multiple erythematous guttate lesions 3378f
Multiple fetuses, diagnosis of 531
Multiple gestations 502, 529, 533
Multiple hormone deficiencies 803
Multiple ligand probe assay 2011
Multiple liver abscesses 1903f
Multiple organ
dysfunction syndrome 2301
failure syndrome 2301
system failure 345
Multiple painful genital ulcers 1278f
Multiple pituitary hormone deficiency 2929
Multiple pregnancy 495
Multiple puncture technique 1129
Multiple pyogenic brain abscesses 2688f
Multiple sclerosis 232, 2736, 2738, 2739t, 2740, 2767, 3292
Multiple sleep latency test 943
Multiple sulfatase deficiency 135, 137
Multiplex ligation dependent probe amplification 55, 58, 67, 2268
Multisectoral nutrition program 1096
Multisystem disorder 92, 2535, 3130
Multisystem inflammatory syndrome 1515, 15241526, 1526f, 1527, 2462
cardiac manifestations of 2462b
Multisystem Langerhans cell histiocytosis, management of 3107fc
Multivitamins 1087
supplementation of 1876
complications of 1480t
control strategy 1481
infection 1481
vaccine 1156
virus 668, 2675
encephalitis 2677
Munchausen syndrome 3482
Munson's sign 3231
Murine typhus 1697, 1698
infection 1698
diagnosis of 1698
treatment of 1698
Murmurs 2326
appearance of 2261
Muscle 48, 2514, 2780, 2788
electron microphotographs of 125f
eosin stain of 2813f
modified Gomori trichrome stain of 124f
development of 2494
disease 86
disorders 2785fc
enzymes 3137, 3170
eye-brain disease 2832
groups, selective involvement of 2825b
imaging 2838
injuries 3282
magnetic resonance imaging 2790, 2843
phosphofructokinase 174
phosphorylase kinase 174
power
assessment of 2838
grading 2583t
pseudohypertrophy 2836
relaxants 348, 722
spasms, treatment of 659
specific kinase 2847f
stage 1625
tissue specimen 1624f
tone 96
norms 629t
ultrasound 2790, 2843
weakness 178
Muscular deficiency 2491
Muscular dystrophy 2464, 2783f, 2789f, 2816
classification of 2816t
Muscular ventricular septal defect 2364f
Musculoskeletal bleeds, pattern of 2057
Musculoskeletal disease 3168
Mushroom poisoning 386
Mustarde's four flap technique 3272
Mutant gene 2516
Mutation 38, 42, 1397
analysis 162
types 38
Myalgia 2514
Myasthenia 2845, 2848
gravis 397
acquired 2848t, 3291
Mycetoma 1416f
Mycobacterial antigens, immunocytochemical staining of 2670
Mycobacterial disease 205, 1456
Mycobacterial growth indicator tube 1437f
Mycobacterial infections 224, 1427
atypical 1455
Mycobacterium 1623
africanum 1427
avium 1456
complex 1550, 1679
intracellulare 1548, 1797
bovis 1129, 1427, 1585
canetti 1427
caprae 1427
indicus pranii 1466
leprae 1341, 1427, 1462
microti 1427
pinnipedii 1427
tuberculosis 667, 1305, 1310, 1318, 1341, 1358, 1427, 1435, 1436, 1439, 1441, 1462, 1797, 1840, 1902, 2440, 3416
infection 1350, 1840
growth of 1437f
Mycophenolate 288
mofetil 1928, 2514, 2523, 3144, 3165, 3605
Mycoplasma 1358, 1699
disease 1700f
genitalium 1277
hominis 654, 1275
infection 209, 1699, 1700, 1701, 2206
drug treatment of 1701b
pneumoniae 1699, 2243, 2677, 2805, 3335, 3346
Mycoses, types of 1647
Mydriatics-cycloplegic eye drops 3238
Myelin oligodendrocyte glycoprotein antibodyassociated
disorders 2736, 2741, 2742
Myelinated nerve fibers 3256, 3257f
Myelination 1231, 2601
Myelitis 1502, 1542, 1696
Myelodysplasia 152, 226
Myelodysplastic syndrome 1962, 2068, 3036, 3036t, 3038, 3038b, 3039t
classification of 3036t, 3037b
clinical features of 3037b
diagnostic criteria for 3038b
Myeloid cells 1955t
Myelokathexis syndrome 225
Myelomeningocele 783
Myeloperoxidase 211, 212, 2509
deficiency 223
Myelopoiesis 1955f
Myelopathies
acute compressive 2807
Myeloproliferative diseases 3036t
Myenteric plexus 1756
MYH9-related diseases 2052b, 2070, 2084t
Myocardial diseases 2427
Myocardial dysfunction 406, 694
predictors of 406
Myocardial infarction 1867
Myocarditis 694, 1498, 1512, 1696, 2278f, 2427, 2428, 2467, 2676
causes of 2427t
pathophysiology of 2428fc
Myocardium 2252
Myoclonic encephalopathy, early 2636
Myoclonic epilepsy 48, 83, 122124, 2766, 2767
Myoclonic epilepsy with ragged red fibers 2766, 2767
Myoclonic seizures 152, 673, 2635
Myoclonus 2717, 2721
dystonia 2720, 2724
Myoglobin 1989, 2485, 2505
Myoglobinuria 2505, 2529, 2758
Myonecrosis 644
Myopathic discharges 2819f
Myopathy 86, 178, 2758
Myophosphorylase 174
Myopia 71, 615, 3220, 3224
Myositis 1533
Myotonia congenita 2780
Myotonic disorders 2823
Myotonic dystrophy 47, 2464, 2780, 2823, 2823f, 2824, 2835, 2960
childhood-onset 2824
Myotubular myopathy 2841
Myxedematous cretinism 2883
N
N-acetyl aspartate 680, 959
N-acetyl cysteine, role of 1940
N-acetyl glutamate
dehydrogenase deficiency 108
synthetase deficiency 105, 107, 108
N-acetylaspartate 2599, 2600
N-acetylcysteine 2201, 3605
N-acetylglutamate synthase 104
Naegleria fowleri 1604
Nail 2928
changes 1961
hypoplasia 63
pallor of 1958f
varnish removers 387
Nailfold capillaroscopy 3364, 3365
Nail-patella syndrome 2518
Naja naja 395, 395f
Naja oxiana 395
Nalidixic acid 2563, 2565, 3605
resistant Salmonella typhi infection 1365, 1367t
Naloxone hydrochloride 3605
Nano bodies 2684
Nanophthalmos 3214
Naphthalene poisoning 388
Napkin dermatitis 3304
Napkin psoriasis 3378f
Naproxen 288, 3605
Narakas classification system 549t
Narcolepsy 946, 947
Narrow-spectrum therapy 1346
Nasal congestion 2180
Nasal continuous positive airway pressure 713
Nasal diphtheria
anterior 1354
Nasal intermittent positive-pressure ventilation 714
Nasal nitric oxide test 2230
interpretation of 2230t
Nasal obstruction, relief of 2144
Nasal prongs 332, 341, 1770
Nasal sprays 246
Nasoduodenal tube 1084
Nasogastric suction 254
Nasogastric tube 749f, 754, 1084
placement 1085f
Nasopharyngeal carriage 1169
Nasopharyngeal isolation 1391
Nasopharyngeal perforation 749, 750f
Nasopharyngitis 2146
National adolescent health program 1280, 1293
National AIDS Control Program 1280, 1561
National Antimicrobial Resistance Surveillance Network 1397
National Commission for Protection of Child Rights 3491
National Council for Education, Research and Training 1293
National Creche Scheme 3515
National Crime Record Bureau 1255, 1256
National Deworming Day 1095
National Drug Policy of Malaria 1592
National Ebola Training and Education Center 1583
National Family Health Survey 488, 1017, 1020, 1021f, 1022f, 1039f
National Filaria Control Program 1630
National Food Security Act 1093
National Governments and Health Systems 1322
National Health and Nutrition Examination Survey 1198
National Health Mission 1222, 3513
National Health Policy 464, 1296, 1601, 3513
National High Blood Pressure Education Program 2556
National Immunization Program 1113, 1148, 1372
National Immunization Schedule 1137, 1155, 1359
National Iodine Deficiency Disorders Control Program 1096
National Iron Plus Initiatives 1095
National Kidney Foundation 2572
National Leprosy Eradication Programme 1465
National Mental Health Survey 1250
National Neonatal Perinatal Database 499, 632, 670
National Nutrition Mission 1020
National Nutrition Monitoring Bureau 1022
National Nutrition Policy 1093
National Nutrition Programs 1093
National Nutrition Survey 1020
National Nutritional Anemia Prophylaxis Program 1095
National Open School 957
National Polio Surveillance Project 1101
National Population Policy 3513
National Representative Snakebite Mortality Survey of India 394
National Reproductive and Child Health Program 1296
National Roadmap for Elimination of Lymphatic Filariasis 1630
National Rural Health Mission 28, 29, 448, 463, 1296
National Rural Health Mission of Ministry of Health and Family Welfare 80
National Strategic Plan 1441, 1561
National Technical Advisory Group on Immunization 1150
National Tuberculosis Elimination Program 1439, 1439fc, 14421444
National Vector Borne Disease Control Program 1101, 1567, 1630
National Wilms tumor study, staging system of 3079t
Natowicz syndrome 182
Natural killer cell 150, 203, 215, 221, 1956
function 218
Nausea 196, 1802, 3118
Navjaat Shishu Suraksha Karyakram 29, 3515
N-carbamoylglutamate 110
Near infrared spectroscopy 685, 2697
Nebulized epinephrine 2172
Nebulized hypertonic saline 2181
Nebulized steroids 2172
Necator americanus 1615, 1616f
hookworm 1616f
Neck
hyperextension of 905f
muscle weakness 398f
problems 3411
webbing of 64
Necrobiosis lipoidica diabeticorum 2972
Necroptosis 133
Necrotizing enterocolitis 289, 489f, 506, 507, 509, 511, 512, 539, 585, 592, 602, 602f, 604b, 606, 626, 686, 687, 764, 1313, 1733, 1835f
differential diagnosis of 604b
management of 606t
Necrotizing fasciitis 644, 1379, 1381, 3312, 3313f
Necrotizing vasculitis 2512
Needle biopsy 3016
Neem oil poisoning 389
Negative pressure ventilation 342
Neisseria
gonorrhoeae 642, 643, 1275, 1307, 1341, 1342, 1390, 1392
infections 1390, 1392
meningitides 646, 1180, 1305, 1325, 1336, 1347, 1390, 1392, 2034, 2146, 2587
Nelfinavir 3605
Nemaline myopathy 2842
Neomycin sulfate 3606
Neonatal 465470
Neonatal acne 3301, 3302f
Neonatal adrenoleukodystrophy 128131
Neonatal alloimmune thrombocytopenia 592, 20682070, 2104
Neonatal anemia 578
Neonatal apnea 696
consequences of 700
Neonatal autoimmune thrombocytopenia 2071
Neonatal bacterial meningitis 645
Neonatal candidiasis 3306
Neonatal care, organization of 460
Neonatal cholestasis 152, 560, 1870, 1821, 1877, 1878fc, 1879
causes of 560b, 1871t
coagulopathy in 1871
intrahepatic causes of 1872t
outcome of 1879
supportive management of 1879t
Neonatal circulation 457, 458f
Neonatal classical presentation 106
Neonatal conjunctivitis 3229
Neonatal Ebstein anomaly 2383f
Neonatal echocardiography 2289
indications for 2289b
Neonatal encephalopathy 676, 896f
Neonatal epileptic syndromes 671
Neonatal gynecomastia 2912
Neonatal healthcare, regionalization of 616
Neonatal heart failure, causes of 2301t
Neonatal hemochromatosis 18761878
Neonatal hemolytic states, causes of 2005b
Neonatal hepatitis 1872
Neonatal herpes simplex virus infection 665, 3305
Neonatal Hirschsprung disease 765
Neonatal hyperbilirubinemia 556, 559
management of 557b
treatment of 559
Neonatal hypocalcemia 2977
Neonatal hypoglycemia 565, 569
acute symptomatic 192
treatment of 570f
Neonatal hypoglycemic brain injury 567fc
Neonatal infection 632, 1423, 1533
Neonatal inflammatory skin 280
Neonatal intensive care unit 201, 460, 464, 466, 468, 488, 489f, 497f, 504, 524, 527, 563, 607, 616, 624, 626, 633, 651, 682, 684, 745, 926
Neonatal intestinal obstruction 758, 758b
preoperative management of 760
Neonatal intestinal stroke 764
Neonatal intractable diarrhea, causes of 1740
Neonatal intrahepatic cholestasis 108
Neonatal jaundice 137, 477, 555t
management of 556
severe 159
Neonatal liver failure 1874, 1877
Neonatal lung transplantation 755
Neonatal lupus
erythematosus 3162, 3162f, 3365
syndrome 2463
Neonatal meningitis 645, 649, 650t, 651b
causes of 651
clinical features for 646
complications of 651t
diagnosis of 647
pathogenesis of 646
risk factors for 646b
treatment of 650t
Neonatal morbidities 443, 446, 446b, 533, 539
Neonatal mortality 9, 443, 444f, 445f, 460, 533
rate 3494, 3497
early 443
Neonatal myasthenia gravis 2812, 2847
severe forms of 2847
Neonatal necrotizing enterocolitis 635, 1804
Neonatal onset intractable diarrhea 1739
Neonatal onset multisystem inflammatory disease 3200
Neonatal osteomyelitis 655, 655f
risk factors for 655b
Neonatal pneumothorax 2213
Neonatal polycythemia 582
Neonatal purpura fulminans 3305
Neonatal reflexes 475, 490
Neonatal respiratory distress syndrome 338
Neonatal resuscitation 467, 468fc
Neonatal sclerosing cholangitis 1918
Neonatal seizures 670, 673
etiology of 670t
management of 674, 675fc
Neonatal sepsis 447, 632, 634, 636, 638, 638t
observational study 633
Neonatal septic arthritis 654
Neonatal stroke 670
Neonatal tetanus 658, 659, 1099, 1361
Neonatal thrombocytopenia 591, 2070
causes of 2070b
classification of 590t
Neonatal thyrotoxicosis 2893
Neonatal transport
advanced 617
Neonatal transport systems 616
Neonatal unconjugated hyperbilirubinemia 559t
Neonatal urinary tract infection 657
Neonatal ventilation 701
Neonatology 4
Neoplasia 2496
Neoplasms 1798
secreting insulin-like growth factor 188
Neostigmine 3606
Nephrin 2523
Nephritic syndrome 2507
Nephritis. Also See Acute interstitial nephritis, acute nephritic syndrome
Nephroblastomatosis 3080f
Nephrocalcinosis 280, 2540, 2548
Nephrogenic diabetes insipidus 2546, 2880
Nephrogenic systemic fibrosis 2489
Nephrolithiasis 2497
Nephron 2481, 2481f
superficial 2482
Nephronophthisis 2498
Nephropathy 2972
Nephrotic range proteinuria 2518, 2520
Nephrotic syndrome 2511, 2513, 25182520, 2521f, 2523, 2524, 2525fc, 2526
congenital 2518, 2524
edema of 2525
episode of 2523
management of 2527
nomenclature in 2520b
Nephrotoxic agents 2528
Nephrotoxic injury 2531
Nerve 2780
biopsy 2788
conduction 2592, 2726
protocols of 2592
studies 2588, 2591, 2804, 2812
velocities 2248, 2799, 2842, 2853
electrical stimulation of 2591
high-resolution ultrasound of 2853
injuries 547
palsy 3059f
Nerve tissue vaccine 1164
Net acid production 258
Net protein utilization 991
Netherton syndrome 3389
Netilmicin sulfate 3606
Neu-laxova syndrome 101
Neural crest cells 2344
Neural plate 783
Neural tube 2606
defects 52, 79, 454, 783, 786, 880, 2604, 2605, 2607t, 2608b, 2609
prevention of 2610b
surgery of 788b
types of 786b
formation of 2606f
Neuraminidase 1479
Neuritic leprosy 1463
Neuroaxis 2579
parts of 2579
Neuroblast migrates 2612
Neuroblastoma 2557, 2748f, 2938, 3069f, 3070, 3072t, 3074, 3291
microscopy of 3071f
staging of 3073
Neurocardiogenic syncope 2858
Neurocutaneous disorders 2749, 2756t, 2757
Neurocutaneous syndromes 3288, 3368, 3368b
Neurocysticercal cyst, development of 2682t
Neurocysticercosis 2682, 2685, 2710
extraparenchymal 2683, 2683t, 2684
Neurodegenerative disorders 2579, 2757, 2770t, 2763, 2770, 2885
Neurodevelopmental therapy 912
Neuroendocrine cell hyperplasia 2221f
Neuroendocrine system 383
Neuroendocrine tumor 1742
Neuroendoscopy 2624
Neurofibromatosis 43, 2339, 2751, 2752, 2753t, 2754, 2755, 3251, 3252f, 3288, 3289, 3368
central 3289
classification of 3368t
diagnostic criteria for 2752b, 2754b
Neurogenic bladder 787
Neurohypophysis 2868
Neuroimaging 25932604
Neuroleptic malignant syndrome 368
Neurological cretinism 2883
Neurological crises 97
Neurological disorders 2579, 2587, 2587t, 3291
Neurometabolic disorders 2757, 2760t, 2762, 2762t
investigations for 2761b
Neuromuscular clubfeet, treatment of 3439
Neuromuscular disorders 88, 339, 694, 2464, 2779, 2781t, 2786fc, 2788, 2807, 2848
classification of 2781fc
diagnosis of 2779
inheritance pattern in 2781
Neuromuscular junction 383, 398f, 2780
blockade 397
Neuromuscular maturity 472
Neuromuscular scoliosis 3418, 3422, 3423
Neuromuscular transmission disorders 2845
Neuromuscular transmission, physiology of 2845
Neuromuscular weakness
localization of 2780t
pattern of 2782t
Neuromyelitis optica 2736, 2740, 2741, 2741f
spectrum disorders 2586
Neuronal ceroid lipofuscinosis 132, 135, 137, 2580, 2721, 2764, 2766, 2767, 2772
disorders 138
Neuronal heterotopia 2623
Neuronal migration, disorders of 790
Neuronal progenitor cells 2612
Neuronopathic Gaucher disease 148
Neuroparalysis 398f
Neuropathic pain 136
Neuropathology 969
Neuropathy 48, 97, 122, 123, 2759, 2972
ataxia retinitis pigmentosa syndrome 2766
Neurophysiology 2587, 2853, 3060
Neuropsychiatric disorders 2749
Neuropsychiatric systemic lupus erythematosus 3166
Neuroregression 2764, 3258f
Neuroretinitis 3258f
Neurosecretion 2868
Neurotransmitter deficiency 83
Neurotransmitter disorders 2585, 2861
Neurotropic disease 1207
Neurotropic flavivirus 2614
Neurotuberculosis 2669
classification of 2669
Neutralization 207
Neutralizing antibodies 1188
Neutropenia 89, 223, 1395f, 2543
Neutrophil 203, 2486, 2509
cytoplasmic antigens 2514
extracellular traps 2047
gelatinase-associated lipocalin 681, 1955, 2530
leukocytosis 1564
Nevirapine 1561, 3606
Nevoid linear hypopigmentation 3327
Nevus
anemicus 3326, 3326f
depigmentosus 3326
flammeus 3320
fuscoceruleus ophthalmomaxillaris 3307
of Jadassohn 3288
of Ota 3288, 3307
simplex 3319
New South Wales Emergency Transport System 616
New Wilson index 1921
Newborn. Also See Neonatal
Newborn cyanosis 600fc
Newborn resuscitation of. See Neonatal resuscitation
Newborn screening 77, 80, 82, 140, 199, 480, 2012
Newborn shock 2466
Newborn stabilization unit 29, 461463
Next generation sequencing 41, 63, 79, 125, 126, 919f, 920, 1972, 1973, 2272, 2517, 2616
Niacin 288, 1053, 3361
deficiency 1053
Nickel 1076
Niclosamide 3606
Nicotinamide adenine dinucleotide 105, 119, 123, 127, 1353, 2038, 2543
phosphate 170, 172, 216, 222, 1989, 2035
Niemann-Pick disease 72, 88, 88f, 133, 135, 136, 141, 152, 156, 158, 159, 159t, 1877, 2766, 2769, 3290
classic 158
clinical features of 159t
Nifedipine 409, 2559, 3606
Night blindness, prevalence of 1023
Nikolsky sign, positive 640
Nimesulide 1334
Nipah virus 2677
Nitazoxanide 3606
Nitisinone 70, 98
administration of 97
Nitrate reductase 2562
Nitrazepam 2645
Nitric oxide 678, 681, 728f, 1880, 2482. Also See Inhaled nitric oxide for PPHN
synthase 678
Nitrites 2485, 2562, 2661
Nitrofurantoin 288, 2563, 3606
Nitrogen oxide 1430
Nitroprusside 3607
Nitrothiazolyl-salicylamide derivative 1608
Nitrous oxide 2045f
synthesis 105, 105f
Nits 3316f
N-linked glycosylation 171f
congenital disorders of 166, 171
N-methyl-D-aspartate 99, 671, 678, 681, 896, 2696, 2741, 2745
receptor 2587, 2693, 2694
antibodies 2746
encephalitis 2744, 2746
N-methyldiethanolamine 366
NMDA encephalitis. See N-methyl-D-aspartate encephalitis
Nocardia
abscessus 1415
asteroids 1415
brasiliensis 1415
cyriacigeorgica 1415
farcinica 1415
infection 1416f
nova 1415
otitidiscaviarum 1415
transvalensis 1415
Nocardiosis 1415, 1417
Nocturnal diarrhea 1733
Nocturnal emission 1229
Nocturnal enuresis. See Enuresis
Nocturnal polysomnogram 944f
Nocturnal polyuria 2501, 2502
Nocturnal urinary volume 2502
Nodal cilia 2229
Nodular goiter 2895f
Nodular heterotopia 2623f
Nodular scabies 3317f
Noise pollution 3506
health impacts of 3507t
Noma 3360
neonatorum 3305
Nonalcoholic fatty liver disease 1869, 1885, 1920
Nonalcoholic steatohepatitis 1869
Nonamino organic acids, urinary excretion of 111
Nonbacterial thrombotic endocarditis 2420
Nonbullous ichthyosiform erythroderma 3387
differential diagnosis of 3388b
Nonbullous impetigo 3311
Nonceliac gluten sensitivity 1819
Noncirrhotic ascites, etiopathogenesis 1844
Noncirrhotic portal fibrosis 1846, 1891, 1911, 1918
Nonclassical congenital adrenal hyperplasia 1270
Nonclassical endocrine glands 2867
Noncommitted ventricular septal defect 2390
Noncommunicable diseases 13, 28, 1224, 2477f
Nondystrophic myotonias 2823
Nonelectrical cold chain equipment 1121
Nonepileptic paroxysmal disorders 2653, 2653t
Nonepileptic seizures 670
Nonessential nutrients 989
Nonfamilial benign hematuria 2506
Nonfatal violence 1259
Nongenetic disorders 2497
Nongonococcal urethritis 1275
Nonhepatotropic viruses 1907
Non-herpetic genital ulcers 1278
Non-Hodgkin lymphoma 1842, 2007, 3042t, 3047, 3048t, 3050t, 3051, 3052, 3052t, 3116f
differential diagnosis of 3052t
subtypes of 3048f
Nonhomogeneous atelectasis 719f
Nonimmune hydrops fetalis 136, 1512
Nonimmune-mediated urticaria 3336
Noninfectious pericarditis 2440
Noninflammatory myopathies 3171
Noninflammatory nonarticular pain 3129
Noninsulin-dependent diabetes mellitus 2958
Noninvasive blood pressure 682
Noninvasive pneumococcal diseases 1378
Noninvasive positive pressure ventilation 341, 342b, 347, 353, 2162
use of 342b
Noninvasive technique 1084, 1085f
Noninvasive tests 1420
Noninvasive urodynamics 2501
Noninvasive ventilation 346, 349, 353
Nonionizing radiation 3508
Nonketotic hyperglycinemia 86, 92, 94, 99, 2636, 27602762, 2766
Nonmuscle heavy chain gene, mutations of 2068, 2084
Non-neuronopathic Gaucher disease 147
Non-nucleoside reverse transcriptase inhibitors 265, 1550, 1558, 1649
Nonobstructive dilatation 780
Nonosseous spinal cord tuberculosis 2674
Nonparalytic polio 1536
Nonparalytic strabismus 3267
Nonpharmacological antipyresis 1333
Nonpharmacological therapies 2645
Nonpolio enteroviral infections 1529, 1534
Nonprogressive ataxias 2726
Nonprogressive cerebellar ataxias 2727
Nonprogressive intellectual disability 2613
Nonproliferative retinopathy 2972
Nonprotein-bound iron 677
Non-rapid eye movement 942, 942t, 2247, 2638, 2655
Nonresolving bronchiolitis 2222
Nonrhabdomyosarcoma soft tissue sarcoma 3094t
management of 3096
Nonscarring alopecia, classification of 3395fc
Nonsedating antihistamines 246
Nonskeletal fluorosis 1081
Nonspherocytic congenital hemolytic anemia 2036
Nonsteroidal anti-inflammatory drugs 276, 377, 729, 1267, 1382, 1513, 1579, 1794, 1825, 1882, 1895, 1925, 2053, 2078, 2125, 2324, 2528, 2546, 3129, 3141, 3152, 3162
Nonstress test 533, 540
Nonstructural protein 1572
Nonsyndromic central hypotonia 2797
Nonsyndromic ichthyoses 3385
Nonsyndromic microcephaly 2612
Nontransferrin bound iron 2022
Nontransfusion-dependent thalassemia 2007, 2024
Nontuberculous extrapulmonary mycobacterial infections 1457f
Nontuberculous mycobacteria 1427, 1436, 1458t
classification of 1455, 1455t
culture of 1457
Nontyphoidal salmonellosis 1368, 1368t, 1369b, 1370
clinical presentations of 1369b
Nonverbal communication, components of 1284t
Noonan syndrome 51, 53, 2342, 3370, 3370f
Norepinephrine 317, 1757, 2302, 3607
Norfloxacin 3607
Normal anion gap metabolic acidosis 264, 265
Normochromic anemia 1967fc
Normocytic anemia 1967fc
Norrie disease 610
Norwegian scabies 3317
Norwood procedure 2394, 2472t
Sano modification of 2394
Nosocomial infections, prevention of 1325
Nosology, advantages of 3440
Nova food classification 1089
Novavax COVID-19 vaccine 1193
NSAIDs 3141
Nuchal translucency screening 533, 539
Nuclear cataract 3241
Nuclear genes 37
Nuclear organizing region 211
Nucleic acid
amplification
assays 1458
detection techniques 1629
sequence-based amplification 1311
vaccines 1189
Nucleophosmin 3026
Nucleoside reverse transcriptase inhibitor 1558
5’-Nucleotidase 1867
Nucleotide
metabolism 2035
oligomerization domain receptors 204
sequencing 1311
Nullisomy 38
Nummular dermatitis 3332
Nusinersen 2813
Nutcracker syndrome 2507
Nutrients 515, 989
absorption of 1729
deficiency of 1031, 1733
groups 989
Nutrition 16, 332, 348, 506, 509, 636, 801, 880, 989, 1089, 1242, 1560, 2307, 2527, 3117
and health education 29
programs 1093
transition 1242
Nutritional counseling 921, 1453
Nutritional deficiency 2072, 2573, 2732
cutaneous manifestations of 3360
Nutritional deprivation 1612
Nutritional disorders 989, 2461, 3229
Nutritional dystrophy 2732
Nutritional requirements 511, 989
Nutritional rickets 1059, 1063t, 2980
Nutritional status 1243, 1429, 1914
classification of 1038t
Nutritional supplementation 521
Nutritional theory 936
Nutritional therapy 192, 1831, 2303
Nuts 999
Nystagmoid movements 3271
Nystagmus 3269, 3270, 3270t
Nystatin 3607
O
OAE. See Otoacoustic emission
Obesity 6, 16, 856, 858, 874, 2158, 2930, 3501
constitutional 858
development of 859
etiology of 859t
evaluation of 862t
exogenous 2987
genetic 858
management 863
pathogenesis of 859t
prevention of 1224
risk factors of 859t
Obestatin 859t
Object permanence 885
Oblique facial cleft 1769f
Obsessive-compulsive disorder 102, 983
Obstructed hernia 781
Obstructed hydrocephalus 2625f
Obstructed total anomalous pulmonary venous drainage 2277f
Obstructive apnea 697
Obstructive hydrocephalus 2625
Obstructive hydronephrosis 2489
Obstructive hypoventilation 2160
Obstructive sleep apnea 943, 944f, 946, 2158, 2160, 2159, 2159b, 2162, 2500
episode of 2160f
management of 946fc
signs of 2159b
symptoms of 2159b
syndrome 61
Obstructive total anomalous pulmonary venous return 2467
Obstructive uropathy 2495, 2540, 2557
Occipital epilepsy 2639
Occlusion 839
Occupational therapy 903, 912f
Octreotide 3607
Ocular 32783283
Ocular apraxia 2498
Ocular cysticercosis 2684
Ocular diphtheria 1354
Ocular infections 1503
Ocular injuries 3278
classification of 3278
Ocular toxocariasis 3235
Ocular toxoplasmosis 3235
Ocular trauma score 3279
Oculo-auriculo-vertebral spectrum 3286
Oculocerebrorenal syndrome of Lowe 2543
Oculocutaneous albinism 3323t
Oculodermal melanocytosis 3288
Oculomandibulodyscephaly 3286
Oculomeningeal nevus flammeus 3371
Odontoid anomalies 3414, 3415
types of 3414f
Ofloxacin 3607
Ofuji disease 3303
Ohm's law 1880
Ohtahara syndrome 2635, 2636, 2646
Oleander poisoning 385
Olfactory nerve 2581
Oligoarticular juvenile idiopathic arthritis 3152
Oligogenic inheritance 42, 49
Oligohydramnios 2491, 2495, 2498
Oligomenorrhea 1263
Oligomeric formulations 1084
Oligospermia 47
Oliguria 2508
Olweus bullying prevention program 1251
Omalizumab 246, 2196
Omeprazole 288
Omicron variant 1516
Omphalitis 643, 644, 644f
Omphalocele 770
Onasemnogene abeparvovec 2813
Oncological emergencies 3110
Oncotic pressure 249
Ondansetron hydrochloride 3607
Ondine's curse 337
Onychomycosis 1654
Open lung strategy 346
Open surgical drainage 1905
Operational taxonomic units 1312
Ophiasis 3397f
Ophthalmia neonatorum 642, 642f, 643, 643b, 3248
causes of 642b
treatment of 643t
Ophthalmic preparations 289
Opioids 364
Opisthotonus 659f
posturing 647f
Opportunistic infections 1544, 1548, 1549
Oppositional defiant disorder 964, 964fc, 965, 965b, 966968
Opsoclonus 3271
myoclonus syndrome 2747, 2748, 3291
Optic atrophy 1998
acquired 3259
Optic chiasm 2869f
Optic disk 3256
drusen 3218
Optic glioma 2752, 2753f
Optic nerve
and pupil 3256
aplasia 3256
avulsion 3281
congenital abnormalities of 3218
developmental anomalies of 3256
head avulsion 3281f
hypoplasia 3218, 3256, 3256f
Optic neuritis 2738, 3258, 3258f
Optic pathway-hypothalamic gliomas 3064
Optical coherence tomography 614, 2703, 2972
Optical low vision aids 3296
OPV. See Oral polio vaccine
Oral cavity 1961
routine suction of 466
Oral contraceptive 1269, 1271, 2130
Oral feeding 715
Oral food challenge test 213, 214
Oral leukoplakia 1981f
Oral polio vaccine 1109, 1113, 1116, 1117, 1120, 1125, 1134, 1137t, 1208, 1212, 1536, 1538
immunogenicity of 1134f
novel 1135
Oral rehydration salt 1042, 1043
Oral rehydration salt solution 5, 12, 488, 1708, 1713, 1718, 1725, 1816, 2208, 3512
Oral rehydration solution
low osmolarity 1711, 1711t
Oral rehydration therapy, scientific basis of 1709
Oral thrush 640, 1653, 1653f
Oral ulcers 1676f
Orbit 3272
disorders of 3275
genetic anomalies of 3272
inflammations of 3275
injuries 3279
magnetic resonance imaging of 3283
Orbital cellulitis 3275, 3276, 3276f
Orbital encephalocele 3275
Orbital hydatid cyst 3276
Orchitis 2913
Organ 208
dysfunction criteria 331t
support 348
system 1547, 1548, 1666, 1826
dysfunction 679t
transplantation 71, 90, 216
Organic acid disorders 188
Organic acidemia 8385, 89, 111, 113, 113t, 114fc, 191, 2636
Organic aciduria 108, 1936fc
Organic anions, transport of 1864
Organic food 1091
Organic murmur 2266
Organic peroxide 2505
Organophosphate poisoning 382, 383f
signs of 383t
symptoms of 383t
treatment of 384b
Orientia tsutsugamushi 1693
Ornithine 93, 100, 108
aminotransferase, deficiency of 100, 107, 108
transcarbamylase 84, 107, 737
deficiency 46, 73, 83, 104, 108
transporter 105, 108
deficiency 108
Ornithodoros
crossi 1410
lahorensis 1410
tholosoni 1410
Orofacial cleft 1767
Orolabial infection 1502, 1503
Oromotor stimulation 513
Oronasal airflow pattern 944f
Oronasal cavity 1315
Oropharyngeal candidiasis 640
Oropharyngeal dysphagia 1779
Oropharyngeal secretions 1469
recurrent aspiration of 2186f
Oropharyngeal squamous cell cancers 1197
Orotic aciduria 1998, 2550
ORS. See Oral rehydration salt (ORS) solution
Orthokeratology 3226
Orthomyxovirus 1493
Orthopedic implants 2597
Orthophoria 3261
Orthostatic proteinuria 2518
Orthotropia 3261
Ortolani maneuver 474f
Ortolani test 474, 3427, 3428f
Oseltamivir 1495, 3607
Osgood-Schlatter disease 3425f, 3434, 3435, 3435f
Osler-Weber-Rendu disease 2384
Osmolality 249
Osmosis 249, 250f, 1731
Osmotherapy 2699
Osmotic diarrhea 1708, 1738, 1738fc. Also See Diarrhea
Osmotic fragility test 2033
Osteoarticular complications 1407
Osteoarticular disease 1668
Osteoarticular infection, diagnosis of 1668
Osteochondrodysplasias 872
Osteoclasts 145
Osteogenesis imperfecta 71, 2984, 2985, 3287, 3442, 3446, 3446f
classification of 3445t
Osteomalacia 2553
Osteomyelitis 148, 652, 654, 655f, 1423, 1964f, 3405, 3406, 3407f
features of 655f
Osteonecrosis 148, 152
Osteopenia 148, 148f, 1082f, 2999
Osteopetrosis 71, 102, 1965f, 3440
management of 3442
Osteoporosis 2972, 29842986, 2999, 3153
prevention of 2999b
pseudoglioma syndrome 2985
Osteoporotic spine 1082f
Ostium primum 2254
Otitis media 1169, 1376, 2133, 2135, 2137, 2138t
pathogenesis of 2134, 2134f
spectrum of 2134t
types of 2133
Otoacoustic emission 199, 480, 624
Otorhinogenic sepsis 2688
Otoscopy 2135
Ovalocytosis 2032
Ovarian failure 63, 1264
Ovarian granulosa-thecal cell tumors 2907
Ovary 3002
Overdistended bladder 2495
Overflow theory 1845
Overlap syndromes 3170
Overnutrition 1244, 1249
Overweight 856864
Ovotesticular DSD 2950
Ovulation 1227
Owl-eye cells 2403
Oxalate 2551
Oxcarbamazepine 2645
Oxcarbazepine 3607
Oxford-astrazeneca COVID-19 vaccine 1190
Oxidation pathway 129
Oxidative phosphorylation system 47
Oxidative stress 677
Oximetry 943
Oxygen 731, 2197
arterial
content 328
partial pressure of 340, 2113
saturation 328
tension 328
alveolar partial pressure of 2112f
arterial partial pressure of 343, 347, 348
capacity 2112
consumption 328, 329f, 2306
delivery 328, 329f
dissociation curve 2113f
extraction 328
partial pressure of 260, 261, 338f, 451, 696, 707, 2113f
saturation 2112, 2197, 2258t, 2259
therapy 341, 510, 607, 720
transport 593, 2112
treatment 723
Oxygenated hemoglobin 2600
inflow of 2600
Oxygenation 355, 703, 709, 2112
assessment of 2113
impairment 2113t
index 732
measures of 261
Oxyhemoglobin dissociation curve 594, 594f
Oxyntic cells 1757
P
P wave 2281, 2310
P450 oxidoreductase (POR) deficiency 2923
Pacemaker 2307
implantation 71
sound 2265
Packed red blood cell
leukofiltration for 2103f
transfusion 586, 2034
Pain 160, 196, 900, 2015, 2608
abdominal 152, 194, 1794, 1833, 2513, 2514, 2534, 2561
amplification syndromes 3129
management 291, 2019, 3118
measurement 2661
relief 408
Painful abdominal crisis 2015
Painful enlarged inguinal lymph node 1278f
Painless flat foot 3403
PAIR 1642
Palamneus gravimanus 404f
Palamneus swammerdami 404
Pale lemon jelly appearance 1625
Palladai feeding 513f
Palliative procedures 2470
Palliative systemic artery 2367
Pallister-Hall syndrome 2951
Pallister-Killian syndrome 64
Palmar erythema 1886f, 1914, 1914f
Palmar freckling 3369f
Palms, dryness of 3392f
Palpable purpura 1690f
Palpation 2117, 2263
PALS. See Pediatric advanced life support
Panayiotopoulos syndrome 2646
Pancarditis 2406
acute 2404t
Pancreas 1758, 2867, 2968
development of 1756, 1756f
divisum 1798
neuroendocrine tumors of 1742
Pancreatic ascites 1845
Pancreatic cholera 1803
Pancreatic disorders 1745
Pancreatic enzyme
direct assay of 1812
supplement 2236
Pancreatic function 1737, 1737t
indirect tests of 1813
Pancreatic malformations 2499
Pancreatic pseudocyst 1801
Pancreatic tumors 1797, 1803
Pancreatitis 1498, 1696, 1797, 1797b, 2550. Also See Acute pancreatitis
diagnosis of 1800t
familial 1802
Pancreatobiliary organs 1542
Pancuronium 3608
Pancytopenia 89, 151, 152
PANDAS 1382
Pandemic influenza 1183
vaccines 1182
Panel reactive antibodies testing 216
Paneth cells 1757
Panhypopituitarism 188
Panic disorder 983
Pansystolic murmur 2265, 2398
Pantoprazole 3608
Pantothenate kinase-associated neurodegeneration 2766, 2767, 2772
Panuveitis 3238
Paper and pencil tests 1933
Papillary cystadenoma lymphomatosum 1774
Papilledema 2625, 2698, 3059f, 3258, 3258f
Papillitis 3258, 3258f
Papilloma 3230
Paps synthase 2 deficiency 2923
Papular urticaria 3332
Papulosquamous disorders 3377
Para-acetamidobenzoic acid 1868
Para-aminobenzoic acid 1349f
Para-aminohippuric acid 1868
Para-aminosalicylic acid 2672
Paracentesis, complications of 1848
Paracetamol 1334, 2662, 3583
poisoning 375, 376fc
toxicity, stages of 375t
Paracoccidioides brasiliensis 1647, 1649
Paracrine immune-neuroendocrine system 1732, 1732f
Paracrystalline inclusion 125f
Paraganglioma 2937, 2937t
Paragonimiasis 1633
Paragonimus heterotremus 1632
Paragonimus westermani 1631, 1632
life cycle of 1633f
Parainfluenza virus 1314
Paraldehyde 674, 3608
Paralysis 2539
onset of 2801
progression of 2801
topography of 2801
Paralytic poliomyelitis 1537
differential diagnosis of 1538t
Paralytic strabismus 3264, 3267t
Paramyxovirus 1468
Paranasal sinuses 2151
Paraneoplastic encephalitis 2744
Paraneoplastic pemphigus 3374
Paraneoplastic phenomena 3072
Parapharyngeal abscess 2156
Paraplegia 2581
Parapneumonic effusion 2209
Parapsoriasis 3379, 3380
hypopigmented variant of 3380f
Parasite 661, 1302
deoxyribonucleic acid 1597
detection 1597, 1602
infection 1585
lactate dehydrogenase 1590
Parasitic disease 1310
Parasitic infections 1430, 1584, 1586, 3285
burden of 1584
epidemiology of 1584
Parasitic infestations 3276, 3315
Parasomnias 2655
Parasympathetic fibers 1756
Parasympathetic system 383, 2500, 2854
Parathormone 2558
Parathyroid glands 2867, 2974
autoimmune destruction of 2977
hypoplasia of 2977
Parathyroid hormone 278, 451, 803, 1078, 2548, 2555, 2936, 2974, 2977, 2991
deficiency 803
levels of 2553
related protein 1946
Parechovirus 2675
Parenchymal disease 2685
Parenchymal hematoma 2714f
Parenchymal liver injury 1922t
Parenchymal lung disease 729f
Parenchymal neurocysticercosis 2683, 2683t, 2684, 2685t
Parental education 1335
Parenteral iron therapy 1994
Parenteral nutrition 509, 1083, 1085
complications of 1088, 1088b
components of 1086
indications for 1086, 1087b
Parenting 930, 1238
and learning disability 956
components of 1284t
of adolescents 1284
Parietal cells 1757
Paris-Trousseau syndrome 2070
Park's classification 1858f
Parkinson's disease 134
Parkinsonian syndrome 2772
Parkland formula 427
Paromomycin 1598
Paronychia 1654
Parotid gland, acute inflammation of 1772
Parotid swelling 1773f
Parotitis 1479, 1479f, 1480, 2676
Paroxysmal cold hemoglobinuria 2039, 2042
Paroxysmal dyskinesias 2655
Paroxysmal exercise-induced dyskinesia 2655, 2720
Paroxysmal hypnogenic dyskinesia 2655
Paroxysmal kinesigenic dyskinesia 2655
Paroxysmal lateralizing epileptiform discharges 1502
Paroxysmal movement disorders 2720
Paroxysmal nocturnal
dyskinesia 2720
hemoglobinuria 1985, 2006
Paroxysmal nonkinesigenic dyskinesia 2655
Paroxysmal supraventricular tachycardia 2452fc
Pars cystica 1756
Pars distalis 2868
Pars hepatica 1756
Pars intermedia 2868
Pars nervosa 2868
Partial anomalous pulmonary venous connection 2268, 2270
Partial choanal atresia 2129
Partial enzyme deficiency 115f
Partial seizures 2636
Partial thromboplastin time 740f, 855, 1411, 1525, 1527, 1867
Partial villous atrophy 1823f
Partner therapy 1279
Parvovirus 2039, 2675
B19 infection 455, 668, 1509, 1510b, 1511f, 1513, 1513t, 2017, 2520
signs of 1510t
symptoms of 1510t
Passive immunization 1507
Passive muscle tone 629
Pasteurella haemolytica 1304
Pasteurella multocida 421
Pastia's line 1381, 1381f
Patau syndrome 60f, 62, 2951, 3285
Patch test 213, 214
Patent ductus arteriosus 506, 515, 735, 740, 742, 744, 748, 2251, 2262, 2266, 2268, 2270, 2274, 2290, 2293, 2296f, 2333, 2336, 2349, 2352, 2358, 2361, 2377, 2393, 2465, 2472
anatomy of 2291f
management of 510, 2336
medical management of 2336
Patent foramen ovale 2329, 2340
Patent vitellointestinal duct 771, 772f
Pathologic fractures 148
Pathologic myoclonus 2717
Patiromer 2574
Patrick Yesudian sign 3369f
Pattern recognition receptors 204
types of 204
Patterson-Kelly syndrome 1993
Pauciarticular juvenile idiopathic arthritis 209
Pauci-immune glomerulonephritis 2509
Paul-Bunnell test 1490
PCP. See Pneumocystis pneumonia
PDA. See Patent ductus arteriosus
Peak expiratory flow rate 2114, 2119
Peak inspiratory pressure 349, 351, 351f, 354, 355, 358f, 702f704f, 707, 708, 746
Peak systolic velocity 552
Pectus carinatum 151f, 2117
Pectus excavatum 87f, 2117
Pedersen hypothesis, modified 562fc
Pediatric acute liver failure 1938, 1939b
study group 1931
Pediatric acute respiratory distress syndrome 332, 343
Pediatric advanced life support 299, 312
Pediatric assessment
pentagon 300f
triangle 299, 299f, 339
Pediatric cardiology 4
Pediatric cardiovascular surgery 2250t
Pediatric cataract surgery, complications of 3246
Pediatric critical care 4, 324
Pediatric dermatology 4
Pediatric emergency medicine 4
Pediatric endocrinology 4
Pediatric end-stage liver disease score 1921
Pediatric enteral nutrition, general principles of 1083
Pediatric epilepsy, treatment of 2646t
Pediatric erythroderma 3349b
Pediatric gait, arms, legs and spine (pGALS) 3402t
Pediatric gastroenterology-hepatology 4
Pediatric hematology 4
Pediatric intensive care unit 303, 324326, 327f, 344, 354, 379, 1392
indications for 368b
Pediatric leukemias 3013
Pediatric malignancies 3006
Pediatric nephrology 6
Pediatric neurology 6
Pediatric neuromuscular disorders 2779
Pediatric oncology 6
Pediatric ophthalmology 6
Pediatric pharmacology 282
Pediatric psychiatry 6
Pediatric radiation oncology 3017
Pediatric respiratory distress syndrome 344t
Pediatric rheumatology 6, 3128
Pediculosis 3274, 3315
capitis 3274, 3316
corporis 3316
pubis 3274, 3316
Pediculus humanus 3316
capitis 3315
corporis 1410, 1695f
Pelizaeus-Merzbacher disease 66, 2766, 2770
Pelkan spur 1058
Pellagra, photosensitive rash of 3361f
Pelvic inflammatory disease 1224, 1267, 1279
Pelvic pubic rami 2494
Pelvicalyceal system 2563f
Pelviureteric junction 774f, 780f, 2491
obstruction 2491
PEM. See Protein energy malnutrition
Pemphigus 3374
foliaceus 3374
vulgaris 214f, 3374
Penetrating eye injury 3279b
Penicillamine 288
Penicillin 1423
benzathine 3608
prophylaxis 2019
resistant streptococcal endocarditis 2424
susceptible streptococcal endocarditis 2424
V potassium 3608
Penicillium marneffei 1676
Penile agenesis 777
Penile hypospadias 475f
Penile intraepithelial neoplasia 1197
Penoscrotal transposition 777f
Pentavalent antimonials 1598
Pentazocine hydrochloride 3609
Pentose metabolism, disorders of 166, 170
Pentraxins 204
Peptic ulcer disease 1419, 1795
etiology of 1795b
Peptide
nucleic acid 1309
types of 396
Peramivir 1495
Percutaneous aspiration-injection-reaspiration 1641, 1642
Percutaneous endoscopic gastrostomy 1085f, 1085t, 1350
Percutaneous liver biopsies 1863
Percutaneous nephrolithotomy 2552
Percutaneous nephrostomy 2493
Percutaneous transcatheter device closure 2472
Percutaneous umbilical blood sampling 540
Perforated appendicitis 1840f
Perianal abscess 1857, 1858
Perianal fistula 1747f, 1825f
Perianal streptococcal dermatitis 3313
Pericardial calcification 2440f
Pericardial cysts 2440
Pericardial diseases 2438t
Pericardial rub 2265
Pericardial tuberculosis 1431
Pericarditis 2285, 2287f
anaerobic 1425
bacterial 2439
causes of 2438t
specific forms of 2439
Pericardium 2253
congenital absence of 2440
diseases of 2438
Periconceptional folic acid 2610
supplementation 2610, 2610b
Perilesional edema 2683f
Perinatal asphyxia 109, 505, 508, 679t
Perinatal mortality 445, 533
rate 9, 445, 523f, 3494, 3497, 3498
Perinatal related lung disease 344
Perinatal risk index 523f
Perinatal stabilization 755
Perineuritis 3258
Perinuclear anti-neutrophilic antibody 213f, 1923, 1924
Periocular structures, congenital abnormalities of 3209
Periodic acid-Schiff stain 1813
Periodic fever 2155
Periodic urine culture 2609
Periodontal disease 795, 2972
Peripheral arterial vasodilation theory 1845
Peripheral blood 69f, 1979, 1981
examination 1999
leukocytes 89
smear 2011, 2026f, 2099
Peripheral capillary oxygen saturation 468, 469, 745
Peripheral cyanosis 595
Peripheral eosinophilia 2684
Peripheral facial nerve injury 548
Peripheral granuloma 3235
Peripheral lymphadenopathy 1432
Peripheral lymphedema 64
Peripheral nerve 2583
branch injury 548
Peripheral nervous system 174, 383, 2583, 3161
Peripheral neuropathy 1876, 2582f, 2972
Peripheral precocious puberty 2906
management of 2911
Peripheral pulmonary stenosis 2339, 2342, 2343
Peripheral white blood cell count 1377
Perisinusoidal cells 1863
Peristalsis 1833
Peritoneal dialysis 90, 2533, 2575f, 2576
Peritoneal tuberculosis 1841
Peritonitis 1834f, 1840f, 2523, 2526
Peritonsillar abscess 2156
Peritubular capillary blood 2482
Periungual desquamation 3180f
Periventricular hemorrhagic infarction 690f
Periventricular leukomalacia 507, 518, 626, 677, 680f, 684
Periventricular-intraventricular hemorrhage 507
Perlman syndrome 526
Permanent childhood hearing loss 200
Permanent dentition 841
development of 838t
period 838
Permanent junctional reciprocating tachycardia 2246, 2443, 2448, 2452
Permethrin 3609
Permissive hypercapnia 347t, 615, 746
Pernicious anemia 1794
Perniosis 435
Peroral endoscopic myotomy 1782
Peroxisomal biogenesis, disorders of 86
Peroxisomal disorders 55, 89, 128, 130, 130t
classification of 129b
diagnosis of 130fc
phenotypic spectrum of 129f
Peroxisome 128
Perrault syndrome 1265
Persistent diarrhea 1607, 1723, 1724, 1728
dietary management of 1728
treatment of 1725fc
Persistent fetal vasculature syndrome 610, 3245
Persistent hematuria 2505
Persistent hyperinsulinemic
hypoglycemia 88, 188
Persistent hypertension 2526
causes of 2557t
Persistent hypoglycemia 188, 570t
etiology of 188b
Persistent neonatal hypoglycemia 569
Persistent pneumonia 2216, 2217
etiology of 2217t
Persistent pulmonary hypertension 359, 458, 508, 528, 596, 598, 695, 696, 720, 727, 729732, 753, 2291
mechanisms of 729b
overall management of 732fc
treatment of 730b, 755
Persistent pupillary membrane 3215
Persistent respiratory distress, causes of 696
Persistent truncus arteriosus 2391
Personal protective equipment, use of 1326
Personality disorders 1254, 1254t
Perthes disease 3431b, 3432, 3433f
differential diagnosis of 3432b
evolution of 3432f
Pertussis 1357, 1359, 2142, 3284
clinical diagnosis of 1358
toxin 1139, 1209
treatment for 1359b
Pervasive developmental disorders 969
Pervasiveness 960b
Pes cavus 87f
foot deformity 2852f
Pesticides 1091
Pet vaccination 1506
Petechiae 545, 1690f
Peter's anomaly 3215, 3228, 3251
Peters plus syndrome 3251
Pethidine 409
Peutz-Jeghers syndrome 1898
Peyer's patches 1342, 2675
Pfizer-biontech COVID-19 vaccine 1189
pGALS. See Pediatric gait, arms, legs and spine
pH 260b
PHACES syndrome 3372, 3372f
Phacomatosis pigmentovascularis 3320
Phage therapy 1324
Phagocyte, congenital defects of 222
Phagocytic cells 3111
Pharmacogenetics 285
Pharmacogenomics 72
Pharmacokinetics 282, 1346, 1472
Pharmacologic therapy 2531
Pharmacological adjunctive therapies 746
Pharmacological antipyresis 1333
Pharmacological chaperone therapy 154
Pharmacological therapy 110, 1781, 2574
Pharmacotherapy 2992
Pharyngitis 1380, 2145, 2148, 2148fc, 2155, 2505
etiological agents of 2146t
Pharyngotonsillitis, causes of 2155b
Pheniramine maleate 3609
Phenobarbitone 70, 559, 674, 2645
sodium 3609
Phenothiazines 365
Phenotypes 35
Phenotypic resistance 1318
Phenoxybenzamine 2560
Phenoxymethylpenicillin 3608
Phentolamine 2560
Phenylacetate 1935
Phenylalanine 70, 83, 93, 96
ammonia lyase 97
catabolism, disorders of 94
hydroxylase 95, 97
metabolism 95f
Phenylethanolamine-N-methyltransferase 2917
Phenylketonuria 70, 72, 79, 80, 82, 83, 86, 91, 94, 96, 96f, 199, 480, 916, 2766
sapropterin for 72
Phenytoin 674, 1908, 2636, 2645
hepatotoxicity 1908
poisoning 378
sodium 3609
Pheochromocytoma 2463, 25572559, 2937, 2937f, 2939
biochemical testing for 2938
preoperative management of 2939t
Philadelphia chromosome 3030
Philadelphia protocol 1337t
Phlebitis 293
Phlebotomus argentipes 1601
Phlyctenular conjunctivitis 3234f
Phorbol myristate acetate 232
Phosphate 70, 2541, 2553, 2554, 2975
excretion 2541
Phosphaturia 2554
Phosphocreatine 567
Phosphodiesterase inhibitor 2399, 2432
Phosphoenolpyruvate carboxykinase 166, 169fc
deficiency 190
Phospholipase C epsilon 1 2524
Phospholipid 2048f
Phosphopenic rickets 2553, 2981
Phosphorus 512, 993, 2549, 2630
homeostasis 2554f
Phosphorylase B kinase (PhK) deficiency 172
Phosphoserine phosphatase 100
Photophobia 3248
Photoreceptor dystrophy 2591
Photosensitivity
in SLE 3156t
Phototherapy 557, 560
aspects of 558b
devices 557
initiation of 557
Phrenic nerve injury 549
Phrynoderma 3360
Phthirus pubis 3315, 3316
Physical abuse 412, 3477
Physical growth, assessment of 804
Physical injury 1230
Physical pain 1230
Physical urticaria 3335
Physiological anisocoria 3215, 3260
Physiological anticoagulant pathway, impaired function of 2098
Physiological jaundice 551
Physiological nystagmus 3269
Physiological umbilical herniation 1755
Physiotherapy 903, 2061
Phytanic acid oxidase 129
Phytohemagglutinin 232
Phytonadione 3363
Piaget's theory 929
Pica 936
PICO 20
PICU. See Pediatric intensive care unit
PIE. See Pulmonary interstitial emphysema
Piebaldism 3287, 3325
Pierre-Robin syndrome 1768f, 1769
Pierson syndrome 2518, 2523, 2524
Pigmenturia 2529
Pill esophagitis 1895
Pilonidal sinus 1859
Pineal gland 2867, 2870
Pink test 2033
Pinworm 1619
Piperacillin 3609
Piperazine 3610
Pirani classification 3438
Piroxicam 288, 3610
Pistol shot sounds 2417
Pituitary gland 2866
anterior 2871f
Pituitary hormones 2868t
Pituitary secretion, regulation of 2869
Pituitary stalk interruption 2873
Pityriasis alba 3328, 3328f
Pityriasis lichenoides 3380
chronica 3380f
et varioliformis acuta 3380f
Pityriasis rosea 3382, 3383
Pityriasis rubra pilaris 3383, 3383f, 3384
Pityriasis versicolor 3315f
Placenta
examination of 531
produces growth hormone 450
role of 2883
Placental transfusion 580
Placing reflex 2584
Plague 1402, 1403, 1404b
Plant poisons and mushrooms 385
Plantar keratoderma 3383f
Plaque
morphea 3366
psoriasis 3379
reduction neutralization test 1206, 1564
Plasma 93, 121, 1870
acylcarnitines 89, 121
adrenocorticotropic hormone
measurement 2925
amino acids 89
aminoacidogram 2761
ammonia 106
anion gap 2540, 2541
carnitine 89
cell malignancies 208, 216
fatty acids 121
glucose 187
concentrations 187
estimation 568
haptoglobin 2003
hemopexin 2003
lactate 89
dehydrogenase 2002
magnesium 279
membrane carnitine transporter 120
methionine 99
osmolality 249
phosphate, low levels of 2542
phytanic acid 130
pipecolic acid 130
porphyrins 198
potassium 2542
reduction of 274
proteins 204, 1031
reabsorption phase 1571
renin 2925
therapies 332
total fatty acid, analysis of 121
transfusion 2104
Plasmalogen synthesis 129
Plasmid mediated metallo-beta-lactamase 1318
Plasminogen activator inhibitor 2045, 2048f
Plasmodium. See Malaria
falciparum 1585, 1587, 3335, 3523
malaria 1593b, 2021
parasite, appearance of 1591f
trophozoite of 1591f
life cycle of 1587
vivax 1587, 1590f, 1966f
Plateau pressure 347, 351f, 352, 707, 708f
Platelet 1469, 2046, 2067, 2072
activation 2046
adhesion 2046
aggregation 2046
aggregometry 2085
concentrate 586
count 2099
derived growth factor 1913f
desialylation 2075
destruction 2072
disorders 2052t
dysfunction 2054, 2087fc, 2573
estimation 2069
flow cytometry 2086
function
analyzer 2085
defect 2054t, 2084, 2086
test 2085, 2085t
granules 1954t
inhibition 2045
release of 1954
rich plasma aggregation 2085
secretion assays 2086
transfusion 2081, 2104, 3117
risks of 592, 592b
Platybasia 2775
Platynychia 1992
Pleomorphic adenoma 1774
Plethoric face 562f
Pleural fluid cytology 2210
Pleural rub 2118
Pleural tuberculosis 1430
Pleurodynia 1533
Plexiform neurofibroma 3369f
Plexus lesion 2583
Plummer-Vinson syndrome 1993
Pluripotent hematopoietic stem cell 1948, 1953f
Pneumatic dilatation 1782
Pneumatosis intestinalis 604, 605f, 606, 764f
Pneumococcal conjugate vaccine 1116, 1167, 1168, 1212, 1214
Pneumococcal diseases 1375, 1376
Pneumococcal infections 1377
specific therapy of 1377
Pneumococcal polysaccharide vaccine 1167, 1212
Pneumococcal vaccine 1125, 1167, 1172
administration of 2526
Pneumocystis 1623
carinii 1546
pneumonia 1548, 1549
infection 1679
specific therapy of 1679
jirovecii 1308, 1650, 1678, 3285
pneumonia 2213
prophylaxis 1987
Pneumocystis pneumonia 1678, 1679f
treatment of 1680t
Pneumolysin 1376
Pneumomediastinum 725, 725f, 726, 2215
Pneumonia 15, 355, 693, 712f, 717, 729f, 1169, 1376, 1548f, 1696, 2202, 2216, 2665
acute 1673
bilateral 1386f
classification of 2202
clinical features of 1703
community acquired 2202, 2204t, 2206, 2209
complications of 2205
development of 2203t
diagnosis of 1668
global action plan for 2208
Pneumonic plague 1403
Pneumopericardium 726, 726f, 605f, 2215
Pneumothorax 339, 380f, 693, 717, 721, 722f, 723, 2213, 2214
asymptomatic 723
causes of 2213t
clinical presentations of 2214
diagnosis of 2214
drainage 724f
Poikilocytosis 577f, 2026f
Point-of-care screening tests 200
Poiseuille's law 1880
Poisoning 365, 371, 372, 382
diagnosis of 368t
Poisonous mushrooms, characteristic of 387t
Poisonous snake 394
Polar cataract
anterior 3240
Polar migration 2475
Polio 29
elimination status 1536f
end game strategies 1136
eradication 1099
and endgame strategic plan 1136
strategy for 1538
vaccines, schedule of 1137
Poliomyelitis 1536, 1538, 2676, 2776
prevention of 1538
Poliosis 3399f
Poliovirus 668, 1529, 1536
vaccines 1134
Polyangiitis 211, 2509, 25122514, 3187, 3188
Polyaromatic hydrocarbons 1430
Polyarteritis nodosa 1332, 2512, 2514, 3179, 3182
diagnosis of 3182b
Polyarthritis 2403
Polyarticular juvenile idiopathic arthritis 3152
Polychromasia macrocytosis 2004
Polycoria 3259
Polycystic kidney disease 2519
adult-onset 80
Polycystic morphology 1269, 1270
Polycystic ovarian syndrome 1224, 1227, 1263, 1266, 1269, 1271, 1271t, 2936, 2958, 2959
Polycythemia 188, 190, 508, 563, 564, 571, 580
association of 581b
clinical manifestations of 581b
etiology of 581b
Polydactyly 2498
Polydipsia 2546
Polyendocrinopathy 215, 2928
syndrome 2927, 2928
Polyenes 1647
Polyethylene glycol 372, 1805, 3608
Polyglandular syndromes 2924
Polyhexamethylene biguanide 1604
Polymerase chain reaction 68f, 648, 662, 1310, 1345, 1373, 1392, 1401, 1411, 1420, 1487, 1497, 1532, 1572, 1581, 1610, 1634, 1644, 1660, 1686, 1700, 1877, 1939, 1972, 2011, 2587, 2677, 2680, 2745, 2952
Polymeric formulations 1084
Polymicrobial infections 1350
Polymicrogyria 893f, 2613, 2614, 2619, 2623, 2623f
Polymorphism 38
Polymorphonuclear leukocytes 1669, 2586
Polymorphonuclear neutrophil 2587
Polymyositis 209, 211, 1946
Polymyxin B 3610
Polyneuritis cranialis 2805
Polyploidy 38, 59
Polyps 1898
Polyribosylribitol phosphate polysaccharide 1209
Polysaccharide vaccine 1101, 1159, 1181, 1378
Polysomnography 943, 2159, 2248, 2588, 2591, 2838
Polysplenia syndrome 2314f, 2317
Polysymptomatic enuresis 2500, 2501
Polythene occlusive wraps 484
Polyunsaturated fatty acids 99, 1825
Polyurethane 288
Polyuria 2539, 2547, 2878, 2879
causes of 2879t
Polyvalent polysaccharide vaccine 1378
Polyvinyl chloride 288
Pompe disease 86, 88, 90, 136, 172, 177, 178f, 179, 2285, 2286f, 2835
infantile 177
infantile-onset 2812
late-onset 177
severity of 177
Ponseti method 3438
Pontocerebellar hypoplasia 2619
Poor vision, diagnosis of 3207fc
Popliteal angle 473, 473f, 629f
Popliteal pterygium syndrome 1769f
Porencephalic cyst 690f
Pork tapeworm 1635
Porphobilinogen 194, 197, 198
Porphyria 70, 194. Also See Acute intermittent porphyria
acute 195, 196fc, 197t
laboratory investigations in 195
classification of 194
cutanea tarda 194, 197, 198
Porphyrin 2485
Porta hepatis 2258f
Portal colopathy 1884f
Portal fibrosis 1913
Portal hypertension 1844, 1880, 1881t, 1882, 1882b, 1887, 1890t, 1892, 1893t, 1912, 1961
causes of 1882f
complications of 1883t
Portal hypertensive
gastropathy 1884f
group 1911f
Portal lobule 1758
Portal tract 1862
Portal vein 1893
branch 1862f
left branch of 1881f, 1892
right branch of 1881f
Portal venous system 1756
Portal venous thrombosis 1880, 1892
Porto criteria 1825
Portosystemic anastomoses 1880
Portosystemic encephalopathy 1931
Portosystemic shunt 109, 2401
Port-wine stain 3320, 3372f
Posaconazole 1648, 1650
POSHAN Abhiyaan 1242
Positive airway pressure therapy 946, 2162
Positive end-expiratory pressure 332, 347349, 351, 351f, 352f, 354, 355, 357f, 358f, 469f, 702f704f, 707, 740f, 746
loss of 621
Positive pressure ventilation 342, 468
Positron emission tomography 190, 959, 978, 1340, 2119, 2602, 3044
Possible severe bacterial infection (pSBI) 632
Post liver transplant 1845
Postasphyxia management 682
Postchiasmatic lesion 2591
Postdischarge nutrition 516
Postenteritis syndrome 1733
Posterior capsular cataract 3242
Posterior capsule defect 3243f
Posterior circulation stroke 2709f
etiology of 2709
Posterior corneal
defect 3228
cataract 3240, 3240f
Posterior embryotoxon 3214
Posterior epistaxis, site for 2125f
Posterior fossa anomalies 2710
Posterior gastric vein 1881f
Posterior hypospadias 776
Posterior keratoconus 3228
Posterior lens capsule 3242f
Posterior lenticonus 3218, 3242, 3242f
Posterior mitral leaflet 2412
Posterior polar cataract 3242
Posterior pole granuloma 3235
Posterior reversible encephalopathy syndrome 2710, 3176f
Posterior sagittal anorectoplasty 768
Posterior subcapsular cataract 3242
Posterior urethral valve 656, 778, 779, 779f, 2491, 2495, 2495f
Posterior uveitis 3234, 3236
Posthemorrhagic ventricular dilatation 684, 690
Postinfectious chronic diarrhea 1741, 1748
Postinfectious cough 2140
Postinfectious glomerulonephritis 2506, 2507, 2511f
Postinflammatory hypopigmentation 3328
Postinjury care 1257
Post-kala-azar dermal leishmaniasis 1596, 1597f, 1598
Post-kasai portoenterostomy 1901
Postmaturity 522, 524
syndrome 523, 524f
Postnatal growth retardation 869
Postnatal resuscitation 755
Postnatal rubella 1482
infection 1482
Postnatal ultrasound 780
Postneonatal mortality rate 9
Postoperative intestinal adhesive obstruction 1833f
Postpartum depression 481
Postpartum infection 665
Postpartum intrauterine contraceptive devices 3514f
Postpolio syndrome 1537
Postremission therapy 3028
Postresuscitation care 333
Postsplenectomy infection 2034
Poststreptococcal glomerulonephritis 1380, 1381
Poststreptococcal reactive arthritis 1379, 1382
Postsynaptic syndromes 2846
Post-transplantation immune-reconstitution 230
Post-traumatic headache 2661
Post-traumatic stress disorder 983, 1251
Post-tricuspid admixture lesions 2390
Postural clubfoot 3438
Postural kyphosis 3423
Postural orthostatic tachycardia syndrome 2657
Postvaricella arteriopathy 2707
Potassium 273, 993, 2551
chloride 3610
cotransporter 672f
excretion of 273
extrarenal wasting of 2544
homeostasis 273
hydroxide 1224, 1277, 1655, 1677
physiology, basics of 273
replacement 2970
salt 288
transcellular shift of 273
Potocki-Lupski syndrome 39, 66
Pott's paraplegia 2673
Pott's spine 2673
Pouch sign 749
Poverty index 28
Povidone-iodine 2505
PPE. See Personal protective equipment
PPHN. See Persistent pulmonary hypertension
Prader-Willi syndrome 49, 5153, 66, 67f, 2249, 2836, 2873, 2933, 29552957, 2960, 2988, 2990, 2990f
Pradhan Mantri Jan Arogya Yojana 464, 464t
Pradhan Mantri Matru Vandana Yojana 3515
Praziquantel 2685, 3610
Prazosin 409, 2560
Preadoption 3489
Prealbumin 1867
Prebiotics zinc 637
Prebiotics, role of 516, 1728, 1752
Precocious puberty 2906, 2908, 2909t, 2910
Precordium 2263
Precursor anogenital lesions 1197
Prednisolone 288, 1928, 3610
Pre-existing posterior capsule defect 3243
Pre-exposure prophylaxis 1166, 1179
Pregnancy 83, 1142, 1484
acute fatty liver of 120
associated plasma protein A 63, 540, 541
medical termination of 2609
termination of 2289
Prehypertension 64
Preimplantation genetic diagnosis 80
Premarital counseling 1288
services 1225, 1288
Premature eruption 845
Premature menarche 2909
Premature pubarche 2908
Premature red cell destruction 2002
Premature thelarche 2908
Prematurity 14, 503, 532, 763
apnea of 507, 518, 699t, 945
Prenatal steroids 615
Preplus disease 608
Prerenal acute kidney injury 2528
Preschool wheeze 2188, 2189
Pressure controlled ventilation 358f
Pressure immobilization method 400, 401f
Pressure support ventilation 352, 356, 705, 705f
Pressure ulcers 3310
Pressure volume
curve 350f
loops 356
Pressure waveform 356
Pressurized metered dose inhalers 2199
Presumed ocular histoplasmosis syndrome 1676
Presynaptic syndromes 2846
Presyncope 2857
Preterm birth 502
complications of 506b
Preterm erythropoietin neuroprotection trial 691
Preterm formula 514
Preterm intrauterine growth restriction, problems of 509
Preterm labor 532
Preterm low-birthweight infants 518b
Preterm milk 488
Preterm neonate 466, 503f, 504
Preterm premature rupture of membrane 447f, 532, 598
Pretricuspid admixture lesions 2390
Preventive chemotherapy 1630
Preventive therapy 1444, 2189
Priapism 2016, 3031
Primaquine 3610
Primary adrenal insufficiency 88, 188, 2926
Primary amebic meningoencephalitis 1604
Primary amenorrhea 1264
diagnostic evaluation of 1265fc
Primary autoimmune cholangitis 209
Primary autonomic disorders 2859
Primary biliary cirrhosis 209, 213, 1869
Primary carnitine deficiency 70, 108, 120, 188
Primary ciliary dyskinesia 2129, 2141, 2229, 2231
Primary coccidioidomycosis 1669
Primary congenital glaucoma 3248
Primary cutaneous histoplasmosis 1676
Primary dysmenorrhea 1267
Primary esophageal anastomosis 750
Primary gastric B-cell lymphoma 1419
Primary headache disorders, diagnosis of 2659
Primary hyperaldosteronism 2557
Primary hypothyroidism 870
Primary immunodeficiency disorders 217, 227229, 233
diagnosis of 215t, 227
management of 227
Primary infundibular stenosis 2342
Primary lactase deficiency 1741
Primary liver tumors 1942
Primary lung abscesses 2243
Primary lymphoid organs 203
Primary mediastinal B-cell lymphoma 3051, 3054
Primary megaureter, diagnosis of 2494
Primary microcephaly 2611, 2613, 2617
Primary monosymptomatic enuresis 2500
Primary myelodysplastic syndrome 1978
Primary myoclonus dystonia 2718
Primary neurologic disease 150
Primary obesity 858
Primary optic atrophy 3257f
Primary osteoporosis 2984
Primary peptic ulcer disease 1795
Primary polydipsia 2501, 2881
Primary prophylaxis 1680
Primary pulmonary hypertension 2277f
Primary pulmonary stenosis 2270
Primary sclerosing cholangitis 1826, 1869, 1912, 1918
Primary spontaneous pneumothorax 2213
Primary vasculitis 2512
Primary ventricular septum 2254
Primitive heart tube, formation of 2252
Primordial dwarfism 52
Prism under cover test 3267
Probiotics zinc 637
Procainamide 288, 317
hydrochloride 3611
Procaine penicillin 3611
Procalcitonin 605
Procedural sedation. See Sedation
Processed food 1005, 1089
Prochlorperazine 2662, 3611
Procrastination 1287
Progesterone challenge test 1265
Progressive disseminated histoplasmosis 1676
Progressive dominantly inherited ataxias 2729
Progressive dystonia 113
Progressive external ophthalmoplegia 122, 123
Progressive familial intrahepatic cholestasis 18671869, 1872, 1874, 1875, 1878, 1911, 1912, 1914, 1917, 1920, 1931
Progressive macular hypomelanosis 3329
Progressive myoclonic epilepsies 2721
Progressive recessively inherited ataxias 2727
Progressive varicella 1499
Prohormone convertase 2989
Proinflammatory cytokines 204
Prokinetic agents 1786
Prolactin 2913
Proliferating cell nuclear antigen 211
Proliferation, disorders of 791
Proliferative diabetic retinopathy 2972
Proliferative glomerulonephritis 2486, 2506
Proline 93
synthesis
defects 91
disorders of 101
Promethazine 409
hydrochloride 3611
Prominent costochondral junctions 2553
Prominent petechiae 1391
Pro-opiomelanocortin 858, 2916
deficiency 2990
Prophylactic antibiotics 229, 1378
Prophylaxis 280, 2407
against
infective endocarditis 2415
rabies 423
tetanus 423
therapy 2631
Propidium iodide 215
Propionibacterium 3274
acnes 2422
Propionic acidemia 85, 108, 114, 115, 188, 202
Propionyl-CoA
carboxylase 112, 114
metabolism 115f
Propofol 364
Proportionate 2612
short stature 64
Propranolol 2560, 2662, 3611
Prosaposin deficiency 152
Prostacyclin 733, 2045f
synthase 728f
Prostaglandin 697, 1330, 1334, 2366, 2379, 2482
infusion 2373
Prostanoids 2399
Prostate 1229
Prostatitis 1229
Prosthetic device-related infections 1386
Prosthetic valve sounds 2265
Protease inhibitor 1558
Proteasome-associated autoinflammatory syndromes 3201
Protection of Children Against Sexual Offences (POCSO) Act 1260, 34773479
Protein 258, 511, 648, 990, 1244, 1731, 2485, 2586
digestibility corrected amino acid score 991
digestion of 1731
efficiency ratio 991
excretion 2486
glycosylation abnormalities 83
hormones 2864
kinase genes 2546
losing enteropathy 150, 1817
malabsorption, tests for 1812
metabolism 1863
replacement 90
requirement 1086
restricted diet 98
serum levels of 138
specific flow cytometric assays 215t
types of 396
Protein C deficiency 2089
Protein energy malnutrition. Also See Severe acute malnutrition 901, 1017, 1033, 1037, 1073, 1429, 1713, 1869, 3360
spectrum of 1033
Protein S deficiency 2089
Proteinase 3 2514
Protein-losing enteropathy, causes of 1817b
Protein-O-mannosyltransferase 2 2623
Proteinuria 161, 162, 2486, 2488, 2507, 2514, 25182521, 2525, 2530, 2556, 2574
asymptomatic 2519
detection of 2519
evaluation of 2486t
non-nephrotic range 2518
presence of 2517
quantification of 2518t
Proteus mirabilis 223, 644
Proteus syndrome 48
Prothrombin time 99, 166, 586, 740f, 855, 1411, 1527, 1867, 1911, 1919, 2053, 2090, 2099
international normalized ratio 1920
Prothrombinase complex 2056
Proton-pump inhibitor 1420, 1785
Protozoa 205, 1302
Protozoal infections 1584
Protracted bacterial bronchitis 2142
Proximal esophageal motility disorders 1779
Proximal hypospadias 777f
Proximal interphalangeal joints, arthritis of 3149f
Proximal renal tubular acidosis 2539, 2541, 2542
etiology of 2540b
Prune Belly syndrome 777, 778f, 2955
Prurigo nodularis 3332
Pruritus
management of 1876
treatment of 1926
Pseudallescheria boydii 1649, 1650
Pseudoachondroplasia 3447, 3448f
Pseudoautosomal inheritance 47
Pseudocoarctation 2344
Pseudo-Cushing syndrome 2933
Pseudo-Darier sign 3306
Pseudodeficiency 138
Pseudodominant autosomal recessive inheritance 45f
Pseudoephedrine 3611
Pseudo-Gaucher cells 152
Pseudogynecomastia 2912
Pseudohermaphroditism 2523
Pseudo-Hurler polydystrophy 135
Pseudohyperkalemia 276
Pseudohypoglycemia 188
Pseudohypoparathyroidism 49, 2875, 2933, 2977
Pseudoinfantile Refsum disease 129
Pseudokidney sign 1837
Pseudomonas aeruginosa 223, 639, 1318, 1321, 1394, 1395, 1395t, 1396, 1398, 2134, 2238, 2243, 2425, 3228, 3305
infections, treatment of 1396t
virulence factors of 1394t
Pseudomonas dermatitis 1395
Pseudomonas infection 430f, 1320, 13941396, 1397f
treatment for 2232t
Pseudoneonatal adrenoleukodystrophy 129
Pseudopapilledema 3259
Pseudoparalysis 3409
Pseudophakic glaucoma 3252
Pseudopseudohypoparathyroidism 2977
Pseudoregression 2763
Pseudorhizomelic chondrodysplasia 129
Pseudostrabismus 3262
causes of 3263b
Pseudotumor cerebri 2704b
classification of 2704t
syndrome 2703
diagnostic criteria for 2704b
Pseudotumors 2058
Psoriasis 3304, 3377, 3379
clinical variants of 3378
treatment of 3379t
Psoriatic arthritis 3130, 3153
Psychiatric disorders 947, 2661
symptom of 987
Psychoanalytic theory 1228
Psychodynamic therapy 1252
Psychoeducation 920
Psychogenic cough 2142
Psychogenic nonepileptic seizures 2656, 2656t, 2657
Psychogenic vomiting 1775
Psychological disorders 986f
Psychometric tests 1933
Psychomotor retardation 152
severe 2524
Psychopathology, assessment of 934
Psychosexual development, stages of 1228
Psychosis, autism 983
Psychosocial development 1231, 1233
Psychosocial health 3473
Psychosocial interventions 856, 962
Psychosocial management 393
Psychotherapy 1282t
Pterin cofactor deficiencies 86
Pterin-4-alpha-carbinolamine dehydratase deficiency 97
Ptosis 178, 398f
bilateral severe congenital 3211f
Puberphonia 949
Pubertal development 1264
physiology of 2899
Pubertal disorders 849
Puberty 865, 1226, 2897t
and sexual maturity rating 1226
assessment of 1226
early 1272
normal 2897
progression of 2900
Puberty precocious. See Precocious puberty
Pubic hair 2908
development 2900, 2901
Pulmonary activated-related chemokine 153
Pulmonary air leaks 720, 721
Pulmonary alveolar proteinosis 2221, 2221f
Pulmonary angiography 2092
Pulmonary arterial hypertension 2270, 2306, 2325, 2334, 2336, 2395, 2396, 2398, 2398b, 2410
management of 2400t
Pulmonary arteriovenous
fistula 2278f, 2383, 2384
malformations 2384
Pulmonary artery 2251, 2266, 2298f, 2320, 2335f, 2338f, 2352, 2356, 2395, 2472
banding 2470
indications of 2473
hypertension 2356, 2400, 2401f
pressure, estimation of 2397
shunt procedure 2367
Pulmonary aspergilloma 1660
Pulmonary atresia 2266, 2295, 2344, 2356, 2358, 2361, 2465
Pulmonary blastomycosis 1673
Pulmonary blood flow 2273, 2326f, 2340, 2356, 2357, 2369, 2373, 2374
Pulmonary cryptococcosis 1661
Pulmonary disease 1460, 1662
Pulmonary disorders 721
Pulmonary edema 406, 506, 1589
management of 409
Pulmonary exacerbation 2232
treatment of 2232t
Pulmonary function test 179, 2119, 2176, 2192, 2397
Pulmonary gas exchange unit 737f
Pulmonary hemorrhage 509, 635, 693, 735, 736b, 739, 739f, 2514
incidence of 735f
management of 740f
pathogenesis of 737f
signs of 736t
symptoms of 736t
Pulmonary hemorrhagic syndromes 2221, 2223, 2225
Pulmonary hydatidosis 1640
Pulmonary hypertension 729, 280, 2223, 2266, 2352f, 2395, 2395b, 2397f, 2398f, 2401f, 2410, 2414
Pulmonary hypoplasia 151, 693, 2163, 2164
Pulmonary interstitial emphysema 724, 725f, 2215
Pulmonary lymphoid tissue hyperplasia 1549
Pulmonary mucormycosis 1682
Pulmonary nocardiosis 1416
Pulmonary paragonimiasis 1633
Pulmonary protein surfactant dysfunction, pathophysiology of 2220f
Pulmonary regurgitation signals 2365f
Pulmonary sequestration 2163, 2165
Pulmonary stenosis 2266, 2270, 2293, 2339, 23562358, 2360, 2365f, 2378, 2379, 2390, 2465
Pulmonary tuberculosis 1327, 1430
Pulmonary valve 2410
balloon dilatation of 2341f
stenosis 2473
Pulmonary vascular markings 2320, 2373
Pulmonary venous hypertension 2388, 2410
severe 2277f, 2411f
Pulse 996
oximetry 593, 601fc, 695, 2326
saturation 347
screening 599
rate 1043, 2262
age-related cut-offs for 2262t
Pulsed-field gel electrophoresis 1309
Pulseless electrical activity 315, 316, 316f, 438
Pulseless ventricular tachycardia 314316, 316f
Pulsus alternans 2262
Pulsus paradoxus 2118, 2262
Punctate cataract 3242
PUO. See Pyrexia of unknown origin
Pupils 2581
Pupillary abnormalities 3259, 3260
Pupillary light reflex 2581
Pupillary reactions 2581
Pure gonadal dysgenesis 1265
Pure red cell aplasia 1542
Purified chick embryo cell vaccine 1164, 1507
Purified protein derivative 1459
Purified vero cell vaccine 1507
Purine nucleoside phosphorylase 229
Purpura 1036
fulminans 1391, 2089f
Purpuric rash 2513
Pursed lips 53, 53f
Purulent urethral discharge 1277f
Pus aspirate 1397
Push endoscopy 1899
Pustular eruptions 3302
Pustular lesions 639
Pustular psoriasis 3378f, 3379
Pyelonephritis 2486, 2562
Pyloric antrum, musculature of 1787
Pyloric atresia 759
Pyloric muscle thickening 1787f
Pyocephalus 648f, 649f
Pyoderma 1379, 2665
gangrenosum 3201
Pyogenic arthritis 3201
Pyogenic brain abscess 2690f
Pyogenic cervical spine infection 3416
Pyogenic infection 3416
Pyogenic liver abscess 1902
Pyramidal signs 152
Pyramidal system 2582
Pyrantel pamoate 3611
Pyrazinamide 1440, 1446
Pyrexia of unknown origin 1488
Pyridoxal-5 phosphate 94, 2766
dependent epilepsies 2760
Pyridoxine 86, 90, 674, 1053, 1245, 2760, 3611, 3362
deficiency 1054
responsive seizures 70
Pyrimethamine 1587
sulfadoxine 3611
Pyrimidine 5’-nucleotidase 2037
Pyrin domains 204
Pyrogens
endogenous 1330
Pyrogens, exogenous 1330
Pyrroline carboxylate synthase deficiency
cutis laxa phenotype 101
spastic paraparesis phenotype 101
Pyruvate carboxylase 85, 169fc
deficiency 108, 170, 188
Pyruvate decarboxylase deficiency 2761
Pyruvate dehydrogenase 89, 1936
complex 166, 211, 169fc
deficiency of 170
deficiency 85, 108, 2761
Pyruvate kinase 576, 1992
deficiency 2005, 2006, 2037
Pyruvoyl-tetrahydropterin synthase deficiency 97
Q
Q fever 1581, 1685
Quadrivalent influenza vaccine 1185
Quadrivalent meningococcal conjugate vaccines 1181
Quadruple marker 63t
Quadruple therapy 1421
Quantifying membrane proteins 2034
Quantitative fluorescent-polymerase chain reaction 58
Quantitative stool acid steatocrit test 1811
Quantitative sudomotor axon reflex test 2856
Quantitative sweat measurement system 2856
Queensland tick typhus 1688
Quick-Wee method 2561
Quinidine 3612
Quinine
dihydrochloride 3612
salt 1594
sulfate 3612
Quinolones 1371, 1424
Quinsy 2156
Quinupristin 3612
Quorum sensing 1318, 1394
R
Rabies 1505, 1506
diagnosis of 1506
encephalitis 2676
exposure, categories of 1165b
immunoglobulin 1165, 1507
infection, transmission of 1506
vaccines 1125, 1164
virus 1505, 2677
Rabson-Mendenhall syndrome 2958
Raccoon eyes 3072f
Rachischisis 786
Rachitic rosary 1061f
Radial pulse 2262
Radiant warmers 485, 485f
Radiation 483, 3002, 3507
endocrine effects of 3000
therapy 3060
Radiofrequency 2454
ablation 2456
Radioisotope studies 2118
Radiology 635, 2340, 2350, 3137, 3138
Radionuclide
cystography 2488, 2564
imaging 780, 1813
renogram 780f
scintigraphy 2488
Radiosensitivity 3017
Radiotherapy 1211, 3045, 3074, 3081, 3096, 3102
Radioulnar synostosis 2070, 2084
Radius, epiphysis of 849f
Ragged red fibers 124
Ragged-doll appearance 178f
Raghib's defect 2324
Raised intracranial pressure 418, 1936, 2672, 2693, 2697, 2699, 2700fc
Raised violaceous vasculitis 435f
Rajiv Gandhi National Creche Scheme 3515
Ramipril 2304
Rampant caries 1764f
Random donor platelets 2104
Randomized controlled trials 20, 20f, 486, 722, 1162, 1292, 1750
Ranitidine 3612
Ranula 1774
Rapid antigen detection test 1520, 2147, 2148
Rapid diagnostic test 1355, 1590, 1597, 2696
role of 1591
Rapid eye movement 942, 942t, 2120
Rapid plasma reagin 666
Rapid urease test 1419
Rapidly progressive glomerulonephritis 2509, 2510
causes of 2509b
Rapid-onset obesity 2248, 2249, 2862
Rare coagulation disorders 2055, 2065
Rare congenital muscular dystrophies 2834
Rash 1332b, 2505, 2676
evolution of 1497
types of 1511
Rashtriya Bal Suraksha Karyakram 80, 448, 521, 611, 919, 1223, 3518
Rashtriya Kishor Swasthya Karyakaram 1247, 1280, 1293, 1296, 3518, 3518f
Rasmussen encephalitis 2640, 2747
Rat bites 423
Raval's vineland social maturity scale 920
Raynaud phenomenon 3158, 3193f, 3365
Reactive arthritis 3129
Reactive infectious mucocutaneous eruption 3353
Ready-to-use therapeutic food 1040, 1044
Recalcitrant pneumothorax 724
Recognized epileptic encephalopathies 2636b
Recombinant antithymocyte globulin 1987
Recombinant erythropoietin 580
Recombinant influenza vaccine 1183
Reconstructive surgery 906
Rectal biopsy 1805, 1809
Rectal examination 1808
Rectal prolapse 1856, 1857
Altemeier classification of 1856b
Rectovaginal fistula 769, 770f
Rectum 766f
Recurrent acid reflux 1783
Recurrent aseptic meningitis 1502
Recurrent aspiration 2185b
Recurrent asthma 1623
Recurrent bacterial infections 1550
Recurrent constipation 1807
Recurrent cough 2142
Recurrent depressive episodes 1252
Recurrent ear infections 88
Recurrent episodic hemiparesis 2710
Recurrent epistaxis 2126
etiology of 2126f
Recurrent fever 3201
Recurrent hypoglycemia 188, 191fc
Recurrent malaria 865
Recurrent otitis media 2134, 2138
Recurrent parotitis 1772, 1773
Recurrent pneumonia 2216
Recurrent respiratory infection 2163, 2166
Recurrent rhabdomyosarcoma 3096
Recurrent tonsillitis 2155
causes of 2155b
Recurrent urinary tract infection 2556, 2565
risk factors for 2565b
agglutination 1700f
distribution width 574, 579, 1967, 1970t, 1993
enzyme defects 2035
folate levels 2000
fragmentation 2004
hemolytic disorders, classification of 1977b
precursors 1964f
transfusion 578, 2102
volume distribution width 1953, 1976
Red filter test 3267
Red reflex test 3221, 3263
Reductive adaptation 1039
Redundant scalp skin 2614
Reed-Sternberg cells 3043
Re-emerging viral infections 1469
Re-entrant tachycardias 2442
Refeeding syndrome 1088
Reflex 2818
seizure 2632
Reflux 1785
esophagitis 1796f
nephropathy 2540, 2558, 2566
Refraction 3222, 3282, 3294
drugs used for 3224t
Refractive errors 3219, 3221, 3224
Refractive esotropia 3265
Refractive surgery 3225
Refractory anemia 3037, 3038
Refractory ascites 1848
Refractory constipation 1807
Refractory cytopenia 3037, 3038
Refractory enuresis 2504
Refractory epilepsy 2644
Refractory Mycoplasma pneumoniae pneumonia 1701
Refractory rickets 2539, 2553, 2554, 2555fc
Refractory sideroblastic anemia 1998
Refractory status epilepticus 2647, 2648, 2651
Refsum disease 129, 131, 132, 3288
infantile 128130
Regulatory T-cell defects 222
Regurgitation 476, 1775
Rehabilitation 2061, 2713, 3298
Relactation 494
Relapse 1366
brucellosis 1407
tumors 1944
Relapsing fever 1410, 1411
timeline of 1410f
Relapsing hepatitis 1542
Remdesivir 3612
Renal adaptation 459
Renal agenesis 64, 773, 2490
bilateral 2490
Renal angina index 2530
Renal anomalies 64
Renal artery 2481
stenosis 2557
Renal biopsy 2521, 2530
electron micrograph of 2517f
indications for 2507b
Renal calculi 2549, 2552
etiology of 2551
procedure for 2552t
Renal complications 1354
Renal cyst 280, 2499
Renal cystic diseases 2498
Renal disease 87, 1512, 2518, 2556, 2875, 3165
end-stage 161, 2527
progression of 2511
Renal dysfunction 2517
Renal dysgenesis 2490
Renal dysplasia 774
Renal epithelial cell 2498
Renal failure 87, 102, 136, 280, 1589, 2461, 2545, 2608
advanced 266, 2540
Renal function
deterioration of 2487
test 367, 1523, 1734, 3137
Renal hypoplasia 2494
Renal involvement 161, 3159, 3186
Renal lump 2491
Renal osteodystrophy 2573
Renal papilla 2497
Renal parenchyma, loss of 2491
Renal replacement therapy 332, 2530, 2533
Renal scintigraphy 2488
Renal static imaging 2488
Renal stones 2488, 2551b
Renal system 1032, 2017, 3292
Renal transplantation 2538, 2575, 2576
Renal tuberculosis 1433
Renal tubular acidosis 265, 276, 803, 2539, 2540, 2542, 2542t, 2543
etiology of 2540b
Renal ultrasonography 2530, 2563
Renal vein thrombosis 2090, 2557
Renin-angiotensin aldosterone system 251, 1845, 1883, 2482, 2574, 2917
Renotubular syndrome 2540
Renovascular disease 2558
Renovascular hypertension 2560
Reoxygenation 3017
Repetitive behaviors 971
Repetitive nerve stimulation test 2588, 2786, 2804
Replacement fluids 257
Replogle tube 750
Reproductive health 1223, 1226, 2921. See RMNCH+A
disorders, screening for 1224
Reproductive organs, development of 1226
Reproductive sexual health education 1222
Reproductive system, development of 2945, 2945fc
Reproductive tract infections, management of 3513
Reservoir 1403
Residual paralysis 1537
Resistant depression, treatment of 1252
Resistant tumors 1944
Resistin 859t
ReSoMAL 1042t
Respiration
anatomy of 2107
muscles of 2109
physiology of 2107
Respiratory acidosis 261, 263
causes of 263t
treatment of 263
Respiratory alkalosis 261, 264
causes of 264, 264t
Respiratory care 528, 2800
Respiratory chain disorders 89
Respiratory cycle 351
Respiratory disease 1532, 1701, 2107
Respiratory disorder 2116
diagnosis of 2116
Respiratory distress 151, 339, 466, 563, 564, 693, 1589, 1833
assessing severity of 694
cardiac causes of 694t
clinical signs of 339b
syndrome 447f, 506, 528, 535, 538, 539, 620, 686, 693, 685, 695b, 706, 717, 719
Respiratory disturbance index 2160
Respiratory epithelial cells 1471
Respiratory failure 336, 2498
etiology of 337, 337b
Respiratory function, assessment of 2838
Respiratory insufficiency, early signs of 2836
Respiratory management 2234, 2699
Respiratory muscle weakness 2807
Respiratory rate 366, 471, 474, 707, 1043, 1569, 2111, 2111f, 2180f
cut-off 2173
normal 300t
Respiratory regulation 259
Respiratory secretions 1469
Respiratory support 381, 510, 713, 718, 2181, 2815
equipment 619
Respiratory syncytial virus 1314, 1358, 1471, 1472, 1699, 2170, 2177, 2180, 2216
Respiratory system 597, 598, 1314, 1691, 2510
development of 2163
examination 695
Respiratory tract 251, 1386, 1468
findings 2676
infection 1514, 1521, 2216, 2523
injury
signs of 426b
symptoms of 426b
Restriction fragment length polymorphism 1310, 2011
Restrictive cardiomyopathy 2434, 2435
etiology of 2435b
Resuscitation 305f, 417, 423
discontinuation of 469
initial steps of 467
Reticulocytes 1972f, 1993
count 1967
specific hemoglobin content 1968
Reticulocytosis 2536
Reticuloendothelial system, Warthin-Finkeldey cells of 1475
Retina
avascular peripheral 614f
Retinal abnormalities 2518
Retinal detachment 3281
Retinal dialysis 3281, 3281f
Retinal dystrophy 861f
Retinal edema 3281
Retinal necrosis
acute 3285
Retinal tears 3281
Retinal trauma 2591
Retinitis 2676
pigmentosa 40, 48, 88, 122, 123, 2498, 2591
Retinoblastoma 30833085, 3086t, 3089t, 3090t, 3091f
advanced manifestations of 3086f
familial 3087f
myriad clinical manifestations of 3085f
Retinoblastoma, management of
bilateral 3088
Retinoic acid 2605
Retinol 1245, 3361
Retinopathy of prematurity 462, 507, 518, 607, 609f, 610, 610f, 611, 611f, 612, 614, 614f, 626, 745, 3255
classification of 608
incidence of 623
score 614
screening 611, 613, 623
termination of 613
tetcam-assisted 613f
Retractile testis 782
Retrobulbar neuritis 3258
Rett syndrome 73, 975, 975t, 976, 976t
revised diagnostic criteria for 977b
Reverse Potts shunt 2399
Reverse-transcriptase-polymerase chain reaction 1506, 1514
Revesz syndrome 1980
Revised National Tuberculosis Control Program 1439, 1442
Revised neuromyelitis optica spectrum disorder 2737t
Rewarming shock 439
Reye syndrome 108, 113, 1930, 1935, 2693, 2698
RGA scoring system 1687t
Rh incompatibility 5512
Rhabditiform larvae 1621
Rhabdomyolysis 86, 2529
Rhabdomyosarcoma 1774, 3093t, 3094f, 3095
tumor node metastasis staging of 3095t
Rhesus 573
incompatibility 551
Rheumatic aortic valve disease 24162419
Rheumatic arthritis 3129
Rheumatic chorea, signs of 2405f
Rheumatic diseases 2510, 3128t
management for 3141
Rheumatic fever 2271, 2403, 2408t, 2410, 2412, 2415
chronic 2404
diagnostic criteria for 2406t
recurrence of 2413, 2415
Rheumatic heart disease 1380, 1382, 2271, 2409, 2411, 2411f, 2412, 2412f, 2413f, 2416, 2425
Rheumatic mitral stenosis 2414f
Rheumatic mitral valve disease 2411t
differential diagnosis of 2412t
pathology of 2410t
Rheumatic valve disease 2410t, 2412, 2415
clinical features of 2409
Rheumatic valvulitis 2406b
Rheumatoid arthritis 209, 795, 1332, 2462
Rheumatoid factor 208, 3133
types of 209, 209t
Rheumatologic disorders 3128, 3133, 3137t, 3292
Rhinitis 2143
medicamentosa 246
Rhino-orbital-cerebral mucormycosis 1682, 1682f
Rhinosinusitis, diagnosis of 2151
chronic 2150, 2153
Rhinoviruses 1314, 1529
Rhipicephalus sanguineus 1688f
Rhizomelic chondrodysplasia punctata 87, 89, 128131, 131f
Rhizopus arrhizus 1681
Rhizopus homothallicus 1681
Rhizopus microporus 1681
Rhombencephalitis 1532
Rhythmic movement disorder 2655
Rib notching 2274
Ribavirin 1471, 3613
therapy 1582
Riboflavin 993, 1052, 1245, 3361
deficiency 1053
Ribonucleic acid 35, 36f, 42, 122, 210, 211, 634, 1066, 1145, 1207, 1430, 1467, 1471, 1479, 1493, 1540, 1543, 1754, 1977
polymerase 37f
single-strand of 36f, 662
Ribonucleic protein 209
Ribonucleoprotein 211
Ribonucleotide 1989
Ribose-5-phosphate isomerase deficiency 166t
Ribosomal ribonucleic acid 37, 1379, 1607, 1634
Rickets 97, 1061, 1063, 2554, 2875, 2980, 2980f, 2981t
laboratory diagnosis of 2555t
pathophysiology of 2980fc
staging of 1061
Rickettsia 1302, 1688
prowazekii 1695, 1696
typhi 1697
Rickettsial disease 1685, 1687
classification of 1685t
Rickettsial infections, diagnosis of 1685, 1686fc
Rickettsial spotted fevers 1692
Rickettsialpox 1692b
Rickettsioses, laboratory diagnosis of 1698
Rifampicin 1440, 1446, 1448
resistant tuberculosis 1446
Rift valley fever 1580
Right aortic arch 2361
Right atrial hypertrophy 2266
Right coronary artery 2361
Right pulmonary artery 2320
Right ventricular function, assessment of 2397
Right ventricular hypertrophy 2283, 2284f, 2320, 2339, 2350, 2351, 2357, 2358, 2360, 2363f, 2398
Right ventricular outflow tract 2289f, 2364f, 2443
obstruction 2270, 2360
Riley-Day syndrome 2859
Risdiplam 2813
Risk-taking behavior and injuries 1256
Risser sign 3419
Ristocetin 2086
induced platelet aggregation 2065
Ritonavir 288, 1558, 3602, 3613
Rituximab 2080, 2523, 2524, 3146
Rizatriptan 2662
RMNCH+A 3513
RMNCH+A strategy 1296
RNTCP guidelines for TB 1441, 1442
Road traffic injuries 1257, 1258
Robertsonian translocation 65
Robinow syndrome 2951
Rochalimaea quintana 1685
Rocker bottom foot 3458
Rocky mountain spotted fever 1688, 1689, 1691
Rodenticide poisoning 384, 385
Roger syndrome 2959
Rolandic epilepsy 2639
Romanowsky stains 1308
Romberg's sign 2580
Romiplostim 2079
Rooting reflex 475, 475f, 490, 2584
Rosai-Dorfman disease 3103, 3108, 3109f
Rosenberg-Patterson criteria 1658
Roseola infantum 1486, 1487
Roseola infections 1485
Ross heart failure classification, modified 2300t
Rotational thromboelastometry 2106
Rotavirus 1172, 1468, 1708
diarrhea, pathogenesis of 1708
infection, pathogenesis of 1708f
vaccine 1116, 1125, 1172, 1173
Rough endoplasmic reticulum 133f
Routine cranial ultrasonography 623
Routine vaccination, schedule of 1144
Roxithromycin 288, 3613
Royal College of Obstetricians and Gynaecologists 557
Royal College of Paediatrics and Child Health 1525
Rozrolimupab 2080
RPGN. See Glomerulonephritis, rapidly progressive
RTA. See Renal tubular acidosis
Rubella 662, 1152, 1477, 1482, 1483, 2039, 3284
acquired 1482
infection, differential diagnosis of 1484t
antibodies 1483
cataract 3241, 3241f
congenital 1483f
elimination 1155
infection 663, 1482
syndrome 52, 662, 663, 663f, 1105, 1152, 1483f
clinical features of 1483t
prevalence of 1154
vaccine 1152
targets for 1154
virus 455, 1152, 1482, 2076, 2675
Rubeola 1120, 1484
Rubinstein-Taybi syndrome 53, 54f, 2614, 2619, 2620
Rumination 936, 937, 1775
Russell's viper 395f, 396
Russell-Silver syndrome 49, 870
RUTF. See Ready-to-use therapeutic food
S
S1. See First heart sound
S2. See Second heart sound
S3. See Third heart sound
S4. See Fourth heart sound
Saccadic eye movement disorder 137
Saccadic pulses 3271
Saccharomyces boulardii 1752
Saccharomyces cerevisiae 1816
Sacroiliitis 3151f
Saddleback fever 1578
S-adenosylhomocysteine 99
hydrolase 98, 99, 99f
S-adenosylmethionine 99
Safe injection practices 1108
Saksenaea erythrospora 1681
Salbutamol 3613
Salicylate 2485
poisoning 376, 377
features of 377b
Salivary antibacterial property 1763t
Salivary gland
benign neoplasms of 1774
cystic lesions of 1773
diseases 1772
classification of 1772t
minor 1772
Salmeterol 3613
Salmon patch 3319
Salmonella bacteremia 1369, 1370
Salmonella enterica 1363
Salmonella gastroenteritis 1369
management of 1370
Salmonella infections 1368t
Salmonella meningitis 1369, 1370
general characteristics of 1370
treatment of 1371t
Salmonella organisms, nomenclature for 1368t
Salmonella typhi 1539
Salmonella typhimurium 1585
Salt and pepper retinitis 53
SAM. Also See PEM
SAM. See Severe acute malnutrition
Sample registration system 443
San Joaquin fever 1665
Sandal gap 60
Sandhoff disease 133, 141
Sandifer's syndrome 2654
Sanfilippo syndrome 182
Sanger sequencing 2952
Sano score 234
Sappinia diploidea 1605
Saprobic cycle 1664f
Sapronoses 1303
Saquinavir 288, 3613
Sarcoid uveitis 3235f
Sarcoidosis 3235
Sarcopenia 1915
SARS-COV-2
infection 1515
vaccine products, storage conditions for 1119
Saturated fatty acids 999
Saw-scaled viper 395f
Scabies
infantile 3316, 3317f
Scalar waveforms 351f
Scalp 3310
psoriasis 3379
Scapula, winging of 2785f
Scarf sign 473, 473f, 629f
Scarlet fever 1381, 1381f, 1484
Scarring alopecia, classification of 3396fc
Scattered nuclear debris 2512
Scheie syndrome 182
Scheuermann disease 3423
Scheuermann kyphosis 3424
Schilling test 1736
Schimke immuno-osseous dysplasia 220
Schistocyte 1977b
Schistosoma
egg of 1643f
haematobium 1643
intercalatum 1643
japonicum 1643
life cycle of 1643f
mansoni 1585, 1643, 1644
Schistosomiasis 1643, 1644
chronic 1644
Schizencephaly 2623
Schizophrenia 454
Schmidt syndrome 2928
Scholastic deterioration 1286b
School health programs 3519
Schwann cells 3071
Scleral injuries 3280
Sclerema neonatorum 641, 3304
Sclerocornea 3214, 3227
Scleroderma 209, 3131, 3191, 3366
classification of 3191t
facies 3193f
syndromes 3193
Sclerosing cholangitis 1918
Sclerotherapy 1887, 1896
Scoliosis 178, 750f, 2581, 3418, 3423
congenital 3420, 3421, 3422t
classification of 3418b
clinical features of 3418
Scorpion antivenom 406, 409
Scorpion sting 404, 408
envenomation, mechanisms of 407fc
local manifestation of 406t
systemic manifestations of 407t
Scorpion venom, composition of 404
Scott syndrome 1898t
Screening test 891, 1821, 1966, 2036
Scrotal pain 1277
Scrotal swelling 781f
Scrotum 777f
physiologic hyperpigmentation of 3301
Scrub typhus 1693, 1694
Scrum pox 1502
Scurvy 1056, 1057f, 1058
clinical manifestations of 1057t
radiological signs of 1057
skeletal manifestations of 1058, 1058t
SDG. See Sustainable development goals
Seashore sign 723f
Seasonal influenza 1183, 1185t
vaccines 1182
Sebaceous hyperplasia 3302
Seborrhea 1224
Seborrheic dermatitis 3304, 3332, 3398, 3398f
infantile 3304f, 3398f
Seckel syndrome 52, 53, 54f, 869, 2614
Second heart sound 2178, 2264
Secondary adrenal insufficiency 188, 2929
Secondary amenorrhea 1265
Secondary autoimmune hemolytic anemia 2040
Secondary bacterial infection 2179
Secondary brainstem dysfunction 2608
Secondary carnitine deficiency 188
Secondary congenital glaucoma 3250
Secondary dysmenorrhea 1267
Secondary energy failure 677
Secondary hypertension 2557
Secondary hypocalcemia 2548
Secondary immune deficiencies 213
Secondary lactic acidosis 85
Secondary lactose intolerance 1741
Secondary lymphoid organs 203
Secondary neurologic disease 150
Secondary obesity 858
Secondary optic atrophy 3259f
Secondary osteoporosis 2985, 2986
Secondary peptic ulcer disease 1795
Secondary pulmonary hypertension 345
Secondary sclerosing cholangitis 1912, 1918
Secondary spontaneous pneumothorax 2213
Second-generation
antiepileptic drugs 2645
cephalosporin 1424
oral antihistaminics 2130
tyrosine kinase inhibitor 3034
Second-line antitubercular drug 1446
Secretory diarrhea. Also See Diarrhea 1708, 1732t
approach to
chronic 1737
pathophysiology of 1709f
Secretory immunoglobulin A 1763
Sedation 360, 361b, 730, 2699
levels of 360, 360t
Seizures 86, 136, 152, 196, 670672, 1542, 1715, 2524, 2632, 2634, 2726, 2759
categories of 2633
causes of 670, 2759
classification of 2633, 2633t
diagnosis of 2634
disorders 84, 2610
generation 671
history 673
management 976
mimics 673
prevention 2642
treatment of 2642
type 672, 2759
Seldinger technique 2293
Selected neurodegenerative disorders 2770
Selective IgM deficiency 215t
Selective insulin resistance 3004
Selective intrauterine growth restriction 532
Selective serotonin reuptake inhibitors 980982
Selenium 1074
deficiency 3363
Self-awareness 1290
Self-disclosure 1282
Self-efficacy 1236
Self-harm 1261
Self-inflating bag 469f
Self-stimulatory behavior 2654
Sella turcica 142f, 184f
Seminal vesicles 1229
Semipermeable membrane 250f
Sengstaken-Blakemore tube 1896f
Sensorineural deafness 279, 280, 2516
Sensorineural hearing loss 178, 274, 661, 924
Sensorium 2579
Sensory examination 2583
Sensory impairment 900
Sensory stimulation 1044
Sensory system examination 2583
Sentinel site surveillance 1099
Sepiapterin reductase 97
SEPN1-related CMD 2831
SEPN1-related myopathy 2828t
associated organ dysfunction 332t
causes of 330f
early-onset 633, 633f, 719
investigations for 712
late-onset 633, 634f
management of 510
screen 635
Septal aneurysm 2321f
Septal tricuspid leaflet 2324f
Septic arthritis 652, 653f, 654b, 654t, 1423, 3129, 3402, 3408, 3409, 3409f
clinical features of 653b
complications of 655b
prognosis for 654
ultrasound features of 654b
Septic shock 329, 334f, 1696, 2667
management of 332t
Septicemia 97
Septicemic plague 1403
Septo-optic dysplasia 2621, 2872
Septum
primum 2254
secundum 2254
Sequelae 614
Serine 93
biosynthesis disorder 2618
protease inhibitor kazal type 1 1802
synthesis defect 91, 92, 100
Seroconversion 1099t
Serological tests 1400, 1494, 1597, 1629, 1644, 1655
Seronegative rheumatoid arthritis 208
Seroprotection 1099t
Serositis
in SLE 3156t
Serotonin selective reuptake inhibitors 366, 1252t
Serous tuberculous meningitis 2670
Serratia marcescens 222
Sertoli cell 2913
Sertraline 1252
Serum albumin 1812
Serum alkaline phosphatase 1919, 1920
Serum ammonia 113, 1799, 1932
Serum ascites albumin gradient 1848
Serum aspartate transaminase 1908
Serum bactericidal antibody 1391
Serum bilirubin 1864, 1908
Serum ceruloplasmin 1867
Serum creatine phosphokinase 2592
Serum creatinine 2486, 2527, 2528
Serum electrolytes 89, 2630
Serum enzymes 3577
Serum estradiol 2909
Serum ferritin 1970, 1993
Serum globulins 1868
Serum glutamic
oxaloacetic transaminase 2818
pyruvic transaminase 2818
Serum iron studies 1970, 1993
Serum magnesium 2549
Serum pancreatic ribonuclease 1800
Serum phosphate, regulation of 2982fc
Serum proteins 1867
electropherogram of 232f
electrophoresis 216
Serum retinol 1023
Serum soluble transferrin receptor 1970
Serum total immunoglobulin E level 245
Sevelamer 3614
Severe acetabular dysplasia 3429f
Severe acquired aplastic anemia 1986
Severe acute hyperammonemia, emergency treatment of 109b
Severe acute malnutrition 1038, 1039f, 1040, 1040b, 1041b, 1041t, 1042, 1042fc, 1045
identification of 1038t
treatment of 1044t
Severe acute pancreatitis 1801b
Severe acute respiratory syndrome coronavirus 2 455, 1187, 1217, 1835
Severe asthma 1657
exacerbation, hospital management of 2197
Severe bacterial infection 632
Severe combined immunodeficiency 75, 205, 214, 215, 218, 219, 228, 229, 1678, 1743, 2077
defects 219
Severe congenital neutropenia 222, 1983
Severe nonproliferative retinopathy 2972
Severe pneumococcal infections 2535
Severe posterior nasal bleeding 2127
Severe recurrent hypoglycemia 568
Severe refractory lupus, treatment of 3166
Severe respiratory distress syndrome 694, 735
Sex chromosome
aneuploidy 62, 63t
disorders 2949
trisomies 62
Sex development 2948, 2949
differences of 2946
disorders of 46, 1226, 29442946 2948, 2950t, 2953
hormone important in 2945
ovotesticular disorders of 2950
Sex hormone binding globulin 1271
Sex steroids 802, 2909
Sexual abuse 412, 1224, 1273, 3485t
Sexual maturity rating 2900t, 2901t
system 1226
Sexual reproductive organs 1227
Sexually transmitted diseases 28, 643, 1223, 1270, 1390
Sexually transmitted infections 1224, 1229, 1274, 1277, 1279, 1280, 1392
management of 3513
SH2D1A deficiency 221t
Shagreen patch 43, 2750f
Shagreen plaque 3371f
Shake test 1119
Shaken baby syndrome 3229
Shawl sign 3364
Shenton line 3428
Shiga toxin 2535
Shigella dysentery 1716
Shigellosis 1714
Shock 188, 328, 328b, 329, 331, 334, 336, 1581, 1589
major etiologies of 329t
management of 1043fc
pathophysiology of 328fc
types of 329t
Shone's complex 2344, 2354
Short duration fever 1331
Short gut syndrome 1746
Short rib
dysplasias 3451
polydactyly syndrome 3451
Short stature 63, 136, 167f, 849, 864, 866f, 873, 2997, 2998
causes of 2997b
evaluation of 867fc
Short synacthen test 2924
Short-bowel syndrome 1815
causes of 1815t
Short-chain acyl-CoA dehydrogenase deficiency 119121, 188
Short-chain fatty acids 118, 1728
Shoulder
dystocia 527f
joint 653f
Shprintzen-Goldberg syndrome 3453
Shuttle hypothesis 2028
Shwachman-Diamond syndrome 1817, 1982, 2070
SIADH. See Syndrome of inappropriate secretion of ADH
Sialadenitis 1772, 1773
Sialic acid storage disorders 137
Sialidosis 3290
Sick euthyroid syndrome 2888
Sickle cell 1976, 2003
anemia 39, 1960, 2013f, 2540
crisis 2014
disease 41, 79, 80, 90, 1976, 2013, 2014t, 2015f, 2016f, 2019, 2091f, 2706
acute clinical complications of 2014t
chronic clinical complications of 2015t
genetic modulation of 2018f
manifestations of 2014
gene, prevalence of 2013f
retinopathy 3291
syndromes 2014
Sideroblastic anemia 70, 2543
Siderosis bulbi 3282
Sigmoid colon 766f
Sigmoid mesocolon 1755
Signet rings 1058
Sildenafil 733, 3614
Silicon 1076
Silver nitrate cauterization 2127f
Silverman Anderson score for respiratory distress 694t
Silver-Russell syndrome 52, 53, 2342, 2906, 2910
Simethicone 3614
Simian crease 60
Simple columnar absorptive cells 1757
Simple cysts 2499
Simple febrile seizures 2630
Simple meconium ileus 766f
Simple partial seizure 2635
Simpson-Golabi-Behmel syndrome 526
Single enzyme deficiency 129
Single fiber EMG (SFEMG) studies 2849
Single hypopigmented macule 3326
Single nucleotide polymorphism 40, 73, 89, 958, 1391
Single peroxisomal enzyme deficiency 129
Single seizure 2642
Single-gene disorder 42
Sinopharm COVID-19 vaccine 1193
Sinovac COVID-19 vaccine 1192
Sinus
arrhythmia 2281f
bradycardia 319f
histiocytosis 3108
of Valsalva 2338
tachycardia 320, 321f, 322t, 322, 2280f, 2442f, 2446
transillumination of 2151
venosus defects 2324
Sinusitis 1376, 2144, 2149, 2150, 2150b, 2192, 2509
complications of 2152
Sinusoidal endothelial cells 1863
Sinusoidal portal hypertension 1885t
Sitosterolemia 2070
Situs inversus 2275f, 2311f, 2313f, 2314f
Situs solitus 2275f, 2309f, 2311f2314f
Six-minute walk test 2398
Sixth aortic arch arteries 2256
Sixth nerve palsy 3265
Sjögren's syndrome 209, 211, 2540, 2542, 3292, 3389
Skeletal dysplasia 53, 86, 87, 872, 3439, 3440, 3441t, 3442t, 3444t, 3456, 3457
antenatal diagnosis of 3453
management of 3455t
radiologic assessment of 3443f
Skeletal fluorosis 1079, 1080
Skeletal immaturity 412
Skeletal maturity, assessment of 847
Skeletal muscle
analysis 124
relaxant 730
Skeletal tuberculosis 1432
Skewed X-inactivation 46
abrasions 1385
and soft tissue infection 1380, 1385, 1423, 1456
antisepsis 3309
bacterial infections of 3311b
barrier function of 3308
care of 466, 3308
changes 1035, 2733
contamination 109
discoloration 2502
disinfectant, choice of 635
disorders of 2510, 3217
fibroblast 124
infection 639, 2508
injuries 3310
invasion of 1468
involvement 3186
lesions 1616
patches 2968
pigmentary dilution of 3323t
prick test 213, 214, 244
problems 62, 3300
pustules 3201
rashes 1946
telangiectasia 3131f
temperature 483
Skin biopsy 2788, 3341
normal 2517
Skin disease
chronic 1385
Skinfold thickness 806, 1035
Skin-to-skin contact 466f, 477f
Skull 473
bone fractures 2687
computed tomography scan of 546
fracture 550
hot-cross-bun appearance of 1963f
Sleep
basic concepts 942
disorders 901, 942, 2661, 3501
management of 906
hygiene 947, 947t
medicine 942
myoclonus 2717
ontogeny 942
problems 976
state 697
walking 947
SLE. See Systemic lupus erythematosus
Slipped capital femoral epiphysis 3404
Slow transit diarrhea 1732
Slow-spike-wave 2634
Sly syndrome 72, 182, 183
SMA with congenital arthrogryposis and bone fractures 2811
Small bowel series 1736
Small chest syndromes 694
Small cysts 2498
Small fiber neuropathy 178
Small intestine 1757
bacterial outgrowth 1736
Small molecule tyrosine kinase inhibitors 3358t
Small perimembranous ventricular septal defect 2321f
Small platelets 2069
Small pneumothorax 2214
Small round cell tumors 3071f
Small vessel vasculitis 2513, 3183, 3189t
classification of 3184t
Smallpox 1217
vaccine 1098
Smith antigen 211
Smith-Lemli-Opitz syndrome 52, 53, 55, 56, 87, 87f, 89, 2614, 2619, 2951
Smith-Magenis syndrome 51, 56, 66
Smooth muscle
antibody 1939
cells, proliferation of 2396f
tumors 2517
Smooth surface caries 1764f
Snake envenomation 397b, 2800
Snake venom 395, 396t
Snakebite 394
envenomation 2529
induced thrombotic microangiopathy 399
Snellen chart 3222, 3271
Snowman appearance 2388f
Social anxiety disorder 983
Social cognitive theory 1235
Social communication disorder 949
Social development 883, 887, 888
Social learning theory 1228
Social media, effects of 1272
Social phobia 983
Social pragmatic disorders 950
Sodium 567, 993, 2482, 2551
benzoate 70, 99, 109, 1935, 3614
bicarbonate 3614
channel 2823
chloride 270
concentration of 269
diuresis 2979
dodecyl sulfate-polyacrylamide gel electrophoresis 1310
glucose linked transporter 1 1730
nitroprusside 2559, 3614
phenylacetate 70, 110, 3614
phenylbutyrate 110
picosulfate 3614
polystyrene sulfonate 2574, 3600
potassium-chloride cotransporter 672f, 674
pump failure 1708
regulation of 270fc
restriction of 1848
valproate 674, 2645
zirconium cyclosilicate 2574
Sodium diarrhea 1731
chronic 1731
Sofosbuvir 3601
Soft mist inhaler 2201
Soft tissue 2597
injuries 545
surgeries 3439
swelling 655f
tumors 3093
Solar refrigerators 1121
Solid-organ transplantation 1214, 2556
Solitary intestinal lymphoid tissue 1369
Solitary painless ulcer 1278f
Solitary plasmacytoma 216
Soluble liver antigen 1939
Soluble nonenzymatic lysosomal proteins 135
Soluble plasma transferrin receptor 1993
Somatic hypermutation 209
Somatic mosaicism 48
Somatization disorder 3129
Somatosensory evoked potential 2591, 2721
Somatostatin 1766
Somatostatinoma 1766
Somatotropes 2868
Somnambulism 947
Sonic Hedgehog pathways 2605
Sore nipples 493
Sore throat 2508
Sotos syndrome 53, 526, 875
South Asian ovalocytosis 2032
South Asian pneumococcal alliance 1099
Soya protein allergy 1745
Space of Disse 1863, 1913
Spasmus nutans 2654
Spastic hemiplegic cerebral palsy 901, 902f
Spastic infant toe-walking 893f
Spastic paraplegia 86
Spastic quadriparetic cerebral palsy 904f
Spastic quadriplegic cerebral palsy 901, 901f
Spastic torticollis 2654
Spasticity, management of 903
Special nutrition program 1093
Specific language impairment 949, 956
Specific learning disorder 954
Specific organ autoimmune disease 209
Specific phobia 983
Specific sleep disorders 945
Specimen collection 1307
Spectacle correction 3224
Speech 519
disorders 948
problems 900, 1770
sound disorder 949
therapy 903
Spermarche 2897t
Spermatogenic failure 47
Spherocytes 2003
Sphincter of Oddi 1758
Sphingolipidoses 156, 2763
Sphingolipids 134f
Sphingomyelin phosphodiesterase 156
Spider nevi 1914, 1914f
Spina bifida 786, 787, 2604
aperta 787f
occulta 788, 788f, 2604, 2607
Spinal accessory nerve 2582
Spinal canal stenosis 2775f
Spinal cord 784f, 2619
anatomy of 2773
compression 3116
causes of 3116b
disorders of 2773, 2775
dysfunction, effects of 2774t
injury 2586, 2776
lesions, clinical features of 2773
malformations 2604
pathology 2801
syndromes 2774t
tumors 2776, 2777, 2777t
Spinal deformity 3418
Spinal dermal sinus 2665
Spinal dysraphism 2566, 2607, 2608f
cutaneous markers of 3307
Spinal muscular atrophy 73, 79, 199, 694, 2779, 2785, 2787f, 28092811, 2813fc, 2814f, 2814t, 2836
disease-modifying therapy for 2813
molecular genetics of 2810f
Spinal neurocysticercosis 2683
Spinal paralytic poliomyelitis 1537
Spinal shock 329, 2583
Spinal stiffness 2836
Spinal tuberculosis 2673, 3425
Spinal tumor 3116f
Spine 474, 3400
selective involvement of 2836
Spinnaker sail sign 725f, 2215f
Spinobulbar muscular atrophy 47
Spinocerebellar ataxia 47, 2729, 2766, 2767
Spinothalamic tract 2583
Spiral septum formation 2255
Spirillum minus 1304
Spirometry values, interpretation of 2115t
Spironolactone 288, 2304, 3615
Spleen 145
enlargement 142f
palpation 2019
radioisotopic scanning of 2317
Splenectomy 70, 2034, 2080, 2081, 2998
complications of 2034
indications of 2028b
Splenic artery embolization 2081
Splenic smear, microphotograph of 1597f
Splenic syndromes 2317
Splenic vein 1880
Splenohepatomegaly 1965f
Splenomegaly 147, 152, 155, 159
Split renal function 2492
Spondyloepiphyseal dysplasia 184f, 3415
Sponging
for fever 1333
Spontaneous bacterial peritonitis 1847, 1848, 1892, 1930f
pathophysiology of 1847fc
prevention of 1849
Spontaneous breathing trials 356
Spontaneous circulation, return of 308, 315
Spoon feeding 513f
Sporadic 1302
Sporothrix schenckii 1647, 1649
Spot urine protein 2523
Spotted fever 330f, 1688
complications of 1691t
rickettsial infections 1687t
Sputnik V COVID-19 vaccine 1191
Sputum examination 2120
Squamous cell carcinoma 3230, 3396
Square wave jerks 3271
Square window sign 473f
SSPE. See Subacute sclerosing panencephalitis
ST segment 2283
St. Vitus dance 2404
Stabilization 300, 301, 414
Staccato speech 2584
Stadiometer 804
Standard deviation score 828, 867
Standard pediatric advanced life support 438
Stanford Binet-Kamat test 920
Stanford University Network for diagnosis of retinopathy of prematurity 614
Staphylococcal abscess 1385f
Staphylococcal infection 639, 1383, 1387, 1388b
Staphylococcal pyoderma 639, 640
Staphylococcal scalded skin syndrome 640, 640f, 1386, 3230, 3305, 3313, 3313f
Staphylococcal toxic shock syndrome 1387b, 1387f, 3313
risk factors of 1387b
infections 1385
Staphylococcus epidermidis 639
Starry sky appearance 2684
Status epilepticus 2635, 2647, 2649, 2649b, 2649f
classification of 2647b
etiology of 2648b
management of 2650
treatment of 2650t
Stavudine 3615
Steeple sign 2171, 2171f
Stem cell
factor 1948
infusion 230
niche 1948
source 230
therapy 74, 180, 2307
transplant 2968, 3028
Stepping down therapy 2195
Stereotactic brain biopsy 2679
Stereotypies 2654, 2720
types of 2654
Sternocleidomastoid muscle injury 3411
Sterile body fluid 1308, 1397
Sterile injection practices 1110
Sterilization 1302
Steroid 409, 1444, 1829, 2586, 2838
catabolism 2917
dependence 2520
eye drops 3238
hormones 2865
induced glaucoma 3253
resistance 2521
diagnosis of 2523
resistant nephrotic syndrome 2522, 2522t, 2523, 2524
sparing agents 2522
stress dose of 2527
use of 1453
Steroidogenesis pathways 2946fc
Steroidogenic acute regulatory protein 458
deficiency 2915, 2922
Steroidogenic pathway 2940t, 2946
Stevens-Johnson syndrome 1498, 1908, 3230, 3231, 3288, 3342, 3352, 3352f, 3352t, 3353, 3353t
STI. See sexually transmitted infection
Stickler syndrome 71
Stierlin sign 1843
Stiff person syndrome 2960
Still's disease 3233
Stomach 1757
aches 3
air bubble 2309f
congenital anomalies of 1786
Stomatitis 1992
Stones, types of 2549
Stoss therapy 1063
Strabismus 615, 2543, 3261, 3261b
assessment 3261
relevance of 3261
special forms of 3267
Strangulation 781
Stratosphere sign 723
Strawberry tongue 3180f
Streptococcal gangrene 1381
Streptococcal infections 983, 1379, 1382, 1383, 2406
nonsuppurative sequelae of 1381
treatment of 1382t
Streptococcal pharyngitis 1379, 1490, 2146f, 2148t
Streptococcal skin infections 640
Streptococcal tonsillopharyngitis 2407t
Streptococcal toxic shock syndrome 1381
Streptococcus 2513
agalactiae 646, 2587
faecalis 1379, 2561
hemolyticus 2889
mutans 1763, 1763f
pyogenes 1305, 1306, 1344, 2146, 2243, 3405, 3408
viridans 642, 1303, 1379, 1772
Streptogramin inactivating enzymes 1318
Streptomycin 1440, 1446, 2672, 3615
Stress 881, 1251
failure 737
overload 1285f
ulcer prophylaxis 332
Stridor 2118, 2168, 2169fc, 2170, 2517
differential diagnosis of 2169t
evaluation of 2121t
String sign 1843
Stroke 86, 136, 2632, 2705, 2758
episodes 83, 123, 127
etiology of 2710t
risk factor for 2556
volume 328
Strongyloides 1621, 1623
infection 1624
stercoralis 1621, 1622f, 1736
life cycle of 1622f
Strongyloidiasis 1621
chronic 1623
Structural chromosomal abnormalities 64
Structural heart disease 694, 2444, 2450
Structural scoliosis 3418
Struvite calculi 2552
Stunting 1035t, 1037, 3495t
Sturge-Weber syndrome 2749, 2755, 2755f, 2757, 3251, 3251f, 3289, 3320, 3371, 3372
Stye 3274
right lower eyelid 3274f
Subacute brucellosis 1407
Subacute cutaneous lupus erythematosus 3365
Subacute necrotizing encephalomyopathy 123
Subacute sclerosing panencephalitis 1476, 2588, 2767
Subacute thyroiditis 2889
Subaortic ventricular septal defect 2322f, 2390
Subarachnoid 2596
hemorrhage 547, 670, 2585
evaluation of 2593
neurocysticercosis 2683
Subclavian artery 2251
Subclinical brucellosis 1407
Subclinical carditis 2404
Subclinical hypothyroidism 2888
Subconjunctival cysticercosis 3236f
Subcortical cysts 2765
Subcutaneous emphysema 1386f
Subcutaneous fat necrosis 545, 641, 2978, 3304
Subcutaneous insulin therapy 2970
Subcutaneous nodules 2404
Subcutaneous tissue 2658
Subdural hemorrhage 547
Subepithelial invasion 1468
Subgaleal hemorrhage 546, 546f, 547
Subglottic hemangioma 2123, 2123f
symptoms of 2123
Subglottic stenosis 2122, 2123f
Subjective global nutritional assessment 1915
Submersion injuries 417419
Submucosal cleft palate 1770f
Submucosal fibroid 1267
Submucosal plexus 1756
Subpulmonary ventricular septal defect 2390
Subsequent epilepsy, risk of 2652
Substance abuse 15, 1250, 1252, 1253
cutaneous signs of 3357t
Substance use disorders 964, 1253
Substrate reduction therapy 138f, 139, 154
Subtelomere fluorescent in situ hybridization 2272
Subtelomeric deletions 55
Subtle seizures 672
Subtotal villous atrophy 1823f
Subvalvar aortic stenosis 2354
Subvalvar pulmonary stenosis 2342
Succinate dehydrogenase 124, 125f, 1989
Sucking 475
blisters 3303
reflex 490, 2584
Sucralfate 288, 3615
Sucrase isomaltase deficiency 170, 1815
Sucrose, role of 1763
Sudden cardiac death 2456, 2460, 2460b
Sudden infant death syndrome 90, 118, 119, 698, 1139, 2247, 2694
Sudomotor testing 2856
Suicide 1261
assessment 1262
Sulbactam 3585
Sulfadiazine 288
Sulfadoxine 1587
Sulfamethoxazole 1371, 1389, 1680, 3617
Sulfasalazine 288, 3143
Sulfur amino acid metabolism, disorders of 98
Sulfur granules, Gram stain of 1418
Sulfuric acid burns 431
Sulthiame 2645
Sumatriptan 3615
Sun exposure 1063
Sunshine deficit 2475
Superego 1231
Superfecundation 530
Superfetation 530
Superficial reflexes 2583
Superior mediastinal syndrome 3115
Superior mesenteric
artery 760, 761, 1756
vein 760, 761, 1880, 1930f
Superior oblique palsy 3266
Superior rectus muscle, traumatic avulsion of 3282f
Superior vena cava 457f, 458f, 2251, 2256, 2258, 2291, 2294
locations of 2324f
syndrome 3115
causes of 3115b
evaluation of 3115b
treatment of 3115b
Supernumerary digits 3307
Supernumerary nipples 3307
Supernumerary teeth 843, 844f
Super-refractory status epilepticus 2647, 2651
Supplement deficient enzyme 153
Supplemental oxygen 2162, 2181
Supplementary immunization activity 1150, 1116
Supplementary nutrition 29
Supportive care 139, 230, 331, 403, 527, 1679, 1692, 1716
Supportive therapy 229, 636, 714, 740, 1355, 1366, 1498, 1543, 1831, 3178
Suppurative arthritis syndrome 1392
Suppurative sialadenitis 1773
Supracardiac total anomalous pulmonary
venous drainage 2277f
Suprachiasmatic nucleus 2868
Supraclavicular fosse 861f
Supranuclear gaze palsies 2581
Supranuclear ophthalmoplegia 152
Suprarenal thoracoabdominal aortic involvement 3176f
Supratentorial primitive neuroectodermal tumor 3064, 3067f
Supratentorial tumors 3064
Supravalvar aortic stenosis 2353, 2354
Supraventricular tachyarrhythmias 2446b
Supraventricular tachycardia 320, 322b, 321f, 322t, 322, 2283, 2447, 2448f, 2453, 2456, 2458f
acute management of 2452
Surfactant 348, 720, 732
protein 710f, 2219
metabolism, disorders of 2221
replacement therapy 710, 714
indications of 1453, 1850
timing of 755
Surgical closure, indications for 2472, 2473
Surgical therapy 1267, 1424, 1786, 1856
Surgical valvotomy 2342
Surveillance
for congenital rubella 1485
for dengue 1574
for development 890
for Japanese encephalitis 1565
for vaccine preventable diseases 1098
of cerebral palsy 897f
of drug resistance 1321
of plague 1404
types of 1101t
Survivor motor neuron 2799
Susceptibility-weighted
angiography 2684
imaging 2689
Sustainable development goals 5, 2732
Sutural cataract 3242
Swallowed maternal blood syndrome 578
Swallowing
dysfunction 2184, 2187
fiberoptic endoscopic evaluation of 2186
reflex 490
Sweat 251, 3581
chloride test 3581
Sweaty feet odor 113
Swedo criteria 1382
Swelling 653f, 1277
Swine flu 1184
Swinging flashlight test 3260f
Swyer syndrome 1265
Sydenham chorea 2404
Sylvian fissures 2596f
Sympathetic fibers 1757
Sympathetic nervous fibers 2481
Sympathetic nervous system 2481, 2574
beta receptors of 2500
Symptomatic hypertension 196
Symptomatic hypoglycemia 567
Symptomatic lead poisoning, medical management of 3511
Symptomatic proteinuria 2519t
Synaptic syndromes 2846
Synchronized intermittent mandatory ventilation 704, 704f, 705f
Syncope 2460, 2856, 2657, 2859
cardiovascular causes of 2858b
diagnostic evaluation of 2859b
differential diagnosis of 2858b
episode of 2657
history of 2858b
Syncytial virus 3612
Syndrome of inappropriate antidiuretic hormone secretion 219, 1391, 1716, 2180f, 2881, 2937, 3144
Syndrome of inappropriate secretion of ADH 2881
Syndromic clefts 1768
Syndromic clubfeet, treatment of 3439
Syndromic ichthyoses 3385, 3389t
Syndromic obesity 2987, 2990
types of 2988t
Synergy 1350
Synpharyngitic hematuria 2510
Syphilis 643, 1275, 1278f, 1341, 2524
Syringe infusion pumps 619
Syringing technique 494
Syringomyelia 2775
Systemic autoimmune collagen vascular disorders 2462
Systemic autoimmune rheumatic disease 210, 211
Systemic autoinflammatory disorders 3198
Systemic disorders 188, 190, 1797, 2461
ocular manifestations of 3283
Systemic glucocorticoids 2181
Systemic hypertension 106
Systemic hypotension 506
Systemic inflammatory response syndrome 331b, 634
Systemic juvenile idiopathic arthritis 3152
Systemic lupus erythematosus 102, 209, 212, 221, 226, 275, 276, 1332, 1744, 1844, 20062008, 2040, 2071, 2075, 2213, 2462, 2506, 2515, 2540, 2960, 3130, 3137, 3155, 3159f, 3164, 3165, 3292, 3365, 3365f
management of 3163
Systemic mastocytosis 3341
diagnosis of 3341t
Systemic mucopolysaccharidosis Hurler syndrome 3228
Systemic rheumatic diseases 3171
Systemic scleroderma 3193
Systemic sclerosis 211
Systemic steroids 2197
Systemic vascular resistance 2306
Systemic vasculitis 2512
Systolic blood pressure 368, 1575, 2263
Systolic murmur 2265, 2265f
Szpilman clinical score 418
T
T wave 2285
Tache noire 1690
Tachyarrhythmias 320, 2442
genesis of 2442
Tachycardia 321f, 644, 2526
management of 322fc
mechanism 2444f
Tachycardiomyopathy 2442, 2443
Tachypnea 339, 1336
Tacrolimus 1928, 2523, 2524, 2577, 3616
Taenia asiatica 1635
Taenia saginata 1304, 1635, 1636f, 1637
Taenia solium 1635, 2682, 3236
life cycle of 2682
scolex of 1636f
Taeniasis 1636
summary of 1637
Takayasu aortoarteritis 2557
Takayasu arteritis 25122514, 3139, 3134, 3174, 3176f, 3177, 3177b
classification of 3175t, 3177b
types of 3175f
Talaromyces marneffei 1647
Talipes deformity 474
Tall stature 874, 877
causes of 874t
evaluation of 875fc
Tamm-Horsfall mucoprotein 2486
Tamm-Horsfall protein 2518
Tandem mass spectrometry 92, 96, 112, 124, 126, 192, 199, 1878, 1924, 2696
Tanner and Whitehouse method 848
Tanner's staging 2900t, 2901
Tapeworm diseases 1635
Tapeworm infections, transmission of 2685
Tar burns 431f
Tardive dyskinesia 2721
Target cell 1977b, 2004
Target disorders for carrier screening 78
Tartrate resistant acid phosphatase 153
Taussig-Bing syndrome 2390
Tay-Sachs disease 79, 88, 132, 133, 135, 136, 141, 143f, 911f, 2772, 3290
Tazobactam 3609
T-cell 218, 1955
activation 206
modulator of 3146
function 2520
lymphoblastic lymphoma 3051, 3051f, 3052
mediated macrophage activation and
delayed type hypersensitivity 206
receptor 205, 1955, 3015
excision circles 199
Td vaccine 1141
TdAP vaccine 1141
Teardrop ulcers 1602
Tearing
excessive 3208
Teen addiction severity index 1253
Teen screening questionnaire 1224b, 1225b
Teenage pregnancy 1224, 1272
problems of 1273b
risks of 1273
Teeth 2928
developmental disorders of 843
protrusion of 2024f
Teicoplanin 3616
Telangiectasia macularis eruptiva perstans 3341
Telecanthus 3210, 3210f, 3272
Telemedicine 1292
Telencephalon 2619
Tel-Hashomer criteria 225
Tellers visual acuity chart 3223f
Tell-tale signs 788f
Telogen 3395
Telomere 58
length 1981
Temper tantrums 937, 2543
Temperature monitoring devices 1122
Temple syndrome 49, 2910
Temporomandibular joint ankylosis 846, 846f
Tendo-achilles tendon 3150f
Tenosynovitis-dermatitis syndrome 1392
Tensilon test 2848, 2848f
Tension pneumothorax 2214
Tension-type headache 2658, 2659, 2663
diagnostic criteria for 2660b
Teratogens 2605
Teratoid rhabdoid tumor
atypical 3066f
Terazosin 2560
Terbutaline 3616
Tertiary lymphoid organs 203
Testicular enlargement
bilateral 2908f
Testicular feminization syndrome 1264, 1265, 1265t
Testicular sonography 2910
Testicular torsion 1853
Testis 777f, 3002
torsion of 1853, 1853f, 1854
Testosterone 2495, 2913, 2945, 2956
Testotoxicosis 2907
Tetanus 1360, 1361, 1425
complications of 1361b
differential diagnosis of 1361b
diphtheria 1120
and pertussis 1116
immunoglobulin 1362
prophylaxis 1212
reduced quantity diphtheria, and acellular
pertussis 1208
toxoid 447f, 660, 1120, 1125, 1212
vaccination 1362
vaccine components 1208
Tetany 2653
Tethered cord 788
Tetrabenazine 2721
Tetracycline 288
Tetrahydrobiopterin biosynthesis 97fc
Tetrahydrofolate 99, 1349f
Tetrahydrofolic acid 1998
Tetralogy of Fallot 229, 748, 2251, 2266, 2268, 2273, 2274, 2278f, 2295, 2298f, 2300, 2339, 23562358, 2360, 2360f, 2361, 2365f, 2366, 2465, 2466, 2472
Tetraploidy 38
Tetrasomy 38, 64
Tetravalent live attenuated dengue vaccine 1202, 1203
Tetravalent purified inactivated whole virus vaccine 1203
Tetravalent recombinant subunit protein candidate vaccine 1204
TGA. See Transposition of great arteries
Thai Red Cross Regimen 1166
Thalamic ventral intermediate nucleus 2725
Thalamocaudate groove 687f
Thalassemia 77f, 1965f, 1972, 1976, 2021, 2025, 2026b, 2026t, 2999b
intermedia 2024
major 70, 71, 1963f, 2024, 2091f
endocrine complications of 2997b
short stature in 2997, 2998
management, principles of 2025b
minor 2024, 2024t
screening and control 2030
Thalassemia major. Also See beta thalassemia
Thamnostylum luckowense 1681
Thelarche variant 2908
T-helper cells 237, 2521
Theophylline 372, 699, 3616
Therapeutic drug monitoring 1347, 1453
Therapeutic hypothermia 681, 681fc, 682
complications of 682b
Therapeutic lifestyle change diet 1005
Therapeutic monitoring 2966
Thermal injuries 3310
Thermal maintenance, incubator for 485f
Thermistor 483
Thermometer 483
Thermoneutral environment 483
Thermostable direct hemolysin 1720
Thiabendazole 3616
Thiamine 90, 993, 1052, 1245, 3361
deficiency 1052, 2461
responsive megaloblastic anemia 70, 1973, 1998
Thin basement membrane nephropathy 2517, 2517f
Thiopental 3616
Thiopurine S-methyltransferase 285
Thiosulfate-citrate-bile salts agar medium 1721
Third heart sound 2264
Third nerve palsy 3266, 3267, 3268f
Third-generation antiepileptic drugs 2645
Thirty-cluster survey 1104
Thoracic aorta, obstruction of 3176f
Thoracic kyphosis 2837
Thoracic lordosis 2837
Thoracic tuberculosis 1430
Thoracocentesis 723, 2119
Threadworm 1619
Three-M syndrome 870
Threonine 93
Threshold disease 608
Threshold effect 122
Thrifty phenotype 520
Throat swab 2147
Thrombin time 586
Thrombin-activatable fibrinolytic inhibitor 2045, 2046
Thrombocytopenia 62, 88, 89, 152, 155, 573, 590, 605, 1498, 2053, 2067, 2068fc, 2070, 2071, 2084, 2124, 2543, 3291
absent radii syndrome 1961, 1983, 2070
associated multiple organ failure 332
causes of 2054, 2069, 2069b
clinical manifestations of 2074
differential diagnosis of 2076t
duration of 2074
early-onset 592fc
etiology of 2074
late-onset 592fc, 2071
syndrome 1191
Thrombocytosis 2034, 3031
Thromboembolism 2034, 2415, 2706
Thrombolysis 2094, 2712
Thrombolytic therapy, indications for 2095b
Thrombomodulin 2536
Thrombophilia screening 2092
Thrombophlebitis 1946
Thrombopoiesis 1953
Thrombopoietic factor, production of 1953
Thrombopoietin 1953, 1954, 2078
receptor agonists 1987, 2077, 2079, 2082
Thrombosis 2034, 2094, 2526
Thrombotic disorders 2088, 2093
Thrombotic microangiopathy 399
Thrombotic thrombocytopenic purpura 1975, 1976, 20062008, 2068, 2069, 2072, 2076
Thumbprint sign 604
Thumb-sucking 935
habit 841f
types of 935
Thymidylate synthase 1651
Thymus 203
Thyroglobulin 1067
Thyroid 1080, 3001
antibodies 64, 2697
diseases 2941
disorder 62, 64
eye disease 3291
function 2883
tests 1737
gland 2867
development of 2882
functional maturation of 2882
hormonal concentrations 2888f
hormone 451, 1032
actions of 2882t
formation of 2883
physiology 2882
secretion of 2883
nodules 2894
nuclear imaging 2885
peroxidase 2696
radionuclear uptake of 2893f
stimulating hormone 64, 191, 200, 455, 482, 858, 870, 911, 1032, 1065, 1067, 12641266, 2621, 2865, 2891, 2892, 2905, 2913, 3001
receptor 2891f
storm 2893
ultrasonography 2886
Thyroid-stimulating hormone screening
primary 2890
Thyroidectomy 70
Thyroiditis 2884, 2889
Thyrotoxic emergencies 2893
Thyrotoxic periodic paralysis 2894
Thyrotoxicosis 2891
factitia 2893
Thyrotropes 2868
Thyrotropin-releasing hormone 2864, 2866
Thyroxine 90, 191, 802
binding globulin 2864
exogenous 2893
hormone 70
Tibial tubercle, osteochondrosis of 3434
Tibial tuberosity 3435f
TIBOLA 1688
Ticarcillin disodium 3616
Tick bite paralysis 2802t
Tick-borne
relapsing fever 1410, 1411, 1411t, 1412
spotted fevers 1688
Tick-borne relapsing fever. Also See Relapsing fever
Tick typhus 1691b
Tics 2654, 2655, 2719, 2721
Tidal volume 352
Tigecycline 1424
Tilted disk syndrome 3256
Tilt-table test 2855
Time constant 350, 703
Tinea capitis 3314, 3397, 3398
black dot type of 3397f
Tinea corporis 3314, 3314f
Tinea cruris 3314
Tinea incognito 3315, 3315f
Tissue 258
based assays 212, 216, 217
biopsy 1644
diagnosis 3077, 3136
dysoxia 329f
factor 2045, 2088
pathway inhibitor 2045
oxygen
consumption, determination of 328
delivery, determination of 328
plasminogen activator 2045, 2048f
total carnitine 121
transglutaminase 1738, 1819f, 1822
transplantation 71
Titmus fly test 3224f
Titratable acidity 259
T-lymphocyte 2520
mediated cytolysis 207
T-lymphopenia 215
Tobramycin 1318, 3616
Tocilizumab 1474, 2514, 3146
Todd's palsy 2709
Todd's paresis 2634
Toddler's diarrhea 1747
TOF. See Tetralogy of Fallot
Togaviridae 1482
Tolerable upper intake level 989b
Toll-like receptors 204, 1493, 1602
function 223
Tone, assessment of 2583b
Tongue
developmental disorders of 841
tie 842, 842f
Tonic-clonic seizure, bilateral 2634
Tonsillar diphtheria 1354
Tonsilloadenoidectomy 2157
Tonsillopharyngitis 2146
Tonsils 2154
adenovirus infection of 2154
asymmetric hyperplasia of 2155
Topical emollients, use of 641
Topiramate 674, 2639, 2645, 3617
Torsades de pointes 321f, 323
Torsion 2496
Torsional disk 3218
Torticollis 3411
causes of 3412
congenital 3412
differential diagnosis of 3412b
evaluation of 3413fc
Torula histolytica 1797
Total anomalous pulmonary venous
connection 598, 2266, 2387, 2388, 2393, 2472
drainage 2274, 2358, 2387
return 2266, 2465
Total anomalous systemic venous drainage 2389
Total arm paralysis 549
Total body
surface area burnt, assessment of 427
weight 248
Total cataract 3243
Total colonic aganglionosis 765f
Total energy expenditure 1086
Total goiter rate 1066
Total intracardiac repair 2367
Total iron binding capacity 1967, 1970, 1993
Total leukocyte count 1908, 2786
Total lung capacity 2115f
Total parenteral nutrition 108, 512, 584, 606, 634f, 686, 690, 1086, 1870
Total serum bilirubin 553, 555, 556, 560, 1864
Total white cataract 3243f
Tourette's syndrome 2655
Tourniquet test 1567
Toxic epidermal necrolysis 3342, 3352, 3352t, 3353t
Toxic ingestions 266
Toxic shock syndrome 1124, 1342, 1379, 1385, 1386, 3314
Toxidromes 366t
Toxin 1342
mediated disease 1386
Toxocara canis 1304, 3285
Toxocariasis 3285
Toxoplasma 2524
gondii 455, 663, 664, 925, 1304, 1305, 1586, 1676, 1797, 2076, 3235
Toxoplasmosis 3285
clinical features of 664
congenital 664, 664f
other agents, rubella, cytomegalovirus, herpes simplex 53, 555, 556, 673, 791, 1877, 2071
retinochoroiditis 3235f
T-piece resuscitator 469f
Trabeculations 2495
Trace elements 992, 1073, 1087, 2630
Trachea, subglottic narrowing of 2171f
Tracheal bronchus 2167, 2168f
Tracheal diverticulum 2167
Tracheal stenosis 2123, 2123f
Tracheobronchial foreign body aspiration 2245
Tracheobronchial tree patterns 2313
Tracheoesophageal fistula 694, 748, 695, 749f, 750, 750f, 751f, 751t, 2122, 2121, 2141, 2163, 2164f, 2216
Tracheomalacia 751, 2163, 2167, 2168f
Tramadol 3617
Transarterial chemoembolization 1946
Transcatheter palliation 2367
Transcatheter therapy 2323
Transcatheter treatment 2293
Transcatheter valve implantation 2295
Transcobalamin deficiency 88, 89, 1997
Transcranial Doppler 2020, 2697, 2711
Transcription 35
Transcutaneous bilirubinometry 556
Transependymal edema 1667f
Transesophageal echocardiography 2313, 2423
Transfatty acids 999
Transfer ribonucleic acid 37, 127
Transferrin receptor 1990f
Transferrin saturation 1970
Transforming growth factor 72, 1602, 1948
Transfusion transmitted infections 2025
Transglutaminase antibody 1737
Trans-Golgi network 132, 133f
Transient aplastic crisis 1511
Transient disorders 3374
Transient elastography 1921f
Transient erythroblastopenia 1975, 1976
Transient hyperammonemia 109
Transient hypoglycemia 187
etiology of 188b
Transient hypoparathyroidism 2977
Transient hypothyroidism 2885
Transient ischemic attack 161, 2705
Transient myeloproliferative disorder 62
Transient neonatal diabetes 2959
Transient neonatal hyperparathyroidism 2978
Transient neonatal pustular melanosis 3302
Transient proteinuria 2519
Transient reticulated pigmentation of the newborn 3300
Transient respiratory distress, causes of 696
Transient tachypnea 598, 693, 695, 712f, 716, 717, 717f, 719
Transillumination of chest 722f
Transjugular intrahepatic portosystemic shunt 1848, 1889, 1892
Translocation 65
Transmission electron microscopy 2230
Transplacental therapy 2289
Transplacental transmission 1306
Transport disorders 1997
Transport incubators 619, 619f
Transport system 463, 618
Transposition of great arteries (TGA) 694, 2251, 2274, 2278f, 2339, 2368, 2372f, 2377, 2378, 2378f, 2379fc, 2471, 2471t
corrected transposition of 2285, 2383, 2385
dextro-transposition of 2266, 2315
D-transposition of 2357, 2358, 2465, 2467
L-transposition of 2358
Transthoracic echocardiography 2321, 2423
Transtubular potassium gradient 2487, 2541, 2542, 2545
Transudate 2209
Transverse myelitis 2737, 2807
acute 2737, 2807
Transverse myelopathy 2774t
Trapezius weakness 2582
emergency care room 415f
epidemiology facts 411b
etiology of 411
Traumatic brain injury 949
Traumatic cataract 3280
with iridodialysis 3280f
Traumatic glaucoma 3253
Traumatic hyphema 3254f
Traumatic lumbar puncture 2666
Traumatic optic neuropathy 3281
Traumatic tap results 2586
Treacher Collins syndrome 1769, 3286
Trematode infections 1631
Tremors 673, 1036, 2721, 2734, 2772
types of 2719t
Trench foot 435
Trendelenburg gait 3431
Treponema pallidum 455, 641, 666, 1275, 1306, 1308, 1332, 1341
hemagglutination test 1277
particle agglutination tests 666
Triage 299, 413
assessment 299
classification 301t, 302
system, goals of 299b
Triallelic digenic inheritance 50f
Triamcinolone 2522
Triamterene 3617
Tricarboxylic acid cycle 118
Trichinella 1624
spiralis 1304, 1624
cysts 1624f
Trichinellosis. See Trichinosis
Trichinosis 1624, 1625, 1625f
ocular manifestations of 1625
summary of 1626b
Tricho-hepato-enteric syndrome 3323t
Trichomonas vaginalis 1274, 1275, 1586
Trichomoniasis 1275
Trichophyton 3314
schoenleinii 3397
Trichorrhexis nodosa 106
Trichosporon
asahii 1650
beigelii 1649
Trichotillomania 3396
Trichuriasis 1617, 1618
Trichuris trichiura 1584, 1617, 1619f
life cycle of 1618f
Tricuspid atresia 2280, 2285, 2285f, 2344, 2356, 2368, 2368f, 2370, 2370f, 2370t, 2371f, 2372f, 2373, 2373f, 2465
classification of 2369b
Tricuspid regurgitation 2266, 2303f, 2340, 2398
Tricuspid stenosis 2266, 2368
Tricuspid valve 2358, 2422f, 2465
atretic 2368f
attachment 2316f
ebstein's anomaly of 2384f
Tricyclic antidepressant 366, 368, 2504
Trifunctional protein 119
Trigeminovascular theory 2658
Triglycerides 89
Trilateral retinoblastoma, management of 3089
Trimethoprim 1371, 1389, 1680, 2605, 3617
Trinucleotide repeat disorders 47, 47t
Triphalangeal thumb abnormality 1979f
Triple A syndrome 2929
Triple marker assay 63t
Triploidy 38
Trisomy-21. See Down syndrome
Trisomy 38, 53, 55, 58, 62, 2951, 3285
Trivalent influenza vaccine 1185
Trivandrum development screening test 630, 894
Trophic feeds 512
Trophism 1471
Trophoblast 450
Trophozoite 1601f, 1606f
Tropical pancreatitis 1802
Tropical pulmonary eosinophilia syndrome 1627, 1629
Tropical sprue 1742
Tropomyosin-related kinase B 858
True hyperkalemia 275
Trümmerfeld zone 1058
Truncus arteriosus 2255, 2255f, 2380, 2381f, 2382, 2391, 2391f
Collett and Edwards classification of 2381f
surgical repair of 2382f
Trypanosoma cruzi infection 1585
Trypsinogen activation peptide 1800
Tryptase 238t
Tryptophan 93, 100, 111
hydrolase 1989
Tsutsugamushi triangle 1693
TT vaccine 1142
Tube agglutination 1310
Tuberculosis 3, 15, 240, 588, 865, 979, 1427, 1428, 1428f, 1438, 1440, 1443, 1445, 1446, 1449, 15481550, 1734, 1742, 1742f, 1743f, 1814, 1830, 1830f, 1840, 1846, 2141, 2142, 2216, 2669, 2925, 3283, 3416. Also See Antitubercular drugs, antitubercular therapy
burden of 1427
control of 1435
diagnosis of 1435, 1435b, 1436t, 1438, 1439
infection 1430
prevention of 1434
preventive therapy 1434, 1444
symptoms of 1435
Tubercular choroidal granuloma near macula 3234f
Tubercular lymphadenopathy 1841
Tubercular meningitis 1661, 2587, 2596f, 2597f, 2707f
Tubercular pericarditis 2439, 2440
Tuberculate macroconidia 1677f
Tuberculin
protein derivative of 1855
skin test 1429, 1435, 1550
units 1435
Tuberculoid leprosy 1463
Tuberculoma 2633, 2673f, 2685, 2685t
Tuberculous arachnoiditis 2674
Tuberculous encephalopathy 2670
Tuberculous enteritis 1841
Tuberculous meningitis 2667, 2669, 2670t, 2671, 2673
severity of 2670t
Tuberculous spinal osteitis 2776
Tuberculous uveitis 3234
Tuberous sclerosis 43, 71, 2750, 3327f, 3370, 3370t
complex 2749, 3289
diagnostic criteria for 2751b
Tubular atrophy 2511
Tubular cells 2553
Tubular disorders 2519, 2544, 2545t
Tubular esophageal duplications 749
Tubular fluid, reabsorption of 2482
Tubular function, assessment of 2487
Tubular hypoplasia 2344
Tubular injury 2529
Tubular proteinuria 2486, 2518
Tubulointerstitial nephritis 2543
Tubulopathy syndrome 97, 274, 279, 280
Tumbling E chart 3222
Tumor 1898, 2491, 3229
induced osteomalacia 2982
lysis syndrome 2485, 2529, 3114, 3114t
development of 3114b
treatment, principles of 3114b
necrosis factor 238f, 1330, 1355, 1391, 1428, 1510, 1644, 1715, 1830, 1928, 1954, 2098, 2986, 3038, 3200
alpha 646, 869, 1675, 1760, 1880, 1913, 2688
receptor-associated period syndrome 225, 226
node metastasis 1943
staging 3095t, 3096t, 3101t
pathology 3074
resection 1946
types of 2776
Tumor lysis syndrome 3114
Turner syndrome 38, 39, 46, 53, 60f, 63, 64t, 71, 872, 1264, 1265, 2903, 2949, 2956, 2960, 3285
clinical features of 63
Twenty-minute whole blood clotting test 398f, 402
Twin reversed arterial perfusion sequence 532
Twins. Also See Multiple gestations
anemia-polycythemia sequence 533
gestation 533
reversed arterial perfusion sequence 532
to-twin transfusion syndrome 518, 532
types of 530f
Two-finger chest compression technique 310f
Two-thumb chest encircling hand technique 310f
Ty21a vaccine 1158
Tympanic membrane 1330
examination of 2136f
Type B insulin resistance syndrome 2960
Type I hypersensitivity 237
Typhlitis 1423
Typhoid fever 1158, 1158f, 1363, 1363f, 1696
pathogenesis of 1364fc
severe, treatment of 1366t
vaccines 1158, 1159t
Typhoid encephalopathy 1365
Typhoid vaccine 1125
candidates pipeline 1160f
Typhoidal salmonellosis 1368
Typhus
nodules of Wohlbach 1689
pathophysiology of 1689fc
Typical adenoid facies 2156f
Typical iris coloboma 3205f
Typical myopathic facies 2795f
Typical percutaneous endoscopic gastrostomy tube 1085f
Typical scheuermann kyphosis 3424f
Tyrosine 93
catabolism, disorders of 97
hydroxylase 1989
kinase inhibitor 3034f
metabolism 97fc
Tyrosinemia 70, 71, 80, 97, 98, 1876, 1877
chronic form of 97
Tyrosinosis 188
U
UDP galactose-4-epimerase deficiency 168
UIP vaccination schedule 1114t
Ulcer 1895, 3228
Ulcerative colitis 212, 1484, 1623, 1736, 1746f, 1824, 1825, 1827, 1829, 1829t, 1830t, 1831, 3292
active 1828f
Ulcerative tissue infections 223
Ullrich congenital muscular dystrophy 2830, 2830f
Ulna, epiphysis of 850f
Ultra-high-performance liquid chromatography 92f, 95, 96f, 98f, 103f
Ultra-low temperature cold chain equipment system 1121
Ultrasonography 648, 754, 785, 1640, 1736, 1739, 1813, 1834, 1899, 1903, 2118, 2211, 2491, 2563, 2628, 3406, 3409, 3428
Ultraviolet rays 3508
Umbilical artery Doppler 540, 540f
Umbilical cord 644
blood banking 74
hernia of 770, 1850f
infections 643
Umbilical granuloma 771, 772f
Umbilical hernia 150f, 772, 1066f, 1849, 1850, 1850f
typical presentation of 1850f
Umbilical polyp 771
Umbilical sinus 771
Umbilical venous route 559f
Umbilical wall malformations 769
Unbalanced chromosomal abnormalities 64, 65
Uncomplicated malaria 1592
treatment regimes for 1592
Uncomplicated typhoid fever, treatment of 1366t
Unconjugated hyperbilirubinemia, causes of 552b
Underfill theory 1845
Under-five mortality 9
Undernutrition 1016, 1017, 2539
prevalence and etiology 1016
Underweight 1243
Undescended testes 780, 781, 2495, 2621, 2496
bilateral 2955f
Undulant fever 1405
Unfractionated heparin 2091, 2093f, 2093t, 2096
Ungual fibromas 3371t
Unilateral cataract 3236f
Unilateral cleft lip 1768f
Unilateral congenital simple ptosis 3273f
Unilateral hydroureteronephrosis 2495
Unilateral pneumothorax 720f
Unilateral retinoblastoma, management of 3091fc
Unilineage cytopenias 1982
Unilobar persistent pneumonia 2216
causes of 2216t
Uniparental disomy 42, 48
Uniparental heterodisomy 48
Uniparental isodisomy 48
Universal choking sign 310
Universal drug sensitivity 1442
Universal Immunization Program 29, 1125, 1162, 1375
Universal precautions 1307
Unstable hemoglobin disorders 2010
Unverricht-Lundborg disease 2636
Upper airway 597, 598, 2117, 2120
cough syndrome 2141
instability 697
lesion 2121t
Upper esophageal sphincter 1779, 1781f
Upper eyelid 2581
Upper gastrointestinal bleeding 1882, 1894, 1896, 1902
age-wise etiological profile of 1895t
causes of 1894, 1894b
Upper gastrointestinal contrast study 750, 754, 760
Upper gastrointestinal endoscopy 391, 392t, 1745, 1777f
Upper gastrointestinal tract 1827
Upper lid
coloboma, congenital sideroblastic 3213f
eversion, congenital sideroblastic 3212
Upper limb pulses 2354
Upper motor neuron 127, 2780
Upper respiratory infection 1331, 2121, 2510
Upper respiratory tract 2120
anomalies 2120
congenital malformations of 2120
infection 1422, 1935, 2140, 2143, 3408
Uracil 36
Urea breath test 1419
Urea cycle 104, 105f, 106
defects 1930, 1935, 1936t
disorder 70, 83, 85, 89, 104, 109, 109t
diagnosis of 107fc
enzymes of 108
Ureaplasma urealyticum 654, 1275, 1699
Uremia 2054, 2498, 2693
Ureter 785
Ureteral stones 2550
Ureteric bud theory 773
Ureteric dilatation 780
Ureterocele 774, 774f
Ureteroscopy 2552
Ureterostomy 779f
Urethra 769f, 777f, 2494
Urethral discharge 1277, 1308
Urethral polyp 778f
Urethritis 1229
Uric acid 89, 91, 2486, 2550, 2551
production 2549
Uricosuria 2543, 2554
Uridine diphosphate 166, 167
glucose 173f
Urinalysis 2485, 2502, 2562, 2571
Urinary acylglycines 121
quantitative analysis of 121
Urinary anion gap 265
Urinary bladder
anatomy of 2568
innervation of 2568
Urinary chloride excretion 267
Urinary concentrating defect 2498
Urinary discoloration, causes of 2505t
Urinary glucose tetrasaccharide 179
Urinary incontinence 2608
Urinary infection, diagnosis of 2562t
Urinary organic acid 121
profile 117f
Urinary origin 2540
Urinary pH 2485
Urinary protein loss, quantification of 2523
Urinary stone disease 2549
Urinary tract infection 94, 108, 652,656, 657t, 698, 774f, 1277, 1332, 1379, 1395, 1654, 1787, 1870, 2494, 2500, 2550, 25612565, 2608
atypical 2562
diagnosis of 656, 656t
Urinary tract, congenital anomalies of 2490
Urine 138, 251, 2508
amino acids 1870
anion gap 2487, 2541
bilirubin 1865
calcium excretion 2542
collection of 2561
concentration of 2485
culture 2562
guanidinoacetate 89
incontinence of 2569
lower volume of 2503
microscopy 2505
organic acid 89
analysis 115
profile 120
osmolality 2547
pH 2541
pregnancy test 1265, 1266
reducing substances 89
sample collection, method of 2562t
sediment 2511
steroid profile 2952
Urinoma 2495
Urobilinogen 1865, 2003
Urogenital sinus 773, 778
Urokinase plasminogen activator 2048f, 2520
Urological disorders 2519
Ursodeoxycholic acid 1826, 1875, 1926, 1928, 3617
Ursodiol 3617
Urticaria 3334, 3335, 3336, 3337b, 3338
activity score 3338
autoimmune origin of 3336b
classification of 3334fc
diagnostic work-up of 3338b
differential diagnosis of 3337b
etiological associations of 3334t
pathophysiology of 3335f
pigmentosa 3340, 3340f
specific drug therapy of 3338
Urticarial rash 3187f
Uterine bleeding 1263
Uterine contractions 453f
Uteroplacental insufficiency 540
UTI. See Urinary tract infection
Utrophin modulation 2821
Uveal inflammation 3246
Uveitic glaucoma 3252
causes of 3233b
complications of 3237
laboratory investigations for 3237b
Uyemura fundus 3283
V
Vaccination 1098, 1392, 1524
against rabies 1507
schedules of 1508
dose and schedule 1156
during pregnancy and lactation 1207
record card 1111
Vaccination card 1111t
administration
practices 1107
routes of 1107
techniques of 1107
candidate pipeline and status 1158
carriers 1121
constituents 1150, 1153
cutaneous adverse effects of 3357
development of 12, 1576
effectiveness 1103, 1169, 1170
efficacy 1103, 1176
epidemiology 1102
failure 1104, 1150, 1170
reasons for 1145
inventory control 1122
management 1122
preventable disease 1101, 1102b, 1112, 1113, 1116, 1147
surveillance for 1098
safety 1198
scare-related adverse events 1124
schedules 1198
storage 1116, 1117, 1118f
strains 1152, 1156
types of 1098, 1100t
vial monitor 1119
types of 1119t
wastage factor 1117
Vaccine-associated paralytic poliomyelitis 11351137, 1537, 2807
Vaccine-derived poliovirus (VDPV) 1135, 1536, 1537
VACTERL syndrome 748
Vacuum assisted delivery 546f
Vagal maneuvers 323, 2452
Vagal nerve stimulation 2646
Vaginal atresia 778
Vaginal bleeding 3484
Vaginal discharge 479, 479f, 1276, 1278, 3484
Vaginal fluid 1276
Vaginal infection 1199, 1653
Vaginal intraepithelial neoplasia 1197
Vaginal smear specimen 1276f
Vaginal trichomoniasis 1307
Vaginitis 1279
Vaginosis
in adolescents 1275
Vagus nerves 2582
Valacyclovir 1471
Valent pneumococcal conjugate vaccine 1171
Valganciclovir 3618
Valine 93
catabolism 93
replaces glutamic acid 39
Valley fever 1665
Valley sign 2818f
Valproate 108, 2605, 2608, 2640
sodium 288, 3617
syndrome 52
Valproic acid 2605
Valsalva maneuver 2585
Valsalva ruptured sinus 2266, 2337, 2338
Valsartan 2560
Valvar aortic stenosis 2349, 2351f, 2352, 2353b
causes of 2350t
Valvar pulmonary stenosis 2339, 2341
diagnostic features of 2341b
Valve of Hasner 3277
Valved holding chamber 2199
Valvular heart disease 136, 2268
van de Kamer method 1736
van der Woude syndrome 843, 1768, 1769f
Vanadium 1075
role of 1076f
Vancomycin hydrochloride 3617
Vancomycin resistance 1388
Vancomycin-resistant enterococci 1320t
Vanillylmandelic acid 2748
VAPP. See Vaccine-associated paralytic poliomyelitis
Variceal bleeding 1887, 1895
Varicella 1496, 1498
diagnosis of 1498
neonatorum 1500
pneumonia 1498
rash of 1497f
specific therapy of 1498
treatment of 1498t
vaccine 1125, 1176
virus 455, 1497
zoster immunoglobulin 1499, 3617
zoster virus 1176, 1471, 1496, 2675, 2676, 2677, 2680, 3285
encephalitis 2677
Varicose bronchiectasis 2238
Variegate porphyria 197, 198
Variola vaccinae 1098
Vas deferens 1229
Vascular access 317, 438, 2293
Vascular cell adhesion molecule 1 1382, 2409
Vascular disorders 337
Vascular endothelial growth factor 608, 1880, 1954
Vascular endothelium 2045, 2045f
Vascular malformations 791, 3321
Vascular pattern, loss of 1746f
Vascular phenomena 3301
Vascular sinuses 2658
Vasculitic rash 2509, 3159f
Vasculitides 2513t
classification of 2513
Vasculitis 1685, 2404, 2672, 3131, 3132, 3132t, 3236
different subgroups of 3132t
organ specific manifestations of 3132t
Vasculopathies 2707, 3365
Vasoactive drug infusions 317
Vasoactive intestinal peptide 1731, 1794
tumor 1736
Vasoactive intestinal polypeptide 1757
Vasodilators 408, 2560
Vaso-occlusive sickle cell crisis 2014
Vasopressin 251, 317
test 2547, 2547t
Vaxchora 1723
VDDR. See Vitamin D deficient rickets
VDPV. See Vaccine-derived poliovirus
Vector 1302, 1403
control 1574, 1630
Vecuronium 3618
Vegetables 995, 996t
Veins
Batson's plexus of 1433
development of 2256
Velocardiofacial syndrome 66, 67f, 71, 1769
Venereal disease research laboratory 666, 1276, 1288
Venography 2091
Venom toxins, effects of 405
Venom-induced consumption coagulopathy 397, 398
Venous thromboembolism 2089, 2094, 2095t
Ventilation 332, 333, 699, 2110
controllers 350
hybrid modes of 708
modes of 352, 704, 722
perfusion
mismatch 595
radionuclide scan 2092
ratio 348
scintigraphy 2398
Ventilator associated pneumonia 359, 632, 744, 1320, 1394, 1395
Ventilator breaths 701
Ventilator graphics 356b
monitoring 356
Ventilator induced lung injury 359, 743, 744
Ventilator parameters 701
Ventilator pressure-time graph 702f
Ventilatory strategies 721, 746
Ventilatory support 309
gradual reduction of 355
Ventricles 2595
Ventricular assist device 2306, 2432
Ventricular dilatation 649f
Ventricular dysfunction 2414
Ventricular fibrillation 314, 316, 316f, 322, 2457
Ventricular septal defect 62, 694, 748, 2266, 2270, 2277f, 2293, 2316, 2320t, 2321, 2323t, 2337, 2344, 23562358, 2360f, 2366f, 2378, 2379, 2381f, 2386, 2420, 2455, 2472, 3484
closure 2295
hemodynamic classification of 2320t
management of 2321, 2322
types of 2319t, 2320f
Ventricular tachycardia 320, 321f, 322, 2443, 2457, 2458
Ventricular tap 2587
Ventriculitis 649f
Ventriculoatrial shunt 2629
Ventriculoperitoneal shunt 2587, 2628
Venturi's effect 2321
Verapamil 2453, 3618
Vernal keratoconjunctivitis 3231, 3231f, 3254f
severe 3231f
Verner-Morrison syndrome 1803
Vernix caseosa 3309
Verruca vulgaris 3317, 3318
Verrucous epidermal nevi 3306
Vertebral osteochondritis 3423
Vertical supranuclear gaze palsy 159
Very long-chain
acyl-CoA dehydrogenase 119, 120
fatty acid 89, 130, 128, 2799
Very low-birthweight 499, 511, 602, 613, 618, 623, 632, 684
Very low-density lipoproteins 2993
Vesicoureteral reflux 657, 657f, 774f, 779f, 2491, 2565, 2566, 2566f, 2567
grading of 2488
management of 779
Vesicular breath sounds 2117
Vesiculobullous disorders 3374
Vesiculobullous lesions, differential diagnosis of 3374b
Vessel vasculitis 2513
Vessel wall inflammation, control of 3177
Vestibular anus 769f
Vestibular schwannomas 2754
Vestibulocochlear nerve 2582
Vibrio cholerae 270, 1305, 1341, 1370, 1707, 1718, 1720, 1720fc, 1721. See Cholera
Vibrio parahaemolyticus 1304, 1717
Video electroencephalography 2589
Video fluoroscopic swallow study 2186
Video magnifier system 3297
Video-assisted thoracoscopic surgery 2209, 2223
Vigabatrin 2645, 3618
Vincristine 3023f
sulfate 3618
Vineland adaptive behavior scales 920, 923
Violence 15, 1258
against children 3477
forms of 1259
Vi-polysaccharide-CRM197 conjugate typhoid vaccine 1160
Vi-polysaccharide-diphtheria toxoid (DT) conjugate typhoid vaccine 1160
Vi-polysaccharide-TT conjugate typhoid vaccine 1160
Vi-polysaccharide vaccine 1159
Viper bite-induced
renal failure, mechanisms of 399fc
shock 397fc
Vipoma 1746
Viral bronchiolitis 94
Viral capsid antigen 1491
Viral cell cultures 1533
Viral conjunctivitis 643
Viral detection 662
Viral diseases 1467, 3317
Viral encephalitis 2667, 2675, 2678t, 2679
differential diagnosis of 2676b
Viral fever 1331, 1332, 1577
Viral gastroenteritis 94
Viral hemorrhagic fevers 1580, 1696
classification of 1581t
management of 1582t
Viral hepatitis 1539, 1541t, 1543fc
chronic 1539, 1916
Viral infections 642, 1467, 1469, 1797, 2192, 2462, 3284, 3305
congenital 1483f
epidemiology of 1467
tests for 2076
Viral isolation 1494
Viral meningitis 652, 2587, 2667
Viral myelitis 2776, 2807
Viral myocarditis 2306
Viral pericarditis 2439
Viral pharyngitis 1490
Viral rhinosinusitis 2151
Viral serology 1543
Viral spectrum 1471
Viral tonsillitis 2154
Viral uveitis 3236
Viral vector vaccines 1190
Virchow's triad 2089, 2090f
Viremia 1468
Virology 1195
Virome 1314
Virulence factors
staphylococcal 1384t
Virus 205, 661, 1302, 1505, 1545, 1563, 2675
isolation 1498, 1513, 1578
stool for 1537
persistence 1534
Visceral fluke 1631fc
summary of 1634
Visceral hyperalgesia 1790
Visceral injuries 550
Visceral involvement 147
Visceral leishmaniasis 1596, 1596f, 1598
coinfection 1596, 1598
diagnosis of 1597
Visceral situs 2273
chest for 2273
Visceral leishmaniasis. See Leishmaniasis
Visceral tuberculosis 1841
Visceroatrial concordance 2310
Visceroatrial situs 2310
Viscerotropic disease 1207
Vision 86, 1047
2020—the right to sight 3205
defects of 880
development 3206
disorders 61
field of 2581
loss 136
screening 889, 3221
testing 90
Visual acuity 2581, 3249, 3294
Visual axis 3261
obscuration 3246
Visual evoked potential 2588, 2591, 2721
Visual function 614
Visual impairment 3205
Visual loss 136
Visual problems 3205
Vitamin 989, 992, 993t, 1727, 3581
deficiency 9, 1021, 1023, 1023t, 1024f1026f, 1047, 1049, 1050t
massive doses of 1050
prophylaxis program 1095
rich food, promoting consumption of 1049
supplementation 747, 1049
B complex 1052
deficiency 1052, 1053f
B1 70, 1052, 3361
deficiency 2461
deficiency 147, 1055, 1055f, 1993, 1996t, 1997, 1998, 2732
formulations 2001t
transport 1997
B6 70, 90, 993, 1053, 3361
deficiency 1056, 1996
source of 1056
deficiency 588, 1059, 1060b, 1062t, 1063t, 2553, 2554, 2555, 2972, 2978
rickets 2368t
dependent rickets 70, 2555, 2980
doses of 2549
extraskeletal effects of 1064
intoxication 2978
levels 1062
metabolism 1059, 1060f, 2553, 2975f, 2980f
refractory rickets 2553, 2553b
synthesis, disorders of 1060
therapy 2553
toxicity 1063, 1064
treatment of 1064b
D2 2553
daily recommended dose of 1087t
deficiencies 3283, 3361
E 994
deficiency 27652767
supplementation 615
antagonists 2093
deficiency bleeding 588, 588b, 588f, 588t, 589, 2064, 2066, 2067t
physiology of 587
K1 586
supplementation 90
utilization of 127
Vitiligo 3322, 3324, 3324f, 3325
treatment modalities for 3325t
Vitreoretinopathy, familial exudative 610
Vitreous hemorrhage 3281
Vocal cord paralysis 2120, 2121
bilateral 2121f, 2122
Vogt's striae 3231
Vogt-Koyanagi-Harada syndrome 3236, 3237f
Voice disorders 949
Voiding cystourethrography 2488
Voiding disorders 2568, 2569, 2571, 2571t
classification of 2568
Voiding frequency 2502
Voltage-gated potassium channel 2587, 2678, 2744, 2745, 2747
Volume controlled ventilation 351f, 358f, 706
Vomiting 3, 92, 97, 102, 196, 254, 406, 1760, 1775, 1777, 1802, 1833, 1895, 2517, 3118
causes of 1776t
chronic 1784
treatment of 1778t
von Gierke disease 191
von Hippel-Lindau
disease 3289, 3371
syndrome 1803, 2937
von Recklinghausen disease 43, 3251
von Willebrand disease 584, 2050, 2053, 2064, 2064, 2065, 2065t, 2070, 2084, 2085, 3130
classification of 2064
epidemiology of 2064
von Willebrand factor 1954, 2045, 2046, 2053, 2056, 2064, 2065, 2084
Voriconazole 1648, 1650, 3619
Vroliks disease 3442
VSD. See Ventricular septal defect
Vulnerability 3463, 3464
Vulnerable children 3163
Vulvar intraepithelial neoplasia 1197
Vulvar vaginal lesions 1197
vWD. See von Willebrand disease
W
Waardenburg syndrome 53, 54f, 3286, 3325
clinical types of 3326t
Waddling gait, mechanism of 2818b
Waist circumference 806, 832
Waldenstrom staging, modified 3431, 3431b
Waldeyer ring 2154
Walker-Warburg syndrome 53, 2833, 2833f
Wallace rule of nines 427, 427f
Warm autoimmune hemolytic anemia 2039
Warm chain 484
Warm fluids 438
Warm shock 331
Warthin's tumor 1774
Warthin-Finkeldey cells 1475
Warthin-Starry silver staining 1401
Warts 225
Warwick-Edinburgh mental well-being scale 934
Waste
disposal 325
final disposal of 1327t
handling of 1327
Water 1031
balance, physiology of 2878
borne infections 1306
deprivation test 2547, 2547b, 2879
excretion 270fc
hammer pulse 2417
intoxication 2502
pollution 3504
control of 3506
sanitation and hygiene 1722
Waterhouse-Friderichsen syndrome 2099
Waterlow classification 1035
Watery eye 3207fc
Weakness 2539, 2608, 2818
progression of 2781
Weaning
failure 356
off ventilator 355
techniques of 355
Weavers syndrome 526
Wechsler's intelligence scale 920, 1933
Wedged hepatic venous pressure 1880
Wegener granulomatosis 2509
classification of 3188b
Weight 804
gain 2577
loss 2162, 2514, 2541
pattern 479
disorders of 499
Weight-for-age 829, 1034
chart 823f, 824f
Weight-for-height 829, 1034
Weil disease 1401
Weil syndrome 1399
Weil-Felix test 1691
Weill-Marchesani syndrome 3253f, 3287
Wellcome trust classification 1034t
Werdnig-Hoffman disease 2809
Wernicke encephalopathy 1052
West Nile fever 668, 1208
West Nile virus 2675
West syndrome 2636, 2637
classification of 2637b
Western blotting 1310
Westley croup scoring system 2171, 2171t
Wet beriberi 1052, 3361
Wheeze 2118, 2175, 2188, 2192
associated lower respiratory tract infection 2116, 2202
Wheezing
airway disorder 61
causes of 2175b
sudden onset of 2175
Whirlpool sign 1898
Whispering pectoriloquy 2117
Whistling face syndrome 53, 53f
White blood cell 109, 647, 1069, 1337, 1538, 1591f, 1669, 1716, 1734, 1948, 2068, 2486, 2530, 2892, 3018
count 605, 655
count 653
White line of Frankel 1058
White matter
diseases 2764t
disorders 2579
injury 684, 686
pathogenesis of 686t
neurodegenerative disorders 2770
White matter tract 2599
White pupillary reflex 611f
Whitehouse method 848
WHO classification of malnutrition 1036t
WHO growth charts (0-5y) 824826f
WHO growth tables (0-5y) 808t
Whole blood aggregation 2086
Whole bowel irrigation 369, 372
Whole cell pertussis 1208
Whole genome sequencing 41, 89, 130, 919f, 1311, 1972
Whooping cough 1139
Wickham's striae 3381f
Widal test 1365
Wide range achievement test 956
Wild poliovirus 1134, 1136
Williams syndrome 40, 5153, 55, 66, 67f, 68, 2324, 2342, 2354, 2354f, 2614
Williams-Beuren syndrome 2339, 2906, 2910
Wilms tumor 775f, 2523, 2524, 3076, 3077t, 3080, 3080t3082t
bilateral 3082
recurrent 3082
Wilson and Jungner criteria 199b
Wilson disease 86, 1867, 1886f, 1907, 1908t, 1912, 1915, 1916, 1926, 1927, 1938, 2540, 2541, 2580, 2720, 2772, 3290
treatment of 1927t
Wilson index 1907, 1921
Wimberger sign 1058
Wiskott-Aldrich syndrome 215, 218, 219, 20682070
Wobbly eye 3208c
Wolf-Hirschhorn syndrome 64
Wolff-Parkinson-White syndrome 178, 2282, 2283, 2283f, 2383, 2443, 2446, 2447, 2448f
Wolfram syndrome 2879, 2959
Wolman disease 1745
Wood's lamp examination 3322
Woodcock-Johnson-IV tests 955
Woolly hair nevus 3399f
Worsening, management of 2153t
Wound 1166, 3310
management 423, 1142, 1143t, 1362, 1362t
Wound management 1362
Wright-Giemsa stain 3025
Wrinkled tissue paper appearance 145
Wrist, skiagram of 1062f
Wuchereria bancrofti 1627
laboratory diagnosis of 1629fc
life cycle of 1628f
Wyburn-Mason syndrome 3289
X
X chromosome
gene on 2554
monosomy of 63
Xanthelasma 1876f
Xanthine 2551
oxidase 1989
deficiency 2550
Xanthochromia 2586
Xanthogranulomatous pyelonephritis 2550
X-autosome translocation 46
XDR-TB. See Extensively drug-resistant tuberculosis
Xeroderma pigmentosum 3288, 3393, 3393f, 3394
Xerophthalmia 1048, 3229
treatment schedule for 1049b
Xerophthalmic fundus 3283
XIAP deficiency 221
X-linked adrenoleukodystrophy 129, 2771, 2928, 2929
X-linked agammaglobulinemia 215, 218, 220
X-linked chronic granulomatous disease 222
X-linked disorders 2518
inheritance of 46b
X-linked hypophosphatemic rickets 2981, 2982
X-linked immunodysregulation 2928
X-linked mental retardation syndrome 51
X-linked recessive
ichthyosis 3385, 3386, 3386t
inheritance pattern 45, 45f
X-linked thrombocytopenia 219, 2068, 2070
45, X/46, XY mosaicism 2949
49, XY DSD 2948
46, XY gonadal dysgenesis 2949t
Y
Yellow fever 1206, 1207b, 1580
vaccine 1107, 1125, 1206, 1206t, 1207, 1207b
Yellow phosphorous poisoning 384
Yersinia enterocolitica 1304, 1305, 1418, 1741, 1898, 2891
Yersinia pestis 1304, 1341, 1402
Y-linked deafness 47
Yolk sac 1948, 1950f
Youth 1289
Youth self-report 933
Z
Zafirlukast 288
Zagreb schedule 1166
Zalcitabine 3619
Zanamivir 1495, 3619
Zebra body myopathy 2840t
Zellweger phenotype 87
Zellweger spectrum disorder 128, 130
Zellweger syndrome 56, 84, 86, 128130, 130f, 2619, 2636, 2761
Zidovudine 1559, 1561, 3619
Ziehl-Neelsen method 1416
Ziehl-Neelsen stain 1308, 1415, 1436, 1437f, 1447, 1462f, 1464
Zifivax vaccine 1193
Zika virus 668, 2614
infection 2612, 2614
congenital 2614b
absorption of 1069
deficiency 1070, 2998, 3363
biomarkers of 1070
causes of 1069
clinical features of 1071t
correction of 1071
finger protein 2620
influx transporters 1068
metabolism of 1068
protoporphyrin 1971, 1972
salt 1072
structure of 1068
sulfate 3619
supplementation 521, 1071, 1071f, 1711, 1722, 2999
therapy 1927
Zinsser-Cole-Engman syndrome 1961
Zollinger-Ellison syndrome 1737, 1746, 1794, 1803
Zolmitriptan 2662
Zonisamide 2639, 2645
Zooanthroponoses 1303
Zoonoses 1302, 1303, 1304
Zoonotic influenza viruses 1492
Zoster sine herpete 1499
Z-score 828
concept of 828
Zycov-D vaccine 1190
Zygomatic arch 1666f
Zygosity 530, 530b, 531f
determination of 531
×
Chapter Notes

Save Clear


1Pediatrics: Yesterday, Today, and Tomorrow
  • Section 1: Introduction to Pediatrics
  • Section Editor: Piyush Gupta
    • 1.1 Evolution of Pediatrics 3
    • 1.2 Child Health: Concepts and Concerns 7
    • 1.3 Evidence-based Care in Pediatrics 19
    • 1.4 Ethical Issues in Pediatrics 24
    • 1.5 Sustainable Development Goals for Child Health 272

Introduction to PediatricsSECTION 1

Section Editor Piyush Gupta
1.1 Evolution of Pediatrics
KN Agarwal
Pediatrics is the medical science for children, who are in a phase of active growth and progressive development. The word pediatrics and its cognates mean healer of children; derived from two Greek words: pais (child) and iatros (doctor or healer).
Newborns, toddlers, children, and adolescents have physical and emotional needs and health concerns different from adults. They are growing at varying rates in different phases of life—somatic growth, growth and development of brain, lymphoid tissue enlargement, and sexual development; thus energy needs and body metabolism remain active. In contrast adults are in a static maintenance phase, thus their macro- and micronutrient needs are more or less regulated and unchanging. Pediatricians take care of all these needs from birth up to age of 18 years. Present estimates are that brain growth completes around 25 years of age. The science of pediatrics has intimate relationship with mother from conception and birth, making obstetrics, gynecology, and pediatrics almost inseparable. In addition, it is hard to recognize diseases in young children with inherent difficulty in oral communication, and in whom eliciting clinical information is problematic.
 
DISEASES OF CHILDREN AND THEIR MANAGEMENT IN ANCIENT TIMES
 
India
The “Atharva Veda” (1,000 bc), a medical textbook explaining how to treat diseases, described breastmilk as nectar. “Charaka Samhita” (400–200 bc) and “Kashyap Samhita” (written by a pediatrician around sixth century bc to second century ad) described importance of breastmilk and advised breastfeeding from the first day of birth. “Sushruta Samhita” (dealing with surgical procedures; 600 bc) stated breastmilk as beverage of immortality. Unfortunately, it advised discarding of colostrum for the first 3 days and advocated feeding of honey and butter to facilitate discharge of meconium. Infant bath with lukewarm water and feeding of cereal and/or lentil (annaprashan) was recommended after 6 months of age.
Charaka knew that blood vessels brought food to various parts of the body and carried wastes away. He also made the earliest Indian reference to smallpox. Madhava (700 ad) practiced inoculation to keep people from catching smallpox, by scraping pus or scabs from the patient and administering as an inoculation, either by sticking it into the skin on a needle, or by blowing the powder up the nose.
 
Egypt
Ebers Papyrus (1550 bc) is a summary of the medical and surgical therapeutics practiced in ancient Egypt. In a tiny pediatric section which is mainly prognostic it reads as follows:
  • To get a supply of milk in a woman's breast for suckling a child, warm the bones of swordfish in oil and rub her back with it.
  • Prognosis for a child on the day of its birth: If it cries nicely, it will live; if it cries badly, it will die. If it wails loudly, it will die; if it drops its face downward, it will die immediately.
Ebers Papyrus also describes a few other topics including breastfeeding, a cure for worms, and treatment of eye diseases.
 
Islamic Empire (Iraq, Iran, Israel, Lebanon, and Syria)
Islamic physicians studied in depth all the medical observations and logic of Hippocrates, his followers, and Galen, combined with the work of the Indian physicians Sushruta and Charaka, whose books were translated into Arabic around 750 ad. Their observations helped to develop useful cures for some diseases. Another achievement of these practitioners was that they started the world's first hospitals, where the contagious patients of smallpox and measles were isolated and treated.
Al Razi (870–900 ad), Persian physician, wrote in a book the first description of how to differentiate measles and smallpox. However, he did not mention inoculation though it was already being done in India. Ibn Sina, the great Arabian physician (known as Avicenna in Europe, 990 ad) discussed tetanus, worm infestations, convulsions, meningitis, and umbilical abscess. He was the first to observe that tuberculosis (TB) and smallpox are contagious.
 
China
Pediatrics was one of the oldest specialties within Chinese medicine and dates from the early first millennium. This form of Asian medicine is the oldest and second largest medical system in the world today and is used by one quarter of the world's population. Children according to Chinese belief are weak and susceptible to diseases that affect the lungs (such as colds, coughs, allergies, and asthma) and the spleen (or digestive complaints such as colic, vomiting, diarrhea, indigestion, and stomach aches). In traditional Chinese medicine, there are four primary methods of treating children—dietary therapy, Chinese herbal medicine, Chinese pediatric massage, and acupuncture.
 
Greece
Around 300 bc and afterward Greek physicians established a logical system for understanding disease. “Hippocratic Writings”, named after the first and most famous of these physicians, (460 bc) give descriptions for cephalhematoma, hydrocephalus, clubfoot, worm infestations, diarrhea, scrofula, asthma, and mumps. Significant advances were made in childbearing with the introduction of the “Hippocratic Corpus” in the third century bc, though this document advised the practice of many superstitions.
Galen (200 ad) suggested advancement in medicine for women, though he focused mostly on specific diseases with some aspects of labor. He also wrote of ear discharge, pneumonia, intestinal prolapse, and possibly rickets.4
Soranus of Ephesus (98–138 ad) wrote in the second century on childbirth and obstetrics. For birth, the mother was made to sit on a birthing stool with a midwife in front of her and female aids standing at her sides. In a normal head-first delivery, the cervical opening was stretched slightly, and the rest of the body was pulled out. He instructed the midwife to wrap her hands in pieces of cloth or thin paper so that the slippery newborn did not slide out of her grasp. On the care of the newborn, his teachings as described in “On Diseases of Women” were followed to a large extent. He was the first to advise the salting and saddling of the newborn infant, a practice dating back to 600 bc. He also described a testing of the breastmilk by the behavior of a drop of milk placed on fingernail. This continued for over 1600 years.
Weakness at birth was attributed to prematurity, with heavy mortality. But Isaac Newton (1643–1727), Christopher Wren (1632–1723), and Jonathan Swift (1667–1745) were all premature infants, yet all lived a long vigorous life.
 
HISTORY OF MODERN PEDIATRICS
Major events related to child health are listed in a chronological order in Table 1.
 
Europe (United Kingdom, Belgium, Denmark, Italy, France, Germany, and Sweden)
In 15th century, four pediatric books were published in succession describing general pediatric ailments such as cough, ear infection, measles, smallpox, rheumatism, and diarrhea. These were written by Paulus Bagellardus (Italy, 1472, De Infantium Aegritudinibus et Remediis), Bartholomaeus Metlinger (Germany, 1473, Ein Regiment der Jungerkinder), Cornelius Roelans (Belgium, 1483, no title), and Heinrich von Louffenburg (Germany, 1491, Versehung des Leibs).
This was followed by detailed description of diseases in children. Eucharius Roesslin (Germany, early 16th century) wrote a book on Midwifery and Pediatrics, which reviewed 35 common ailments including many infections. Faventinus de Victorious (Italy, 1544) published a book with chapter on aphthous ulcers, measles, and smallpox. Thomas Phaer (England, 1544) published the first English language pediatric book, “The Boke of Chyldren” with chapters on meningitis, diseases of the ear, quinsy, diarrheal disorders, worm infestations, smallpox, measles, fever, and a disease description similar to Kawasaki disease.
Many infectious disorders were described subsequently. Giovanne P Ingrassia (Italy, 1553) differentiated scarlet fever from measles. Hieronymus Mercurialis (Italy, 1583) wrote about King's evil (scrofulous glands). Guillaume de Baillou (France, 1640) was the first to describe whooping cough as distinct entity covering the 1578 epidemic, as well as rubeola and scarlet fever. Johannes Sgambatus (Italy, 1620) made important descriptions of diphtheria while Thomas Bartholin (Denmark, 1646) described its contagious nature and mode of death by throttling.
The second English language book by Robert Pemell (1653) covered extensively many common infestations, otitis, oral ulcers, fevers, smallpox, measles, and erysipelas. The third English book in 1664 by J Starsmare covered the same topics including scrofula. Thomas Sydenham (England) described chorea in 1686, measles in 1670, and scarlet fever in 1675. Willis (England, famous for circle of Willis) described pertussis in 1675. Walter Harris (England, 1689) wrote a book on diseases of infants covering plague, venereal diseases, and strongly advocated inoculation against smallpox. This popular book had 18 editions and continued for another 53 years. John Fothergill (England, 1748) described ulcerative pharyngitis, diphtheria, and scarlet fever.
Chickenpox was described in 1760 by François Boissier de Sauvages (France). In 1765, Nils Rosén von Rosenstein (Sweden) described scarlet fever of 1744 epidemic in detail including the poststreptococcal nephritis. The credit of describing tubercular meningitis in three clinical stages with autopsy findings goes to Robert Whytt (Scotland, 1768).
Michael Underwood's (UK) book on diseases of children in 1784 was probably the best early published treatise on pediatric diseases. It had 17 editions and provided first descriptions of poliomyelitis and sclerema. Neonatal tetanus was first described by Joseph Clarke (Ireland) 1789. In the same year Edward Jenner published his report of 23 years of vaccination to prevent variola (smallpox).
By late 1700s and early 1800s, the need to attend specifically to the care, development, and diseases of children became more apparent and specialization in pediatrics evolved, particularly in Germany and France. The Society for Infant Therapeutics was formed in Germany in 1883. The British Pediatric Association was established in 1928 with George Frederic Still as the first President. The Royal College of Paediatrics and Child Health status was granted to British Paediatric Association in 1996. Its official journal “Archives of Diseases in Childhood” started its publication in 1926.
The first generally accepted pediatric hospital in Europe, the Hôpital des Enfants Malades (Hospital for Sick Children), opened in Paris in June 1802. The famous Great Ormond Street Children's Hospital of London was established by Charles West in 1848 followed by Hospital for Children at Edinburgh in 1856.
 
Pediatrics in the USA
The Father of American Pediatrics is considered to be Abraham Jacobi (1830–1919), a German pediatrician, who arrived in New York in 1853 and established the pediatrics chair at the New York Medical College in 1861. He is credited with the organization of the first pediatric society, publication of pediatric journal, and development of pediatric departments in New York hospitals. He was a prolific writer and taught extensively about the feeding and hygiene of children. He, in association with pioneers such as Luther Emmett Holt in New York, J Forsyth Meigs in Philadelphia, and William McKim Marriott in St. Louis rapidly expanded the specialty through their writings and teachings. The first independent pediatrics hospital was founded in Philadelphia in 1855 followed by Boston (Massachusetts) in 1869. The American Academy of Pediatrics was established in 1930 and the American Board of Pediatrics in 1933.
Luther E Holt Sr., who succeeded Jacobi, wrote the book, “The Care and Feeding of Children” in 1894, which was later developed into the “Holt's Pediatrics.” JP Crozier published “The Diseases of Infants and Children”, which in turn became Griffith and Mitchell's “Pediatrics”, then Mitchell and Nelson's “Pediatrics”; Waldo E Nelson's “Pediatrics” in 1954, and in 1984 “Nelson's Pediatrics”, edited by Richard Behrman. It has been the world's most trusted pediatrics resource for over 80 years. Pediatrics specialties have developed in diagnosis and management with approach of intrauterine diagnosis and treatment, identifying genetic disorders and study of genomics. The advances continue to provide the medical community with new diagnostic tools and therapies. Today in addition to general pediatrics, pediatricians can choose to specialize in a number of fields, including:
  • Adolescent medicine
  • Child abuse
  • Developmental and behavioral pediatrics
  • Neonatology
  • Pediatric allergy and immunology (In the USA, allergy is the biggest culprit, as it impacts 14.4 million kids, or 20% of children 17 and under)
  • Pediatric cardiology
  • Pediatric critical care
  • Pediatric dermatology
  • Pediatric emergency medicine
  • Pediatric endocrinology
  • Pediatric gastroenterology-hepatology
  • Pediatric hematology
  • Pediatric infectious diseases5
  • Pediatric nephrology
  • Pediatric neurology
  • Pediatric oncology
  • Pediatric ophthalmology
  • Pediatric pulmonology
  • Pediatric psychiatry
  • Pediatric rheumatology
Table 1   History of major events related to pediatrics.
Year
Pioneer
Event
1789
Edward Jenner, England
Cowpox vaccination for smallpox, first vaccine for any disease
1789
Benjamin Rush, USA
Description of cholera infantum, summer diarrhea
1818
James Blundell, England
First successful human blood transfusion for postpartum hemorrhage
1857
Louis Pasteur, France
Identification of microbes as a cause of disease
1865
Gregor Mendel, Austria
Principles of heredity
1882
Robert Koch, Germany
Discovery of the tubercular bacillus; Koch's postulates
1885
Louis Pasteur, France
Rabies vaccine; pasteurization of milk
1890
Emil von Behring, Germany
Discovery of diphtheria toxin and antitoxins
1895
Wilhelm C Roentgen, Germany
Discovery of radiograph (X-ray)
1900
Karl Landsteiner, Austria
Discovery of blood groups
1908
Archibald Garrod, England
Inborn errors of metabolism
1910
James Herrick, USA
Sickle cell anemia
1913
Bela Schick, USA
Schick test for immunity to diphtheria
1921
Edward Mellanby, England
Vitamin D deficiency causes rickets
1921
Thomas B Cooley, USA
Thalassemia major
1922
Frederick G Banting and Charles H Best, Canada
Discovery of insulin to treat diabetes mellitus
1923
Alexander Thomas Glenny, England and Gaston Ramon, France
Diphtheria toxoid for active immunization
1926
Louis W Sauer, USA
Vaccine against whooping cough (pertussis)
1927
Albert Calmette and Camille Guerin, France
Vaccine against tuberculosis
1928
Alexander Fleming, England
Discovery of penicillin
1931
Alvin C Coburn, USA
Hemolytic streptococcal infection and rheumatic fever
1943
Selman A Waksman, USA
Discovery of streptomycin
1948
United Nations
The formation of WHO
1952
Virginia Apgar, USA
Development of the Apgar score
1952
James Watson and Francis Crick, England
Double-helix structure of DNA
1954
Jonas Salk, USA
Inactivated polio vaccine
1956
La Leche League, USA
Promotion of breastfeeding
1957
Albert Sabin, Poland/USA
Oral polio vaccine
1959
The United Nations
Declaration of the rights of child
1959
Mary Ellen Avery and John Mead, USA
Surfactant
1963
Robert Guthrie, USA
Screening test for phenylketonuria—newborn screening
1964
John Enders, USA
Vaccine against measles
1965
Louis Gluck, USA
First newborn intensive care unit
1966
Dilip Mahalanabis, India
Development of modified ORS in Kolkata
1967
Maurice Hilleman, USA
Vaccine against mumps
1970
Maurice Hilleman, USA
Vaccine against rubella
1974
Michiaki Takahashi, Japan
Vaccine against chickenpox (varicella)
1977
Robert Austrian, USA
Vaccine against pneumococcal pneumonia
1977
WHO
Eradication of smallpox from the world
1978
Robert Edwards and Patrick Steptoe, UK
First test tube baby—Louise Joy Brown
1981
Baruch Blumberg and Irving Millman, USA
Vaccine against hepatitis B
1981
Robert Gallo, USA
HIV (AIDS) virus identified
1986
Alec Jeffreys, England
DNA typing or genetic fingerprinting
1992
Maurice Hilleman, USA
Vaccine against hepatitis A
2000
Francis S Collins and J Craig Venter, USA
Mapping of human genome
(AIDS: acquired immunodeficiency syndrome; DNA: deoxyribonucleic acid; HIV: human immunodeficiency virus; ORS: oral rehydration solution; WHO: World Health Organization)
6
Impact of genetics in pediatric illnesses ranges from as low as 5% of pediatric illness (in a General Hospital), to 70% of children admitted to an acute neonatal intensive care unit in the USA. The present day training is incorporating identification and management in primary health care.
Obesity tops the list of health concerns. The Centers for Disease Control and Prevention (CDC) reports that more than a third of US children are overweight or obese. Healthy food is advised in schools with more physical exercise.
Other pediatric specialists especially those in pediatric surgery, pediatric urology, or pediatric radiodiagnosis, are not necessarily pediatricians; however they undergo training in their own fields, and then receive additional specialty pediatric training.
 
HISTORY OF PEDIATRICS IN INDIA
Pediatrics made a formal beginning in Mumbai (erstwhile Bombay) in 1928, under the leadership of George Coelho, called the Father of Pediatrics in India. He was the head of the department of pediatrics at the Bai Jerbai Wadia Hospital for Children, the first independent children's hospital in India. In 1929, Dr Coelho started the Association of Pediatrics of India in Bombay in 1950. Pediatric departments soon came into existence at other centers, Nair Hospital, Mumbai (Shantilal Sheth), Patna (LSN Prasad), Delhi (PN Taneja), and Indore (JN Pohowalla).
In 1933, Dr KC Chaudhry founded the first independent pediatric journal namely, the “Indian Journal of Pediatrics”, in Kolkata (Calcutta). In 1948, he started the Indian Pediatric Society. By 1958, the Indian Pediatric Society organized nine national pediatric conferences in different cities and in 1961 the first Asian Pediatric Conference was held at New Delhi. His efforts to make pediatrics an independent subject are worth mentioning.
The state of Tamil Nadu has the honor and pride of having created the first chair of professor of pediatrics in India at the Madras Medical College (Chennai) in 1948 with the appointment of Professor ST Achar.
The Indian Pediatric Society and the Association of Pediatricians of India combined to form the Indian Academy of Pediatrics (IAP) as the single representative body of pediatricians of India and the first national conference of the IAP was held in Pune in 1964. The official journal of the IAP “Indian Pediatrics”, incorporated the “Indian Journal of Child Health” and the “Journal of the Indian Pediatric Society” and commenced publication in January 1964 from Kolkata.
The academy has promoted different specialties in the field of pediatrics through its various chapters. One of the major activities undertaken by the IAP since its inception is to organize continuing medical education programs all over the country. IAP has its office in Mumbai while Delhi is the seat of its official publication, “Indian Pediatrics.
 
Pediatric Education in India
Dr AM Sur, Nagpur (University of Bombay) was the first to start pediatrics examination in MBBS. Medical Council of India decided in 1997 that pediatrics will be a separate subject for examination of undergraduate (MBBS) training. The first postgraduate course for diploma in child health was started at Bai Jerbai Wadia Hospital for Children in 1944 under University of Bombay (Mumbai) in 1946. First MD pediatrics course was also started at Nagpur.
Doctorate of Medicine (DM) courses were started late with gastroenterology in Postgraduate Institute of Medical Education and Research (PGIMER) at Chandigarh in 1989, followed Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow in 2009. DM in neonatology also began at PGIMER, Chandigarh in 1989. Subsequently DM neonatology courses have begun in other centers including All India Institute of Medical Sciences (AIIMS), New Delhi. In 1991, SGPGIMS, Lucknow, started DM in clinical genetics and reserved one seat each for pediatric postgraduates for DM courses in neurology, cardiology, gastroenterology, and immunology. AIIMS, New Delhi now offers DM courses in pediatric neurology (2009), nephrology (2013), and pulmonology (2013). PGIMER, Chandigarh offers DM courses in pediatric critical care, pediatric hemato-oncology, child and adolescent psychiatry, and pediatric rheumatology (2013). The first MCh course in pediatric surgery was started at AIIMS, New Delhi in 1972.
 
PAST, PRESENT, AND FUTURE
Throughout human history, numerous advances have improved the quality and longevity of life around the globe. Dating back to ancient civilizations, there is evidence of societies working to improve the health of the general public. The Babylonian sewage systems were among the first designed to protect the water supply from contamination and disease. Similarly, Indus valley civilization of South Asia (Mohen-jo-daro) was prominent in hydraulic engineering, had flush toilets, connected to common sewerage. The discovery of pasteurization by Louis Pasteur in the 1860s helped to ensure the safety of food supplies throughout the world. With the implementation of the constitution of the World Health Organization (WHO) in 1948, the mass TB immunization campaign with bacillus Calmette-Guérin vaccine in 1950, and the onset of the Malaria Eradication Program in 1955, many of the important developments related to global health in modern times occurred in the post-World War II period of the 1940s and 1950s. In 1980, smallpox was officially eradicated from the planet. The WHO (March 2014) has declared its South East Asia region polio-free (80%), as the disease is still endemic in Afghanistan, Nigeria, and Pakistan. The dreaded “Measles” remains a continued risk for importation of disease and occurrence of outbreaks in communities. Recent outbreaks of diseases erroneously thought by many to be contained by country borders or eliminated by vaccines have highlighted the need for proper training of all pediatricians in global health. Beyond infectious diseases, they should know how to care for other conditions in global child health, ranging from malnutrition to the nuances of care for immigrant and refugee children, and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS). The recent coronavirus disease-2019, pandemic has taken a heavy toll world over. This virus is mutating and becoming more serious. Fortunately world was successful in developing vaccine against Corona very fast.
In the 2020 Global Hunger Index, India ranks 94th out of the 107 countries demonstrating the seriousness. The report also said that anemia prevalence among adolescent girls is twice that of adolescent boys. Malnutrition caused 69% of deaths of children below the age of 5 years in India, according to the State of the World's Children 2019, UNICEF said that every second child in that age group is affected by some form of malnutrition. This includes stunting (35%), wasting (17%), and overweight. With the prevalence of overweight and obesity in children being 15%, childhood obesity is now an upcoming epidemic in India. With 14.4 million obese children, India has the second-highest number of obese children in the world, next to China. Only 42% of children (in the age group of 6–23 months) are fed at adequate frequency and 21% get adequately diverse diet. Timely complementary feeding is initiated for only 53% of infants aged 6–8 months.
The potable water, hygienic food, and essential immunizations can only help India, to meet proclaimed objectives of the UN General 7Assembly as the Decade of Action on Nutrition 2016-25. This present state of undernutrition can create future generation with poor mental functions including cognition, soft neurological signs, and low physical stamina.
1.2 Child Health: Concepts and Concerns
Piyush Gupta, Neha Thakur
Fundamental to understanding of the field of pediatrics is the understanding of the term “health” and “disease”. Let us first look at how most of the people understand “health” and “disease”.
 
THE CONCEPT OF HEALTH
Health is a fundamental human right, recognized in the Universal Declaration of Human Rights (1948). It is also an essential component of development, vital to a nation's economic growth and internal stability. It is a well-known fact now that better health outcomes play a crucial role in reducing poverty.
 
Naturalist versus Normativist Theory
Most people consider health to be an absence of any perceptible disease. Thus, for many, health is understood as an absence of any disturbance in the somatic functions of the body and is an objective phenomenon. This is popularly known as the naturalist's theory. For this school of thought, there are only these two absolute categories which a doctor should understand and follow, e.g., a kidney is diseased or not. The other school of thought discards the “objective” nature of the definition of health and considers health with reference to the degree to which the person fulfills one's social roles. This is known as the normativist's theory. Medical science is embedded in the social constructs and thus health cannot be restricted to somatic disturbances alone.
 
Definition of Health
Health is a state of complete physical, mental and social wellbeing, and not merely the absence of disease or infirmity” [World Health Organization (WHO)], 1948. This is a conceptual and a utopian definition of health. It is an ideal goal that is elusive. Can the physical, mental, and social wellbeing be ever “complete”? Nonetheless, it acts as the benchmark for the whole humanity to strive for. At a pragmatic level, this definition fails because by this definition everyone is labeled as unhealthy. As it was not possible to attain this level of health, “absence of somatic disturbances” were still considered as healthy even after the launch of this definition.
In 1984, the WHO gave an operational revised definition of health defining it as “the extent to which an individual or group is able to realize aspirations and satisfy needs, as to change or cope with the environment is a resource for everyday objective of living; it is a positive concept, emphasizing social and personal resources, as well as physical capacities.
Health is not an absolute phenomenon, but a gradient ranging from worst health status to the best health status, and therefore it is challenging to define the exact cut off point for discriminating between the healthy and nonhealthy.
 
Defining Health in Children
The standard WHO definition cannot be applied to children as such because of a very basic difference between an adult and a child, i.e., the child is growing and developing. Thus, in a child mere absence of a disease is insufficient to define health; not growing or developing appropriate to age also needs to be viewed as not being normal and hence not in good health. Health for children and adolescents (0–19 years) should thus be defined as the state of physical, mental, social, and spiritual wellbeing that allows the child to grow and develop optimally to attain his/her full genetic potential as an adult.
 
THE CONCEPT OF DISEASE
 
Definitions
Illness: Illness is the subjective sense of feeling unwell. In small children this must be sensed by the caregivers.
Disease: The pathological process which is what is diagnosed by the pediatrician. Caregivers may approach the pediatrician for an illness. However, it is important to know that a child may be ill but not diseased.
Sickness: Sickness is the social construct associated with disease. A sick role is what the caregiver assumes based on his/her perception of the disease. This perception is acquired from the society in which the caregiver lives.
Illnesses or health-related conditions which may not be categorized as a disease at one point of time may later be labeled as a disease, as we understand more about the condition. For example, obesity even though not considered as a disease till a few years back is now being considered as a disease by some proponents of this view and treated by using various medical and surgical methods.8
There are instances when parents report an illness but pediatrician may not diagnose it as a disease and the parents may feel upset as they may start doubting themselves or the doctor. But this is due to limited understanding about many signs and symptoms. As more diagnostic methods and tools evolve it may be possible to label the illness as a disease. Labeling a child as diseased or nondiseased is thus conditional to the extent of understanding of the associated clinical presentation at that point of time.
 
Causation of Disease: The Epidemiological Triad
Disease occurs because of an interplay between an agent, a susceptible host, and an appropriate environment. These three together constitute the epidemiological triad, as shown in Figure 1. The center of the triad represents time, i.e., length of disease process, incubation period, etc. A disease can be eliminated or prevented by controlling any or all these factors or the interplay between these three factors.
 
Agent
An agent is one, which can cause a disease. The size of the inoculum or dose of the agent must be enough to cause the disease. It must be virulent enough to attack the host and can be either living or nonliving. Living agents include various bacteria, viruses, fungi, protozoa, etc., and are usually responsible for infectious diseases. Nonliving agents directly responsible for inflicting a disease exist in the form of physical (electric current, extremes of temperatures, pressure, or sound), chemical (poisons, endogenous wastes as urea, bilirubin, ammonia), mechanical (motor vehicle, mechanical force), nutritive (deficiency or excess intake of various food elements), and social (illiteracy, poverty) factors.
A disease may have single or multiple agents. In the case of a living agent, its ability to produce a disease mainly depends on four attributes: (1) infectivity, (2) pathogenicity, (3) virulence, and (4) susceptibility.
  1. Infectivity: It is defined as the ability of a living agent to enter and multiply in a host. It depends upon the dose of the inoculum. The more the number of infective particles, the more is the degree of infectivity. It is also thought of as the minimum number of particles or agents required to establish infection in at least 50% of the hosts [infectious dose (ID50)]. This number may vary with the agent, route of its administration, its source, and with a few host factors like age or race. Measles is an infection with high infectivity. Leprosy has low infectivity.
  2. Pathogenicity: It is defined as the ability of the agent to produce disease in the host. The pathogenicity is also altered by many host and environmental factors, apart from dose, route, and source of infective inoculum.
  3. Virulence: It is defined as the ability to produce severe clinical manifestations including complications, death, and sequelae. One of the simple methods for assessing virulence is by estimating the case fatality rate (CFR). Virulence also depends on the same factors as those in infectivity and pathogenicity.
  4. Susceptibility: It is defined as the ability of the agent to survive in the host or in a free state. Susceptibility, therefore, depends on both intrinsic (host) as well as extrinsic (environmental) factors.
zoom view
Fig. 1: The epidemiological triad.
Immunogenicity: It is defined as the ability of the agent to produce a specific immunity. An agent may induce humoral, cellular, or mixed type of immune response in a host. Immunogenicity is altered by various host factors (age, nutritional status) as well as agent factors (dose and virulence of the inoculum). The intrinsic ability of agents in inducing and effecting a long-lasting immune response differs in different organisms. For some organisms, a single exposure results in a lifelong immunity (measles), while bacteria causing cholera or pneumonia are devoid of producing an everlasting immune response.
 
Host
A host is one in whom the disease manifests, for example, the human being. Various attributes of children may render them susceptible to a disease. These attributes include certain biological and social traits. Genetic characteristics such as human leukocyte antigen (HLA) haplotype, race, age, and sex may be important in the causation and outcome of a disease. Social factors such as socioeconomic status, school exposure, peer group, caretakers, behaviors, etc., are other important host characteristics.
The clinical outcome of the entry of a pathogen in the body depends on two interacting forces: (1) virulence of the micro-organism, and (2) the resistance mechanisms of the body. Resistance of the body is determined by immunity.
Immune system is an organization of cells and molecules with a defined function to protect against infective, autoimmune, and malignant disorders. A successful pathogen needs to breach several surface barriers such as keratinized layers of skin, mucosal layers with associated enzymes, mucus, etc. Microbes that overcome these initial barriers are exposed to the next level of defense, viz., the innate (nonspecific) immunity and acquired (specific) immunity; both of which have two components each—cellular and humoral.
 
Environment
All things surrounding the human body are considered part of the environment. In the context of community medicine, environment implies the external environment. Environment for man is not limited to the climatic conditions alone. The various environmental factors are classified into physical, biological, and social environment.
  • Physical environment: The physical aspects of the environment include air, water, light, heat, radiation, gravity, pressure, and various chemical agents. Man exerts a great deal of control over these factors. Of late, the population explosion and industrialization are resulting in a heavy degree of air, water, noise, and other kinds of pollution.
  • Biological environment: Certain diseases do not occur in some areas because the agent, or vector cannot exist in that environment due to biological reasons. The biological environment includes (A) infectious agents of disease, (B) reservoirs of infection, (C) vectors that transmit disease, and (D) plants and animals.
  • Social environment: The social factors relevant to health include the socioeconomic status, social customs, and traditional beliefs. Old beliefs may provide resistance to new health practices. Social factors like isolation or alienation also produce diseases like schizophrenia, depression, and suicide.
 
DISEASES OF PUBLIC HEALTH IMPORTANCE
The basis for labeling a disease as a public health problem is that it affects a large proportion of population exerting a great burden on the community. It may be noted that there is no single prevalence cut off for all health problems to be labeled as a public health problem. There are different prevalence cut offs for different health problems such as iodine deficiency, vitamin A deficiency, etc.9
In addition, diseases which have the potential to spread rapidly such as Ebola in recent times would also qualify as a public health problem in spite of not being widely prevalent.
 
Equity and Inequality in Health
Equity and equality have different connotations for health and should not be used interchangeably.
 
Equity
It is concerned with (A) creating equal opportunities for health and (B) bringing health differentials between communities, down to the lowest possible level. It implies that ideally everyone should have a fair opportunity to attain their full health potential and that no one should be disadvantaged from achieving this potential if it can be avoided.
 
Health Inequality
This can be defined as differences in health status or in the distribution of health determinants between different population groups. For example, differences in hemoglobin concentration between adults and newborn babies or differences in nature and rate of morbidity and mortality in different countries or social classes. Some health inequalities are attributable to biological variations (the hemoglobin example); these are unavoidable. In others, the uneven distribution may be unnecessary and avoidable as well as unjust and unfair, so that the resulting health inequalities also lead to inequity in health.
 
INDICATORS OF CHILD HEALTH AND DISEASE
Health information produced should be useful, accessible, and appropriate for the various stakeholders. Health indicators are aggregated relevant statistical data pertaining to wellbeing that can be developed for different aspects of health and healthcare. As per WHO an ideal health indicator should be valid (should measure what it is intended to measure), objective (should give same results under same conditions even by different observers), sensitive (should be sensitive to changes in the health conditions), and specific (should reflect changes only in the situation concerned). Here we will primarily focus on the current commonly used indicators.
 
Stillbirth Rate
It is the number of stillborn infants (after 28 weeks of gestation) related to the total number of births (live and still) during the same period. It is expressed in relation to 1,000 total births.
zoom view
 
Perinatal Mortality Rate (PMR)
Number of deaths occurring in the perinatal period (includes stillbirths plus the neonatal deaths occurring in the first 7 days after birth) in a given year to the total number of births (live and still) in the same year. It is also expressed as rate per 1,000 total births. For inclusion in this rate, the stillbirth or live births should be either (1) >1,000 g in weight, (2) >28 weeks in gestation or if (1) and (2) are not available, should measure 35 cm or more in length at birth.
In developing countries, this is defined as:
zoom view
It is considered a sensitive indicator of maternal health.
 
Neonatal Mortality Rate (NMR)
It is the number of neonatal deaths in relation to 1,000 live births per year.
zoom view
 
Infant Mortality Rate (IMR)
It is the number of infant deaths in a year in relation to 1,000 live births during the same period.
zoom view
This is irrespective of the fact that some of those infants who died in this year might have been born in the last few months of the previous year.
 
Postneonatal Mortality Rate (PNMR)
zoom view
Postneonatal mortality rate can also be expressed as a difference between infant and NMRs.
 
Child Mortality Rate
It is computed as:
zoom view
Here 1–4 years mean that the age of children should be ≥1 year and ≥4 years; but not completed 5 years yet.
 
Under-five Mortality
This is expressed as a sum of infant mortality (<1 year) rate and child mortality (>1 and <5 years) rate.
 
Crude Birth Rate
This is equivalent to the number of live births reported in a given year per 1,000 of total population at the middle of the year.
zoom view
It is expressed as rate per 1,000. It is a crude measurement of fertility, because it also takes into account that section of the population which is not of childbearing age, e.g., children and elderly.
 
Maternal Mortality Ratio
This measures the risk of dying from causes associated with childbirth. The numerator gives the deaths arising during pregnancy or from puerperal causes, i.e., deaths occurring during and/or due to delivery, complications of pregnancy, childbirth, and the puerperium. Women exposed to the risk of dying from puerperal causes are those who have been pregnant during the period. Their number being unknown, the number of life births is used as the conventional denominator for computing comparable maternal mortality ratio (MMR).
zoom view
10
Maternal mortality ratio is a pseudo index since the denominator is not the total number of pregnant women at a given time. WHO defines maternal mortality as death at pregnancy or within 42 days of delivery; in some defined areas, a period as long as a year is used.
 
Maternal Mortality Rate
The number of women who die as a result of pregnancy and childbirth complications per 100,000 women of reproductive age (15–49 years) in a given year.
 
Physical Quality of Life Index
It is a composite index that combines infant mortality, life expectancy (LE) at 1 year of age and literacy rate. Equal weightage is given to each indicator and resulting Physical Quality of Life Index (PQLI) is measured on a scale from 0–100. The desired goal is to attain a PQLI of 100 (present value in developing countries is 30–50 and in the developed world it is 90–98).
An example showing the calculation of PQLI: Available data shows that the minimum and maximum life expectancies of countries is 25 and 75 years, respectively. Also the upper and lower limits of IMR is 10/1,000 and 250/1,000.
For a country X whose PQLI we want to calculate, we have the following data:
Life expectancy at age 1 year = 60 years, IMR = 50 per 1,000 live births, and basic literacy rate (BLR) is 50%.
zoom view
zoom view
Higher the value of IMR, the lower the quality of health status and hence a higher value of IMR has been considered as the lower limit of IMR. Thus we find,
IMR index = 250 − 50/250 − 10 = 200/240 = 0.83
Both these indices are multiplied by 100 and thus we obtain life expectancy index (LEI) as 70 and IMR index as 83.
PQLI = (LEI + IMR index + BLR)/3 = (70 + 83 + 50)/3 = 67.67%
 
Child Mortality
Global under-five mortality rate declined by 59%, from 93 deaths per 1,000 live births in 1990 to 38 in 2019 (Fig. 2).
Over the last two decades large majority of countries have halved their under-five child mortality and 85 countries have achieved two-thirds reduction during the same period. This indicates uneven distribution of under-five child mortality. However, even with noticeable reduction in child mortality nearly 5.2 million under-five children lost their lives in 2019 alone. These children accounted for nearly 70% of all deaths among children and youth <25 years. On an average 14,000 under-five children died per day in 2019 as compared to 34,000 in 1990. Sub-Saharan Africa accounted for the highest 53% followed by South Asia (27%). Most common causes of death in under-five children were complications arising from preterm birth, birth asphyxia/trauma, pneumonia, congenital anomalies, diarrhea, and malaria as shown in Figure 3. Higher rates of death were seen in severe acute malnourished child. These deaths could have been prevented by providing easy availability and accessibility of basic health services, immunizations, nutrition, and access to clean water and sanitation. Injuries and drowning were the most common causes of death in older children. There has been a paradigm shift of pattern of deaths in older children from infectious diseases to accidents and injuries.
zoom view
Fig. 2: Levels and trends in child mortality report 2020. Estimates developed by the UN Inter-agency Group for Child Mortality Estimation.Source: UNICEF. (2020). Levels and Trends in Child Mortality. United Nations Inter-Agency Group for Child Mortality Estimation (UN IGME), Report 2020. [online] Available from https://data.unicef.org/resources/levels-and-trends-in-child-mortality [Last accessed August, 2021].
11
zoom view
Fig. 3: Most common causes of death in children aged <5 years.Source: WHO and Maternal and Child Epidemiology Estimation Group (MCEE) provisional estimates 2018.
zoom view
Fig. 4: Most common causes of death in children aged <1 month.Source: WHO and Maternal and Child Epidemiology Estimation Group (MCEE) provisional estimates 2018.
Among under-five deaths maximum deaths were seen in first month of life (47%) followed by infants (28%) and toddlers (25%). Large percentage (80%) of newborn deaths are due to complications related to preterm birth, intrapartum events such as birth asphyxia, or infections such as sepsis or pneumonia as shown in Figure 4.12
Children aged 5–9 years had the largest decline (61%) in mortality over the last two decades. This could be explained by sharp decline in infectious diseases. However, this progress was not seen in neonatal deaths. Around 6,700 newborns died per day in 2019. They accounted for a larger share of under-five child mortality in 2019 (47%) as compared to 1990 (40%). Hence, there is a faster decline in global death rate of children aged 1 month to 60 months compared to neonatal period. If we continue with the present trend over the next decade 23 million 5- to 24-year-old will succumb to illness or injury and 48 million under-five children would die. This prompts us to synergize our efforts to prevent child death. Nearly half of these under-five deaths were seen in newborns. Majority of these newborn deaths can be prevented by high quality antenatal care, skilled birth attendant, institutional delivery, and appropriate postnatal care for mother and baby. A comprehensive approach to bring down neonatal death rate and thereby under-five child mortality is the need of the hour. In India, under-five mortality has reduced from 83.1 deaths (95% uncertainty interval 76.7–90.1) in 2000 to 42 deaths (31.5–45.7) per 1,000 livebirths in 2019-2021, and the NMR decreased from 38.0 deaths (34.2–41.6) to 24.9 deaths (18.0–27.5) per 1,000 livebirths. India has shown a declining trend in under-five mortality, however when compared to rest of the nations it occupies the position of second worst nation after Nigeria as far as under-five child mortality is concerned. India is the only large country in the world where gender differences have been observed in mortality. Survival of boys is more compared to girls with gender differential being 3%. Thus, India needs to address its high under-five child mortality by providing universal health coverage easy availability and accessibility of essential health services adopt innovative approaches to increase access, coverage, and quality of child health services with incorporation of community and facility-based care.
 
GLOBAL CHILD HEALTH
Global child health refers to widespread health impacts that affect large numbers of children and adolescents across boundaries of geography, time, and culture. It includes the impact on the global ecosystem and other health determinants, such as poverty and genetics. Global health implies a context that includes the whole world and produces its own institutional complexities.
 
The Achievements
Since the development of first children's hospital “Hôpital des Enfants Malades (French = Hospital for Sick Children)”, in Paris in 1802, pediatrics has extended its scope in clinical practice, and is recognized as an independent discipline. Box 1 enlists the top 10 achievements in the field of pediatrics.
One of the most famous milestones in the history of medicine is the inoculation of children and adults with dried scab material recovered from smallpox patients by variolation technique in 17th and 18th centuries. It was Edward Jenner in 1796 who first vaccinated with smallpox vaccine. Currently, vaccination is available against numerous infectious diseases which led to their sharp decline. Through vaccination, scientists and physicians were not only able to offer protection but eradicated diseases like smallpox globally and poliomyelitis in many countries, including India. About 80% of all the world's children are immunized against the six main vaccine-preventable diseases. Diseases close to being eliminated or eradicated include polio, leprosy, neonatal tetanus, guinea worm infestations, and Chagas disease. The latest is development of coronavirus disease 2019 (COVID-19) vaccine which is one of the most important preventive measures in the fight against COVID.
The fact that breastmilk is best for an infant is known from antiquity. However, it was in 1981 that WHO and United Nations Children's Fund (UNICEF) brought the International Code of Marketing of Breast Milk Substitute. It was gradually adopted with modifications by many countries including India. Exclusive breastfeeding for the first 6 months of life has shown immediate and long-term advantages in prevention of infections, adult diseases, and food allergy. Well-baby clinic means that mother and child should be seen as a pair in clinics and not individually. Way back in 1892, Pierre Robin stimulated mothers to bring their healthy infants for weighing. Concept of Road to Health Card was introduced in 1974 by David Morley. It helped to identify growth faltering in children at the earliest. Today, under-five clinics and well-baby clinics are norms offering inclusive preventive advice on infant care, feeding, immunization, growth, and development.
Survival of low birth weight babies, extremely premature infants has necessitated prompt recognition of developmental and other deficits. The term Behavioral Pediatrics was coined and defined by Friedman. It is as “an area within pediatrics which focuses in psychological, social, and learning problem of children and adolescence.” There is multidisciplinary team approach with pediatrician, developmental pediatrician, therapists, speech therapist, and others. Specialists in this area investigate and manage communication delays, autism, attention-deficit disorders, and other learning disabilities that require early diagnosis and intervention.
Oral rehydration therapy (ORT) in diarrhea has been able to prevent more deaths occurring annually worldwide, than any other treatment modality. This “simple solution” has resolved a monumental problem and saved millions of lives till date. However, about 8,000 children still die each day from diarrheal dehydration, a toll which the clinicians can and must strive to reduce.
United Nation convention on Rights of the Child was passed as an International declaration in 1990. The rights of the child declaration confers rights for a life with dignity, protection from exploitation, and rights to education, love, play, be the first to get help, have a name and family, etc.
Although genetics emerged as a specialty about half a century ago it was pediatricians who took lead in this field because of their recognition of genetic disorders, syndromes, and malformations in children. As of now genetics has emerged into a specialized subject and has expanded to prenatal screening of diseases, cytogenetic, molecular genetics and in diagnosis of several disorders including asthma, growth failure, hypertension, and diabetes type 2.
The development of genomics was the natural progression of research in genetics. From single gene identification to the formation of Human Genome Project and finally to mapping of the Human Genome in 2003. Its application to pediatrics is similar to genetics and for population studies. Proteomics coined in 1994, seeks to investigate protein functions as it relates to its environment and biological setting. It will lead to development of new drugs and biomarkers. Metabolomics derives its name from “Metabolome” a term used to describe collection of metabolites in body fluids, tissue organs, and biological cells. It is likely to help detection of diseases, classify patients based on biochemical profiles, and monitor disease progress.
Bioinformatics play a critical role in understanding the molecular basis of diseases, identifying markers for disease predisposition, diagnosis and prognosis of disease, and help in developing better vaccines and therapeutics. In future bioinformatics is going to play a major role in reducing neonatal and child morbidity and mortality.13
With advent of ultrasonography many fetal developmental anomalies are picked up in antenatal life. This has led to the development of new branch called fetal medicine and surgery. Fetal surgery is possible either by minimal or major surgical intervention. Minimal surgery is by fetoscopy used for fetal transfusion, bladder neck obstruction, and certain congenital heart ailments. The major fetal surgery is now available for neural tube defect and diagrammatic hernia, through a cesarean section.
The last few decades have witnessed tremendous advances with new knowledge being accumulated in the fields of physiology, biology, immunology, and in the development of new drugs. It is now possible to prevent the progress of various diseases before they seriously damage the health of an individual. Several genetic disorders and inborn errors of metabolism are better understood, and several of these can be detected by screening pregnant mothers and newborn infants. Fetal malnutrition is recognized as the programing event for several noncommunicable diseases (NCDs) in the adult life. Nutritional interventions through diet and micronutrient administration in pregnancy may help in preventing a staggeringly high incidence of these disorders. Childhood sexual abuse, juvenile delinquency, and adolescent violence can be prevented by promoting harmony between parents, children, and between siblings. Injuries can be prevented by greater awareness in community and better designs of the incriminating agent.
 
The Challenges
Despite an encouraging progress with respect to certain health indicators globally, there are still wide differences in health status between and within countries. Achieving equity in health and sustaining the efforts to ensure that the world's most vulnerable people have access to health services are the most formidable global health challenges today.
 
Increasing Population
Current world population is 7.9 billion (2021). India has a population of 1.39 billion (2021). This exponential increase in population is increasing the burden on the demands of healthcare resources.
 
High Maternal Deaths
Even though maternal deaths are preventable and there has been steady decline in maternal deaths worldwide, still in 2013 there were 2.89 lakh maternal deaths globally. The difference in MMR, between the richest and poorest countries is quite high. The lifetime risk of maternal death in industrialized countries is 1 in 4,000, versus 1 in 51 in countries classified as “least developed.” The predominant causes of maternal deaths are the direct obstetric causes namely; hemorrhage (27%), hypertensive diseases of pregnancy (14%), and sepsis (11%).
Large expansions in antenatal care coverage are still needed as only 64% of pregnant women received the recommended minimum of four antenatal care visits or more. In addition, despite increasing coverage of delivery by a skilled birth attendant both globally and in several regions, coverage is still only 51% in the WHO African Region and in low-income countries.
 
High Child Mortality
The world has achieved progress in child survival in the past three decades, and millions of children have had better survival chances as compared to two decades ago. There is marked progress in reducing child mortality rates over last two decades with the annual rate of reduction in the global under-five mortality rate increasing from 1.9% in 1990–1999 to 3.7% in 2000–2019. Detailed discussion is provided under the heading child mortality.
 
Infectious Diseases
Globally, an estimated 3.2 billion people are at risk of being infected with malaria and developing disease, with 1.2 billion at particularly high risk (greater than a one-in-thousand chance of getting malaria in a year). The population at risk of contracting malaria has increased by 32.5% globally and by 43% in Africa. According to the latest estimates, 229 million cases of malaria occurred globally in 2019 and the disease leading to 409,000 deaths.
1.4 million people died from tuberculosis in 2019, including 208,000 people with human immunodeficiency virus (HIV), and major efforts will be required to ensure that all cases are detected, notified, and treated. 206,030 people with multidrug- or rifampicin-resistant TB (MDR/RR-TB) were detected and notified in 2019.
For dengue—the world's fastest growing arboviral infection—effective, long-term vector control and disease-prevention measures (including future vaccines) will require strong and well-funded national programs and strategies, and the support of partners in the global public health community, to reduce morbidity and mortality by 2020.
Emerging and re-emerging infectious diseases such as Ebola, H5N1 viruses, Cholera, and Middle East respiratory syndrome coronavirus (MERS-CoV) infections are other global health issues that will need serious global attention to control it.
 
Noncommunicable Diseases
Noncommunicable diseases kill 41 million people each year, equivalent to 71% of all deaths globally. Almost three quarters of all NCD deaths (28 million), and 85% of the 15 million premature deaths, occur in low- and middle-income countries. NCDs amount to 15 million people dying prematurely—before the age of 70 years—from heart and lung diseases, stroke, cancer, and diabetes, according to a new WHO report.
 
Access to Water and Sanitation
In 2017, 71% of the global population (5.3 billion people) used a safely managed drinking-water service—that is, one located on premises, available when needed, and free from contamination. A staggering 2 billion people have no access to toilets, latrines, or any form of sanitation facility at all and therefore practiced open defecation. 785 million people lack even a basic drinking-water service, including 144 million people who are dependent on surface water. Lack of sanitation facilities puts these people at high risk of diarrheal diseases (including cholera), trachoma, and hepatitis. In addition, wide disparities continue to exist, not only between different regions of the world but also between urban and rural areas and between different socioeconomic groups within countries.
 
Health Expenditure
Before the COVID-19 pandemic, global spending on health continued to rise, albeit at a slower rate in recent years. 2018 was the first year in 5 years in which global spending on health grew slower than gross domestic product (GDP). US tops the list of countries spending on health at 16.9% of GDP. India is way below and finishes at second from the bottom of the list with 3.6% in the year 2018. More formal financial transfers to protect those too ill to work are less common. Only one in five people in the world has broad-based social security protection that also includes cover for lost wages in the event of illness, and more than half the world's population lacks any type of formal social protection, according to the International Labour Organization (ILO).
 
Increasing Years Lived with Disability
Aging of the world's population is leading to a substantial increase in the numbers of individuals with sequelae of diseases and injuries. 14Rates of years lived with disabilities (YLDs) are declining much more slowly than mortality rates. The nonfatal dimensions of disease and injury will require more and more attention from health systems. The transition to nonfatal outcomes as the dominant source of burden of disease is occurring rapidly outside of sub-Saharan Africa. Leading causes of YLDs included low back pain and major depressive disorder among the top ten causes of YLDs in every country. YLD rates per person, by major cause groups, indicated the main drivers of increases were due to musculoskeletal, mental, and substance use disorders, neurological disorders, and chronic respiratory diseases; however HIV/AIDS was the main reason for the increasing YLDs in sub-Saharan Africa. Also, the proportion of disability-adjusted life years (DALYs) due to YLDs increased globally from 21.1% in 1990 to 31.2% in 2013. DALYs due to communicable diseases such as HIV/AIDS and diarrheal diseases have reduced by 50% since 2000. DALYs from diabetes accelerated by >80% between 2000 and 2019. DALYs from Alzheimer's disease have more than doubled between 2000 and 2019. Emerging health issues for the future are emerging diseases like Ebola, COVID-19, antimicrobial resistance development, climate change impacts, and shortage of skilled health manpower.
 
CHILD MORBIDITY
There has been a remarkable progress in child mortality. However, both children and adolescent still suffer from significant challenges in surviving and developing to their full potential. Over the last two decades there has been a change in epidemiology of global child health with better control of infectious diseases and changes in social life. Now noncommunicable illnesses and injuries are on the rise. At present the most common child morbidities are congenital anomalies, injuries, and NCDs (chronic respiratory diseases, acquired heart diseases, childhood cancers, diabetes, and obesity). Age-wise distribution of child morbidity is shown in Table 1.
 
Neonatal Period
With improving maternal and newborn healthcare services there has been a significant decline in global number of newborn deaths from 5 million in 1990 to 2.4 million in 2019. However, even now children face the highest risk of death in their first month of life. Thus, we need to concentrate and invest on the greatest burden of deaths and disability in this age group to bring about the desired results in a child's health. Efforts taken in providing efficient antenatal, natal, and postnatal health care will go in a long way in saving life of mothers, newborns, prevent stillbirths, reduce disabilities and pave the way for optimal child development. Common morbidities in this age group are shown in Table 1.
 
Low Birth Weight
Low birth weight babies are babies with birth weight <2.5 kg. In 2015, globally 20.5 million low birth weight babies were born. On an average nearly 70% of world's low birth weight babies are born in developing countries. These babies are more likely to die in their first month of life and account for nearly 10% of neonatal mortality. Hence, if we provide better care to this group of babies we will be able to curb the NMR. Further long-term complications like diabetes, hypertension, and obesity are seen more commonly in low birth weight babies as compared to those babies with normal birth weight. Aim of World Health Assembly (WHA) on nutrition target was to decrease the prevalence of low birth weight to <30% by 2025. However, attainment of this reduction has been limited in all regions of the world. Globally the annual average rate of reduction (AARR) in low birth weight prevalence was only 1.2% between 2000 and 2015 as against desired rate of 2.74%. There is no apparent change in low birth weight prevalence in Latin America, Caribbean Island, and Western Europe. On the contrary, there has been slight increase in prevalence of low birth weight babies in North America from 7.3% in 2000 to 7.9% in 2015.
TABLE 1   Age-wise distribution of child morbidity.
Age of child
Morbidity
Less than 1 month
Low birth weight, prematurity, birth asphyxia, sepsis, congenital malformation, congenital anomalies including heart disease
1 month to 60 months
Malnutrition, anemia, diarrhea, pneumonia, vector-borne illness, tuberculosis
Adolescents
Injuries, noncommunicable illness, substance abuse, mental health disorder, human immunodeficiency virus (HIV), undernutrition and obesity
 
Prematurity
Prematurity is defined by WHO as birth of baby before 37 weeks of pregnancy. It is not only the foremost cause of neonatal deaths but now it has also become one of the most important cause of death in under-five children. Globally, each year, 15 million preterm babies are delivered which accounts for 11% of all deliveries. In India, it accounts for nearly 13% of all deliveries. Survival of these preterm births have improved in developed nations but their survival in middle- and low-income countries is still dismal.
 
Birth Asphyxia
Birth asphyxia is defined as a failure to initiate or sustain spontaneous breathing at birth. Globally 2.5 million newborn deaths are due to birth asphyxia. First day and especially the first hour of birth is critical for survival. Skilled birth attendant at time of delivery and proper postnatal check-ups are crucial for wellbeing of mother and child. Nearly 17% of deliveries were not attended by skilled birth attendants in 2020.
 
Sepsis
Defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. 1.3–3.9 million annual neonatal sepsis cases are reported globally with 400,000 to 700,000 annual deaths worldwide. In institutional deliveries an estimated 4–56% of all deaths occurred in the neonatal period due to hospital-acquired sepsis. About 84% of these deaths could have been prevented by early diagnosis and timely treatment. Highest number of neonatal sepsis was seen in low-income countries particularly the African region. Group B Streptococcus and Escherichia coli infections accounted for 70% of early-onset neonatal sepsis.
 
Congenital Malformations
There has been an exponential increase in frequency of congenital anomalies with 1 in 33 infants being affected leading to 3.2 million children with disabilities due to birth defects every year.
 
Children Aged 1–5 Years
Children <5 years of age are particularly susceptible to infectious diseases like malaria, dengue, tuberculosis, HIV, pneumonia, and diarrhea. Despite being preventable illness, diarrhea, pneumonia and malaria are still responsible for 29% of global deaths in under-five children. Children living in low-income group countries like sub-Saharan Africa are worst affected. Poor socioeconomic status and illiteracy contribute to high burden of infectious diseases in developing countries. These risk factors are major determinants of undernutrition, infectious diseases, gender inequity, child labor, and child abuse. Although diarrheal disease is both preventable and treatable, it is the second leading cause of death in under-five children. Each year diarrhea kills 525,000 under-five children. 15Majority of these deaths could have been averted by provision of safe drinking-water, adequate sanitation, and hygiene. Globally, there are nearly 1.7 billion cases of childhood diarrheal disease every year. Diarrhea is also single most leading cause of malnutrition in under-five children. If it lasts for several days, it leads to salt and water loss causing severe dehydration which is the main cause of diarrhea deaths. Malnourished children have impaired immunity which predisposes them to severe infections. Worldwide, 780 million individuals lack access to improved drinking-water and 2.5 billion are deprived of proper sanitation. Diarrhea due to infection is widespread across developing countries. Children under 3 years living in low-income countries suffer from an average three episodes of diarrhea per year. Each episode of diarrhea predisposes a child to malnutrition.
 
Malnutrition
It refers to deficiencies, excesses, or imbalances in a person's intake of energy and/or nutrients. It can be of two types: undernutrition which includes wasting, stunting, underweight; or obesity. Both types predispose a child to diet-related NCDs. Globally in 2020, nearly 149 million under-five children were estimated to be stunted, 45 million were estimated to be wasted and 38.9 million children were overweight or obese. Malnourished children are more prone to infections particularly diarrhea and pneumonia.
 
Pneumonia
It is an important cause of under-five child morbidity and mortality. It accounts for 15% of deaths in under-five children killing nearly 808,694 children in 2017. It is an important vaccine-preventable illness, and it can be treated by antibiotics even then it is killing a child every 39 seconds. Pneumonia and diarrhea together are the major causes of under-five children mortality and account for 29% of deaths leading to loss of 2 million young lives. Low-income group countries in sub-Saharan Africa and South Asia account for 90% of under-five deaths due to diarrhea and pneumonia. Causes and solutions for both diarrhea and pneumonia are interrelated hence an integrated action plan for diarrhea and pneumonia [Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea (GAPPD)] was developed by WHO to end preventable child deaths from diarrhea and pneumonia.
 
Malaria
It is another important cause of under-five child morbidity and mortality killing a child every 2 minutes. Deaths due to malaria in under-five children accounted for 67% of global malaria deaths. WHO has initiated WHO Global Malaria Programme (GMP) to control and eliminate malaria. Over last two decades, 21 countries have eliminated malaria and 11 have been endorsed malaria-free by WHO.
 
Tuberculosis
It claims lives of nearly 600 under-15 children every day with majority of deaths being seen in under-five children. Countries have developed national programs for prevention, surveillance diagnosis, and treatment of tuberculosis, yet 1 million children are falling ill every year. Off these 1 million children only 50% are identified and registered by national programs. WHO has announced End TB strategy. The most important road map to achieve it is prevention, appropriate diagnosis, and management of childhood tuberculosis. Apart from tuberculosis another important communicable illness in under-five is HIV infection. Both HIV and tuberculosis are seen more commonly in undernourished children. They affect similar populations in resource-limited settings and predispose the child to persistent diarrhea and other opportunistic infections further deteriorating their nutrition status. Each day approximately 880 children are getting infected with HIV virus and 310 children are dying due to AIDS-related cause. Majority of these children (90%) live in sub-Saharan Africa. However there has been a bright spot in childhood HIV, with the launch of nation wise programs to prevent mother to child transmission which has brought about rapid decline in number of new cases in children <5 years.
 
Adolescents
Survival chances of children aged 10–14 years vary in different regions of the world. It is worst in sub-Saharan Africa, Central and South Asia, Latin America, and Caribbean Islands. Probability of a 10-year-old dying in sub-Saharan Africa is 10 times as and when compared to high-income countries like North America and Europe. Nearly 1.5 million adolescents or 5,000 adolescents per day lost their life in 2019. Major causes of mortality in them were injuries, violence, substance abuse, early pregnancies, unsafe abortions, etc. Globally on an average 43 per 1,000 girls aged <18 years of age are giving birth per year.
 
Injuries
Inadvertent injuries are the foremost cause of death and disability among adolescents. Road Traffic Accidents stands out as a major killer in the year 2019. Majority of the victims were vulnerable road users like amblers, cyclists, or drivers of two wheelers. Many countries still have not enforced road safety laws and more and more young drivers are coming up on the roads. Furthermore, lack of safety equipment like helmets, use of safety belts, or driving under the influence of drugs or alcohol has worsened the outcome. Graduated licences for novice drivers is essential and should be enforced by the law of the land. Drowning is another important cause of adolescent deaths. More than 30,000 adolescents, particularly boys, have died due to drowning in the year 2019. Children should be taught and monitored while swimming to prevent these deaths.
 
Violence
Fourth leading cause of adolescence death is interpersonal violence. Low-income countries have a higher prevalence of deaths due to violence in adolescent males. Sexual violence too accounts for significant proportion with 1 in 8 reporting sexual abuse. This also increases the risk of HIV, sexually transmitted infections, mental health, early pregnancy, and early school dropouts. Proper parenting, early childhood development (ECD), community participation, sexual education, restriction on alcohol consumption, and law enforcement are the keys to reduce violence and its consequences.
 
Mental Health
Mental health particularly depression is one the foremost causes of disability in adolescents. It accounts for nearly 16% of global burden of diseases. Suicide is the third leading cause of death in children aged 15–19 years. Children as young as 14 years start showing symptoms of depression. Factors associated with poor mental health are violence, poverty, social stigma, exclusion, lack of education, parental divorce or separation, and living in fragile settings. If the mental health is unaddressed at adolescence, these children will grow up with limited opportunities of living a fulfilling life in adulthood. In order to address and prevent this disability children should be taught socioeconomic skills early in life. Every effort should be made at individual and at community level to strengthen ties between adolescents and their families.
 
Alcohol and Substance Abuse
Drinking alcohol and substance abuse is a major health issue for adolescents both in developing and developed countries. Driving under its influence is one of the major causes of road traffic accidents. 16155 million adolescents globally have started consuming alcohol below the legally permitted age. Prevalence of heavy episodic drinking among adolescents aged 15–19 years was 13.6% in 2016, with males most at risk. The most used psychoactive drug in adolescents is cannabis (4.7%) in 2018. Neurocognitive alterations due to substance abuse lead to behavioral, emotional, social, and academic problems in later life. Countries have developed programs for prevention of use of alcohol and drug by incorporating population-based strategies interventions, activities in school, community, family, and on the individual level. Legal system of each country has a set minimum age for consumption of alcohol. Drug consumption is banned in all countries with strict punishments for its perpetrators.
 
Tobacco Use
Tobacco smoking is prohibited in many countries of the world yet 1 in 10 adolescents aged 13–15 years are smoking tobacco.
 
HIV/AIDS
1.7 million adolescents aged 10–19 years are living with HIV in the year 2019 with a significant majority (90%) living in WHO African region. 1994 saw a peak in the number of new cases thereafter there has been a substantial decrease in fresh cases. However, adolescents account for 10% of new adult HIV infection. Early onset of sexual behavior, lack of use of protective measures, poverty, broken families, and lack of education are key contributing factors.
 
Other Infectious Diseases
Improved vaccination coverage has helped in decreasing death and disability due to vaccine-preventable illness. For example, adolescent mortality due to measles has decreased by as much as 90% in African region over the last decade. Diarrhea, pneumonia, and meningitis still account for the most important causes of morbidity in adolescents aged 10–14 years. Human papilloma virus infection is another vaccine-preventable illness which is becoming common in adolescents. It is normally seen after a sexual activity and can lead to both short-term disease (genital warts) or more severe cervical cancer in later age. HPV vaccination has been advised at early adolescence (9–14 years). Even then by 2019 globally only 15% of girls have received it.
 
Early Pregnancy and Childbirth
Early age of sexual activity and teenage pregnancy are on the rise leading to death in girls aged 15–19 years due to pregnancy-related complications. 12 million girls aged 15–19 years and 777,000 aged under 15 years are getting pregnant per year. Global adolescent birth rate in 2020 was 43 births per 1,000 girls. Universal access to sexual and reproductive healthcare services, family planning programs, sexual education, better access to contraceptive measures, strict law enforcement regarding minimum age of marriage, and safe access to abortion is the need of hour.
 
Nutrition and Micronutrient Deficiencies
Anemia particularly iron deficiency is an important cause of adolescent morbidity. Many countries like India have started nation-wise iron folic acid supplementation and regular deworming to prevent micronutrient (including iron) deficiencies. Good eating habits is foundation of good health. There should be regulatory laws to stop promotion of food which are high in saturated fats, trans fatty acids, free sugar, or salt.
 
Decreased Physical Activity, Undernutrition, and Excess Screen Time
With advent of latest technology and ever-expanding digital media there has been an increase in duration of screen time. This has led to with restriction of outdoor physical activity. With the ongoing COVID pandemic the situation has worsened. Obesity is on the rise leading to increased prevalence of noncommunicable illness in adolescents. Globally in the year 2016 nearly one in six adolescents were overweight. Prevalence varied in different regions of the world from 10% in South-East Asia to over 30% in America. WHO had recommended at least 60 minutes of physical activity daily. Globally only one in five adolescents meet these guidelines. Frequency of slothfulness is high particularly in female adolescents as and when compared to male adolescents.
 
EARLY CHILDHOOD DEVELOPMENT
Early childhood years from conception to 6 years are the most fundamental period in a child's life which lay the footing for further learning and development. Brain growth is maximum in the initial years with 90% being in first 6 years. Millennium year had brought remarkable progress in poverty reduction in developing countries yet children in those countries were still lacking from reaching optimum development and wellbeing. This could be due to limited access of children to health services, poor nutrition, and poor psychosocial development. It is the effective nurturing of child's initial years that will decide the fate of his rest of his life. It is seen that the most disadvantaged children are the ones to have least access to health care. Prolonged exposure to stress (both physical and mental) would trigger inappropriate biological responses which would interferes with development of brain. This would contribute to a vicious cycle of poverty, inequality, and social exclusion. Nearly 250 million under-five children living in low- and middle-income countries are not able to reach their developmental potential due to extreme poverty.
Child's health begins right after conception. Maternal health, nutrition, and environment would impact on her baby's growth and development. After birth, initial years of his life would be the foundation stone for his physical and mental health. The building blocks of a child's life remarkably depend on his foundation. Hence, getting the foundation right is the most important direction toward which countries health policy should concentrate. Numerous factors influence early child survival outcomes, but an important share is attributable to health service provision and the social determinants of health. Maternal care, namely availability of prenatal care, medically-assisted deliveries and institutional deliveries significantly reduces infant mortality. Other factors associated with infant and child mortality include poverty, location (urban/rural), access to electricity, and caregivers’ level of education. Despite the need of ECD there is little urgency shown by governments across the world. For example countries like sub-Saharan Africa, only 0.012% of gross national product is spent on preprimary education.
To provide ECD opportunities for children to survive thrive multisectoral involvement of health nutrition and early learning is required. UNICEF has adopted the global program on ECD which concentrates on early years of child. Objectives of the program for both child and his parents or care givers are enumerated below:
  • Essential services for children up to age of school entry: Equitable access to quality child care, health, nutrition, protection, and early learning services to address their developmental needs.
  • Nurturing care by parents or care givers: Enforces on positive parenting, stimulation, and learning. Nurturing care framework (Fig. 5) has been described for every child so as to help them to reach their full potential. It comprises of five inter-related and indivisible components such as good health, adequate nutrition for mother and child, security and safety, responsive care giving, and early learning.
Nurturing care of a child starts even before conception. Healthy and happy mothers give birth to healthy babies. It reduces chances of prematurity, low birth weight, and congenital disorders. Mothers can communicate with their fetus by about second trimester of pregnancy when the growing fetus begins to hear. After birth early skin to skin contact and exclusive breastfeeding helps in growth, optimal nutrition, and care of the newborn.17
zoom view
Fig. 5: Components of nurturing care.Source: World Health Organization, United Nations Children's Fund, World Bank Group. Nurturing care for early childhood development: a framework for helping children survive and thrive to transform health and human potential. Geneva: World Health Organization; 2018.
For preterm babies nurturing care is particularly important as these babies are vulnerable. It is imperative for caregivers and health professionals to provide adequate care to both mother and child and create a supportive environment for their optimal development. Other factors that compromise ECD include poverty, poor maternal nutrition, exposure to environmental pollutants, toxic chemicals, poor mental health in caregivers, inadequate breastfeeding, malnutrition, recurrent infections, chronic illnesses, unintentional injuries, poor stimulation, neglect, maltreatment, disabilities, gender differentiation, and unstable home. In developed nations emerging problems are early parenthood, substance abuse, maternal depression which have negative impacts on ECD. In low- and middle-income countries poverty is an important cause of suboptimal development and stunted growth. War, disaster, and displacements have impaired the lives of millions of children globally. 250 million children are staying in war affected countries another 160 million are residing in country suffering from food crisis due to prolonged famine, water depletion. Two percent of humanitarian funding is allotted for child's education and development but a very minimal portion is spent on ECD. Children are the future of the world, and we urgently need to integrate the Nurturing Care Framework into humanitarian policies, programs, and services for the upliftment of children.
 
Good Health
For children to have good health, parents or caregivers should monitor their physical and emotional conditions, provide affectionate response to their daily requirements, protect them from dangers both inside and outside their homes, practice hygiene, and provide early and appropriate treatment for their illness. To provide good health, the care giver too should be physically and mentally fit. Thus, it is a vicious cycle of healthy parents and healthy children.
 
Adequate Nutrition
Parents have a duty to provide healthy nutrition to their offsprings. This begins right from conception. Healthy mothers bear healthy fetus and would be able to exclusively breastfeed her child. Infant's brain growth depends a lot on the nutrition he receives. Thus, exclusive breastfeeding for 6 months followed by introduction of nutrient enriched complementary feeds are key criteria in the initial stages of child brain and physical growth. Besides healthy diet social and emotional interaction involved in feeding a young child too have a significant role to play. Both food safety and family food security are essential for adequate nutrition.
 
Responsive Caregiving
Infants until they develop speech, try to communicate with their parents or caregivers through movements, eye contact, sounds, and gestures. It is impertinent for caregivers to recognize them and react to them to protect them from adversities, illnesses, and help them to learn and build social relationships.
 
Opportunities for Early Learning
Learning starts right from conception. Initially described as epigenesis a biological mechanism. It then continues through infancy when motor and fine skills are obtained from the environment a child is placed in. For example, through touch feel of simple household objects like cups, plates, and spoons a child can decipher shapes, learn colors provided the caregiver is interacting and motivating the child.
 
Security and Safety
Young children need protection at home and outside their homes as they themselves cannot anticipate dangers. Children <5 years are hyperactive and are prone to poisoning, foreign body aspiration, and injuries. They can encounter fear from strangers, feel uncomfortable when left alone. They are prone to both physical and sexual abuse. These experiences give rise to overwhelming fear and stress thereby leading to emotional and social alienation.
Aim of nurturing care is to make a child safe and secure, allow him to bloom to his full developmental potential.
 
ECD and COVID-19
The ongoing pandemic of COVID-19 has given rise to new set of challenges for parents and caregivers. With closure of schools, development of new modes of online teaching, restricted movement of children, less interaction with peer groups, and the daily lives of the little ones have changed. In addition to it parents are suffering from job loss, social insecurities in addition to added responsibilities of interacting to a greater extent and spending quality time with their children.
 
CHILD LABOR
Globally in the year 2020, 160 million children were being subjected to child labor. COVID-19 has increased the susceptibility of additional 9 million children. Thus, by the end of 2021, 1 in 10 children would be driven to child labor and almost half of them would be working in perilous state endangering their health and development. Broken families, poverty, overpopulation, unemployed parents, and death of parents or caregivers are pushing children into child labor and their numbers are increasing day by day. The aftermaths are astounding leading to physical harm, mental harm, or death. Children are deprived of their fundamental rights of schooling, health care, and often subjected to undue stress and sexual exploitation. Current pandemic with increasing economic insecurities, political and social instability is leading to adverse socioeconomic and financial impact which has given rise to a large migrant population and refugee children. Nearly 30 million children are living outside their country of birth. These children are neither protected by law of the land or any government bodies and are easily available for menial works at reasonable cost. Sometimes these children are illegally trafficked 18for sexual exploitations, or they become subjects of illegal organ donation. Attempts by WHO and UNICEF to stop child labor has been hindered over since 2016 and with rising armed conflict and unstable geopolitical scenario there has been a rise in the incidence of hazardous work by children living in these countries by about 50% as compared to global average. UNICEF along with ILO has emphasized on birth registration. This would ensure governments to enforce minimum age of work and help to remove children from labor to schools. Population control, increased work opportunity, parental education, and comprehensive social services would help in the long run to keep a child protected and within his family.
 
VIOLENCE AGAINST CHILDREN
Child abuse implies to all aggression against any child under 18 years of age inflicted by parents, caregivers, or strangers. Globally, year 2019 saw nearly 1 billion children aged under 18 years suffering from abuse physical, sexual, or emotional. Consequences of child abuse have long lasting effects on physical and mental wellbeing. Exposure to violence in early years impacts health and wellbeing of a child. 2030 agenda for Sustainable Development is to end abuse, exploitation, trafficking, and all forms of violence against children. Maltreatment can occur at any stage of a child's life. It can be physical, sexual, psychological, or emotional. Perpetrators can be parents, care givers, friends, and neighbors. Setting can be either at home, school, orphanage, etc. Schools and playgrounds can be a perfect place for bullying or harassing. Bullying can be physical, mental, or social. Nowadays in a world of digital media cyber bullying is on the rise. Adolescents (males or females) can be victims of intimate partner violence. However, it is seen more commonly in adolescent unmarried females. She can be a victim of sexual abuse including online sexual harassments. Impacts of these abuses can be multidimensional. It could lead to death (homicide, suicide) or injuries. If the assault occurs at a younger age, there is negative impact on the cognitive development of child due to impaired development of brain and nervous system. Recurrent exposure to physical and mental abuse would later lead to anxiety, depression and eventually to substance abuse high-risk sexual behavior, unintended pregnancies, abortions, sexually transmitted infections, and HIV.
Violence against children is preventable. WHO has developed the word INSPIRE where each word stands for a strategy. I for implementation and enforcement of law, N for norms and value change, S for safe environment, P for parental and caregiver support, R for response service provision, and E for education and life skills. Children are the future of tomorrow, and it is their right to grow up in a safe and secure environment. It is the duty of parents, caregivers, health workers and policy makers to ensure that they are provided one.
To conclude, the world has undergone remarkable progress in young child survival over the past two decades. Declining global child mortality particularly under-five mortality is an indicator of better coverage of essential health services, health system readiness, and better implementation of child health policies. Despite this progress there are certain gray areas which need to be addressed. Reduction in child mortality is not uniform, countries in sub-Saharan Africa still account for 50% of global under-five mortalities. Rate of reduction in neonatal mortality is still slow and accounts for nearly half of under-five child mortality. Prematurity, birth asphyxia, diarrhea, pneumonia, and vector-borne diseases remain as the most common cause of under-five child mortality. For adolescents, road traffic accidents, injuries, drowning, and burns are leading causes of mortality and morbidity. Gradually, the focus of child health is now shifting from child mortality to nurturing care and provision of better environment for development and growth of child. It is a known concept that an adolescents physical and mental health would depend on the care he receives in his initial life. By improvising the environment and concentrating on a child's physical and mental health in his initial years would pave the way for a healthy nation and a healthy world.
19
1.3 Evidence-based Care in Pediatrics
Joseph L Mathew
In recent years, the term evidence-based medicine (EBM) has transformed from an esoteric academic concept to a practical process of enhancing healthcare delivery. Over the past two decades, resistance among physicians and other healthcare providers to this facet of clinical practice has gradually diminished. The term EBM itself has been widened to evidence-based practice or evidence-based healthcare, although many experts prefer to use the more neutral phrase “evidence-informed” rather than evidence-based. Whatever term is used, broadly it refers to the scientific discipline of incorporating research and clinical evidence into healthcare decisions and practice. For want of a more specific definition, evidence-based pediatric care can be taken to include the principles, processes, and practice of EBM for the health and wellbeing of children.
 
WHAT IS EVIDENCE-BASED HEALTH CARE?
Excerpts from some of the definitions of EBM during the evolutionary years, help to clarify the concept and (perhaps more important) the scope of EBM (Table 1).
For practical purposes, the 1998 description of EBM as the “integration of good evidence with clinical expertise and patient values” by Strauss and Sackett, is simple yet elegant. It captures the importance of clinical expertise as well as research-based evidence, the two concepts that are sometimes in conflict. The third dimension of “patent values” emphasizes that healthcare delivery is not a mechanical process, but centered around the key stakeholder, viz., the patient. It also highlights that clinical decisions and actions are to be individualized, besides the fact that clinical (and other healthcare) decisions are to be shared by healthcare providers and recipients.
At this point, it is very important to also understand, what is not evidence-based care. The blind application of the results or conclusion(s) of research publications (such as systematic reviews or other types of research) into clinical practice is one common mistake. Likewise, selective identification and utilization of research papers to support or justify whatever a professional is doing (or prefers to do), also does not constitute evidence-based care. Further, interpretation (and application) of data selectively (i.e., without understanding the full context) is also inappropriate. Ignoring the values, preferences, and wishes of patients by not involving them in decisions concerning their health, is a serious violation of the principles of evidence-based care.
Other misconceptions about EBM are that its purpose is to make the practice of health care more democratic, in the sense that, professionals with and without vast experience or expertise are at the same level of subservience to research evidence. This is completely erroneous as the definition itself emphasizes the need for clinical expertise, in order to practice evidence-based care. Some professionals mistakenly believe that the main application of EBM is to judge whether interventions that work in developed country settings can be applied to local settings; while others feel that evidence-based care reduces the need for clinical judgment as all children with a given clinical condition could be treated with a uniform protocol.
Strictly speaking, the term evidence-based may be a misnomer because it implies that there is a scope for nonevidence-based practice as well. However, in fact almost all healthcare professionals use some kind of evidence for their clinical decisions and it is unlikely that anyone acts solely on personal whims. However, there is wide latitude in what constitutes evidence, and even more dissent about what constitutes best evidence. All professionals would agree that evidence is based on observations in the clinical and research setting, and that greater the number of observations pointing in a given direction, the more likely (though not necessary) that it points toward the truth. However, best evidence creates controversy. Many professionals argue that their personal experience and clinical observations constitute the best evidence for their patients (and practice setting). However, the traditional evidence hierarchy places expert opinion right at the bottom of the pyramid (Fig. 1), even below case reports of individual patients. But, the definition of EBM insists that clinical expertise is a significant component. This apparent paradox can be resolved by understanding that the quality of evidence (and its categorization as good, better, or best) is in proportion to the efforts made to remove or resolve bias from the process of generating and/or interpreting the observations comprising evidence. The term “bias” reflects anything which leads investigators away from the truth. In research methodology, it represents a systematic error due to limitations in methods and procedures used to conduct the research study. It is to be distinguished from random error whereby research investigators may be led away from the truth purely due to chance, hence it is an error outside their control.
TABLE 1   Excerpts from definitions of evidence-based medicine.
1995
“EBM is the process of systematically finding, appraising, and using results obtained from well-designed and conducted clinical research to optimize and apply clinical decisions” (Sackett et al. BMJ. 1996;312:71-2)
1996
“Conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patient” (Straus and Sackett. BMJ. 1998;317:339-42)
1998
“Integration of good evidence with clinical expertise and patient values” (Haynes et al. BMJ. 2002;324:1350)
2002
“To encourage practitioners and patients to pay due respect— no more, no less—to current best evidence in making decisions” (Haynes et al. BMJ. 2002;324:1350)
2003
“Integrating clinical expertise with best available external evidence in the care of the individual patients keeping in mind the patient's circumstances” (Sehon and Stanley. BMC. 2003;3:14)
2005
“Way of thinking arguing that healthcare decisions need to be focused on research-based evidence” (de Backer, Verh K. Acad Belg. 2005;67:205-17)
2005
“Evidence-based medicine is a set of principles and methods intended to ensure that to the greatest extent possible, medical decisions, guidelines, and other types of policies are based on and consistent with good evidence of effectiveness and benefit” (Eddy DM. Health Affairs. 2005;124:9-17)
2010
“The use of mathematical estimates of the risk of benefit and harm, derived from high-quality research on population samples, to inform clinical decision-making in the diagnosis, investigation or management of individual patients” (Greenhalgh T. How to Read a Paper: The Basics of Evidence-Based Medicine, 4th edition. John Wiley & Sons; 2010. p. 1. ISBN 978-1-4443-9036-0)
(EBM: evidence-based medicine)
20
zoom view
Fig. 1: The evidence hierarchy. (CSR: Cochrane systematic reviews; RCT: randomized controlled trial; SR: systematic reviews)
It is for this reason that any form of evidence having a low(er) risk of bias climbs upward on the evidence hierarchy and vice-versa. This is precisely why randomized controlled trials (RCTs) of interventions and systematic reviews of RCT are ranked highest in the evidence hierarchy. Among systematic reviews, Cochrane reviews are superior on account of methodological rigor, multiple quality-control processes at various stages, and a robust peer review as well as editorial process.
Patient values include the unique circumstances (such as healthcare setting, personal or social issues, economic status, etc.) of individual patients, for and (hopefully) by whom, healthcare decisions are made. In a well-developed healthcare system (unlike the provider-driven settings in most developing countries), patients, i.e., consumers of healthcare are provided the professional's judgment (based on clinical expertise) and the best evidence (based on relevant research and the experience in that healthcare setting); and they are encouraged to make decisions factoring in their perception, situation, and expectations. The role of the professional is to facilitate this process and guide patients in the right direction, addressing their concerns. Ideally, this is how evidence-based care is to be practiced. Therefore, it may happen that while professional judgment and research evidence point in a certain direction, the patient may choose not to take that direction on account of his or her values. Such situations are to be respected by healthcare professionals. When such a decision is a shared process between the patient and the professional then it too constitutes evidence-informed practice.
 
EVIDENCE-BASED PRACTICE
A detailed description of how to practice evidence-based healthcare is outside the scope of this chapter. Readers may access the large number of resources freely available through the internet. A brief outline of the steps involved in evidence-based practice is presented in Table 2.
It should be clearly recognized that evidence is a tool to facilitate appropriate decision-making and is not the decision itself. A parallel can be drawn from the various laboratory tests ordered by healthcare professionals. Good physicians use the results of laboratory tests to confirm what they suspect on the basis of their knowledge and clinical expertise. They also factor in the circumstances of an individual patient and the local healthcare setting. They would not base their decision(s) solely on the basis of the test results no matter how impressive they may be. This is how evidence is expected to be used in the real world. In contrast, some physicians order a battery of laboratory tests without clinical justification; and then proceed to treat the abnormal results irrespective of their relevance. There are some who practice EBM in a similar inappropriate fashion.
 
Quality of Evidence
Evidence used for decision-making should be critically appraised for quality. This essential step determines its internal and external validity. Quality usually refers to two different aspects, viz., methodological quality (related to the study design) and process quality (related to the procedures used to generate the evidence). The former includes methodological refinements in research studies that are designed to reduce bias, e.g., randomization and allocation concealment to minimize selection bias, intention-to-treat analysis to mitigate attrition bias, etc. The latter includes procedures to minimize errors in data collection, e.g., averaging of multiple measurements, instrument calibration, using gold standard tests or methods, etc. There are various tools available for appraising primary and secondary research for methodological quality, whereas the judgment of process quality is often left to the discretion of researchers, or journal editors or the peer review process. Quality of evidence does not imply the quality of the reporting or presentation of the evidence. The traditional belief that publications in prestigious journals, or authored by renowned investigators, can be assumed to be of high quality, is not necessarily true.
 
Tertiary Research
The complexity involved with understanding, interpreting, and thereafter applying research evidence has spawned a new brand of analysis referred to as tertiary research (for want of a better term). This form of research has become critical for healthcare stakeholders (professionals, patients, policy-makers, advocacy groups, lay press, etc.) to cut through the technical jargon in research, identify the relevant message, and provide a summary that can serve as a tool for evidence-based decisions. In that sense, it demands a very high level of skill and integrity from the tertiary researcher. The former, because it is more complicated than generating primary or secondary evidence and leaving the stakeholder to interpret the same. The latter because the tertiary researcher can consciously or unconsciously mislead the stakeholder in the direction of his/her own biases. Unfortunately, although a lot of tertiary research products are in circulation (commentaries, evidence-based editorials, evidence summaries, and nonsystematically generated guidelines/recommendations) which are appealing to the end-user, the methodological process for validation of such research is still under development.
 
CHALLENGES TO EVIDENCE-BASED CARE IN PEDIATRICS
 
Decision Questions versus Clinical Questions
Healthcare professionals expect research evidence to provide answers to their decision-making questions, such as “Should I use this medicine or vaccine or test or procedure?” However, research evidence is designed to address specific clinical questions in the famous PICO format [identify the patient problem or population (P), intervention (I), comparison (C), and outcome(s) (O)] from which individual stakeholders (professionals, patients, and healthcare systems at large) are expected to derive conclusions and then make their own decisions. Thus, evidence cannot dictate what a professional should do. It is designed to provide information on the basis of which, the professional and patient together have to make a shared decision, incorporating clinical experience and personal values, respectively. This requires knowledge and skills to understand, interpret, and apply research evidence. This is the art of practicing the science of EBM.21
TABLE 2   Steps in evidence-based practice.
S. No.
Steps
Remarks
1.
Identify an area in your healthcare practice where a decision is required for a particular patient or problem
In general, a common starting point for EBM is an encounter with a patient, and the need for answers for that particular patient. Common examples are situations raising the questions: “What shall we do for this problem?” or “Would this approach work for this patient?”
2.
Frame an answerable question by converting decision questions into clinical questions, using the PICOT format:
P = Population/Patient/Problem
I = Intervention or Exposure
C = Comparison
O = Outcome(s) of interest
T = Time-frame over which outcomes are considered
P: Population refers to the broad group into which an individual patient (for whom the decision is required) fits, for example children with asthma, typhoid, etc. A common error is trying to frame a question specific for the actual patient such as “a 3.5-year-old boy with moderate persistent bronchial asthma having a common cold.” To redress the imbalance, some experts prefer to use P for Problem, i.e., describe what is the problem, rather than who is having the problem
I: Exposure is a better term than Intervention, because it encompasses not only interventions (such as medications, vaccines, health education, care packages, etc.), but also diagnostic tests, risk factors, prognostic factors, etc.
C: Although many clinical decisions may not appear to involve comparisons, they almost always reflect unexpressed comparisons against doing nothing, following the current practice, etc.
O: Outcomes could be hard outcomes such as mortality, cure, etc., or soft/surrogate outcomes which are indirect markers believed to reflect the hard outcome(s). These are more plentiful but less robust. When in doubt, opt for patient-centric outcomes, i.e., those which are meaningful from the perspective of patients
T: Time frame is often not included, but is important because the same outcome (for example mortality, cure, etc.) has different interpretations depending on the timeframe over which they are expressed. Further, many outcomes develop over time (and although important may not be captured adequately in a research study), while others occur in the short term and are easier to record
3.
Search scientific literature to access and identify the best evidence addressing the clinical question
  • Scientific literature search is a formal discipline to be distinguished from the usual internet searches
  • Literature search could be broad-based (sensitive, i.e., designed to minimize missing any relevant publication) or focused (specific, i.e., designed to filter irrelevant material)
  • Some of the tips and tricks to refine literature searches include: (1) choosing appropriate search terms with the aid of MeSH terms, (2) starting with a highly sensitive search and narrowing down to a more specific search, (3) using multiple databases that include the Cochrane Library, Medline through PubMed, and subject-specific databases, (4) using Filters/Limits to increase specificity, and (5) recording the output carefully
  • It is important to target high-quality evidence in literature search. Hence, one could restrict the search to specific study designs associated with low(er) risk of bias, or look for systematic reviews of such studies
  • The common practice of a “quick search” using search engines like Google, Google Scholar, etc., is not preferred because; (1) the search strategy used by such engines is not disclosed, (2) the yield is compromised by poor specificity, and (3) widely publicized/open access materials are more likely to be retrieved
4.
Critically appraise the literature
  • Critical appraisal is designed to assess two important sources that create bias in research studies, viz., (1) bias associated with inappropriate choice and/or execution of study designs, and (2) bias associated with inappropriate processes (methods, instruments, etc.) used to capture data
  • There are numerous tools that facilitate a rapid and fairly easy appraisal of methodological quality. Most of these are available online and reflect: (1) whether the study included methodological refinements limiting bias, thereby assessing validity, (2) the main results and whether these are both statistically as well as clinically significant; and (3) if yes, whether the results could be applied to the individual patient in the real-life setting
  • Process quality requires some understanding of the subject area, in order to judge whether the procedures described in the research evidence, are valid (or not)
5.
Synthesize the best evidence
  • For users, i.e., those who would use the evidence, such a synthesis would be available through a systematic review. For producers, i.e., those who generate the evidence, the synthesis is under the umbrella of a systematic review (with or without meta-analysis)
  • If systematic reviews are not available, synthesis involves carefully extracting data from individual pieces of evidence and putting it together
6.
Interpret the evidence
Interpretation of evidence requires basic knowledge and skill in the subject area, research methodology, and biostatistics. Although an in-depth knowledge may not be required, broad understanding is required to interpret the evidence as opposed to blindly believing the authors’ conclusions
7.
Consider applying the evidence based on your clinical expertise and a shared understanding of the patient's values
  • Before attempting to apply the evidence, a free and frank discussion with the patient (and especially family where children are involved) is required to explain the information gained through your clinical expertise and the current best evidence
  • This has to be put together with the patient (family) preferences, beliefs, perceptions, apprehensions, concerns, expectations, desires, financial status, logistic considerations, etc. The evidence should be applied only after a mutually acceptable shared decision is reached jointly by the healthcare provider and recipient
8.
Assess the results
  • Evaluate the results, irrespective of whether or not the intervention was applied
  • Ensure that patients (families) are participants in the evaluation process
(EBM: evidence-based medicine; MeSH: medical subject headings)
 
Practical Challenges in Accessing and Applying Evidence
Often, healthcare professionals appreciate the value of incorporating evidence in their decision-making processes, but the evidence is either unavailable or inaccessible (at the time or place required). This is largely related to the healthcare setting wherein crowded clinics or wards and limited technological facilities pose challenges to the real-time access and application of research evidence. 22This situation has undergone tremendous improvement with the availability of mobile phone-based applications and better internet connectivity at the point-of-care.
 
Generalizability of Evidence
Another major limiting issue in evidence-based practice is the issue of generalizability of evidence. As for many issues in healthcare, evidence generated from a particular setting may not be directly applicable to other settings. This could be on account of biological characteristics of the patient (population) or disease, healthcare system differences, locally relevant guidelines, or even cultural practices or traditions. Some of these limitations may operate even when evidence is generated from the same or similar setting. For example, evidence on milder forms of disease cannot be extrapolated to patients with severe disease, or those with comorbidities, etc. In such situations, professional judgment is required to determine applicability of evidence, i.e., can the evidence be implemented in my setting? If yes, would it result in similar effects?
 
Efficacy versus Effectiveness
Research evidence usually presents information on the efficacy (and sometimes) safety of interventions from research settings, whereas in real life, we require information on effectiveness. In simple terms, efficacy addresses the issue “Does this work in a highly controlled research setting?” whereas effectiveness reflects “Will this work in the real-world healthcare setting that I am working in?” Assessment of effectiveness requires a careful appraisal of issues beyond efficacy and safety, and encompasses aspects like the healthcare setting, feasibility, logistics, and cost considerations of the intervention (and its alternatives), social aspects, and other issues.
 
Evidence on Healthcare Interventions versus Health Problems
It should also be recognized that healthcare interventions (therapeutic/diagnostic) rather than health problems are the usual starting point for generating primary and secondary research evidence. Therefore, practice of EBM can become a process of applying interventions that are supported by evidence, at the cost of ignoring other options for which robust evidence on efficacy may not be readily available. For example, research evidence may suggest that a particular vaccine is efficacious in a given setting, but there may not be sufficient evidence on alternate measures to tackle the healthcare problem (through better sanitation, hygiene, nutrition, education, etc.). In such a situation, implementation of the efficacious intervention gives the impression of evidence-based practice.
 
GRADING OF EVIDENCE
Recognizing that all evidence is not of equal quality for the purpose of making decisions, the GRADE approach was initiated about two decades back. GRADE is an acronym for Grading of Recommendations Assessment, Development and Evaluation. It is a system to evaluate the strength of evidence and the level of confidence that can be placed in it. In general terms, high-quality evidence reflects a high level of confidence that the effect presented in/by the evidence is close to the true effect. Reduced levels of confidence are reflected by terms such as moderate, low, or very low quality of evidence. In addition, the GRADE approach entails a semiobjective assessment of the management alternatives, and patient values; based on which evidence can be downgraded or upgraded. This helps to frame recommendations for healthcare practice along with explicit statements on the strength of the recommendations.
 
EVIDENCE TO DECISIONS
The GRADE approach also facilitates stakeholders to examine the evidence for contextual relevance and local applicability. This is important for translating high-quality research evidence to real-world healthcare decision-making. The Evidence to Decision (EtD) framework clarifies criteria used to assess specific interventions and the available alternatives, the basis for decision judgments, the strength and quality of research evidence, and locally relevant considerations. EtD frameworks are thus helpful for guideline development panels to make judgments about the priority level of the healthcare problem (in terms of epidemiologic burden, urgency, etc.), the balance between the expected desirable and undesirable effects, certainty of the evidence, resource allocation issues, judgments on cost-effectiveness, potential impacts on equitable distribution, stakeholder acceptability, and implementation feasibility.
 
BEYOND EVIDENCE
 
Health Technology Assessment
It should be recognized that evidence-informed pediatric practice involves much more than accessing, appraising, and applying the relevant evidence. It involves a careful appraisal of additional issues such as financial costs, cost-effectiveness of interventions, social implications, feasibility, logistics, long-term impact, etc. These components together form the broader discipline of health technology assessment (HTA). Most developed healthcare systems rely on information provided by HTA organizations/institutions to guide their decision-making system. In contrast, many developing healthcare systems lack such facilities and experience challenges in making rational decisions at the individual, institutional, organizational, or national level.
 
Clinical Practice Guidelines
It may be too much to expect busy healthcare professionals to undertake the multiple steps of EBM outlined in Table 2, during each and every encounter with patients. It would be much easier if robust evidence on specific PICOT questions could be channelized into guidance for healthcare professionals to make evidence-informed clinical decisions.
Broadly, clinical practice guidelines (CPGs) are documents that guide (but not necessarily impose) decisions regarding facets of healthcare such as diagnosis, treatment, prevention, etc. These are distinct from the traditional “expert opinion” or “expert consensus” based guidance, in the sense that they are based on thorough examination of current evidence, and the guidance offered is directly linked to that evidence, with remarks on estimates of confidence in the evidence. The main product of guidelines is evidence-based recommendations that may include aspects such as risk/benefit ratio, cost-effectiveness, and implementation considerations. Many guidelines explore alternate options or courses of action, to help healthcare providers and recipients to make shared decisions, based on the evidence.
One of the benefits of developing and implementing evidence-based guidelines is that it can contribute to standardizing healthcare delivery, thereby enhancing quality. It also helps greatly in minimizing the use of healthcare interventions that are not of proven benefit. Naturally, the success of CPGs depends on compliance of healthcare providers to these guidelines. This necessitates mechanisms for audit of healthcare practices, and provisions for instituting measures to ensure compliance. There is also extensive debate about whether guidelines should be interpreted as “rules” that must be mandatorily followed, or merely as “aids” to healthcare providers.
High-quality guideline documents clearly outline the scope and purpose of the guidance, and ensure that all relevant stakeholders are involved in development. Thus, guidelines relevant to pediatric practice should ideally include not only healthcare professionals such as pediatricians, pediatric nurses, etc., but also representatives of patients and other child health advocates. The quality of guidelines naturally rests on the methodological processes used which should 23include systematic search for high-quality evidence, and a clear linkage between the evidence and the recommendations framed. Additional hallmarks of quality include clear declarations of potential conflicts of interest of the guideline development panel members, and editorial independence.
 
EFFORTS TO ENHANCE EVIDENCE-BASED CARE IN PEDIATRICS, IN INDIA
Recognizing the need to support pediatricians in using evidence as a tool in clinical practice, “Indian Pediatrics” initiated the EURECA section some years back. EURECA is an acronym for Evidence that is Understandable, Relevant, Extendible (to the local setting), Current and Appraised critically. The goal was to provide high-quality, up-to-date evidence on various issues in child health in an easy to understand format, thereby facilitating pediatricians in the country and region, to make informed decisions in pediatric practice.
Later, the EURECA section in Indian Pediatrics was replaced with a Journal Club, that appeared every alternate month. Each Journal Club critically assessed a current research publication from the evidence perspective, and also the clinical perspective. The goal was to empower pediatricians to appreciate the nuances of EBM, and how to bridge research evidence to clinical practice. However, the exigencies associated with the coronavirus disease 2019 (COVID-19) pandemic have temporarily halted the Journal club.
Indian Pediatrics has been conducting Research Methodology and Thesis Writing workshops for several years. These workshops expose pediatricians in training, to understand basics of research methodology, and also to design (and conduct) good quality research through their thesis studies. Further, there is emphasis on reporting and presenting the research well.
The Indian Council of Medical Research (ICMR) funded Advanced Center for Evidence-Based Child Health located at Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh has been conducting multiple training workshops for those involved in child health, including pediatricians, pediatric nurses, and public health specialists. Further, the center undertakes systematic reviews on topics relevant to child health in India, and provides inputs for clinicians and policy makers.
In India, the first glimpses of HTA training emerged in 2009 through the SIGNET Program. SIGNET was an acronym for Singapore Indian Group Networking for Empowerment Training. Through this program, funded by the Temasek Foundation (Singapore), Indian healthcare professionals (physicians, nurses, and hospital administrators) in the public as well as private sectors were empowered to become users of evidence (both external as well as local) for managing locally relevant healthcare problems. This was a unique approach going well beyond training in research methodology or EBM, to transform local institutional healthcare systems.
More recently, the Government of India has established a Medical Technology Assessment Board and an HTA Unit in the Department of Health Research. Formal HTA is being conducted on relevant issues. There are also numerous training workshops and courses to develop better understanding of HTA.
 
THE WAY FORWARD FOR EVIDENCE-BASED CARE IN PEDIATRICS
The way forward to develop a system of evidence-based care in pediatrics revolves around empowerment. Empowerment is a broad term that encompasses multiple facets and multiple stakeholders. On the one hand, we need to empower healthcare providers and healthcare consumers to contribute together to generate high-quality evidence. This includes research evidence (through well-designed studies, systematic reviews, and even tertiary research) as well as clinical evidence (through meticulous documentation of observations, peer review, and external validation). This in turn requires developing a pool of people with the requisite knowledge and skills who in turn can become the nucleus for building up (and sustaining) the effort. Such efforts have been made in recent years through the activities of the South Asian Cochrane Network and Center, SIGNET program, the Advanced Center for Evidence-Based Child Health, Indian Academy of Pediatrics, and its official journal, Indian Pediatrics. These efforts have been highly successful in enlarging the pool of producers who generate primary and secondary evidence.
However, currently most of these efforts are provider-driven rather than demand-driven. It is believed that a demand-driven approach can be boosted through introduction of principles of EBM at the undergraduate training level (for all categories of healthcare professionals associated with child health) and most important, postgraduate training in Pediatrics. This approach would create a large pool of users of evidence, who would not only create demand for evidence-informed healthcare practices, but also create a demand among healthcare recipients/consumers for evidence-based practice. The list of evidence users extends far beyond healthcare professionals and encompasses virtually everyone who participates in decisions affecting children. This includes policymakers, organizational leaders, healthcare institutions, lay press, and of course the general public. In fact, each and every person in the country (whether professional or lay person) is a healthcare stakeholder who can be empowered.
Therefore, empowerment efforts in India should focus on both evidence users (who would demand appropriate evidence on locally relevant issues) and evidence producers who could fulfill the demand.
24
1.4 Ethical Issues in Pediatrics
Sanjiv Lewin
Physicians are faced with increased ethical dilemmas especially in the practice of pediatrics with advances in technology and social changes. Recognition of ethical conflicts and consults for appropriate decisions are uncommon in our practice (Lantos JD et al., 2019). It is society that permits us to practice our profession with an understanding that we will be professional and ethical in our practice as we are given the honor of serving society as physicians. Thus, abiding by our code of ethics becomes essential to maintain our place in society. Only the profession can (self) regulate ethical conduct and thus strengthen our professional place in society. This chapter gives us an overview of ethics in the practice of pediatrics with a purpose of education (Savitha D et al., 2018).
 
PRINCIPLES OF ETHICS
 
Definition
Ethics is a generic term that covers many aspects of examining and understanding the moral life. Beauchamp and Childress (Principles of Biomedical Ethics, 2009) identify principles that assist us in making moral ethical judgments in clinical practice. The core principles are beneficence, nonmaleficence, justice, and autonomy.
 
Beneficence
Beneficence is simply “Always Do Good.” Always do good for your patient who remains at the center of all a physician's roles and responsibilities. In pediatrics, it means that the wellness of the child we care for, remains at the center of all our clinical decisions. This principle insists that it is the physician's responsibility to always protect and promote the best interests of the child (our patient). Educating and providing symptomatic medicines for a viral fever in a child; prescribing an appropriate antibiotic for a bacterial pneumonia; advising a magnetic resonance imaging (MRI) scan for an infant with regression of milestones and a suspected degenerative brain disorder; and, advising a bone marrow aspiration for a child with suspected acute leukemia would be examples of beneficence.
 
Nonmaleficence
Nonmaleficence would be easy to understand as “Do No Harm.” The patient (the child under our care) remains at the center of our focus and we should always try never to advise or do anything that would harm. Should there be some harm, one needs to understand and choose an option where the benefit to the child is significantly more than the cost or harm the option will cause. Prescribing only relevant injectable vaccines to a child to prevent epidemiologically proven common or high impact childhood disease; rationalizing and hence avoiding too many chest X-rays during care of respiratory ailments in young children; and, advising a potentially painful bone marrow aspiration using adequate anesthesia when indicated are examples of decisions that attempt to minimize harm to our child. Balancing benefits versus harm (including costs to the family and may be even community) is probably the most common ethical decision we take as physicians in resource constraint settings.
 
Justice
Justice is being fair to the child primarily and controversially extended to include fairness to the guardians in resource constraint settings. One needs to fairly distribute benefits and also probably risks and costs. Choosing sparse resources while caring for twins in a neonatal intensive care setting; deciding admission to children attending a busy emergency facility when beds available are limited; raising funding for expensive rare interventions (Dressler and Kelly, 2018); and, probably one may argue insisting on interventions way beyond family economic capacities are examples where justice is an important principle that needs to be considered.
 
Autonomy
Autonomy is respecting an individual's values and beliefs. This becomes more significant as the child grows up for as long as they are dependent children, immature, and poor of understanding; most decisions are taken by parents and legal guardians. Autonomy insists that the patient (family) perspectives be taken into consideration in redefining the partnership in healthcare that exists between doctor and patient. Legally the age of 18 years is when the individual has legal rights to decide for themselves. However, it is not uncommon to have an adolescent with the maturity and understanding of what they need or not. An adolescent refusing an abortion, a child refusing an injection versus an oral option, and a family refusing treatment for a child because of their own religious beliefs or superstitions may be examples of issues related to autonomy.
 
ETHICAL WORKUP OF A PATIENT
When patients come to physicians, we clinically diagnose after a workup that includes a detailed history and physical examination. We may then order investigations to confirm the same and initiate specific treatment chosen from options available. This process requires a degree of clinical reasoning where data collected is analyzed and a diagnosis is justified based on evidence.
Similarly, when we feel uncomfortable with a scenario or decision, a similar ethical workup to collect facts, analyze, and justify, hence reaching a “diagnosis” and hence choosing the most ethical solution (Percival T, Medical Ethics, 1803). Steps of an ethical workup may be summarized as below:
  • Medical facts: Collecting clinical facts of the patient including options available
  • Ethical obligations: Identifying obligations of the physician to the patient, family, profession, institution, and society
  • Conflicts: Identify conflicting obligations if any
  • Consensus: Reaching a decision that minimizes conflict
 
 
Ethical Obligations
The physician clearly has an obligation not only to the child but also to society clearly in the case of vaccine preventable diseases.
 
Conflicts
Beneficence and nonmaleficence are clearly in favor of the physician's decision to vaccinate the child for the risk:benefit ratio is high. The issue of justice arises as not vaccinating the individual increases the risk of transmission in the population. One may argue that there is a conflict with the principle of autonomy of the guardian and minor. 25The child is immature and does not understand the situation, but one may argue that (social) justice needs to prevail if it is the parents who refuse to vaccinate their child.
 
Consensus
An immature child who cannot understand the situation, needs, and benefits may not be able to claim the need for physicians and parents to respect their autonomy in this case at this age. The benefit is overwhelming and harm is minimal for vaccination. Justice is served as not only does it protect the individual child, but also improves population protection through reduction of transmission of vaccine preventable diseases. It may be argued that insisting on the vaccination irrespective of a crying upset 18-month-old child would be considered ethically correct. Educating the guardians will be necessary to implement this decision. Of course, an adolescent even though <18 years old refusing a vaccination may raise different challenges requiring different decisions to make it ethical.
 
Ethical Obligations
As a pediatrician, the primary concern is the wellbeing of the child. However, the patient being a minor your relationship arguably may also extend to the legal guardians (i.e., parents) though it does not bind the decision. Your professional obligations remain with what is best for your child patient. Your institution may differ being a government or private institution; the former with the mandate to provide public sponsored care and the latter based on the ability to pay for costs incurred. Society clearly dictates that you behave professionally in the interest of every individual even the child.
 
Conflicts
This certainly exists as the parents clearly do not want any intervention for their child and are not only in conflict with the physician, but also at conflict with the child's needs.
 
Consensus
Discussions toward a consensus may need to include not only the parents, but also social workers and counselors where discussion occurs on many fronts. What is in the best interest of the child? Are the parent's choices aligned with that of the child or should we play child's advocate? Does not the physician have a responsibility to parents and society? What will be the outcome should we agree or disagree with the parents? In an ideal world, the consensus would clearly be to keep the child's wellbeing optimum and operate through a court order even if it means placing the child in the state social welfare system. In our settings, this is certainly much more of a challenge given time factors and an overwhelmed judicial and social welfare system.
 
INFORMED CONSENT AND ASSENT
A child needs a bone marrow transplant. Should we obtain consent from the child and/or parents?
A corner stone of biomedical ethics is the concept of informed consent. Consent is most essential for strengthening trust in any doctor–patient relationship. Informed consent is even more vital in research ethics. Common law dictates that “every human being of adult years and sound mind has a right to determine what should be done with his or her body.” Hence, all medical interventions interfering with the human body (including the mind!) require consent.
 
Consent
The Indian Contract Act (1872) defines consent as “when any two persons agree upon the same thing in the same sense they are said to consent.” Consent may be verbal or written.
The Indian Penal Code (1872, 1860) goes on to recognize that for clinical examination, diagnosis, and treatment consent can be given by any person who is conscious, mentally sound, and over the age of 18 years. Consent may be implied or express.
  • Implied consent or “tacit consent” for history taking and simple physical examination when one requests a consult.
  • Express consent may be oral or written usually required for procedures and interventions when offered an intervention.
Consent should always be informed. Information must be comprehensible in the vernacular language and in nonmedical terms though there is place for a therapeutic privilege where duty to disclose is subject to exceptions. Exceptions may be if the patient refuses to be informed, or if information is unlikely to be processed rationally leading to significant psychological harm or frightening patients.
 
Assent
For all children, proxy consent “substitute consent” is the norm with parents or legal guardians giving consent for children under their care. Between the ages of 12 and 18 years, assent is a concept that respects autonomy of a mature minor. Assent is an agreement when legally the person cannot give consent. It indicates that the child is old enough to understand and willing to participate in what is being proposed, either in clinical care and treatment or in research studies. Hence, legally consent is required from parents and legal guardians of children under 18 years, but it is vital to obtain assent (agreement) from the child itself. We may explain the need for a surgical procedure for a child with appendicitis and obtain a written informed consent from the parents. Simultaneously, the physician may sit down next to the child and in developmentally appropriate language explain what the child should expect and obtain a willingness to participate. This second step is an example for assent.
 
DISCLOSURE COUNSELING
A child has been diagnosed with human immunodeficiency virus (HIV) infection. Should we tell the child?
Disclose is to make new information known to another or simply to reveal information. At times, it may be necessary “to reveal” a diagnosis or management plan to a child to strengthen trust and build on a relationship toward enhanced cooperation, hence improving adherence. This is especially important when children begin to grow up and ask questions demanding answers. Children may ask many questions like for those infected with HIV: How long will I need to take this medication? Will I die from this disease? When will I die? How did I get this disease? What did I do wrong to get this disease? Successful disclosure requires physicians to understand the ability of the child to understand and comprehend (intellectual development and maturity of coping skills) as well as clarity in existing family support mechanisms and parental understanding of the situation. There is no ideal age for disclosure, usually appropriate when questions are raised by the child. It remains a process never a one-time conversation with simple to more complex information being provided in bits.
Many parents and guardians of children fear disclosure especially related to serious illnesses (cancer, tuberculosis, leprosy, HIV, etc.) as they worry about the fears, emotional wellbeing, and ability to cope of their children. Stigma and fear of discrimination also are high on the list given the possibility that children may share information with those not concerned with the family.26
Disclosure is an important step forward to improve successful adherence and enhance the partnership. Self-esteem improves while depression in both child and parents diminishes with disclosure. It is often that children learn of their illnesses with inadequate information and wait for their own parents, guardians, and physicians to be honest with them. Disclosure strengthens the doctor–patient relationships. An adolescent child on daily antiretroviral therapy requires disclosure counseling to strengthen partnership and adherence by addressing guilt, anger, and understanding of needs; and a child with retinitis pigmentosa progressively going blind will also need disclosure consoling to enable preparation and coping mechanisms are examples for disclosure.
 
WITHHOLDING AND WITHDRAWING TREATMENT
A child has been on ventilator for over 2 weeks and appears seriously brain damaged. Should we withdraw or withhold treatment?
Physicians are expected to value life and do everything in their power to save life. At times, one wonders if we are prolonging life or prolonged death. Death may be cardiac or brain (whole or higher function) death. Complexities of technology in healthcare delivery now days are intense and only increasing. Traditionally, interventions are considered ordinary or extraordinary suggesting that they were either common and simple; or, uncommon and complex interventions. These terms are not easy to use to classify interventions. Hence, preferred terms used are appropriate, or inappropriate interventions. An example is a when a severely asphyxiated newborn is on a ventilator and dialysis for multiple organ dysfunction with a poor prognosis. If the parents decide to withdraw care, it may mean discontinuing ventilation, dialysis or even the nasogastric feeds.
At present, there are no laws that govern withdrawing or withholding interventions though it is not uncommon for concerned physicians to sit down and discuss prognosis and costs to families while looking at various options including withdrawing or withholding. Recognizing the possible futility of medical interventions is an ethical issue that requires us to accept that dying is not necessary losing, but a part of the cycle of life and we are not God(s).
 
ACCEPTANCE OF GIFTS
Should we accept gifts from pharmaceutical representatives?
Physicians have a fiduciary responsibility to all our patients. The pharmaceutical industry is a business with a purpose to earn profits for their shareholders. The industry has enormous budgets allocated to maintaining an army of representatives to visit, “educate,” and “update” physicians as well as to fund gifts for physicians. It is psychologically proven that persistent visits by pharmaceutical representatives on many occasions through the week for prolonged times are effective to change prescription behavior. The visit usually includes exchanging pleasantries, praising the physician, speaking of the products, and ends with a gift (samples, pens, pads, books, invitations, etc.). Of course, those who are heavy prescribers of their products get additional awards of various degrees from invitations to talk at conferences and at continuing medical educations (CMEs) at expensive hotels or resorts, with all necessary frills. An added opportunity to partake of a meal is a strong incentive for behavior change. So, what is wrong if anything? We may argue and say that we have updated knowledge following attending such educative talks. It is often that samples are handed out to try out on our patients to see if they are effective or not. The visits are also argued as reciprocal courtesy we show each other being a part of the healthcare industry. The most common denial all of us good doctors give is that there is absolutely no way our prescription behavior patterns will change simply by a representative's visit or accepting pen and pad! Unfortunately, we are very wrong.
There is much literature that has repeatedly studied and demonstrated the effect of gift giving on physician's prescription habits that change with time. Factors enhancing this effect include the number of visits made, the acceptance of gifts by the physicians, and food is especially a good factor! As professionals, a status earned and permitted by society, we are certainly duty bound to keep ourselves up-to-date and competent as well as follow an ethical code of conduct that is self-regulated by our peers. Our focus of clinical care and treatment is always on our patient's best interest. If there is any conflict of interest in our decision-making process where we choose one over another for reasons not keeping our patients’ best interest in mind, then we are failing in our duty as professionals. Accepting gifts from pharmaceutical industry changes prescription behavior as we reciprocate the act of giving. Educational programs sponsored by industry also pressurize organizers not only to call industry friendly speakers, even sometimes provides slides and material to talk on and dictate topics to be covered. As responsible physicians, it is our responsibility and duty to not accept gifts and be aware of conflicts of interest when reading, listening, or viewing education programs and material.
 
GENETICS AND ETHICS
Can we choose our dream baby?
The advances in genetics appear to be a double-edged sword from an ethical viewpoint. The ethical question is if we are beginning to play God? Is not tampering with genetic material and the process of fertilization and birth not directly interfering with the creation of life with all its uncertainties? On the other hand, why not use science to improve our lives and the lives of others to come, and, solve our own problems? Do we not have so many terrible genetic disorders that bring misery to individuals and their families that may be turned around by genetics? Are we on a slippery slope where if we allow one activity as being ethical then how can we not allow others who ask? Is it a perfect race that we strive for in the future? Is there going to be less perfect creatures (like us) allowed into this world or less females due to sex selection as is not uncommon in our part of the world? Related to genetics and reproductive manipulation, additional ethical issues that are raised include questions as to when does life begin and would discarding early fertilized cells amount to “killing”?
In every walk of pediatric practice, one will face ethical challenges especially where technology is available and when interpersonal relationships exist. Recognizing and responding to ethical challenges is the first step as a pediatrician.
27
1.5 Sustainable Development Goals for Child Health
Raju C Shah, Pratima Shah
In 2015 reviewing the results of the Millennium Developmental Goals, it was realized that some of the countries of the world need to work on certain goals to achieve poverty reduction. In September 2015, world's Heads of State and Government agreed to set the world on a path toward sustainable development through the adoption of the “2030 Agenda for Sustainable Development.” This agenda includes 17 Sustainable Development Goals, or SDGs, which set out quantitative objectives across the social, economic, and environmental dimensions of sustainable development—all to be achieved by 2030. The goals provide a framework for shared action “for people, planet, and prosperity,” to be implemented by “all countries and all stakeholders, acting in collaborative partnership.”
India along with many countries of the world realizing the opportunity to improve wellbeing of people of our country as well as planet at large embraced the program. As is evident SDGs encompass all the sectors which are important which includes Health, Education, Infrastructure, Employment, Energy, and Environment. India set time-bound targets to achieve all these goal in the time frame.
As articulated in the 2030 agenda, “never before have world leaders pledged common action and endeavor across such a broad and universal policy agenda.” Almost 169 targets accompany the 17 goals and set out quantitative and qualitative objectives for the next 15 years (Fig. 1). These targets are “global in nature and universally applicable, taking into account different national realities, capacities, and levels of development and respecting national policies and priorities.”
The 17 goals are as follows:
  1. Goal 1: End poverty in all its forms every where
  2. Goal 2: End hunger, achieve food security and improved nutrition, and promote sustainable agriculture
  3. Goal 3: Ensure healthy lives and promote wellbeing for all at all ages
  4. Goal 4: Ensure inclusive and equitable quality education and promote lifelong learning opportunities for all
  5. Goal 5: Achieve gender equality and empower all women and girls
  6. Goal 6: Ensure availability and sustainable management of water and sanitation for all
  7. Goal 7: Ensure access to affordable, reliable, sustainable, and modern energy for all
  8. Goal 8: Promote sustained, inclusive, and sustainable economic growth, full and productive employment and decent work for all
  9. Goal 9: Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation
  10. Goal 10: Reduce inequality within and among countries
  11. Goal 11: Make cities and human settlements inclusive, safe, resilient, and sustainable
  12. Goal 12: Ensure sustainable consumption and production patterns
  13. Goal 13: Take urgent action to combat climate change and its impacts
  14. Goal 14: Conserve and sustainably use the oceans, seas, and marine resources for sustainable development
  15. Goal 15: Protect, restore, and promote sustainable use of terrestrial ecosystems, sustainably manage forests, combat desertification, halt and reverse land degradation, and halt biodiversity loss
  16. Goal 16: Promote peaceful and inclusive societies for sustainable development, provide access to justice for all, and build effective, accountable, and inclusive institutions at all levels
  17. Goal 17: Strengthen the means of implementation and revitalize the global partnership for sustainable development
zoom view
Fig. 1: Sustainable Development Goals (SDGs).
In India, National Institution for Transforming India (NITI) Aayog has been given the role to coordinate “Transforming Our World: the 2030 Agenda for Sustainable Development.” To achieve these tasks, the draft mapping of the goals and targets as an initial step on proposed nodal and other ministries has been carried out in consultation with the Ministry of Statistics and Program Implementation (MoSPI). NITI Aayog being a nodal functionary realized the need of purposeful partnership of stakeholders to pursue certain specific objectives to realize SDGs.28
To track the progress and the tempo with which we are achieving need to be continuously measured with evidence backed manner and if needed modulated so as to achieve SDGs. A most elaborate SDG monitoring system known as a National Indicator Framework which includes about 300 indicators and has a coordinated system of generating and managing data developed in our country has helped us in the success of the program. Due to this The SDG India index and Dashboard published every year has become very important tool for key monitoring and reporting.
The years 2020-21 were full of challenges due to unprecedented and dreadful pandemic due to coronavirus disease 2019 (COVID-19). However, systematic management plan focusing on specific groups and specific system-wide measures helped the world in successfully meeting the challenge.
In the year 2010, Human Poverty Index was replaced by The Global Multidimensional Poverty Index (GLOBAL MPI), which was developed by Oxford Poverty and Human Development Initiative which uses information from 10 indicators. India has ranked 62nd in this global MPI for the year 2020 out of 107 countries under assessment.
TABLE 1   Targets of sustainable development goal 3 for health.
Goal No.
Targets
Other concerned Ministries/departments
3
Goal
Ensure healthy lives and promote well-being for all at all ages
Nodal Ministry
Health and Family Welfare (H&FW or HFW)
3.1. By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births
H&FW, Ayush, WCD, Tribal Affairs
3.2. By 2030, end preventable deaths of newborns and children under 5 years of age
H&FW, Ayush, WCD
3.3. By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
H&FW, Ayush, Tribal Affairs
Drinking Water and Sanitation
Food Processing Industries
3.4. By 2030, reduce by one-third premature mortality from noncommunicable diseases through prevention and treatment and promote mental health and wellbeing
H&FW, Ayush, WCD, Tribal Affairs
Centrally Sponsored Schemes (CSS)
3.5. Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol
Home Affairs, H&FW, Ayush
National Health Mission including NRHM
3.6. By 2020, halve the number of global deaths and injuries from road traffic accidents
Road Transport and Highway, H&FW, Ayush
3.7. By 2030, ensure universal access to sexual and reproductive healthcare services, including for family planning, information and education, and the integration of reproductive health into national strategies and programs
H&FW, Ayush
Human Resource in Health and Medical Education
3.8. Achieve universal health coverage, including financial risk protection, access to quality essential healthcare services and access to safe, effective, quality, and affordable essential medicines and vaccines for all
H&FW, Ayush, Tribal Affairs
National Mission on AYUSH including Mission on Medical Plants
National AIDS and STD Control Program
Integrated Child Development Service (ICDS)
3.9. By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water, and soil pollution and contamination
MoEF and CC, H&FW, Ayush
3a. Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate
H&FW, Ayush
3b. Support the research and development of vaccines and medicines for the communicable and noncommunicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use the full provisions in the Agreement on Trade-related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
H&FW, Ayush, Commerce
Related interventions
Pradhan Mantri Swasthya Suraksha Yojana (2006)
3c. Substantially increase health financing and the recruitment, development, training, and retention of the health workforce in developing countries, especially in least developed countries and small island developing states
H&FW, Ayush
3d. Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction, and management of national and global health risks
H&FW, Ayush
(AIDS: acquired immunodeficiency syndrome; CC: climate change; MoEF: Ministry of Environment and Forests; NRHM: National Rural Health Mission; STD: sexually transmitted disease; WCD: Women and Child Development)
 
SUSTAINABLE DEVELOPMENT GOAL FOR HEALTH
 
Ensure Healthy Lives and Promote Wellbeing for All at All Ages
The SDG health goal has nine targets and four subpoints (Table 1). The first three targets are continuation of MDGs, the next three are on noncommunicable diseases (NCDs), and the last three are mixed. Nine health targets and four subpoints are as described here.
 
Addressing Issues of Child Mortality
The Government of India adopted the National Policy for Children on April 26, 2013. Guidelines outlined in the policy must be honored by the Government at the national, state, and local levels. The policy mentions the undeniable rights of every child such as survival, health, nutrition, education, development, protection, and participation.
The policy states that the state shall take necessary measures to:
  • Improve maternal healthcare, including antenatal care, safe delivery by skilled health personnel, postnatal care, and nutritional support.29
  • Address key causes and determinants of child morality through interventions based on continuum of care, with emphasis on nutrition, safe drinking water, sanitation, and health education.
  • Provide universal and affordable access to services for prevention, treatment, care, and management of neonatal and childhood illnesses and protect children from all waterborne, vector borne, communicable, and other childhood diseases.
The health of the mother has an important impact on the health of the child. Thus measures for improvement of mother's health are important for improving the survival of the newborn. Higher resources are allocated under National Rural Health Mission (NRHM) to states and districts with weak health indicators. The major programs addressing the needs of mother and children (at child care and child survival) are discussed below, in brief.
 
Institutional Delivery through Janani Suraksha Yojana and Janani Shishu Suraksha Karyakram
To ensure skilled birth attendance by promoting institutional delivery will help to reduce both maternal and neonatal morality. Janani Suraksha Yojana provides cash assistance and encourages pregnant women to opt for institutional delivery. In Janani Shishu Suraksha Karyakram, the pregnant woman gets complete zero expense delivery including cesarean section operation, as well as transport, food, drugs, and diagnostics.
 
Facility-based Newborn Care
Special newborn care units (SNCUs) are setup at district hospitals and medical colleges. These care for the sick newborn and are equipped with radiant warmer, phototherapy unit, oxygen hoods, infusion pumps, laryngoscope and endotracheal tubes, bag and mask, nasal cannulas, and weighing scale. SNCU is a 12–20-bedded unit and requires four trained doctors and 10–12 nurses for round the clock services. Almost 400 SNCUs are now functional in the country.
Newborn stabilization units are setup at community health center/first referral units. These units provide services like resuscitation, provision of warmth, early initiation of breastfeeding, prevention of infection and cord care, and supporting care including oxygen, intravenous (IV) fluids, and provision for monitoring of vital signs including blood pressure and referral services. These are four-bedded units with trained doctors and nurses for stabilization of sick newborns.
Newborn baby care corners are setup in all facilities where deliveries are taking place. This is one-bedded facility attached to the labor room and operation theater for provision of essential newborn care. The services include resuscitation, provision of warmth, and prevention of infection and cord care, and early initiation of breastfeeding. The equipment at newborn care corners include weighing scale, radiant warmer, suction machine, and mucus sucker.
 
Home-based Newborn Care
Home-based newborn care through Accredited Social Health Activist (ASHA) workers has been initiated to improve newborn care practices at the community level and for early detection and referral of sick newborn babies. All newborns will be visited by ASHA workers as per the specified schedule, up to 42 days of life. They have to ensure recording of weight of the newborn; BCG (Bacillus Calmette–Guérin) vaccination, first dose of oral polio vaccine and diphtheria, pertussis, and tetanus vaccination; both the mother and the newborn are safe till 42 days of the delivery; and that registration of birth has been done.
 
Capacity Building of Healthcare Providers
Trainings are conducted under NRHM to train doctors, nurses, and auxiliary nurse midwife (ANM) for early diagnosis and case management of common ailments of children, as per the Integrated Management of Neonatal and Child Illness (IMNCI) strategy and “Navjaat Shishu Suraksha Karyakram.”
Integrated Management of Neonatal and Child Illness includes interventions to prevent and manage the most common major childhood illnesses, which cause death, i.e., neonatal illnesses, acute respiratory infections, diarrhea, measles, malaria, and malnutrition. The objective is to implement IMNCI package at the household level and subcenter, primary health center level, to provide a comprehensive newborn and child health services to address major neonatal and childhood illnesses. More than 500 districts and 500,000 healthcare providers have been trained in IMNCI.
Navjaat Shishu Suraksha Karyakram program is launched to address basic newborn care and resuscitation, and issues at birth, i.e., prevention of hypothermia, prevention of infection, and early initiation of breastfeeding. The objective of this program is to have one person trained in basic newborn care and resuscitation available at every delivery.
 
Management of Malnutrition and Other Morbidities
Malnutrition reduces immunity of children to infections thus increasing mortality and morbidity among children. Exclusive breastfeeding is promoted for first 6 months of life as it reduces neonatal mortality. Appropriate infant and young child feeding practices are also promoted. For prevention of anemia, iron and folic acid are provided to the children. Almost 600 nutritional rehabilitation centers have been established for management of severe acute malnutrition, across the country. Reduction in morbidity and mortality due to acute respiratory infections and diarrheal diseases is encouraged by early identification of cases and managing them properly. Promotion of zinc and oral rehydration salts supplies is ensured. Micronutrient malnutrition is addressed by supplementation with micronutrients through supplies of vitamin A, iron, and folic acid tablets.
 
Universal Immunization Program
Immunization program of India is one of the largest immunization programs in the world. Under this program, Government of India is providing vaccination to prevent seven vaccine-preventable diseases, i.e., diphtheria, pertussis, tetanus, polio, measles, BCG, and hepatitis B. Haemophilus influenzae B vaccine as part of a liquid pentavalent vaccine is also introduced in all the states. “Mission Indradhanush” was introduced to strengthen routine immunization which includes some newer initiatives, e.g., provision of autodisable syringe to ensure injection safety and vaccine reminder.
 
Mother and Child Tracking System
A web-based mother and child tracking system has been introduced to enable tracking of all pregnant women and newborns, so as to monitor and ensure that complete services are provided to them. States are encouraged to send beneficiary wise SMS alerts to ANMs on weekly basis and also reminders to beneficiaries reminding them of the dates on which services are due.
 
Integrated Child Development Services Scheme
Integrated Child Development Services is a centrally sponsored scheme aimed at holistic development of children below 6 years of age and pregnant women and lactating mothers by providing a package of six services comprising of (1) supplementary nutrition; (2) preschool nonformal education; (3) nutrition and health education; (4) immunization; (5) health check-up; and (6) referral services through Anganwadi center at grassroots level.
 
India Newborn Action Plan
The India Newborn Action Plan (INAP) is India's committed response to the Global Every Newborn Action Plan (ENAP), launched in June 2014 at the 67th World Health Assembly, to advance the Global Strategy for Women's and Children's Health.30
zoom view
Fig. 2: Goal-wise performance for India. (SDG: sustainable development goal)Source: SDG India Index and Dashboard 2020-21. NITI Aayog.
zoom view
Fig. 3: State-wise performance on achieving SDG. In 2020, 12 States/UT joined the category of frontrunners. (SDG: sustainable development goal; UTs: union territories)Source: SDG India Index and Dashboard 2020-21. NITI Aayog.
The ENAP sets forth a vision of a world that has eliminated preventable newborn deaths and stillbirths. It includes six pillars of intervention packages across various stages with specific actions to impact stillbirths and newborn health. The six pillars are: (1) preconception and antenatal care; (2) care during labor and childbirth; (3) immediate newborn care; (4) care of healthy newborn; (5) care of small and sick newborn; and (6) care beyond newborn survival.31
SDG India index 2020-21 report has incorporated 16 out of 17 goals and covers 70 SDG targets. It has provided goal wise results and compared with results of 2019-20 (Fig. 2). State-wise comparison is also provided (Fig. 3).
 
SDG India Index—Goal 3: Good Health and Wellbeing
To measure this goal and to capture 8 out of 13 SDG targets, 10 indicators are identified and monitored. Scores for this goal range for different states between 59 and 86 while for union territories (UTs) between 68 and 90. Gujarat and Delhi turned out to be best performers amongst states (Fig. 4).
Under Goal 3 related to health, there is a consistent considerable progress. One of the important targets was to reduce under 5 mortality to 25 per 1,000 live births; and as per SRS 2016-18, we have reached to 36 per 1,000 live births. Five states namely Kerala, Tamil Nadu, Maharashtra, Punjab, and Himachal Pradesh have achieved this target, 91% of children in age group of 9–11 months were fully immunized. As per same information system 94.4% of total deliveries were institutional deliveries during April to December 2019. The Maternal Mortality rate also reduced to 113 per 100,000 live births as against global target of 70 per 100,000 live births by 2030.
zoom view
Fig. 4: SDG 3 index score of states/UTs. (SDG: sustainable development goal; UTs: union territories)Source: SDG India Index and Dashboard 2020-21. © NITI Aayog.
32